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Neuroblastic tumor patients present an heterogeneous clinical 
evolution, from spontaneous regression to a high propensity for 
widespread metastatic dissemination. Although the application of a 
well-defined pre-treatment risk classification plays a central role in the 
improvement of survival during the last years, more efforts must be 
done to improve patient’s survival in general and specifically in the 
subgroup of high risk patients. The morphological study of the tumoral 
tissue is contributing to such improvement. The histological category or 
the percentage of tumoral stroma, as well as the degree of 
differentiation of neuroblastic cells, evaluated by the pathologist with 
light microscopy, are factors that play a role in the diagnosis and 
prognosis of the patients.  Given the role of tumoral extracellular 
matrix in biotensegrity and mechanotransduction, its architecture and 
the topology of its elements, as well as their interaction are being 
increasingly considered. Its quantification and characterization with 
microscopic image techniques start to be used. 
We hypothesize that the destiny of a neuroblastic tumor cell is 
complex and, is in part directed by characteristics of a set of non-
cellular extracellular matrix structural elements. Additionally, we think 
that the application of the patterns derived from the morphometric 
analysis of such elements and their association with the impact of the 
known prognostic factors, patient’s survival will be improved. We aim 
to develop morphometric techniques to characterize different 
extracellular matrix scaffolding and vascular elements to find out 
potential uses as new prognostic markers for a better pre-treatment 
 stratification of the patients or as therapeutic targets to be able to 
remodel the aberrant elements of the tissue scaffolding, including 
microvascularization.  
We constructed 19 tissue microarrays including more than 500 
neuroblastomas which were stained with alcian blue pH 2.5, Gomori, 
Masson’s trichrome, orcein and anti-CD31 for glycosaminoglycans, 
reticulin fibers, collagen type I fibers, elastic fibers and blood vessels, 
respectively. The slides were digitized with a whole-slide scanner and 
different image-analysis algorithms were designed or customized to 
specifically detect and characterize the amount, the size and the shape 
of the different extracellular matrix elements studied. These 
parameters were related to different neuroblastoma subgroups, taking 
into account several clinical, histopathological and genetic features. 
The results obtained showed that reticulin fibers were the main 
components of the fibrous scaffolding and that microvasculature 
amount and architecture were relevant in the prognosis of 
neuroblastoma patients. A stiff and poorly porous extracellular matrix 
with irregularly-shaped vascular lumens was mainly detected in tumors 
belonging to patients with unfavorable prognosis. A subgroup of the 
high risk cohort with very poor survival could be defined by 
morphometric variables of reticulin fibers and blood vessels. 
Specificallly, those samples with high stained areas occupied by 
reticulin fibers forming large, crosslinking, branching and disorganized 
networks and by blood vessels, as well as with irregularly-shaped 
capillaries and sinusoid-like vessels and dilated venules, presented a 
very unfavorable survival. In this cohort, cells with MYCN gene 
  
 
amplification led to detectable topological changes regarding reticulin 
fibers and bood vessels. 
We can conclude that it is possible and convenient to quantify 
the fundamental substance and characterize the architecture of the 
fibrous scaffolding and the vascular system of neuroblastic tumors by 
means of the morphometric analysis of microscopic images. Some of 
the morphometric features related to the different extracellular matrix 
elements studied could be used as a diagnostic support for the ultra-
high risk group of patients, after studying a larger cohort. The obtained 
results suggest the need of developing multidisciplinary efforts for an 
international integration of these studies, and that the morphometric 
information of the elements of the extracellular matrix, including the 
vascular system, could be used for a therapy based on 
mechanotransduction. 
 
 
      
  
Los pacientes con tumores neuroblásticos presentan una 
evolución clínica heterogénea, desde la regresión espontánea hasta 
una alta propensión para la diseminación metastática generalizada. 
Aunque la aplicación de una clasificación de riesgo pre-tratamiento 
bien definida tiene un papel central en la mejora de la supervivencia 
durante los últimos años, han de llevarse a cabo más avances para 
mejorar la superviencia de los pacientes en general y específicamente 
el subgrupo de pacientes de alto riesgo. El estudio morfológico del 
tejido tumoral está contribuyendo a dicha mejora. La categoría 
histológica o el porcentaje de estroma tumoral, así como el grado de 
diferenciación de las células neuroblásticas, determinadas por el 
patólogo con el microscopio óptico, son factores con un papel 
importante en el diagnóstico y el pronóstico de los pacientes. 
Actualmente, dada la relevancia de la matriz extracelular tumoral en la 
biotensegridad y la mecanotransducción, su arquitectura y la topología 
de sus elementos, así como su interacción están siendo cada vez más 
considerados. Su cuantificación y caracterización con técnicas de 
imagen microscópicas empiezan a ser utilizadas. 
Nuestra hipótesis es que el destino de una célula tumoral 
neuroblástica es complejo y entre otros factores, está determinado por 
las características de un grupo de elementos estructurales  no celulares 
de la matriz extracelular. Además pensamos que aplicando los patrones 
derivados del análisis morfométrico de estos elementos y asociandolos 
al impacto de los factores pronósticos conocidos, se mejorará la 
supervivencia de los pacientes. Nuestro objetivo es el desarrollo de 
  
 
técnicas morfométricas para caracterizar distintos elementos del 
andamiaje de la matriz extracelular y de la vascularización con el fin de 
encontrar usos potenciales como nuevos marcadores con valor 
pronóstico para mejorar la estratificación de los pacientes, o como 
dianas terapéuticas para ser capaces de remodelar los elementos 
aberrantes del andamiaje tisular, incluyendo la microvascularización. 
Hemos construido 19 micromatrices de tejido incluyendo más 
de 500 neuroblastomas, que fueron teñidos con alzul alcián a pH 2,5, 
Gomori, tricrómico de Masson, orceína y anti-CD31 para 
glicosaminoglicanos, fibras de reticulina, fibras de colágeno tipo I, 
fibras elásticas y vasos sanguíneos, respectivamente. Las laminillas 
fueron digitalizadas con un escáner de preparaciones y distintos 
algoritmos de análisis de imagen fueron diseñados o personalizados 
para detectar y caracterizar la cantidad, el tamaño y la forma de los 
distintos elementos estudiados de la matriz extracelular. Estos 
parámetros se relacionaron con los distintos subgrupos de 
neuroblastoma, teniendo en cuenta varias características clínicas, 
histopatológicas y genéticas. 
Los resultados obtenidos mostraron que las fibras de reticulina 
eran los componentes mayoritarios del andamiaje fibroso y que la 
abundancia y arquitectura de la microvascularización era relevante 
para el pronóstico de los niños con neuroblastoma. Una matriz 
extracelular rígida y poco porosa con vasos sanguíneos con luces 
irregulares se detectó principalmente en tumores pertenecientes a 
pacientes con pronóstico desfavorable. Un subgrupo de la cohorte de 
alto riesgo con muy mala supervivencia pudo ser definido por variables 
morfométricas de las fibras de reticulina y de los vasos sanguíneos. 
 Concretamente, las muestras con un mayores áreas ocupadas tanto 
por fibras de reticulina formando grandes redes entrecruzadas, 
ramificadas y de organización compleja, como por vasos sanguíneos, 
junto con capilares y vasos tipo sinusoide de forma irregular y vénulas y 
arteriolas dilatas, estaban asociadas a un pronóstico muy desfavorable. 
En esta cohorte, las células con amplificación del gen MYCN 
conllevaron cambios topológicos detectables en relación a las fibras de 
reticulina y los vasos sanguíneos.  
Podemos concluir que es possible y conveniente cuantificar la 
sustancia fundamental, caracterizar el andamiaje fibroso y el sistema 
vascular de los tumors neuroblásticos gracias al análisis morfométrico 
de imágenes microscópicas. Algunas de las características 
morfométricas relaciondas con los distintos elementos de la matriz 
extracelular estudiados podrían ser usadas como ayuda diagnóstica del 
grupo de pacientes con riesgo ultra alto, tras estudiar una mayor 
cohorte. Los resultados obtenidos sugieren la necesidad de realizar 
trabajos multidisciplinarios para integrar de estos estudios a nivel 
internacional y que la  información morfométrica de los elementos de 
la  matriz extracelular, incluyendo el sistema vascular, pueda ser 
utilizada para una terapia basada en la mecanotransducción. 
 
 
 
 
 
 
      
  
 
  
%: Percentage 
CS: Chondroitin sulfate 
D: Deletion 
d: differentiating 
DS: Dermatan sulfate 
ECM: Extracellular matrix 
EFS: Event-free survival 
FISH: Fluorescent in situ hybridization 
G: Gain 
GAGs: Glycosaminoglycans 
GN: Ganglioneuroma 
HA: Hyaluronan (hyaluronic acid) 
HC: Histochemistry 
HE: Hematoxylin –eosin 
Hep: Heparin 
Het: Heterogeneous 
Hom: Homogeneous 
HR: Hazar ratio 
HS: Heparan sulfate 
HSV: Hue, Saturation, Value 
iGNB: Intermixed ganglioneuroblastoma 
IHC: Immunohistochemistry 
INPC: International Neuroblastoma Pathology Classification 
INRG: International Neuroblastoma Risk Group 
INRGSS: International Neuroblastoma Risk Group Staging System 
 IOD: Integrated optic density 
KS: Keratan sulfate 
LINES: Low and Intermediate Risk Neuroblastoma European Study 
microRNA: miRNA 
MLPA: Multiplex-ligand probe amplification 
MNA: MYCN amplification 
MNNA: MYCN non-amplified 
n (GNB): nodular (ganglioneuroblastoma) 
n: number 
NB: Neuroblastoma 
NCA: Numerical chromosome aberration 
ncRNAs: non-coding RNA  
ND: Non-deleted 
NG: Non-gained 
OS: Overall survival 
pd: poorly differentiated 
R, G, B: Red, Green, Blue 
ROC: Receiver Operating Characteristic 
SCA: Segmental chromosome aberration 
SEHOP: Spanish Society of Pediatric Hematology and Oncology 
SIOPEN: Society of Paediatric Oncology European Neuroblastoma 
Network 
SNP: Single nucleotide polymorphism 
tEFS: Time of event-free survival 
TMA: Tissue microarray 
tOS: Time of overall survival 
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1. General background of neuroblastoma 
Neuroblastoma (NB) is an extremely heterogeneous pediatric 
tumor accounting for 15% of the childhood deaths from cancer, 
although its survival has dramatically improved in the last years. NB can 
undergo spontaneous regression or maturation without cytotoxic 
therapy or, on the contrary, can have a high propensity for locally 
invasive growth and widespread metastatic dissemination despite 
aggressive treatment (1). It is the most common solid extra-cranial 
tumor in children and includes a very heterogeneous group of entities 
characterized by well-defined and delimited genetic, histopathological 
and clinical features (2). 
Neuroblastoma is a disease of the sympathoadrenal lineage of 
the neural crest, and therefore tumors can develop anywhere in the 
sympathetic nervous system. Most primary tumors (65%) occur within 
the abdomen, with at least half of these arising in the adrenal medulla. 
Other common sites of disease include the neck, chest, and pelvis (3). 
The symptoms are usually diffuse and depend largely on the location of 
the primary tumor, as well as on the presence and location of 
metastatic disease. Patients with a local disease may suffer severe 
abdominal pain or may be free of local symptoms, in which case the 
tumor is incidentally discovered. Two major paraneoplastic syndromes 
(secretion of vasoactive intestinal peptide and opsoclonus-myoclonus) 
are more commonly seen in patients with localized tumors, suggesting 
that the syndrome itself might modify the malignant potential of the 
tumor (3). In contrast, patients with metastatic neuroblastoma typically 
present unspecific symptoms such as fever, pallor and anorexia. 
Metastatic site specific symptoms, such as bone pain, limping and 
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sometimes marrow failure, related to bone or bone marrow 
metastases are also common. 
The median age at diagnosis for neuroblastoma patients is 
around 18 months. Approximately 40% of the patients are diagnosed 
by 1 year of age, 75% by 4 years of age and 98% by 10 years of age (4). 
In Spain, a mean of 71 children between 0 and 14 years of age have 
been diagnosed with neuroblastoma every year, during the years 1990 
to 2009, accounting for 10% of the childhood malignancies, after 
leukemias (27%), tumors of the central nervous system (20%) and 
lymphomas (13%) (5). In the cohort of Spanish patients between 0-14 
years, from 1983 to 2002, neuroblastoma has a rate of 11 cases per 
million (6). 
The diagnosis of neuroblastoma is based on the presence of 
characteristic histopathological features of the tumor tissue or the 
presence of tumor cells in a bone marrow aspirate or biopsy, 
accompanied by raised concentrations of urinary catecholamines. High 
risk patients often have raised concentrations of serum lactate 
dehydrogenase, ferritin, or chromogranin, but these are relatively non-
specific for the population as a whole and do not seem to be 
independently prognostic of outcome in the light of modern biological 
covariates. Enhanced sensitivity and specificity for detecting bone 
metastases as well as occult soft tissue disease is provided by 
metaiodobenzylguanidine scintigraphy (3). 
Following the new staging system published by the 
International Neuroblastoma Risk Group (INRG) classification in 2009 
(2), neuroblastoma patients are clinically classified in different groups 
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depending on their risk of relapse or event-free survival (EFS), based on 
clinical features, complex combinations of genetic aberrations, 
histopathology and DNA index (figure 1). 
Figure 1: INRG consensus pre-treatment classification schema. L: Localized 
tumor, M: metastatic, Ms: special metastatic, GN: ganglioneuroma, GNB: 
ganglioneuroblastoma, NA: Not amplified, Amp: Amplified. Very low risk: 5-
year EFS >85%; Low risk: 5-year EFS >75% to ≤85%; Intermediate risk: 5-year 
EFS ≥50 to ≤75%; High risk: 5-year EFS <50%. EFS: Event-free survival. 
Reproduced from “The international Neuroblastoma Risk Group (INRG) 
classification system: an INRG Task Force report”, Cohn et al, J Clin Oncol 
2009, 27(2):289-97(2). 
Therapeutic approaches depend on the pre-treatment risk 
group and include surgery, chemotherapy, radiotherapy, and 
biotherapy, as well as observation alone in carefully selected 
circumstances (3). Currently, two European clinical trials attempt to 
enhance the treatment on patients with localized disease (Low and 
Intermediate Risk Neuroblastoma European Study, LINES 2009), as well 
as in patients with metastatic disease (High risk Neuroblastoma Study 
1, 2012). 
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2. International neuroblastoma pre-treatment risk 
stratification 
2.1. Clinical data  
2.1.1. Stage 
The new staging system includes two stages of localized 
disease, L1 and L2, which are dependent on up to 20 image-defined risk 
factors; and two stages of disseminated disease, M and Ms (2). These 
stages correlate to the former International Neuroblastoma Staging 
System (INSS) in such a way that previous stage 1 becomes now L1, 
stages 2 and 3 become L2, stage 4 becomes M and stage 4S becomes 
Ms (7, 8).  L1 corresponds to localized tumors not involving vital 
structures, L2 are locoregional tumors with presence of one of more 
image-defined risk factors, M correspond to distant metastatic disease 
(except stage Ms) and Ms is defined as metastatic disease in children 
younger than 18 months with metastases confined to skin, liver and/or 
bone marrow (7).  
2.1.2. Age 
Age is a strong prognostic factor, independent of the validated 
staging system in use, given that outcome gradually worsens with 
increasing age. Previous findings indicate that the age cut-off should be 
set somewhere between 15 and 19 months and it has been established 
that 18 months of age is the optimal cut-off point (9), except for 
patients with diploid, stage M, MYCN non-amplified tumors, where the 
cut-off has been established at 12 months of age (10).  
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2.2. Histological data 
Based upon previous classifications, the pathologists currently 
use the International Neuroblastoma Pathology Classification (INPC), a 
modification of the original Shimada’s System (11-13). The INPC 
classifies four histological types: Neuroblastoma (NB) 
(Schwannian stroma-poor), intermixed Ganglioneuroblastoma (iGNB) 
(Schwannian stroma-rich), nodular Ganglioneuroblastoma (nGNB) 
(composite Schwannian stroma-rich/stroma-dominant and stroma-
poor) and Ganglioneuroma (GN) (Schwannian stroma-dominant). There 
are three grades of neuroblastic differentiation: undifferentiated (u), 
poorly differentiated (pd) and differentiating (d). In localized stages, 
the INRG classification defines three prognosis-related categories: GN 
and iGNB with excellent prognosis regardless of the age, nGNB and 
dNB, and pd/uGNB and pd/uNB defining low/intermediate and 
intermediate/high pre-treatment risk groups, respectively, depending 
on the patient’s age and the status of MYCN and 11q (13).  
2.3. Genetic data 
2.3.1. MYCN 
MYCN amplification (MNA) (2p24) occurs in 20-25% of primary 
cases of NB and is strongly associated with unfavorable advanced stage 
disease, aggressive behavior and high risk of relapses (4). It was the 
first genetic marker included in risk stratification systems and patients 
with a MNA tumor are considered as high risk patients in all existing 
risk stratification systems. The use of fluorescent in situ hybridization 
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(FISH) is mandatory for the proper detection of MYCN status in 
European studies. 
2.3.2. 11q 
Rearrangements in chromosome 11q occur in approximately 
20-30% of primary NB and are associated with poor outcome (13). 11q 
deletion (11qD) is also inversely related to MNA, indicating that these 
abnormalities represent distinct genetic subtypes of advanced stage NB 
(14-16). It has been related with decreased progression-free survival 
(16), although some exceptions have been described (17). 
2.3.3. Ploidy 
In children younger than 12-18 months of age with 
disseminated disease and normal MYCN copy number, DNA index has 
been found to have prognostic value (18-21). Tumors with a near 
diploid/tetraploid DNA content present a defect in genomic stability 
resulting in unbalanced chromosomal rearrangements which 
contribute to their unfavorable behavior (4).  
3. Other genetic markers in neuroblastoma 
Although prognosis has experienced a substantial improvement 
during the past years, there are still high risk subgroups doomed to 
therapeutic failure despite aggressive treatments. This calls for a need 
to investigate new therapeutic targets or elements that may improve 
the pre-treatment risk stratification.  
Among these new elements, the INRG classification has 
recently considered that molecular data such as the presence or 
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absence of diverse segmental chromosomal aberrations (SCA) and 
other clinico-biological parameters enables the risk-based classification 
of the majority of these tumors (13).  
Deletions of the short arm of chromosome 1 are identified in 
about 25-30% or the cases. They correlate with MNA and predict an 
increased risk of relapse in patients with localized tumors (3, 22). Most 
of the deletions involve the 1p36 region (22) where one or more 
suppressor genes have been described (23-25). 17q is often 
translocated to various chromosomal partners resulting in unbalanced 
translocations and 17q gain. 17q gain is associated with high risk 
disease features, such as advanced disease stage and age at diagnosis, 
MNA, 1p deletion, diploid or tetraploid chromosomal content and is an 
independent genetic parameter for outcome (26, 27).  
Regarding specific genes, ALK gene, at 2p23.2, has been 
demonstrated to be constitutively activated by gene mutations, copy 
number variations and/or amplifications in familial and sporadic 
neuroblastomas (28, 29) and PHOX2B mutations are thought to 
predispose to neuroblastoma by increasing proliferation and promoting 
dedifferentiation of cells in the sympathoadrenal lineage (30). ALK and 
PHOX2B genetic alterations, as well as their overexpression have been 
related to poor prognosis of the disease (31, 32). These genes are 
therefore attractive targets for novel therapeutic strategies (31). 
A segmental genomic profile, rather than the single genetic 
markers, adds prognostic information to the clinical variables age and 
stage in neuroblastoma patients without MNA, underlining the 
importance of pangenomic studies (10, 33-35). Pangenomic techniques 
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are acquiring a central diagnostic role at present, as the presence of 
one or more segmental chromosome aberrations has been related with 
tumor aggressiveness (33, 36, 37). Based on these observations, 
multilocus and pangenomic or array-based genetic profile with typical 
segmental chromosomal aberrations (deletion of 1p, 3p, 4p, 11q; and 
gain of 1q, 2p and 17) are taken into consideration in low risk patient 
therapy (37, 38). In the recently-opened Society of Paediatric Oncology 
European Neuroblastoma Network (SIOPEN) LINES study (European 
Low- and Intermediate-Risk Neuroblastoma) the genomic profile is 
taken into account for therapeutic stratification in such a way that it 
has been confirmed that SCA lead to a higher risk of relapse even in 
infants without MNA localised unresectable/disseminated 
neuroblastoma (39).  More studies are necessary to determine the 
prognostic impact of the unusual group of tumors with no 
chromosome alterations (silent profile) (16, 37, 39) and other 
phenomena such as chromothripsis (40) or loss of heterozigosity (41). 
Genetic association studies provide near-unbiased screens of 
common and rare variants with complex traits and highlight distinct 
loci in sets of genes among which to search for likely causal candidates. 
Complex trait-based exome chip analyses and exome sequencing 
studies highlight coding mutations within specific genes, but generally 
lack statistical power to establish significant associations. Therefore, 
association studies and rare variant analyses typically rely on down-
stream bioinformatics analysis to further reduce their shortlisted 
candidate genes to numbers that allow in depth experimental follow-
up studies. Analyses of genetic variation data have been augmented by 
integration with complementary data sets, among others differential or 
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tissue-specific gene expression data, protein-protein interaction data 
or existing literature-based knowledge (42-47).  
The majority of the genome is transcribed as non-coding RNA 
(ncRNAs), which directly control gene expression and influence the 
initiation and progression of several cancers. They can function as 
oncogenes or tumor suppressor genes. The expression patterns of a 
small-ncRNA family of miRNA (microRNA), define novel methods for 
stratification of neuroblastoma (48) and individual miRNAs have been 
linked to some known risk factors in neuroblastoma such as MYCN, 
1p36 and 11q loss (49-53). Recently, a new prognostic 25-miRNA 
signature has been established, validated and tested in more than 500 
neuroblastomas. This gene signature discriminates patients with 
respect to EFS and overall survival (OS), and has been shown to be an 
independent predictor of patient survival (54).   
The aberrant demethylation or methylation of gene promoter 
regions is responsible for the deregulated expression of oncogenes or 
for the inactivation of tumor suppressor genes. Neuroblastoma can be 
clustered based on the methylation pattern of 10 genes, allowing the 
identification of several clinically-relevant groups of tumors (55). Global 
methylation studies have demonstrated that a methylator phenotype, 
characterized by the methylation of multiple regions, is a hallmark of 
neuroblastoma with poor prognosis (56). Several tumor suppressor 
genes have been shown to be silenced by aberrant hypermethylation 
of their promoters in neuroblastoma (55, 57-59) and the study of these 
genes has the potential to become a prognostic outcome predictor 
because it is associated with several clinical risk factors such as MNA, 
age at diagnosis and stage (60).  
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4. Tumoral scaffolding 
Many processes relevant to neuroblastoma, such as stem cell 
differentiation, neuronal maturation, neurite extension, MYCN 
expression and the malignant potential and phenotype of tumor cells 
have all been shown to be influenced by extracellular matrix (ECM) 
stiffness (61). It has been demonstrated that cross-talks between 
Schwannian stroma and neuroblasts triggers tumor differentiation and 
inhibits angiogenesis (62). Other studies have demonstrated that 
neuroblastoma cells in culture respond to a 3D environment in a 
different manner from that found in a 2D environment. These studies 
suggest that the regulation of gene expression and morphology in 
neuroblastoma cultures is complex and depends on the geometry of 
the matrix as well as on its composition, structure, and mechanical 
properties (63).  
In the general context of cancer, within the tumor ECM,  a 
variety of support cells (fibroblasts, Schwann cells), tumor-associated 
immune cells and vascular (blood and lymph) endothelial cells are 
found, lying among a network of various reticulin, collagen and elastic 
fibers merged within the interstitial fluid (glycosaminoglycans, 
proteoglycans and glycoproteins) and gradients of several chemical 
species, which constantly interplay with cells and provide much of the 
structural support available to parenchymal cells in tissues, providing 
tensile strength and flexibility (64, 65).  
Cells are linked to each other and to the ECM forming a 
mechanical biotensegral system which triggers a mechanical balance 
between compression and tension forces (ECM and cells forces, 
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respectively). Tensegrity is an architectural principle put forth by 
Buckminster Fuller in the 1960s (66, 67). According to the tensegrity 
principle, structures or tensegrity systems are stabilized by continuous 
tension with discontinuous compression (68). The principle of 
tensegrity applies at essentially every detectable size scale in the body, 
under the term of biotensegrity, from the musculoskeletal system to 
proteins or DNA (69, 70). As a tensegrity network, a single cell requires 
continuous tension (mediated by cytoskeleton elements as 
microfilaments and intermediate filaments) and local discontinuous 
compression (mediated by ECM and other cytoskeleton elements as 
microtubules). Several studies have demonstrated that cells can 
function as independent prestressed tensegrity structures through 
their cytoskeleton architecture (71-79). The individual prestressed cells 
are poised and ready to receive mechanical signals and convert them 
into biochemical changes (80).  
ECM can be considered as a dynamic and multifunctional 
regulator which has its own biotensegrity system with reticulin and 
elastin fibers acting as tensional elements and fundamental substance 
and collagen fibers as resistant compressive elements. This tensegral 
network is considered to be a solid state regulatory system of all cell 
functions and is responsible for changes in cell shape and movement 
and for genetic and protein changes (64, 81, 82). As a result of the cell-
ECM biotensegrity, substrate rigidity can therefore control nuclear 
function and hence cell function (83). Cells can use such substrate 
rigidity to exert traction forces on ECM and thus, cause its alteration. 
Indeed, in a state of reciprocal isometric mechanical tension, a dynamic 
mechanical balance exists between cell traction forces and resistance 
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points of the ECM. This dynamic biotensegral system enables our cells 
to mechanosense and to modify their microenvironment, thus 
promoting ECM remodeling in homeostasis and in tissue disorders. The 
manipulation of this mechanical balance could promote tissue 
regeneration. In fact, different elasticities of the ECM drive 
mesenchymal stem cell differentiation in a very specific way. 
Neurogenic, myogenic or osteogenic differentiations are induced in 
identical conditions of matrix serum and with variation of ECM 
softness, strength and stiffness, respectively (84). Furthermore, ECM 
stiffness guides cell migration. Fibroblasts prefer rigid substrates and 
when placed on flexible sheets of polyacrylamide, they migrate from 
the soft area to the stiff area (85). 
Cancer can be understood as a disease of the developmental 
processes that govern how cells organize into tissues (86). Numerous 
studies have demonstrated that the tumor ECM not only responds to 
and supports carcinogenesis, but actively contributes to tumor 
initiation, progression and metastasis, and must not only be 
understood as a reactive neighboring, but also as an active contributor 
(87). In fact, it has been published that chronic growth stimulation, 
ECM remodeling, alteration of cell mechanics and disruption of tissue 
architecture are a non-genetic basis influencing cancer progression (88, 
89). Given the complexity both within and outside the cancer cell, and 
the interactions between cancer cells and the surrounding stroma, it is 
not surprising that a single perturbation within a tumor can create a 
cascade of changes in multiple pathways and networks, some of which 
may have lethal repercussions (90).  
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Tumor malignancy is driven, among other factors, by the 
remodeling of contiguous stromal tissue to foster growth, metastasis 
and therapy resistance. Tumor cells alter the mechanical properties of 
the microenvironment to create favorable conditions for their 
proliferation and/or dissemination (91). They promote stiffening of 
their environment, which feeds back to increase malignant behaviors 
such as loss of tissue architecture and invasion (92). Matrix remodeling 
by tumor-associated stromal cells entails the assembly of a highly 
dense ECM, whose physicochemical attributes enhance malignancy 
through morphogenic deregulation, tumor cell proliferation, vascular 
recruitment, and stromal cell differentiation (93-95). Both tumor and 
stromal cells produce and assemble a matrix of collagens, 
proteoglycans, and other molecules such as cytokines that hinder the 
transport of macromolecules and stimulate the otherwise quiescent 
host cells to initiate a variety of processes, including desmoplasia and 
angiogenesis (96, 97). Mediated by increased deposition, unfolding and 
crosslinking of fibrilar adhesion proteins, stiffening increases cell 
contractility which, in turn, can directly and indirectly alter gene 
expression via altering transcription factor activity and the release of 
matrix-bound pro-tumorigenic growth factors (98-101). Similarly, 
changes in the microstructure, elasticity, distribution of pore sizes, 
chemical composition and fiber arrangement due to ECM remodeling 
can control aspects of tumor cell phenotype such as adhesion, 
mechanics and motility (102-106). The speed of malignant cells in vitro 
is also affected by the geometry of the ECM. Human glioma cells move 
faster through narrow channels than through wide channels or in non-
stretched 2D surfaces. This is thought to be triggered by an increase in 
the polarity of the traction forces between cell and ECM (107). Recent 
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publications describe that not only neoplastic ECM stiffness, but also 
the firmness of tumor cells play a significant role in tumor progression. 
Steadiness of tumor cells, specially the metastatic cells, is lower than 
that of the normal cells of the same sample, and is currently caused by 
the loss of actin filaments and/or microtubules and the subsequent 
lower density of the scaffold (108, 109).  
Furthermore, an elevated ECM stiffness progressively increases 
interstitial fluid pressure which thereafter interferes with effective 
spread of anti-cancer therapeutics within the solid tumor (11-13). The 
deregulation and disorganization of the tumor stroma alter the 
composition, structure, and stiffness of the ECM elements, leading to 
limited penetration and dissemination of therapeutic agents within 
solid tumors and enable the creation of niches within tissues and 
organs that offer sanctuary to tumors and activate therapy resistance 
programs (110, 111). Huge evidence has been provided that cancer 
therapeutic agents (chemotherapy and radiotherapy), which usually 
lack of total specificity, trigger collateral damage of tumor ECM 
mechanical properties and benign stromal cells, which were previously 
fighting the tumor, in such a way that cancer therapy resistance arises 
and relapse and metastasis are favored. This fact becomes evident 
while analyzing post-treatment biopsies that account for a high degree 
of fibrosis and calcification. Cancer therapeutics triggers DNA damage 
of tumor and stromal cells which results in the secretion of a spectrum 
of proteins, including the Wnt family members. The expression of Wnt 
by the prostate tumor microenvironment lymphocyte B cells 
attenuates the effects of cytotoxic chemotherapy in vivo, promoting 
tumor cell survival and disease progression (112, 113). Doxorubicin-
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based chemotherapy of human breast carcinomas triggers 
overexpression of maspin which induces the accumulation of collagen 
fibers, thus causing disease progression (114). A novel Toll receptor-9-
dependent mechanism that initiates tumor regrowth after local 
radiotherapy has also been reported (115). 
4.1. Glycosaminoglycans (GAGs) 
Since glycosaminoglycans (GAGs) have been recognized as 
essential players in critical biological processes regulating cellular 
properties, owing to their particular biofiltering, scaffolding and cell 
anchoring properties, they have been related to diverse malignancies 
and they are now understood as key players in cancer cell biology and 
novel therapeutical agents (116, 117). 
GAGs are long, non-branched polymers of several disaccharides 
(up to 200 repeated saccharides), consisting of one uronic acid (almost 
always glucuronic acid and sometimes iduronic acid) and one 
hexosamine (glucosamine or galactosamine), presenting variable 
degrees of sulfation, and constitute the main components of the 
fundamental substance of the ECM (64). According to their chemical 
composition, GAGs can be divided in acid and sulfated: chondroitin 
sulfate (CS), dermatan sulfate (DS) and heparan sulfate or heparin (HS, 
Hep); acid and non-sulfated: hyaluronan (HA); and non-acid and 
sulfated: keratan sulfate (KS). GAGs can form proteoglycans by means 
of a linkage tetrasaccharyde, linking GAGs to a central protein (core 
protein) through a serine residue and catalyzed by four specific 
enzymes (figure 2 A). The formation of the linkage tetrasaccharyde is 
key for GAG synthesis to start in GAGosomes (118-120). Proteoglycans 
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can be located at the cell surface (syndecan, glypican), in the 
intracellular compartment (serglycin), secreted to the extracellular 
medium (small leucine-rich proteoglycans, hyalectans) or within the 
basement membrane (agrin, collagen XVIII, perlecan) (figure 2 B) (121, 
122).  
Diagnostic methods have typically centered on the analysis of GAG 
structure and concentration. HA has the capacity to bind large amounts 
of water to form viscous gels with special filtering properties and it is 
capable of forming polyvalent connections with other ECM proteins. 
This GAG, as well as the rest, has the capacity of modulating host-
tumor interaction, lymphangiogenesis, angiogenesis and multidrug 
resistance. It can therefore be used as a drug carrier (123). HA 
accumulates in the stroma of various human tumors and modulates 
intracellular signaling pathways, cell proliferation, motility and invasive 
properties of malignant cells: a high stromal HA content is associated 
with poorly differentiated tumors and aggressive clinical behavior in 
human adenocarcinomas. On the contrary, squamous cell carcinomas 
and malignant melanomas tend to have a reduced HA content (123). 
When tumors produce HA, this fact is associated with invasion, host-
tumor interactions, lymphangiogenesis/angiogenesis, ephithelial-
mesenchymal transition and with local and distant metastases in 
glioma, pancreatic adenocarcinoma, breast cancer and porstate cancer, 
respectively (123). Other studies have found a link between poor 
prognosis in prostate cancer and under-sulfation or overexpression of 
CS. Aggresive breast cancer tissue shows an increase of approximately 
15% on GAG content with longer chains compared to non-lethal breast 
cancer tissue (124). The role of hyaluronan and its receptor CD44 has 
I. INTRODUCTION 
-  - 
 
been studied in vitro with different neuroblastoma cell lines. It has 
been demonstrated that CD44 and hyaluronan promote invasive 
growth into the brain, and that MYCN amplification down-regulates the 
expression of CD44, thus enhancing tumorigenic properties of 
neuroblastic cells (119, 125).  
Figure 2: A) synthesis of GAGs after linkage of a linkage tetrasaccharyde to a 
serine protein of a core protein, to form a proteoglycan. SER: serine, XYL: 
xylose; GAL: galactose; GlcA: Glucuronic acid. 1-5: enzymes for the synthesis of 
the linkage tetrasaccharyde. 1: Xylosintransferases, 2: β-4 
galactosyltransferase, 3: β-3 galactosyltransferase, 4: β-3 
glucuronosyltransferase, 5: N-acetylglucosaminyltransferase. B) Different 
proteoglycanes depending on their location in the tissue. SLRPs: small-leucine-
rich proteoglycans. B has been reproduced from “proteoglycans in prostate 
cancer”, Iris J. Edwards, Nature Reviews urology 9, 196-206, 2012 (122). 
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4.2. Fibrous component 
The architectural role of the fibrous component of the ECM is 
clear and central for tissue homeostasis. In fact, scaffold architecture 
has been found to have a significant impact on cell growth (126).  
Fibrous components of the extracellular matrix are classified in 
three groups, according to light microscopy findings (shape, staining 
properties and arrangement) and chemical properties: collagen, 
reticular and elastic fibers (127).  
 Reticulin and collagen type I fibers 
The primary proteins present in the ECM are the collagens.  
They are secreted by connective tissue cells, as well as by a variety of 
other cell types. As a major component of skin and bone, they are the 
most abundant proteins in mammals, constituting 25% of the 
total protein mass in these animals. A typical collagen molecule is 
extremely rich in proline and glycine, long, stiff and has a triple-
stranded helical structure, in which three collagen polypeptide chains, 
called α chains, are wound around one another in a ropelike superhelix 
(128).  Reticulin fibers, or type III collagen, are fine fibers forming an 
extensive branching network in certain organs. Their distribution is 
rather restricted: they are usually found mainly in the basement of 
epithelial tissues, the surface of adipose cells, muscle cells and 
Schwann cells, outside the endothelium of the hepatic sinusoids, and in 
the fibrous reticulum of lymphoid tissues. These fibers have a diameter 
of less than 2µm  and support not only the physical structure of the cell 
but also various biological functions, largely through their ability to 
bind multiple interacting partners such as other ECM proteins, growth 
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factors, signal receptors and adhesion molecules (65, 127). Collagen 
type I fibers account for 90% of the body collagen and usually form 
thick bundles in bone, skin, tendons, ligaments, cornea and internal 
organs. These collagen strands can measure up to 100µm thick and 
usually follow a wavy course without branching in tissues. 
It has been found that an aligned fiber matrix  enhances 
differentiation of human neural crest stem cells towards the Schwann 
cell lineage (129) and evidence has pointed to collagen crosslinking as a 
significant contributor to the changes in cellular mechanical 
microenvironment that accompanies tumor progression (130).  
Reticulin fibers are considered to play an important role in the 
adherence of cells and to constitute a skeletal framework suitable for 
individual cells and tissues (131). They are known to increase in amount 
and disorganize with aging and stress in physiological conditions (132). 
Desmoplasia (collagen type I and reticulin fibers accumulation) is 
associated with several malignancies. The deregulation and 
disorganization of the tumor stroma alter the composition, structure, 
and stiffness of the ECM, leading to the creation of niches within 
tissues and organs that offer a proper environment for tumors to 
successfully establish metastasis and activate therapy resistance 
programs (110, 111, 133). In primary breast tumors, collagen type I 
density is associated with breast cancer metastasis and may serve as an 
imaging biomarker of metastasis. The expression of COL11A1 gene 
continuously increases during ovarian cancer disease progression, with 
the highest expression in recurrent metastases. Knockdown of 
COL11A1 decreases in vitro cell migration and invasion and tumor 
progression in mice (134). The tumor-stromal interface of breast 
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primary tumors in 3D culture was studied with second harmonic 
generation, showing that randomly organized matrix realigned the 
collagen fibers allowing individual cells to migrate out along radially 
aligned fibers (135). The architecture of the collagen scaffolds in 
tumors is severely altered (100, 133).  
 Elastic fibers 
As basic structural elements, elastic fibers aberrations trigger 
severe pathologies such as Marfan’s syndrome, emphysema, 
hypertension, actinic elastosis, and aortic aneurysms (136). 
Nevertheless, little evidence has been reported about its role in 
neoplastic processes.  
Elastic fibers are generally twisted or straight strands of 0,2-
1,5µm which sometimes branch to form a coarse network in loose 
connective tissue or form flattened sheets in dense elastic tissues such 
as the aorta (127).  
It has been found that elastic fiber increase, together with a 
decrease in collagen fibers is associated with oral squamous cell 
carcinoma and lymph node metastasis (137).  Elastin-rich lung ECM is 
largely remodeled during tumor invasion. The degradation of elastin 
produces peptides displaying a wide range of biological activities and 
increase invasive capacities of lung cancer cells by post-transcriptional 
regulation of metalloproteinase-2 (138). This mechanism has also been 
found to act in melanoma progression, another cancer associated with 
rich elastin microenvironment (139). 
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4.3. Vascular component 
It is now widely accepted that angiogenesis is essential for 
tumor growth and metastasis (140, 141). Therefore, controlling tumor-
associated angiogenesis is a promising strategy in limiting cancer 
progression.  
Depending on their size and composition, blood vessels can be 
divided in capillaries (5-15µm), post-capillaries/metarterioles (15-
20µm), sinusoid-like blood vessels (20-50µm), venules/ arterioles (50-
200µm) and veins/ arteries (>200µm) (figure 3). In order to grow over 
the limit of oxygen and nutrients diffusion, tumors have developed 
different strategies to provide blood supply. These mechanisms are 
sprouting angiogenesis: the growth of new capillary vessels out of 
preexisting ones; intussusceptive angiogenesis: the division of 
preexisting vessels in two new vessels by the formation of 
transvascular tissue in the lumen of the vessels; recruitment of 
endothelial progenitor cells or angioblasts; vessel co-option: tumor 
cells can grow along existing vessels without evoking an angiogenic 
response; vasculogenic mimicry: tumor cells dedifferentiate to an 
endothelial phenotype and make tube-like structures, providing tumors 
with a secondary circulation system; mosaic vessels: both endothelial 
cells and tumor cells form the luminal surface of the vessels (142-144).   
 
Doctoral thesis                                                   Irene Tadeo Cervera 
-  - 
 
 
Figure 3: Types of blood vessels stained with IHC anti-CD31 in neuroblastic 
tumors. A) capillaries (arrow) (5-15µm) and post-capilary venules (asterisk). B) 
post-capillary venules (15-20µm). C) Sinusoid-like blood vessels (20-50µm). D) 
venules (50-200µm). E) vein (>200µm). F) metarterioles (15-20µm). G) 
arterioles (50-200µm). H) artery (>200µm). 
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In many, aspects, tumor vessels are different from normal 
vessels. They are dilated, tortuous and poorly covered by pericytes 
(145, 146). The fact that tumor growth is dependent on angiogenesis 
has given rise to anti-angiogenic therapies targeting different pro-
angiogenic molecules (147). The tumor microenvironment comprises 
numerous signaling molecules and pathways that influence the 
angiogenic response. Understanding how these components 
functionally interact as angiogenic stimuli or as repressors and how 
mechanisms of resistance arise is required for the identification of new 
therapeutic strategies (148).  
 In neuroblastoma, as well as in other malignancies, different 
studies have shown conflicting results, some indicating a prognostic 
value of angiogenesis and others rejecting such conclusions (149-154). 
This may arise from the fact that tissue vascularization has been 
quantified following different methods (151, 152), all based on the 
detection of the differential staining of the vessels with more or less 
specific immunostaining (against factor VIII, von Willebrand factor, 
CD34, CD31, caveolin or CD105) on image sections (154), hot spots 
(149), whole sections (151) or in tissue microarrays sections (153), 
thereby indicating the need for robust morphometric techniques which 
may standardize the measurement of angiogenesis.  
5. Role of computerized image analysis 
To effectively treat cancer, critical networks that are vital for 
the adaptive or compensatory mechanisms of cancer cells, but that are 
not required by normal cells, need to be identified and targeted, as a 
major limiting factor in successful treatment is the collateral damage to 
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normal tissue. Multimodality and multiparametric molecular and 
functional imaging provide unprecedented opportunities to image the 
ECM and the interactions between cancer cells and stromal cells (90). 
Imaging examinations have become essential as they allow repeated 
information to be recovered over time. The information obtained can 
be used to refine models and ultimately be applied to clinical practice 
(155). Innovative diagnostic methods that provide indications 
complementary to the conventional histopathology are under analysis. 
Morphometric techniques attempt to decrease human error, increase 
efficiency, assess large areas or huge amounts of tumor samples, 
create reproducible results, and help to standardize the 
measurements. The growing size and number of medical diagnostic 
images require the use of computer-automated segmentation 
algorithms for the delineation of ECM structures of interest, which play 
a vital role in the research of new biomedical-imaging markers (156). 
This is critical to analyzing whole sets of histochemical and 
immunohistochemical images to identify, describe and quantify tissue 
alterations of the ECM.  
Despite sustained progress in our knowledge of biological 
signaling events regulating tumor malignancy, the clinical prognosis for 
many cancer types does not increase at the same rhythm. Increasing 
experimental evidence suggests that this discrepancy may be due in 
part to an under-appreciation of physical phenomena contributing to 
disease progression. As a result, cancer researchers are increasingly 
collaborating with mathematicians, chemists, physicists and engineers 
to study physicochemical characteristics of solid tumors and their role 
in modulating intracellular signaling (157). Some mathematical 
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concepts are therefore being investigated as tools to solve medical 
problems. For example, topological network analysis and the graph 
theory in combination with Vonoroi tessellations (158) have recently 
been found to be useful in the diagnosis of muscular dystrophies and 
neurogenic atrophies, in the classification of neuromuscular disease or 
to model the progression of dementia (159-161). All the generated 
information is subject to capture relevant information about the 
organization of different tissue markers. Another novel approach to 
cancer research is the texture analysis of different tissue images and 
machine-learning methods to train automated algorithms which find 
different patterns in the tissue capable of discriminating between 
prognostic groups, among other variables, resulting in computer-aided 
diagnosis tools (162-165). 
In this way, a computer-based grading system to support 
diagnosis for neuroblastoma that uses grades of differentiation and 
stromal development has been published (166, 167). Discrimination of 
stroma-poor and stroma-rich regions has also been reported using a 
mathematical model applied to digitized hematoxylin-eosin (HE) 
stained whole-sections with extraction of textural features (168). In 
addition, evidence has been provided that nuclear texture automated 
analysis can help to discriminate between different differentiated small 
round cell tumors (169). In an attempt to study the significance of new 
markers in neuroblastic tumors, the development of statistical 
modeling recently enabled our group to understand the prognostic 
value of new ECM and neuroblastic cell markers and to establish the 
degree of influence on neuroblastic tumors outcome (170). 
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Our hypothesis generated after bibliographic revision are:  
1- The destiny of a neuroblastic cell is not only directly decided by its 
genes but also by other cells and by the set of non-cellular 
extracellular matrix structural elements that converge in a cellular 
or tissular function. 
2- In the same way than in healthy tissues, the composition and 
architecture of the extracellular matrix elements are related to 
histological subtypes of neuroblastic tumors with specific and 
quantifiable biological characteristics. 
3- Extracellular matrix patterns derived from the architectural 
scaffolding could be morphologically and topologically characterized 
and could be related to patients prognosis (risk of relapse or death) 
and therefore:  
a. May give rise to more accurate pre-treatment risk 
stratification. Specifically, we expect the study of these 
extracellular matrix markers to help defining a 
subgroup of patients with very poor survival, or ultra-
high risk patients, which are the patients who may 
benefit the most from an enhanced stratification 
and/or novel therapies. 
b. May be useful as new candidate elements for novel 
therapies. 
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To test these hypotheses, the following objectives were set: 
1- Develop novel and accurate image analysis algorithms to be capable 
of characterizing glycosaminoglycans, reticulin fibers, collagen type I 
fibers, elastic fibers and blood vessels in neuroblastic tumors. 
2- Perform statistical analysis to: 
a. Correlate the extracellular matrix elements studied to 
clinical and biological features with known prognostic 
value (histopathology, age, stage, MYCN status, 11q 
status and genomic profile) in order to determine 
histological patterns with different degrees of 
malignancy. 
b. Correlate the extracellular matrix elements analyzed 
with the risk of relapse or death, individually and in 
combination with other variables. 
c. Deeper study the prognostic value of the 
morphometric variables in the high risk patient’s 
subgroup. 
3- Discuss the multipotentiality of features regarding 
glycosaminoglycans, reticulin fibers, collagen type I fibers, elastic 
fibers and blood vascularization. 
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Las hipótesis generadas tras la revisión bibliográfica son: 
1- El destino de una célula neuroblástica no se decide únicamente y 
directamente por sus genes, sino también por otras células y un 
conjunto de elementos estructurales no celulares de la matriz 
extracelular que convergen en una función celular o tisular.  
2- Del mismo modo que en tejidos sanos, la composición y 
arquitectura de los elementos de la matriz extracellular se 
relacionan con los subtipos histológicos de los tumores 
neuroblásticos con características específicas y cuantificables 
biológicas. 
3- Los patrones de matriz extracelular derivados del andamiaje 
arquitectónico podrían ser caracterizados morfológicamente y 
topológicamente y podrían relacionarse con el pronóstico del 
paciente y, por lo tanto podrían:   
a. Dar lugar a una estratificación de riesgo pre-
tratamiento más ajustada. Específicamente, 
esperamos que el estudio de estos marcadores de 
la matriz extracelular ayude a definir un subrupo 
de pacientes con muy baja supervivencia, o 
pacientes con ultra alto riesgo, que son aquellos 
que más podrían beneficiarse de una 
estratificación mejorada o de nuevas terapias. 
b. Ser útiles como elementos candidatos para nuevas 
terapias.  
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Para comprobar estas hipótesis, se fijaron los siguientes 
objetivos:   
1- Desarrollar algoritmos de análisis de imagen nuevos y precisos para ser 
capaces de caracterizar los glicosaminoglicanos, las fibras de reticulina, 
las fibras de colágeno tipo I, las fibras elásticas y los vasos sanguíneos 
en tumores neuroblásticos.  
2- Llevar a cabo análisis estadísticos para:  
a. Correlacionar los elementos de la matriz extracelular 
estudiados con las características clínicas y biológicas 
con valor pronóstico conocido (histopatología, edad, 
estadío, estatus de MYCN, estatus de 11q y perfil 
genómico) para distinguir patrones histológicos de con 
diferente grado de malignidad.  
b. Correlacionar los elementos analizados de la matriz 
extracelular con el riesgo de recaída o muerte, 
individualmente y en combinación con otras variables.  
c. Estudiar con más profundidad el valor pronóstico de las 
variables morfométricas en el subgrupo de pacientes 
de alto riesgo. 
3- Discutir la multipotencialidad de elementos relacionados con 
los glicosaminoglicanos, las fibras de reticulina, las fibras de 
colágeno tipo I, las fibras elásticas y con la vascularización.  
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1. Materials 
1.1. Samples 
We have analyzed 19 tissue microarrays (TMA) containing at 
least two representative cylinders of 1mm of 544 neuroblastic tumors 
including 458 primary tumors and 86 non-primary tumors from 499 
patients, which were referred to the Spanish Reference Centre for NB 
Biological and Pathological studies (Department of Pathology, 
University of Valencia) from 1996 to 2007 (table 1), as well as control 
cylinders of different tissues including 24 different peritumoral tissue, 
tissue from 4 different other tumors and tissue from 29 different 
normal tissues/organs (table 2). Histologic and genetic studies were 
approved by the Spanish Society of Pediatric Hematology and Oncology 
(SEHOP) (file number: 59C18ABR2002) and European Committee (file 
number: 2010-021396-81), as well as by the Ethical Comitee of the 
University of Valencia. Participants or their family members/informants 
signed written informed consent forms for histological and genetic 
studies performed in our laboratory.  
Most of the tumor samples were received frozen whereas a 
minority was received fresh in culture medium or paraffin embedded. 
The material was processed in the Pathology Service of the Hospital 
Clínico Universitario de Valencia. Following the diagnosis routine, the 
frozen and fresh samples were used to obtain several touch 
preparations, cell cultures (only for fresh samples) and frozen material 
for molecular techniques. A tumor sample was fixed in formalin and 
embedded in paraffin blocks for further histological and/or genetic 
tests in tissue sections. For histological research purposes, a fragment 
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of such material was included in TMAs. All received materials and the 
remainings after histopathological and genetic diagnosis were stored in 
the Healthcare Collection of Neuroblastic Tumors of the National 
Resgistry of Biobancs of the ISCIII (Reference: B0000339) at the 
Pathology Service of the Hospital Clínico de Valencia-INCLIVA. The 
steps followed are shown in figure 4.  
 
Figure 4: Pathway followed by a tumor sample received in the laboratory. The 
tumor is sectioned. One part is used for histological and genetic diagnosis on 
paraffin embedded tissue (or, exceptionally, on touch preparations) and the 
other section is frozen to be used for multilocus-pangenomic studies and 
storage. From the paraffin block, a cylinder can be extracted and introduced in 
a TMA, which is the case for the study of ECM. FISH: Fluorescent in situ 
hybridization, HE: Hematoxylin-eosin, ECM: Extracellular matrix. 
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Table 1: Description of the neuroblastic samples included in the TMAs. 
Type of sample Number 
(n) 
Percentage 
(%) 
Different biopsies 544 (499a) 100 (91.5) 
Primary tumors 458 84.2 
Non-primary tumors 86 15.8 
a
belong to different patients 
Peritumoral tissues were obtained from paraffin blocks of 
tumors which include preserved organ/tissue where the tumor is 
located (liver, adrenal gland…). Normal tissues were obtained from 
paraffin blocks obtained from autopsies and tissue from other tumors 
was obtained from other malignancy’s biopsies, stored at the 
Pathology Department. All non-neuroblastic samples included in the 19 
TMAs are described below, in table 2.  
As a consequence of this study, an image database including 
5,725 images (544 tumoral samples x 2 cylinders + [24+4+29] control 
cylinders = 1,145 cylinders x [4 stainings + 1 HE]) was generated. 
Thirteen variables were calculated for the 1,145 cylinders stained for 
reticulin fibers, 1 variable was calculated for the cylinders stained for 
collagen fibers, 2 variables were calculated for the GAGs samples and 
78 variables (13 x 6 subgroups) were calculated for the blood vessel 
study. A total of 105,340 data (1,145 cylinders x [13+1+2+76] variables) 
were generated. 
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Table 2: Type and quantity of peritural tissue and not neuroblastic samples.  
Samples 
Number  
of cylindres 
Peritumoral tissue: 24 
 Lymph node  1 
 Adrenal gland  8 
 Liver  2 
 Striated muscle  1 
 Pancreas  2 
 Simpathetic ganglia and 
paraganglia, fat  
10 
Other tumors tissue (not NB): 4 
 Lymphoma  1 
 Olfactory estesioNB  1 
 CC. sarcoma of the kidney  1 
 Adrenocortical carcinoma  1 
Non-tumoral tissue/organs: 29 
 Kidney  14 
 Liver  2 
 Striated / Smooth muscle  5 
 Spleen  1 
 Placenta  5 
 Salivary gland 2 
1.2. Data relating to patients/samples 
All data relating to patients, as well as biological findings, were 
filled and then exported from the self-designed database Neupat, in 
the Spanish Reference Centre for NB Biological and Pathological studies 
(Department of Pathology, University of Valencia) (171).  
1.2.1. Clinical data 
Age, stage and follow up information such as state of the 
disease, overall survival and event free survival were provided by the 
pediatric oncologists in charge or by the Reference center for NB 
clinical studies, directed by Dr. Victoria Castel and Dr. Adela Cañete, in 
Hospital La Fe of Valencia. 
II. MATERIALS AND METHODS 
-  - 
 
A. Age 
The patient’s age at diagnosis is indicated in months. It has 
been classified into different groups according to the INRG: less than 12 
months, between 12 and 18 months and more than 18 months (table 
3). The cohort studied ranged from 0 months (diagnosis at birth) to 223 
months (18 years) with an average age at diagnosis of 26 months (2 
years). 
Table 3: Distribution of the patients according to INRGSS groups of age at 
diagnosis. 
Age at diagnosis 
(months of age) 
Primary biopsies All samples 
n   % n % 
< 12 219 47.8 240 44.2 
12-18 47 10.3 59 10.8 
≥ 18 172 37.6 221 40.6 
unknown 20 4.4 24 4.4 
Total 458 100 544 100 
B. Stage 
Stage at diagnosis was also collected following the INSS, but 
was converted to the INRG Staging System (INRGSS) stages following 
the correlation described by Simon et al, and Monclair et al (7, 8). 
Therefore, the previous stage 1 becomes now L1, stages 2 and 3 
become L2, stage 4 becomes M and stage 4S becomes Ms (7, 8). The 
stages of the studied cohort of patients are shown in table 4. 
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Table 4: Distribution of the samples according to INRGSS stage. 
INSS  
stage 
INRG  
Stage 
Primary biopsies All samples 
n % n % 
1 L1 145 31.6 150 27.5 
2 L2 48 10.7 59 11.0 
3 95 20.7 124 22.8 
4 M 112 24.4 146 26.8 
4s MS 32 6.9 36 6.6 
Unknown 26 5.7 29 5.3 
Total 458 100 544 100 
C. Event-free survival (EFS) 
The EFS is the proportion of patients who have suffered no 
event, understanding relapse or exitus as an event. The EFS time (tEFS) 
is the period of time elapsed between the diagnosis of the disease and 
the first event, in case of relapse or death, or the last contact with the 
patient (last evaluation), in case of no event. 
D. Overall survival (OS) 
The OS is the percentage of patients who were alive when the 
study finished. The OS time (tOS) is the time elapsed between the 
diagnosis of the patient and the last evaluation or the death. All deaths 
were considered. 
1.2.2. Histopathological data 
Paraffin sections were stained with HE and 
immunohistochemical (IHC) techniques for NB84, TH, NSE, S100 and 
Ki67 (for the identification of neuroblastic cells, degree of 
differentiation, schwannian stroma and proliferation) and examined by 
a pathologist to evaluate the amount of neuroblastic cells, and 
histopathologically categorize them according to the INPC (12), into 
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neuroblastic tumors, including GN, iGNB, u/pd/d nGNB; and 
neuroblastomas: uNB, pdNB, dNB) (table 5). The pathologist also 
assessed the amount of neuroblastic cells in each biopsy (table 6). 
Table 5: Distribution of the samples according to histopathology (category and 
degree of differentiation). 
histopathology 
Primary biopsies All samples 
n % n % 
GN 18 3.9 22 4.0 
 iGNB 29 6.3 40 7.3 
u/pd nGNB 4 0.9 5 0.9 
d nGNB 1 0.2 1 0.2 
uNB 60 13.1 66 12.1 
pdNB 270 59.0 301 55.2 
dNB 35 7.6 55 10.1 
NB NOS 41 9.0 54 10.1 
Total 458 100 544 100 
GN: ganglioneuroma, iGNB: intermixed ganglioneuroblastoma, u/pd/d nGNB: 
undifferentiated/ poorly differentiated/ differentiating nodular 
ganglioneuroblastoma, uNB: undifferentiated neuroblastoma, pdNB: poorly 
differentiated neuroblastoma, dNB: differentiating neuroblastoma, NOS: no 
otherwise specification neuroblastoma. 
Table 6: Distribution of the samples according to the amount of neuroblasts. 
Percent of 
neuroblasts 
Primary biopsies All samples 
n % n % 
<10 6 1.3 7 1.3 
10-50 129 28.2 166 30.5 
51-60 55 12.0 67 12.3 
>60 268 58.5 
 
304 55.9 
Total 458 100 544 100 
1.2.3. Genetic data 
The number and type of alterations detected in the tumors of 
the 19 TMAs is shown in table 8, presented as the combined results 
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arising from the different genetic techniques, including FISH and 
multilocus/pangenomic techniques. 
A. Fluorescent in situ hybridization (FISH) 
Touch preparations, paraffin sections and/or TMAs were used 
to study MYCN copy number and integrity of the chromosomal regions 
1p36, 11q24 and 17q22. These were investigated with commercial 
probes: MYCN (2p24)/LAF (2q11); MLL (11q23) /SE 11; MPO (17q22) 
ISO 17q/p53 (17p13), cocktail probes dual color direct labelled 
(Kreatech, Biotechnology) and 1p36 (D1Z2)/centromere Chromosome 1 
(Qbiogene). Assessment and interpretation of FISH results were 
performed according to previously published European guidelines (172-
174) (figure 5, table 7).  
 
Figure 5: FISH technique. Cell and fluorencence labeled DNA probe, 
complementary to the region of interest are denatured and hybridized. MYCN 
gene (in red), 11q23 (in red) and the centromeres of cromosomes 2 and 11 (in 
green) are shown, with the counting of the proportion of signals. 
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A minimum of 100 nuclei for TMA or 200 nuclei for paraffin or 
touch preparations were scored for TMA cylinders and whole sections, 
respectively, taking into consideration the selection of non-overlapping 
nuclei and the analysis of multiple focal planes to ensure the detection 
of all signals (175).  
Table 7: Recommendations for the terminology and definitions of the genetic 
results that have been formulated for neuroblastic tumors by the ENQUA 
group (172). 
Marker Status Description 
 
MYCN 
no amplification 
Same number of gene signals and 
control probe signals. 
gain 
Number of gene signals is between 1 
and 4 times higher than the number of 
control probe signals. 
amplification 
 
Number of gene signals is 4 times 
higher than the number of control 
probe signals.  
*Homogeneous: amplified cells are 
found in combination with cells 
showing gain. 
*Heterogeneous: tumor amplified and 
non-amplified (not disomic) cells are 
found. 
 
1p36, 
11q 
no deletion 
Same number of the region signals and 
control probe signals. 
imbalance 
Less signals (but minimum 2) of the 
region than control probe signals. 
deletion 
One signal from the region with at least 
2 control probe signals. 
 
17q 
no gain 
Same number of region signals and 
control probe signals. 
gain 
 
Number of region signals is between 1 
and 4 times higher than the number of 
control probe signals. 
B. Multilocus/pangenomic techniques 
DNA from frozen tumors was extracted using 
phenol/chloroform/isoamyl alcohol extraction after proteinase K 
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treatment. More than one tumor piece was analyzed in some cases 
with heterogeneous tissue in order to extend the description of the 
tumor genotype. Given that only biopsies with more than 50% of tumor 
cells can be analyzed by multilocus-pangenomic techniques, several 
biopsies couldn’t be analyzed by these techniques. In some cases, DNA 
was extracted from a set of 5 sections of 10µm from paraffin-
embedded samples, following the same steps with minor 
modifications, after deparaffinization.  
 Multiplex-ligand probe amplification (MLPA) 
MLPA was used as a cost-effective first approach method in the 
detection of frequent SCAs in NB. The technique was performed using 
the SALSA MLPA Kit (A1-B1) P251/P252/P253 developed by MRC-
Holland in co-operation with SIOPEN. The SALSA MLPA P251 (A1-B1 
series) probemix contains probes for chromosomes 1, 3 and 11; P252 
(A1-B1 series) probemix for chromosomes 2 and 17; and P253 (A1-B1 
series) probemix for chromosomes 4, 7, 9, 12 and 14. Each panel 
includes control probes located in chromosome regions rarely altered 
numerically in NB. The technique is summarized in figure 6. The 
interpretation guidelines are described elsewere (1, 176).  
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Figure 6: A) Explanation of the main steps of the MLPA process. B) Example of 
a tumor with several segmental aberrations processed by MLPA-Vizard 
software (Austrian Research Centers) and using SALSA MLPA Kit A1 NB 
P251/P252/P253. Image A reproduced from the book Guidelines for Molecular 
Analysis in Archive Tissues, by Stanta G. Ed. Springer, 2011. Chapter 33: 
Multiplex Ligation-dependent Probe Amplification (MLPA), Berbegall A.P.et al, 
pages 215-24 (177). 
  Single Nucleotide Polymorphism array (SNPa) 
For SNPa, two systems were used: Affymetrix® and Illumina®, 
excluding chromosome X from the study. A brief explanation of the 
techniques and examples of both methods are provided in figure 7.  
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Figure 7: SNPa technique. A) Illustration of the SNP concept. B) microarray 
chip by Affimetrix® containing 262,256 probes. B’) microarray chip by 
Illymina® containing 299,140 probes. C) Chip array output with each color 
indicating the status of the hybridization (example of Affimetrix®), D) Drawing 
of what occurs for each probe. E) Results of a tumor DNA with some genetic 
aberration (Affimetrix®). E’) results of a tumor DNA with some genetic 
aberrations (Illumina®). Images B, C and D reproduced with courtesy of 
Affymetrix®. 
Affymetrix® (Affymetrix, Inc., Santa Clara CA): GeneChip Human 
Mapping 250K arrays (262,256 SNPs) were used following the protocol 
provided by the supplier. The primary data analysis was made using 
GDAS software (Affymetrix), while genomic profiles were generated 
using CNAG (Copy Number Analyzer for Affymetrix GeneChip Mapping 
arrays) Version 3.0 with the AsCNAR (allele-specific copy-number 
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analysis using anonymous references) function (178). The UCSC 
genome browser, assembly February 2009, was used to visualize gene 
regions.  
Illumina® (Illumina, Inc., San Diego, California, USA): the 12-
sample HumanCytoSNP-12 BeadChip includes 299,140 markers. 
Genotypes were determined with the software Genome Studio 
c.2011.1 (Illumina, Inc., San Diego, California, USA) and the evaluation 
of the profiles was made with Karyostudio v.1.4 (Illumina, Inc., San 
Diego, California, USA).  
 Combined results 
FISH, MLPA and SNPa results were combined into a single 
diagnosis for the different genetic regions with prognostic interest or 
found most frequently. As a result of this combination, and given that 
different results from two different techniques or two or more 
different tumor areas arise from the intratumor heterogeneity of these 
tumors, we can find heterogeneous aberrations for some chromosome 
regions. Specifically, MYCN gene, 2p, 17q, 11q and 1p were studied by 
different techniques and thus heterogeneity can be informed for most 
of them. 1q and 2p aberrations are mostly gains, whereas 3p and 4p 
are usually deletions. The data can be found in table 8. 
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Table 8: Distribution of the samples according to the status of different 
regions by FISH, MLPA and SNPa techniques. 
Region Status 
Primary biopsies All samples 
n % n % 
MYCNa 
Hom MNA 63 13.7 80 14.7 
Het MNAc 14 3.1 18 3.3 
G 19 4.2 28 5.1 
Het Gc 9 1.9 10 1.8 
MNNA 351 76.7 406 74.7 
NR 2 0.4 2 0.4 
11qa 
D 70 15.3 84 15.4 
 ND 321 70.1 375 68.8 
Het Dc 7 1.5 8 1.5 
NR 60 13.1 77 14.3 
1pa 
D 93 20.3 122 22.4 
ND 302 65.9 345 63.5 
Het Dc 54 11.8 60 11.0 
NR 9 2.0 17 3.1 
17qa 
G 170 37.1 208 38.2 
NG 222 48.5 256 47.0 
Het Gc 13 2.8 15 2.8 
NR 53 11.6 65 12.1 
1qb 
Aber. 24 5.2 28 5.1 
NAber. 259 56.6 292 53.6 
NR 175 38.2 224 41.3 
3pb 
Aber. 33 7.2 35 6.4 
NAber. 250 54.6 285 52.3 
NR 175 38.2 224 41.3 
4pb 
Aber. 15 3.3 17 3.1 
NAber. 268 58.5 303 55.6 
NR 175 38.2 224 41.3 
2pa 
G 53 11.5 69 12.7 
NAber. 370 80.8 429 78.9 
Het Gc 12 2.8 16 2.9 
NR 22 4.8 30 5.5 
Total 458 100 544 100 
Hom: homogeneous, Het: heterogeneous, MNA: MYCN amplification, G: Gain, 
MNNA: MYCN Not amplified, NR: No results (unknown data or not evaluable 
result), D: deletion, ND: non-deleted, NG: non-gained, Aber: aberration; 
NAber: not aberration. 
a
Combination of FISH, MLPA and SNPa, 
 b
Combination 
of MLPA and SNPa, 
c
Heterogenity arises from different results between FISH 
and Multi-pangenomic techniques (MLPA-SNPa) and/or different tumor 
pieces. 
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The combination of all the genetic data defined an overall 
genomic profile, where the presence of at least one SCA (by FISH, 
MLPA or SNPa) classified the sample as a SCA profile, and the absence 
of it by MLPA or SNPa, classified the sample as a numerical 
chromosome aberration profile (NCA) (table 9). In the case of samples 
with only FISH for 2 to 4 chromosome regions status or MLPA with not 
evaluable chromosome profile or with non-informative profile for any 
chromosome, the sample was classified as unknown because we could 
not affirm the absence of any segmental aberration in those 
chromosomes not analyzed by FISH/MLPA techniques. 
Table 9: Distribution of the samples according to MLPA/SNPa results. 
Multi-
pangenomic  
results 
Primary biopsies All samples 
n % n % 
SCA 223 48.7 280 17.8 
NCA 95 20.7 97 51.4 
NR/NE 140 30.6 167 30.8 
Total 458 100 544 100 
SCA: segmental chromosome aberrations, NCA: numerical chromosome 
aberrations, NR: no results, NE: not evaluable.  
C. Ploidy 
DNA content was analyzed by image cytometry to selectively 
study neuroblasts, excluding apoptotic or stromal cells from cytometric 
measurements (179), following the INRG recommendations. Feulgen 
stained paraffin sections images were captured at 50 magnifications 
(OLYMPUS BH-2 with ProgResTM c10Plus camera, JENOPTIK (JENA) and 
ProgRes CapturePro 2.1 software) and at least 500 to 600 alleatory and 
isolated neuroblasts nuclei and 25 to 50 lymphocytes serving as 
internal reference of diploidy were analyzed with the software 
ImagePro Plus, the median integrated optic density (IOD) values of 
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G0/G1-phase fractions of tumor cells and the median IOD values of 
G0/G1-phase fractions of diploid cell types (lymphocytes) were 
assessed.  Median IOD of tumor cells divided per median IOD of diploid 
cells gave us an IOD value of the sample which is related to a ploidy 
following the intervals shown in table 10.  
Table 10: Distribution of the biopsies according to their ploidy.  
Bord: Borderline. 
1.2.4. Risk group 
The combination of all previous variables define a risk group, 
following table 1. How our data were grouped is shown in table 11:  
Table 11: Distribution of the samples according to the risk group. 
Risk group 
Primary biopsies All 
samples n % n % 
Very low risk 184 40.4 196 36.1 
Low risk (LR) 77 16.9 94 17.2 
Intermediate risk (IR) 34 7.5 44 8.1 
High risk 110 24.2 150 27.6 
Unspecified LR or IR 24 5.3 29 5.3 
Unknown 29 5.7 31 5.7 
Total 458 100 544 100 
 
IOD value 
 
Ploidy 
Primary biopsies All samples 
n % n % 
1 - 1.19 Diploid 67 14.6 77 14.1 
1.20 -1.25 Bord. diploid 3 0.7 3 0.6 
1.26 - 1.74 Triploid 156 34.1 182 33.4 
1.75 – 1.80 Bord. triploid 7 1.5 10 1.8 
1.81 - 2.19 Tetraploid 20 4.4 25 4.6 
2.20-2.26 Bord. tetraploid 1 0.2 1 0.2 
> 2.26 Others 22 4.8 11 2.0 
Unknown 182 39.7 235 43.3 
Total 458 100 544 100 
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2. Methodology 
2.1. Construction of tissue microarrays (TMAs) 
TMAs were constructed including all the evaluable cases 
described in the section “1.1. samples”. The samples were included 
chronologically in the corresponding TMA at least twice (two cylinders) 
to properly represent, if the case was given, different histologies of the 
sample and to have a higher chance to maintain at least one 
representative sample of each case after the processing of the TMA 
sections. The steps followed were (figure 8):  
1. Select the samples to include: discard not evaluable samples, 
paraffin blocks with scarce material, etc... 
2. Select two areas per sample in the HE section corresponding to 
the paraffin block as representative as possible of the tumor. 
This step was performed by the pathologist. 
3. Design one grid per TMA where the order of every sample is 
indicated and taking into account that two control cylinders 
will be included to provide a proper orientation of the grid and 
the TMA when constructed, given that they are placed 
asymmetrically. In general, the TMAs were composed of 6 
rows, 10 columns and two independent control samples in the 
lower left corner. The samples were assigned to the 
corresponding TMA following a chronologic order. 
4. Construct an empty paraffin block which will be the receptor 
block. 
5. Fix the receptor block in the fixed plate of the manual Beecher 
Instrument (Silver Springs, MD, USA) for TMA construction. 
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6. Perforate the receptor block using the perforator needle 
provided by the instrument with the smaller diameter. 
7. Provisionally cover the plate with the receptor block with a 
mobile plate where the paraffin block containing the sample, 
called the donor block, is placed. 
8. Compare the sample in the paraffin block with the HE section 
to identify the representative regions selected by the 
pathologist to be included in the TMA. 
9. Perforate the donor block using the needle with 1mm diameter 
which keeps extracted sample section inside. 
10. Move the mobile plate to expose the receptor block and 
introduce the extracted cylinder into it. 
11. Move the plate with the receptor block 2 mm in the X axis, a 
distance between two cylinders which is enough to avoid 
contaminations. 
12. Repeat steps 6 to 11 until the row is over. 
13. Go back to the first cylinder of the row and move the plate with 
the receptor block 2mm in the Y axis to start a new row. 
Repeat steps 6 to 12. 
14. When the process is over, following the designed grill, incubate 
the receptor block overnight at 37ºC to assure the cohesion 
between the paraffin of the block and the paraffin of the 
introduced cylinders. 
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Figure 8: Steps followed to construct a TMA. A) HE of a sample with two 
representative areas selected and their corresponding location in the paraffin 
block (already perforated). B) Beecher Instrument (Silver Springs, MD) and the 
different parts composing it (1 and 2: fixed plate and receptor block; 3: small 
needle to perforate the receptor block; 4 and 5: mobile plate with one donor 
block and its HE to be able to locate the representative regions selected by the 
pathologist; 6: big needle to extract cylinders from donor blocks; 7: 
fingerwheel to move in the X axis; 8: fingerwheel to move in the Y axis. C) TMA 
obtained where each sample is represented by 2 cylinders and 2 control 
cylinders are placed asymmetrically. 
2.2. Cutting and staining of the sections 
The TMA paraffin blocks were cut routinely. Several serial 
sections of 3µm were made and stained histochally (HC) for GAGs, 
reticulin fibers and collagen type I fibers and IHC anti-CD31 for blood 
vessels. The consecutive order of the slides that enables the 
histological correlation of the serial cuts is shown in table 12.  
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Table 12: Number of the slide stained with the different techniques for every 
TMA. Gomori: reticulin fibers, Masson’s tricrome: Collagen type I fibers, Alcian 
blue: glycosaminoglycans, CD31: Blood vessels. Orcein technique was 
performed only in TMAs 1 and 2 with the slide numbers 29 and 50, 
respectively. 
TMA nº  Gomori 
Masson's  
Trichrome 
Alcian  
Blue 
CD31 
TMA 1 27 28 26 14 
TMA 2 46 48 47 11 
TMA 3 10 11 12 8 
TMA 4 25 26 28 24 
TMA 5 27 28 29 26 
TMA 6 26 27 28 30 
TMA 7 24 27 28 30 
TMA 8 28 29 24 23 
TMA 9 27 29 30 26 
TMA 10 27 28 29 32 
TMA 11 10 11 13 8 
TMA 12 7 8 9 4 
TMA 13 3 5 6 4 
TMA 14 3 5 6 20 
TMA 15 4 5 6 9 
TMA 16 16 15 18  - 
TMA 17 5 4 6 9 
TMA 18 7 8 9 10 
TMA 19 4 5 6 8 
-: unknown. 
2.2.1. Staining of the fundamental 
substance: GAGs 
One section of each TMA was stained with Alcian blue pH 2.5 
Stain Kit (Artisan™, Dako). Acid GAGs (HS, CS, DS and HA), sulfomucins 
and sialomucins were stained in blue, the nucleus were stained in red 
and the cytoplasms in pale pink (figure 9). The staining proceeded as 
follows:  
1. Deparaffinize and hydrate sections. 
2. Rinse in distilled water. 
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3. Stain in Alcian blue pH 2.5 solution. (Alcian blue pH 2.5: Mix 1 g 
alcian blue with 100 ml 3% acetic acid and adjust pH to 2.5 
using acetic acid). 10 mins. 
4. Wash in running tap water. 2 minutes. 
5. Rinse in distilled water. 
6. Counterstain in 0.1% nuclear fast red solution. (0.1% fast red 
solution: Dissolve 5 g of aluminium sulfate in water. Add 0.1 g 
of nuclear fast red and slowly heat to boil and cool. 10 minutes. 
7. Dehydrate. 
8. Mount. 
Figure 9: Alcian blue staining for fundamental substance. Acid 
glycosaminoglycans are stained in blue and nuclei and cytoplasms are stained 
in red and pink, respectively. 
Doctoral thesis                                                                 Irene Tadeo Cervera 
-  - 
 
2.2.2. Staining of the fibrous component 
 Staining of the reticulin fibers 
Reticulin stains are silver stains based on the argyrophilic 
properties of reticulin fibers. Sections of the 19 TMAs were stained 
with a slightly modified Gomori which stains reticulin fibers in black 
(figure 10). The first step in the staining procedure consists of oxidation 
of the hexose sugars in reticulin fibers to yield aldehydes. The second 
step is called sensitization in which a metallic compound such as 
ammonium sulfate is deposited around the reticulin fibers, followed by 
silver impregnation in which an ammonical or diamine silver solution is 
reduced by the exposed aldehyde groups to metallic silver. Further 
reduction of the diamine silver is achieved by transferring the sections 
to formaldehyde; this step is called revealing. The last step consists of 
toning by gold chloride in which the silver is replaced by metallic gold 
and the color of the reticulin fibers changes from brown to black. The 
detailed protocol used was:  
1. Deparaffinize and hydrate. 
2. Rinse in distilled water. 
3. Oxidize with 1% potassium permanganate. 1minute. 
4. Rinse in distilled water. 
5. Sensitize with 2% potassium metabisulfite. 1 minute. 
6. Rinse in distilled water. 
7. Silver impregnation in 2% ferric alum. 2 minutes. 
8. Rinse in distilled water. 
9. Treat with Wilder’s reagent. 2 minutes. 
10. Rinse in distilled water. 
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11. Reveal with formaldehyde. 5 minutes. 
12. Rinse in distilled water. 
13. Tone with 0.2% gold chloride. 2 minutes. 
14. Rinse in distilled water. 
15. Treat with 2% potassium metabisulfite. 2 minutes. 
16. Rinse in distilled water. 
17. Treat with 2% sodium thiosulfate. 
18. Wash in running tap water. 5 minutes. 
19. Dehydrate. 
20. Mount. 
Figure 10: Gomori staining for reticular fibers. Reticulin is stained in 
black, nuclei in grey/brown and collagen fibers are unspecifically 
stained in red/purple. 
 Staining of the collagen fibers 
The quantification of the collagen fibers was performed on 
Masson’s trichrome stained sections. Masson’s trichrome stain consists 
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in the sequential staining with Harris hematoxylin which stains nuclei 
dark red, aniline blue which stains collagen and reticulin blue and 
molybdic orange G which stains erythrocytes dark orange. Figure 11 
shows the result of the technique. The protocol followed is detailed 
next:  
1. Deparaffinize and hydrate. 
2. Rinse in distilled water. 
3. Stain with Harris hematoxylin. 5 minutes. 
4. Wash in running tap water. 
5. Bleach in chloridric alcohol followed by lithium carbonate. 
(Chloridric alcohol:  1% chloridric acid in 70º alcohol). 
6. Wash in running tap water. 
7. Rinse in 1% acetic water. 
8. Stain with Ponceau fuchsin. (Ponceau fuchsin: Dissolve 0.15 g 
of acid fuchsin and 0.3 g of Ponceau xylidine in 0.9 ml of acetic 
acid and 450 ml of distilled water). 5 minutes. 
9. Rinse in 1% acetic water. 
10. Stain with molybdic orange G. (Molybdic orange G: Mix 8 g of 
orange G and 8 g of phosfomobdylic acid in 400 ml of water). 5 
minutes. 
11. Rinse in 1% acetic water. 
12. Stain with aniline blue. (Aniline blue: Mix 0.8 g of aniline blue 
and 0.8 ml of acetic acid in 400 ml of distilled water). 5 
minutes. 
13. Rinse in 1% acetic water. 
14. Rinse in distilled water. 
15. Dehydrate. 
16. Mount. 
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Figure 11: Masson’s trichrome staining for collagen fibers. Collagen fibers 
(type I and reticular) are stained in blue, nuclei in dark red and erythrocytes 
are stained in dark orange. 
 Staining of the elastic fibers 
Orcein is a natural dye obtained from lichens which are found 
to stain elastic fibers dark brown (figure 12). The steps followed were: 
1. Deparaffinize and hydrate. 
2. Rinse in distilled water. 
3. Oxidize with 1% potassium permanganate. 10 minutes. 
4. Rinse in distilled water. 
5. Bleach with 2.5% oxalic acid. 3 minutes. 
6. Rinse in distilled water. 
7. Rinse in 70º alcohol. 
8. Incubate in orcein solution. (Orcein: dissolve 1 g of orcein in 98 
ml of ethylic alcohol 70º and add 2 ml of concentrated 
chloridric acid). 3 hours. 
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9. Rinse in distilled water. 
10. Differentiate with chloridric alcohol. (Chloridric alcohol:  1% 
chloridric acid in 70º alcohol). 2 minutes.  
11. Wash in running tap water. 
12. Rinse in distilled water. 
13. Stain nuclei with Harris hematoxylin. 1 minute. 
14. Wash in running tap water. 
15. Rinse in distilled water. 
16. Dehydrate. 
17. Mount. 
Figure 12: Orcein staining for elastic fibers. Elastin is stained in brown and 
nuclei in blue.  
II. MATERIALS AND METHODS 
-  - 
 
2.2.3. Staining of the vascular 
component 
 Staining of the blood vessels 
CD31 is a single chain type 1 transmembrane protein with a 
molecular mass of approximately 135 kDa, belonging to the 
immunoglobulin superfamily. CD34 was also applied to a subgroup of 
96 samples but this marker was also stainig cells other than endothelial 
(congress nº 3). CD31 is expressed on endothelial cells of epithelial 
origin (all continuous endothelia, including those of arteries, arterioles, 
venules, veins, and capillaries, but it is not completely expressed on 
discontinuous endothelium in, for example, splenic red pulp). In 
addition, CD31 is expressed diffusely on the surfaces of 
megakaryocytes, platelets, myeloid cells, natural killer cells, and some 
subsets of T cells, as well as on B-cell precursors. Cells labeled by the 
antibody predominantly display membrane staining, with weaker 
cytoplasmic staining (figure 13). The protocol used is detailed next: 
1. Deparaffinize and hydrate. 
2. Rinse in distilled water. 
3. Epitope retrieval: Use high pH target retrieval solution 
(Dako) in autoclave at 1.5 atmospheres. 3 minutes. 
1. Wash in running tap water. 
2. Rinse in distilled water. 
3. Block inner peroxide: Incubate in 3% H2O2. 5-10 minutes. 
4. Rinse in distilled water. 
5. Incubate in primary antibody: monoclonal mouse anti CD31 
(Dako, clone JC70A) at 1/50 dilution. 30-45 minutes. 
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6. Rinse in distilled water. 
7. Incubate in secondary antibody with EnVision FLEX/HRP 
visualization system (Dako). 30 minutes. 
8. Rinse in distilled water. 
9. Dehydrate. 
10. Mount. 
Figure 13: Immunohistochemistry anti-CD31 for blood vessels. Endothelial 
cells of blood vessels are stained in brown and nuclei in blue.  
2.3. Digitization of the sections 
A morphometric analysis of a huge amount of images 
necessitates digitization. A preliminary subset of 24 samples was 
digitized using the photomicroscope Leica DMD 108. 6 sequential 
photos were made at 20x magnifications and then carefully merged 
with Adobe Photoshop to reconstruct a single whole cylinder image 
(figure 14).  
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Figure 14: Process of HE and CD31 immunostaining image capture. A) At 20x 
magnification, 6 individual images of the cylinder must be captured to 
reconstruct the whole cylinder image. B) The whole 1mm cylinder image at 
40x magnification must be reconstructed from 20 individual images. 
Following our experience, this method needs approximately 
two weeks to digitize 30 samples (2 cylinders per sample) for a single 
staining at 20x magnification, or approximately 6 to 7 weeks at 40x 
magnification.  In order to enhance the standardization of the image 
capture conditions and therefore, the quality of the measurements and 
to save time, a second method consisting of whole slide scanning was 
followed, as described next. 
All the sections stained with the different methods were 
digitized with the ScanScope XT scanner, Aperio technologies. 
ScanScope XT scanner is a brightfield scanner that digitizes whole 
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sections at 20x and 40x magnification providing high resolution images 
in approximately 15 to 30 minutes per slide, depending on the 
magnification and the size of the tissue. 40x magnification was used, 
originating images with a resolution of 0.25 µm/pixel. Given to the 
enormous amount of pixels scanned, the images were compressed in 
JPEG2000 to 100-200 megabytes for the average size of a TMA, and 
saved to a proprietary TIFF format (SVS).  
The sections were placed in a mobile plate one by one.  An 
option for TMAs digitization provided by the scanner driver was used. 
This option recognizes the tissue cylinders and places several points per 
sample where the objective adjusts the focus to obtain clear and 
focused images. The mobile plate with the section moves in 
consecutive stripes until it sweeps the whole section while the 
objective scans. Individual scanned stripes are originated and stitched 
together automatically to reconstruct the whole image, which can be 
visualized up to 40x magnifications with the Image Scope viewer 
software (Aperio technologies). The process is briefly shown in figure 
15. 
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Figure 15: Digitization process. A) ScanScope XT, Aperio technologies. B) 
Mobile plate with one section on it. The plate is introduced in the scanner and 
placed under the objective to start the process. C) Preview of an area of the 
section. Blue arrows show the pre-set points where the scanner shall readjust 
the focus.  Green points have already been properly focused and yellow points 
still have to be focused. The red arrow shows different marks corresponding 
to the different horizontal stripes which are going to be scanned individually 
and then stitched together. D) 4 single consecutive stripes are shown 
corresponding to the section in E. E) All the stripes are stitched to form a 
single image of the whole section. The image is opened in the free viewer 
ImageScope, Aperio technologies. 
2.4. Subjective assessment of the presence of 
ECM elements and histological observation 
A subgroup of 96 samples among all the studied, included in 
the TMAs was subjectively analyzed by a pathologist to assess the 
amount of each ECM element. The criteria used were:  
 non-informative: artefact, scant material, lost cylinder. 
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 negative: no expression or <5% of stained area is 
detected. 
 positive 1+:  mild staining, 5-10% of the area. 
 positive 2+: moderate staining, 10-50% of the area. 
 positive 3+: strong staining, >50% of the area. 
In adition to the subjective assessment, all the images of the 
four markers were observed by three researchers in order to find 
repeating patterns related to the organization of each ECM marker 
regarding neuroblastic cells, immune cells, blood vessels, etc…or any 
spetial recognizable organization.  
2.5. Design of algorithms and measurement 
procedures 
2.5.1. Previous considerations 
Before describing the methods and the process for image 
analysis applied for each marker (table 13, figure 16), some 
considerations must be done:  
A. Working images 
The scanned section by Aperio ScanScope XT was automatically 
recorded in a proprietary format (SVS) consisting in JPEG2000 serial 
images put together and recorded in TIFF format. When working 
directly on the whole section, the image was used in TIFF format.  
When working with other softwares, individual images of every 
cylinder had to be extracted. Images were extracted whether in TIFF 
format or in JPEG format. As a rule, given the enormous amount of 
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images stored, the chosen format was JPEG, compressed with the 
highest quality (quality 80), with an average weight of 60KB per image 
and an average size of 5500x5500 pixels. The compression of the 
images to JPEG, triggers a loss of some morphological properties, 
specifically in the roundness parameter. Nevertheless, the majority of 
the morphological measurements are not affected by compression 
(180-182). 
In the particular case of blood vessels, a very good accuracy in 
the brown color of the stained pixels was required, and the images had 
to be stored in TIFF format, with an average weight of 80KB per image 
and an average size of 6500*6500 pixels. 
Besides the image format, another important characteristic to 
take into account was the information contained in every pixel. The 
image was recorded in RGB color system, which comes from the 
combination of one intensity value for the Red, Green and Blue 
channels. Alternatively, this color configuration can be changed to 
better distinguish between different intensities and hues of the brown 
color. This was the case of the images used to measure blood vessels, 
which were switched from the RGB to the HSV color system, whose 
acronym comes from Hue, Saturation and Value of each pixel. In both 
cases and depending on the light intensity, pixels take a value which 
can range from 0 to 255 for each of the color channels, where 0 
corresponds to the absence of light (black), and 255 corresponds to 
totally saturated (white) pixels. 
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B. Methods for image analysis 
Depending on the staining to be measured and the availability 
of morphometric systems, different methods for image analysis were 
used:  
o To use a commercial software for image analysis with 
established protocols which the user can adapt to the 
marker specific color. This was the case for GAGs. 
Aperio Image Scope, provided with an image analysis 
toolbox for positive pixel count was used on the whole 
scanned section (.svs format).  
o To use a commercial software for image analysis which 
allows the user to configure personal image analysis 
protocols or macros capable of recognizing and 
describing the specific color and shape of the element 
of interest. Image Pro-plus v.6.0 was used to create 
macros to measure reticulin and collagen type I fibers. 
o To design a personal application capable of solving 
commercial softwares lacks. In collaboration with the 
group VISILAB of the University of Castilla La Mancha, a 
specific software to measure lymph and blood vessels 
was developed (183) (congress 5). 
C. Validation of the techniques 
Artifacts such as calcifications, necrosis, non-tumor areas, fat, 
precipitates, etc... were excluded from the analysis. Structures 
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belonging to the tumor tissue, such as huge fibrous trabecules, big 
nerves, etc… were also excluded when substantially altering the 
measurements. The assessment of the robustness was done by: 
 Subjetively validating, by at least two researchers, the results 
of the application of differentialy customized algorithms, 
through the observation of the resulting segmented images.  
 Performing a comparison between the results of the 
application of the algorithms on images coming from different 
methods of image capture: a photomicroscope and a slide-
scanner. This test was only performed for reticulin fibers, given 
the higher complexity of this analysis compared to that of 
GAGs or Collagen type I (congress 4).   
 Comparing the results of the application of the two 
customizations of the same algorithm on the same images. The 
algorithm was customized differently trying to be as accurate 
as possible by maintaining the size values and changing the 
RGB color ranges (congress 4).  
 Comparing the hand-selected blood vessels and the AngioPath 
algorithm selection for the blood vessels on the same images, 
to calculate the sensibility and specificity of the algorithm.  
 In all cases, the algorithms were validated using a preliminary 
pool (n=96 samples) of tumor and control tissue images and 
comparing the results with the subjective assesment of the 
cylinders by a pathologist. Non-tumoral samples were also 
used as controls of proper measurements (table 13).  
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 Validating, by three researchers, the adequacy of the results, 
once the algorithms were considered adequate and accurate 
and all the measurements were performed.  
Table 13: Description of the different non-tumoral samples used as control 
samples.  
Tissue Scaffolding Vascular system 
Kidney Loose. ( more reticulin 
fibers for kidney; more 
GAGs for salivary 
gland)  
Mostly 
capillaries* 
 (+ arterioles, 
highly 
vascularized) 
Placenta 
Salivary gland 
Muscle 
Loose in endomysium; 
Dense in perimysium 
Liver 
Reticular 
Mostly sinusoids 
(+ venules and 
arterioles) 
Spleen 
* Capillary networks are mainly terminal in the kidney and plexiform in the 
remaining structures 
D.  Summary of the methods and process of image 
analysis 
The different methods used are summarized in table 14. 
Table 14: Summary of the methodology used for the different components of 
the ECM.  
Marker Staining Software Algorithm 
GAGs 
Alcian blue 
HC 
Image 
Scope 
Positive 
Pixel Count 
Reticulin fibers Gomori HC 
Image Pro-
plus 
Self-
configured 
macros 
Collagen type I fibers 
Masson’s 
tricrome HC 
Elastic fibers Orcein HC - - 
Blood vessels CD31 IHC AngioPath 
HC: Histochemistry, IHC: Immunohistochemistry. All sections have been 
digitized with Aperio Scan Scope XT. 
II. MATERIALS AND METHODS 
-  - 
 
Figure 16: Flowchart showing the multi-resolution neuroblastoma image 
analysis system. Images belonging to different samples stained with different 
markers have been quantified by image analysis following a common process 
including segmentation (differential recognition of the staining) with specific 
input parameters for each marker and method and extraction of some given 
parameters. Adapted from Tadeo et al. (184). 
2.5.2. Algorithm for the fundamental 
substance: GAGs 
Each cylinder was analyzed individually with Aperio Positive 
Pixel Count algorithm on Aperio ScanScope software by selecting each 
cylinder outline in the whole section image. This algorithm was used 
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with the default parameters and counted the number of pixels 
belonging to a given staining intensity, being the intensity of each pixel 
the average between the values of red, green and blue (RGB) 
intensities. It recognizes Alcian blue stained pixels which have average 
intensities over 221. Nuclear fast red stained pixels were detected with 
weak, middle and strong intensities, painted in yellow, orange and 
brown following default parameters (figure 17). The remaining 
customizable parameters were set by default. 
 
Figure 17: Segmentation obtained with the positive pixel count algorithm on a 
control tissue of a salivary gland. A) Original image. B) Mark-up image after 
segmentation. Alcian blue staining is marked in blue and nuclear fast red is 
marked in yellow, orange or maroon, depending on the intensity of staining. 
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Measurements obtained. The number of alcian blue stained 
pixels was multiplied by the area of a single pixel (0.25*0.25 µm/pixel; 
see resolution of the image) to obtain the total alcian blue stained area 
per cylinder. Additionally, the outline of each cylinder was carefully 
selected to measure the area of analysis and then, the percentage (%) 
of alcian blue stained area per cylinder was calculated as area positive 
for alcian blue / total area of the cylinder x 100. The % of GAGs per 
patient sample was calculated using the mean of the % of GAGs of all 
the cylinders belonging to the same case.  
Assessment of the spatial distribution. The spatial distribution 
of the areas with GAGs was assessed subjectively by consensus of three 
researchers. Three patterns of distribution were recognized: 
homogeneous distribution when only one texture was recognized in 
the whole cylinder; diffuse heterogeneous when two intermixed 
textures were recognized; and focal heterogeneous when two textures 
were recognized but the positive area was zonal or focal (figure 18). 
Figure 18: Different patterns recognized. In all cases, the marked-up image is 
shown, with the blue color being the alcian blue stained area and the yellow 
and orange areas being the cellular areas. A) Homogeneous distribution of the 
GAGs. B) Diffuse heterogeneous distribution of the GAG: two intermixed 
textures are recognized. C) Focal homogeneous distribution of the GAG: the 
cells area is homogeneously distributed and the GAG area is restricted to a 
focus at the lower part of the cylinder. 
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2.5.3. Algorithm for the fibrous 
component 
Image Pro-Plus software (Media Cybernetics), which enables 
the design of specific algorithms, was used to analyze the fibrous 
component. An image of every cylinder was extracted in a separate 
JPEG-quality 80 image from the whole section scan.  
A. Algorithm and measurement procedure of reticulin 
fibers 
An algorithm capable of specifically detect the reticulin fibers 
and measure their amount, size and shape was customized. This 
algorithm proceeded as follows (figure 19):  
1. Calibration of the image. The software recognizes the size of 
the pixels and converts the measurements in pixels to µm. The 
resolution of the scanned section is 0.25 µm per pixel. 
2. Segmentation: detection of dark colored pixels with the red, 
green and blue ranges set at 0-119, 0-115 and 0-126 
respectively. 
3. Slight smoothing (3 points) of the selection and application of 
an 8-connect mode, where pixels that share only a corner are 
considered as a single object.   
4. Small areas in nuclei were also stained in these ranges of color, 
as nuclear background, and are also detected. The ranges of 
some variables have been modified to discriminate the fibrous 
elements from the nuclear signal and generate a mask image or 
binary image, where the fibers are presented in white on a 
black background. For this purpose, small and round objects 
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have been excluded from the analysis (roundness under 3, area 
under 7.5 µm2, length under 8 µm and width under 1.5 µm). 
5. Once the fibers are properly recognized, the chosen 
parameters are measured and the information is incorporated 
to an excel file. 
6. An image of the binary segmentation and a snapshot of the 
selected fibers marked-up in red on the real background image 
are also filed for further review. 
7. The previous process gives us the total stained area. Then, we 
measure the tissue area to know the % of stained area. For this 
purpose the image is blurred to eliminate tissue nuances, a 
segmentation is carried out to differentiate the tissue signal 
from the background (absence of tissue) by selecting the red, 
green and blue ranges of 0-181, 0-178 and 0-172, respectively. 
Unspecific signals are eliminated by excluding small areas 
(under 5000 µm2), and the area of the cylinder is saved in an 
excel file. 
8. A calculation is done to know the % of stained area 
corresponding to the reticulin fibers as total stained 
area*100/cylinder area. 
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Figure 19: Criteria used for the segmentation and measurement of the 
reticulin fibers.   
An example of the segmentation process in a control tissue 
(kidney) is provided by figure 20. 
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Figure 20: Segmentation process on a control cylinder containing kidney 
tissue. A) Original image. B) Image after segmentation. The reticulin fibers 
recognized by the algorithm are marked-up in red. 
Measurements obtained. Eleven parameters were measured to 
be able to describe the quantity of the fibers as well as the size and the 
shape of every fiber.  
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 The quantity parameters measured were the density of 
reticulin fibers (number of fibers per mm2) and the total area 
occupied by the fibers which was converted to % of stained 
area in combination with the cylinder area.  
 The size parameters measured were:  
 width (µm): diameter along the minor axis of the object. 
 length (µm): diameter along the major axis of the object. 
 area (µm2): area of the object. 
 The shape parameters measured were (guide for the 
interpretation of the reticulin fibers measurements, figure 
21):  
 aspect: ratio between the major axis and the minor axis of 
an ellipse equivalent to the object. It gives an idea of how 
ovoid the fibers networks are (length vs. width). A round 
object such as a wavy reticulin fiber network would have 
an aspect close to 1 whereas a straight line or an isolated 
reticulin fiber or a reticulin fiber network subject to 
tension would have a much higher aspect value. Aspect 
also provides information related to the predominance of 
isolated fibers or fiber networks. Moreover, a tissue where 
the majority of the fibers tend to be oriented in the same 
way, exerting greater strain, is related to a higher aspect 
value. 
 roundness: ([perimeter2] ÷ [4 x π x area]). Empirically, 
roundness provides data regarding the degree of 
crosslinking of the fibers. It gives an idea of how deform or 
soft the fibers or fiber networks are. A less deform object 
(with low degree of crosslinking and deformity) would 
II. MATERIALS AND METHODS 
-  - 
 
have a roundness close to 1 whereas, theoretically, a soft 
object (more subject to deformation) would have a higher 
roundness deviation.  
 perimeter ratio: ratio of convex perimeter to real 
perimeter of the object, being convex perimeter the 
perimeter of the convex outline of each object. It reflects 
the irregularity of the fibers or fiber networks outline. The 
more the outline is irregular (wavy), the smaller the value 
is, varying from approximately 0.700 (irregular) to near 
0.999 (regular). A value of 1 means a perfectly smooth 
outline. 
 fractal dimension: the fractal dimension of the objects 
outline ranges from 1 to 2 and describes the amount of 
space and self-similarity of the structure. For example, a 
line exists in a single dimension and, therefore, has a 
fractal dimension of 1. On the other hand, a square exists 
in two dimensions and has a fractal dimension of 2. This 
parameter gives an idea about the disorganization or 
geometric complexity of the fibers networks: a fractal 
dimension of 2 represents the highest fiber mass and a 
value of 1 represents the most organized and porous ECM. 
 branching: number of one-pixel-thick open branches. This 
parameter also gives an idea of the organization of the 
fibers forming scarce or extensive networks. 
These parameters were measured for every fiber and then the 
average value was used to describe the characteristics of the fibers in a 
given cylinder. Finally, a second average value resulting from all the 
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cylinders representing the same sample was calculated to describe the 
general or final characteristics of the fibers in a given sample. 
Guide for the interpretation of the reticulin fibers measurements: 
 
Figure 21: Examples of the shape parameters measurements. Two types of 
theoretical fibers outlines: A-C) straight or regular and D-F) wavy outline. 
Several degrees of crosslinking: A, D) No crosslinking, B, D) poor crosslinking 
and C, F) high crosslinking. Mark-up images (white represents the fibers) of 
reticulin fibers from tissue studied with G) regular outline without crosslinking 
and H) irregular and crosslinked fibers. Individual fibers of A and D are isolated 
and long and, therefore, their aspect (ovoid measurement) is very high. Fibers 
of figures B, C, E and F are counted as a single object which has similar width 
and length and, thus, their aspect decreases, being the most compacted and 
wavy networks more close to 1. Perimeter ratio, fractal dimension and 
roundness are closer to 1 when the fibers have smoother outlines, are more 
organized without or with scarce branching networks or there is less deformity 
and no crosslinking. The element with the highest deformity or the extensive 
fiber networks more irregular and messy (higher roundness, perimeter ratio 
and fractal dimension) is presumably the stiffest. 
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Assessment of the spatial distribution: Some characteristic 
patterns of distribution were recognized subjectively for the reticulin 
fibers (figure 22). 
 
Figure 22: Representative samples of the four main subjective distribution 
patterns recognized for reticulin fibers. A) Organoid or glomerular pattern 
where the cells are grouped in roundish areas surrounded by fine reticulin 
fibers strands. B) Lobular or pear-like pattern where the cells are grouped in 
polygonal areas surrounded by thick strands of reticulin fibers. C) Reticular of 
network pattern where cells are arranged in an irregular manner forming rows 
and reticulin fibers form networks across them. D) Trabecular pattern where 
the cells are arranged forming regular and lineal areas flanked by more or less 
thick reticulin bundles.   
The assessment of the distribution patterns which every 
cylinder exhibit became a very complicated task because of huge 
heterogeneity and subjective influence. Different approaches for the 
development of an algorithm to automatically classify the samples 
were performed in collaboration with the “Instituto de Aplicaciones de 
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las Tecnologías de la Información y de las Comunicaciones Avanzadas” 
(ITACA) of the Polytechnic University of Valencia which allowed the 
classification of every sample into the major different patterns of 
distribution recognized for the reticulin fibers. These approaches were:  
1. Subjective assessment of the pattern of 96 different biopsies by 
three researchers. The pattern was assigned individually and 
then a consensus has been found. 
2. Non-supervised classification or clustering of all the cylinders 
(n=1135): Supposing that the morphometric measurements 
characterizing the fibers are related to the patterns described, 
all the morphometric variables were combined, excluding the 
most influencing ones by principal component analysis (PCA). 
Euclidean distance and Ward’s clustering method were used. 
The images of a specific cluster were validated by comparing 
them with the subjective assignation of the patterns (congress 
7). 
3.  Automated classification of the images corresponding to the 
subjectively classified 96 samples, based on extracted image 
dictionaries following three steps: dictionary learning, 
classification method and performance test (figure 23) 
(congress 8). 
o Dictionary learning: A global dictionary was trained for 
all the images together. Then, a local dictionary was 
trained for every individual image. Both were trained using 
a KSVD algorithm. Finally, we obtained a signature for 
every image, comparing both dictionaries, which was 
associated to the subjective pattern previously assigned. 
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These signatures were reduced using a ReliefF algorithm 
to increase its discriminative power (uninformative 
characteristics were removed). We therefore obtained a 
reduced signature set with each signature associated to a 
reticulin fiber spatial distribution pattern. 
o Classification method: To classify a given image, the 
previous steps were performed to obtain the image 
signature which was compared to the reduced signature 
set by calculating the Euclidean distance, giving rise to a 
series of distances associated to a potential class. We 
chose the three reduced signatures from the set of 
signatures more similar (smaller Euclidean distance) to the 
resulting signature of the image analyzed, each of the 
three being associated to a pattern. The major distribution 
pattern was assigned to the image, using the K-nearest 
neighbor algorithm.   
o Performance test: The performance of the model was 
tested by a leave-one-out cross validation strategy.
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B. Algorithm and measurement procedure of collagen 
fibers. 
In the same way as for reticulin fibers, an image of every 
cylinder was extracted in a separate JPEG-quality 80 image from the 
whole section scan to be able to work with Image Pro-Plus software 
which was used to design an algorithm capable of specifically detect 
the bundles of collagen type I fibers. This algorithm proceeds as follow 
(figure 24):  
1. Calibration of the image. The software recognizes the size of 
the pixels and converts the measurements in pixels to µm. The 
resolution of the scanned section is 0.25 µm per pixel. 
2. Color contrast enhancement to better distinguish different blue 
hues set at brightness 68, contrast 81 and gamma 10. 
3. Detection of dark blue colored pixels with the red, green and 
blue ranges of 0-17, 0-90, 255-255, respectively.  
4. Slight smoothing (3 points) of the selection and application of 
an 8-connect mode, where pixels that share only a corner are 
considered as a single object.   
5. As Masson’s trichrome not only stains type I collagen, but also 
reticulin fibers, and some unspecific elements, very restrictive 
characteristics of size and color must be applied. Following the 
reticulin fibers settings with a change in the width parameter, 
round objects (roundness under 2), small fibers area under 7.5 
µm2, length under 8 µm and a width under 10 µm have been 
excluded. Only fibers forming big bundles are thus detected. 
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6. Once the fibers are properly recognized, the chosen 
parameters are measured and the information is extracted to 
an excel file. 
7. An image of the binary segmentation or mask and a snapshot 
of the selected fibers marked-up in red on the real background 
image are also filed for further review. 
8. The previous process gives us the total stained area but we 
need to measure the tissue area to know the % of stained area. 
For that purpose the image is blurred to eliminate tissue 
nuances, segmentation is carried out to differentiate the tissue 
signal from the background (absence of tissue) by selecting the 
red, green and blue ranges of 0-181, 0-178 and 0-172, 
respectively. Unspecific signal are eliminated by excluding small 
areas (under 5000 µm2) and the area of the cylinder is 
extracted and saved in an excel file. 
9. A calculation is performed to know the % of stained area 
corresponding to the collagen type I bundles. 
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Figure 24: Criteria used for the segmentation and measurement of the 
collagen type I fibers.   
An example of the segmentation process in a control tissue 
(striated muscle) is provided by figure 25. 
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Figure 25: Segmentation process on a control cylinder containing striated 
muscle tissue. A: Original image. B: Image after segmentation. The collagen 
type I fibers recognized by the algorithm are marked-up in orange.  
Measurements obtained. As the segmentation was done under 
strict conditions, the continuity of some fibers and thus the accuracy of 
the shape and size parameters was lost. Then, the parameter 
calculated for collagen type I fibers was the total area occupied by 
fibers which is translated to % of stained area in combination with the 
cylinder area. 
II. MATERIALS AND METHODS 
-  - 
 
C. Measurement procedure for elastic fibers 
No algorithm was used. The amount of elastic fibers was 
observed by three investigators who subjectively assessed the % of 
stained area in 96 biopsies, following the score shown in 2.4. 
“Subjective assessment”. 
2.5.4. Algorithm and measurement 
procedure for the vascular component 
The algorithm was developed in collaboration with the VISILAB 
group of the engineering school of the University of Castilla La Mancha. 
The steps are described hereafter but further information is provided 
in Fernandez-Carrobles MM. et al, 2013 (183, 185) (congress 5). 
Images of the single cylinders were extracted in TIFF format, at 
40x magniﬁcation, with a size varying between 6200 and 7300 pixels. 
Experiments were performed on a Dual Xeon 3.2 GHz and 2 GB RAM. 
The method has been implemented by the research group using C/C++ 
and IPP and OpenCV libraries for image processing. Also, the Intel TBB 
library has been used for parallelization of the algorithms. The 
algorithm developed for the segmentation of the blood vessels consists 
of two parts: segmentation based on HSV color model and a radial 
algorithm (figure 26).  
 Segmentation based on HSV color model  
Closed vessels with and/or without obvious lumen can be 
detected through their continuous brown color. The main aim of this 
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algorithm section is the brown color segmentation through an HSV 
color model. This part of the algorithm proceeds as follows: 
1. Conversion of the cylinder RGB image to HSV color model. This 
conversion permits a more accurate segmentation of the brown 
color to extract the vessels contour.  
2. Extraction of the S and H channel from HSV image. S channel 
stands out most brown shades and ground staining but this is not 
enough. For this reason H channel is also used.  
3. Application of a binary inverted thresholding to S channel image 
and of a binary thresholding to H channel image. The values of 
the image pixels are compared to our brown (H and S) accepted 
thereshold. The threshold applied to the H channel is always 20 
but the inverted thereshold applied to the S channel is 10 for 
weak stains, 20 for normal stains, and 30 for strong stains. Other 
values can be chosen for specific stains. We obtain a binary 
image or mask where the pixels of interest (under the thereshold 
value) are marked in black on a white background. 
4. Application of a logical OR and NOT operator to both binary 
images. The first segments brown color and erases the rest of 
the colors. The second is needed to highlight the contour vessels. 
5. Elimination of small artifacts of the input image and joining close 
structures. Erode and dilate operations of 2 and 4 iterations 
respectively are performed in the image. Erosion, E(x,y), is done 
by means of a convolution where the minimum value of the 
neighborhood pixels are selected, thus reducing the number of 
false positives. Dilation is the opposite operation of erosion.  
6. Application of a contour ﬁnding operator. This algorithm is used 
to detect the vessel contour pixels that divide each segment of 
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the image, allowing their storage through sequences and in a 
way such that they can be later manipulated individually. This 
operator is applied to images created by a binary thresholding or 
a Canny operator.  
7. Discard false positivities such as some macrophages, which could 
be detected as small vessels. To remove these false positivities 
only the vessels whose width is higher than 20 pixels (4.6 µm) 
were selected.  
 Radial algorithm  
This algorithm ﬁnds the vascular lumen and their brown 
endothelial surrounding cells and, then, the unconnected parts are 
joined together. Once the opened vessels are closed, the 
morphometric measurements are calculated. The algorithm proceeds 
as follow:  
1. Extraction of the green channel from the RGB image. Green 
channel helps to better distinguish the different vascular lumens. 
Besides, the use of a single channel can reduce the 
computational time and also reduce the RAM memory used to 
process images.  
2. Application of a binary thresholding to extract vascular lumens 
from the image. The threshold value was established at 236, 
after statistical analysis of the image histogram.  
3. Application of a combination of erode (3 iterations) and dilate (2 
iterations) operations to join large structures and remove the 
smaller structures from the previous binary image. 
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4. Filling of those closed contours having internal holes smaller 
than 400 pixels or 92 µm minimum size. 
5. Performance of a second erosion of 1 iteration creating space 
between the vascular lumens and the vessel membrane. 
6. Radial analysis consists of computing the normal direction for 
each vascular lumen point on the border with a possible vessel 
point. Then, the radial direction is used to check if there is any 
part of the membrane vessel nearby within a radio of 3 µm. To 
this end the endothelial cells detected in the previous algorithm 
are also used. Notice that a dilatation of 2 iterations is 
performed to the endothelial cells to avoid overlapping with the 
vascular lumen. A vessel is considered valid depending on the 
ratio of checked pixels that actually belong to the membrane 
vessel. The ratio is adjusted depending on the length of the 
vascular lumen contour, being equal to 60%, 50%, and 40% for 
small, medium, and big vessels, respectively. Small vessels are 
those with a vascular lumen contour length lower than 12.42 
µm, medium vessels between 12.42 µm and 31.05 µm, and large 
vessels greater than 31.05 µm. Figure 4 shows different vessels 
classified by size. Once a pixel is considered as a valid vessel a 
linear interpolation is done to close the open vessels.  
7. Application of a contour ﬁnding operator to ﬁnd the vessels 
contours of radial algorithm.  
8. Removal of the small artifacts. 
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 Extraction of measurements 
 At this point, the algorithm provides two images composed of 
closed and open vessels. In the following steps both images are joined 
together and the morphometric measurements are calculated. 
1. A binary thresholding is applied on the previous two images. This 
thresholding is performed in order to obtain a binary image with 
only the vessel contours; therefore the threshold value is 0.  
2. Application of a logical AND and NOT operator to both images to 
combine into the same image those vessels segmented by the 
HSV color model and those obtained by the radial distribution 
analysis and to invert the image and highlight the contour 
vessels.  
3. A contour finding algorithms applied to find the vessel contours 
of the final image. This procedure is similar to point (7) of the 
color-based segmentation algorithm and the radial analysis.  
4. For each valid vessel, its position by means of its center pixel and 
twelve morphometric measurements are given. Morphometric 
measurements are also provided for each group of vessels 
according to their height.  
5. All morphometric measurements are saved in an Excel format 
file and the final image with the vessel segmented and labeled is 
stored in a TIFF format file. 
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Figure 26: Vessel segmentation process. Division of the algorithm in two steps: 
the segmentation based on HSV color model (left) and then the radial 
algorithm for joining opened vessels (right). 
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An example of the segmentation processs is provided in figure 
27. 
 
Figure 27: Segmentation process on a NB sample immunostained with CD31. 
A) Original image. B) Image after segmentation. Note that the big blood vessel 
with an interrupted staining of the endothelial cells surrounding the vascular 
lumen has been closed, thus providing morphometric measurements. 
Measurements obtained. All the vascular vessels recognized 
are classified in 6 categories corresponding to different types of 
vessels, differentiated by their largest diameter or length: capillaries or 
vessels between 5-15µm; post-capillary venules and metarterioles with 
15-20µm; sinusoid-like blood vessels, collecting venules and end 
arteries with 20-50µm; venules and arterioles with 50-200µm; veins 
and arteries with >200µm; and measurements corresponding to total 
vasculature. Note that the measurement used to distinguish between 
the different subgroups is the length instead of the width. Such 
decision was made to avoid missclassifications due to collapsed blood 
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vessels.  For each of the categories, the next measurements were 
obtained (examples of the measurements in two different control 
tissues are provided in guide for the interpretation of the blood 
vessels measurements, figure 28):  
 The localization of every vessel is provided as x and y 
coordinates, to be able to remove and locate any artifact or a 
given vessel measurement. 
 The quantity parameters are: 
 Vessel density: number of vessels of each of the 6 
categories (per mm2, in combination with the cylinder 
area). 
 Total area occupied by vessels which is converted to % of 
stained area in combination with the cylinder area. 
 For the different subgroups of blood vessels, the relative 
density and relative area of vascularization in a given 
subset with respect to the total vascularization is 
calculated as two new quantity parameters. Note that 
these values are obtained from the average of all the 
individual samples and therefore, the relative area or 
number of vessels distributed in the different size 
categories does not equal 100%. 
 The size parameters measured were:  
 area (µm2): area of the object 
 length (µm): diameter along the major axis of the object. 
 width (µm): diameter along the minor axis of the object. 
 perimeter (µm): perimeter of the object. 
 The shape parameters measured were:  
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 aspect: ratio between the major axis and the minor axis of 
the best-fitting ellipse equivalent to the vessel contour. It 
gives an idea of how ovoid/flattened the vascular vessel is 
(length vs. width). A round object would have an aspect of 1 
whereas an elongated vessel would have a much higher 
aspect. 
 roundness: ([perimeter2] ÷ [4 x π x area]). It gives an idea of 
how deform the vascular vessel is. A round object would 
have a roundness of 1 whereas a deform object would have 
a higher roundness.  
 perimeter ratio: ratio of convex perimeter to real perimeter 
of the object, being convex perimeter the perimeter of the 
convex outline of each object. It reflects the irregularity of 
the vessels outline.  
 deformity (µm2): [area of the convex outline of each vessel - 
area of the vessel]. The vessels with the highest irregular 
contour have the highest difference between the convex 
outline area and the vessel outline area and have the 
highest deformity value. 
 shape factor: Its value is affected by the object’s shape but 
independent of its dimensions. It represents the degree of 
deviation (value >1) from the circle shape (value = 1).  
 Vertices or Branching: Calculates the approximate contour 
polygon with less distance between vertices using the 
Douglas-Peucker algorithm (186) and provides the number 
of vertices, which can be assimilated to the dregree of 
branching of the vessel.  
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Guide for the interpretation of the blood vessels measurements: 
 
Figure 28: Examples of vessels measurements in two control tissues. A) 
Placenta with abundant capillaries. B) Adrenal gland with sinusoid-like blood 
vessels. C) Data obtained from the placenta analysis. D) Data obtained from 
the adrenal gland analysis. When looking to the shape parameters, we can 
observe that all of them rise when changing the vessel group, except the 
perimeter ratio parameter which decreases. Bigger vessels are more irregular. 
Moreover, the total values of placenta vessels are smaller (more regular) than 
the total values of the adrenal gland vessels, which is coherent with the type 
of vessels found in both tissues. Placenta has the highest % of vessels (41%) in 
the capillary class (5-15µm), whereas adrenal gland has the majority of its 
vessels (40%) in the sinusoid-like class (20-50µm). Rel.: relative; per.: 
perimeter; round.: roundness; per. rat.: perimeter ratio; deform.: deformity; 
branch.: branching. 
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These parameters were measured for every vessel and then 
the average value was used to describe the vessels of different types in 
a given cylinder. Finally, a second average value resulting from all the 
cylinders representing the same sample was calculated to describe the 
vessels in a given sample. 
2.6. Statistical analysis 
All statistical analyses were performed using the software SPSS 
v. 22. In all cases, only p-values <0,05 were considered as statistically 
significant. We made a distinction for clinical and biological variables 
between the INRG groups and our groups, in such a way that, for 
example, although we have the information about MYCN states gain 
and heterogeneous amplification, these states are considered as 
MNNA according to the INRG classification. Following this argument, 
our data were grouped as follows:  
 Stage INRG: This variable was not grouped and, thus, L1 
vs. L2 vs. M vs. Ms were used. 
 Age INRG: ≥18 months vs. <12 months + 12-18 months 
 Histopathology INRG: GN + iGNB vs. (nGNB, NB) d vs. 
(nGNB, NB) u/pd vs. NB NOS. 
 MYCN INRG: Hom MNA vs. Het MNA+G+Het G+MNNA 
 11q INRG: D + Het D vs. ND 
 Ploidy INRG: Diploid + tetraploid (=diploid) vs others 
(=hyperdiploid). 
 Risk group INRG: Very low risk + low risk + intermediate 
risk vs high risk. 
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2.6.1. Validation of the morphometric 
technique. 
Different steps were followed for the assessment of the 
robustness: 
 The comparison between the results of different 
methods of image capture and between the results of 
the application of the same algorithm customized 
differently was carried out for reticulin fibers. Bivariate 
correlation was used with the Pearson’s correlation, 
with the following possible interpretations:  r=0.01 to 
0.19: no or negligible relationship; 0.20 to 0.29: weak 
positive relationship; 0.30 to 0.39: moderate positive 
relationship; 0.40 to 0.69: strong positive relationship; 
0.70 or higher: very strong positive relationship.  
 A Receiver Operating Characteristic (ROC) analysis was 
performed to test the sensibility and specificity of the 
blood vessels algorithm, comparing the hand-selected 
blood vessels and the algorithm selection on the same 
images. Sensitivity is the probability of detecting the 
marker when it is stained and specificity is the 
probability of not detecting the marker when it is not 
stained. 
 The subjective categories assessed by a pathologist and 
the morphometric measurements were compared 
using non-parametric test for independent samples 
(Kruskal-Wallis or Mann-Whitney).  
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2.6.2. Validation of the clinical and 
biological data. 
To validate our data with the previously described risk of 
relapse pre-treatment classification of the INRG (2), all variables taking 
part in the INRG risk classification were related with EFS and OS. Only 
the primary biopsies with complete information for all the variables 
and a minimum follow-up time of 3 months (263 cases out of 458) 
were considered. Given that in theINRG classification ploidy has only 
been found to be relevant in non-amplified neuroblastic tumors of 
patients with advanced disease under 18 months of age at diagnosis, 
and that this variable accounts for a relatively high number of unknown 
cases which would decrease the total number of cases analyzed, this 
feature was not taken into consideration for this first approach.  
A. Description of the clinical, genetic and survival 
variables 
The distribution of our data, grouped following the INRG pre-
treatment risk stratification guidelines, was compared with the 
published one. Descriptive statistics such as mean, confidence interval 
and standard deviation were calculated for EFS and OS.  
B. Univariate survival analysis 
Survival analyses were performed with Kaplan-Meier estimator 
and Log-rank with EFS and OS.  
Doctoral thesis                                                                 Irene Tadeo Cervera 
-  - 
 
C. Multivariate survival analysis 
Those variables showing significant statistical relationships, 
with a significance level of 95%, underwent multivariate analysis using 
Cox regression analysis with the stepwise forward (Wald) method, to 
know which one of them was the most influencing.  
2.6.3. Relationship between the 
quantity and the distribution of the ECM 
elements studied and the clinico-biological 
features of the tumors. 
A. Description of the variables 
The count, mean, median, standard deviation, minimum and 
maximum were provided, using the data base including all the patients 
biopsies (n=458). Categorical variables were compared with 
contingency tables and Kappa concordance index with the following 
possible interpretations:  <0.20: negligible; 0.21-0.40: minimal; 0.41-
0.60: moderate; 0.61-0.80: Good; 0.81-1.00: excellent. 
B. Favorable and unfavorable ECM histologic 
patterns: univariate analysis with INRG clinical and 
biological variables 
Given that our continuous numerical variables did not follow 
normal distributions, they were related to categorical variables using a 
non-parametric test for independent samples (Mann-Whitney for 
variables with two categories or Kruskal-Wallis for variables with more 
than two categories). Finally, categorical morphometric variables 
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(distribution patterns) were compared with categorical clinical and 
genetic variables using Chi-square test and contingency tables. The 
total database was also used.  
2.6.4. Survival analysis:  
To know whether the ECM elements morphometric variables 
affected survival or not, two approaches were made. First, we used 
multivariate analysis to know if they could help to improve the INRG 
pre-treatmet risk stratification in combination or in addition to the 
parameters with known prognostic value. Second, we investigated 
inside the high risk patients group with known poor prognosis, if these 
new morphometric variables of the studied ECM elements could 
provide a new sub-classification of these patients who could 
beneficiate from novel therapeutic agents against these elements. 
A. Multivariate analysis 
The influence of the variables on OS and EFS was checked using 
Cox regression analysis with the stepwise forward (Wald) method. In it, 
Wald value and p-values indicate the strength of the relationship 
between the factor tested and survival. In addition, B value indicates 
the sense of the relationship (positive or negative). For this purpose, 
only the patients with complete information for all the variables 
(clinical, biological and morphometric) were used. New morphometric 
parameters were related to survival on their own and in combination 
with the INRG prognostic factors. The major value as prognosis factor 
will be assigned to those variables showing a statistically significant 
relationship with prognosis in combination with all INRG variables. 
Those variables showing a statistically significant relationship with 
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prognosis in combination with all INRG variables excluding stage will 
have a lower prognostic power than the previous. Finally, the 
morphometric variables related with prognosis when tested on their 
own can not be considered as having prognostic value. 
B. Study of the high risk group 
All morphometric variables were dichotomized using mainly 
the median value and, in some cases, the first or third quartile to 
perform survival analysis with Kaplan-Meier and log-rank test in the 
high risk patients group.  
2.6.4. Study of ECM elements after 
treatment and in other samples 
A. Description of the variables 
The count, mean and standard deviation, using the total data 
base including all the primary and non-primary biopsies as well as 
peritumoral tissue, other tumors tissue and non-tumoral tissue, was 
provided. For this particular purpose and in order to simplify the 
analysis, only the amount of GAGs, fibers and blood vessels were taken 
into account (% of stained area for GAGs and fibers and density -
number of vessels/mm2- for blood vessels). 
B. Univariate analysis  
Given that our continuous numerical variables did not follow 
normal distributions, they were related to categorical variables using a 
non-parametric test for independent samples (Mann-Whitney or 
Kruskal-Wallis). The total database was also used. As the number of 
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cases in some of the categories was low, the analysis was performed 
between the main groups. 
2.7. Topological integration of reticulin fibers 
and blood vessels regarding neuroblastic cells 
The correlative topology and organization of the ECM elements 
that have been studied can be determined through the Graph Theory 
mathematical analysis consisting in mathematical structures used to 
model pairwise relations between objects. For this purpose, a 
preliminary assay in collaboration with the Department of Cell Biology 
of the University of Sevilla and the Institute of Biomedicine of Sevilla 
was carried out with reticulin fibers and blood vessels, taking into 
account that at least 4 regions of interest (ROIs) have been extracted 
from each image to avoid tissue artifacts such as tissue breaks, 
precipitates or necrotic areas (figure 29). A subset of alleatory cases 
including samples from 10 high risk patients and 10 non-high risk 
patients; and 10 MNA plus 10 MNNA samples were selected. Following 
this method, we were able to compare different binary images 
obtained from the analysis of reticulin fibers and blood vessels which 
were assessed on serial thin sections with preserved histology. These 
overlapping images enabled both ECM markers to be considered at the 
same time and allow the co-location and study of the interaction 
between fibers and blood vessels taking the cell nuclei as a reference. 
The steps followed were:  
 Overlap the binarized images corresponding to the different 
markers together with a binarized image representing the 
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neuroblastic cells in the same composite image to combine the 
positional information from the different structures.  
 Convert the composite image in a graph. First, identify the 
centroid of the neuroblastic cells nuclear signals. Second, use 
the centroids as seeds to perform a Voronoi tessellation, 
forming a Voronoi diagram composed by Voronoi cells. These 
cells emerge from the different seeds and are characterized by 
the fact that all the points belonging to a given cell are closer to 
their corresponding seed than to any other seed.  
 Establish a network of cellular contacts. In this network, the 
nuclei centroids are detected and converted in nodes and the 
whole graph is formed by joining the nuclei of adjacent Voronoi 
cells.  
 Extract 146 features from the images with the binarized 
reticulin fibers, blood vessels and cells nuclei. 17 of them were 
related to geometrical features (position, area, or intensity of a 
marker) and the rest arised from the topologic networks. 3 
networks were done: the first with all the nuclei, the second 
with the tesselations containing reticulin fibers and the third 
with the tesselations containing blood vessels.  
 Perform statistical analyses to find differences between 
groups. We have performed preliminary comparisons based on 
the risk of relapse (high risk vs. non-high risk) and the status of 
MYCN (MNA vs. MNA) using the binarized images of reticulin 
fibers, blood vessels and neuroblastic cells nuclei as the 
reference features to provide the biological clues. 
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Although the development of the algorithms and the 
intepretations of the results obtained after their application to 
characterize the different ECM elements (objective 1), are in fact part 
of the results of this research, they have been explained in the material 
and methods section. In the present section, we will: 
 describe the resuls of the validation of the algorithms designed 
to characterize the architectural scaffolding and the vascular 
system of the neuroblastic tumors.  
 show the results of the verification of the behavior of the 
clinical and biological INRG parameters in our studied cohort.  
 present the data resulting from the morphometric analysis of 
the neuroblastic and control samples contained in TMAs, 
stained with the proper techniques to detect the different ECM 
elements studied and digitized. 
 Expose the results of the statistical analysis relating the data 
coming from the morphometric analysis with the INRG 
prognostic clinical and biological variables and testing the 
prognostic value of the ECM elements studied.  
1. Morphometric measurements 
A. Subjective validation of the customization of the 
algorithms 
At least two TMAs cylindres were used to validate the 
customization of the algorithms and to reassert the choice of the 
softwares and algorithms.  Many trials were done for each algorithm to 
find the most balanced values for the RGB colors and size and shape 
parameters ranges to obtain faithful to reality measurements. Figure 
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30 shows examples of right and wrong softwares and customization of 
the algorithms.  
 
Figure 30: Example of the subjective validation process. Different ranges of the 
parameters were tested and the best-fitting result was chosen as the final 
calibration of the algorithms.  
B. Comparison of images arising from two image 
capture methods 
The first image capture method consisted of the photography 
of 6 consecutive 20x images with a photomicroscope (Leica DMD 108) 
and the reconstruction of the cylinder image. The second method was 
the digitization of the whole TMA with a slide scanner. Different light, 
color and resolution configurations were therefore considered. The 
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results of the comparison between two image capture methods in 24 
samples are shown in table 15. For all the variables tested, a very good 
correlation, with Pearson’s index >0.7, was found. 
Table 15: Results of the correlation between the morphometric data obtained 
after two intake techniques. 
Parameter 
Pearson’s 
correlation 
p-value 
Quantity 
Number of fibers/mm2 0.942 0.00 
% of stained area 0.935 0.00 
Size 
Area 0.955 0.00 
Length 0.952 0.00 
Width 0.952 0.00 
Shape 
Aspect 0.962 0.00 
Roundness 0.866 0.00 
Perimeter ratio 0.875 0.00 
 
C. Comparison of the morphometric measurements 
arising from two different customizations of the 
same algorithm 
The p-values resulting of the comparison between the 
morphometric measurements obtained after the analysis by two 
algorithms customized by the same researcher, at two different days, 
with different values for color and shape detection of the fibers but 
trying to be as accurate as possible, on the same images (n=97) are 
summarized in table 16. As can be observed, a very good correlation, 
with a Pearson’s index >0.7, was mostly found although some 
morphometric variables showed moderate and good correlations. 
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Table 16: Results of the correlation between the morphometric data obtained 
after two algorithm customization. 
Parameter 
Pearson’s 
correlation 
p-value 
Quantity 
Number of fibers/mm2 0.596 0.00 
% of stained area 0.807 0.00 
Size 
Area 0.550 0.00 
Length 0.710 0.00 
Width 0.770 0.00 
Shape 
Aspect 0.652 0.00 
Roundness 0.436 0.00 
Perimeter ratio 0.711 0.00 
Fractal dimension 0.728 0.00 
Branching 0.510 0.00 
D. ROC test for the blood vessels algorithm 
AngioPath tool was validated by means of a ROC analysis. An 
average of 97% sensitivity and 99% specificity was obtained. A 
comparison of a given cylinder where the blood vessels were selected 
by hand and automatically is shown in figure 31. 
Figure 31: Example of an image used for the calculation of the sensitivity and 
the specificity. A) Original image. B) Blood vessels selected by hand with 
Photoshop. C) Blood vessels selection obtained from the automated analysis. 
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E. Consistency with the subjective assessment. 
In all cases (n=96 biopsies and 148 cylinders), the comparison 
between the continuous variables indicating the % of stained area and 
the subjective assigned score results in p-values = 0.000. The increasing 
score assessed subjectively is associated to increasing objective 
amounts. Nevertheless, there is no correspondence between the value 
of subjective scoring and the objective quantification of the marker 
(table 17). In general, we can observe an overestimation of the amount 
of positive area in the subjective assessment.  
Table 17: Correlation between the subjective scoring and the morphometric 
data. 
Subjective 
score 
GAGs 
Reticulin 
 fibers 
Collagen  
type I fibers 
Blood  
vessels 
0 (<5%) 5.07±5.2 0.49±0.27 0.00±0.00  - 
1+ (5-10%) 6.5±7.0 2.27±2.09 0.04±0.14 0.54±0.9 
2+ (10-50%) 7±3.5 2.9±2.4 0.06±0.15 1.48±1.07 
3+ (>50%) 14.7±6.9 7.17±6 1.01±2.06 3.08±2.77 
The results of the measured non-tumoral samples were also 
compared to the known histological composicion showing a good 
correspondence to reality (table 18). 
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Table 18: Measuremetns of the different non-tumoral samples used as control 
samples. The mean percentage of stained area is shown. 
Tissue GAGs 
Reticulin 
fibers 
Collagen 
type I 
fibers 
Vascular system 
capillaries/sinusoids 
Kidney 6.8±8.8 14.7±3.7 2.0±4.3 113±174/13±32 
Placenta 3.2±1.9 10.2±2.3 1.5±1.8 431±123/69±18 
Salivary 
gland 
41.1 11.3 6.1 174/6.3 
Muscle 6.3±4.0 10.8±7.1 4.4±2.1 140±112/11.4±6 
Liver 0.8±0.09 8.2±9.7 0.02±0.03 0.0/0.0 
Spleen 1.8 6.02 0.0 21/0.0 
2. Clinical and biological data. 
2.1 Description of the clinical, genetic and 
survival variables. 
In our study, 36% of the patients (n=96) relapsed and 28% of 
the patients (n=74) died. The median EFS was of 92.5±4.1 months (IC 
95%: 84.3-100.7) and the patients had a 5-year EFS of 63.1±3.1%. The 
median OS was of 114.5±4.2 months (IC 95%: 106.3-122.8) and the 
patients had a 5-year OS of 69.4±3.1%. The minimum, median and 
maximum follow up time were 3 months, 47±36.7 months, and 144 
months for EFS/ 157 months for OS, respectively. Tables 19 and 20 
provide the information of the count, mean, confidence interval and 
standard deviation of tEFS, tOS and 5-year EFS and OS % depending on 
the stage, the age, the histopathology and the genetic features of the 
samples. 
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2.2. Univariate survival analysis 
The p-values resulting of the Kaplan-Meier test comparing the 
INRG variables with EFS and OS in 263 patients with ≥3 months of 
follow-up information are shown in table 21. All the INRG variables 
were related to prognosis, except histopathology, which shows a 
tendency.  
Table 21: p-values resulting of the Kaplan-Meier test comparing the INRG 
variables with EFS and OS. 
Factor EFS OS 
p-value p-value 
Stage 
L1 
0.000 0.000 
L2 
M 
Ms 
Age (months) 
<12 
0.000 0.000 
12-<18 
<18 
≥18 
Histopathology 
GN+iGNB 
0.203 0.055 
(nGNB/NB) d 
(nGNB/NB) pd, u 
NB NOS 
GN+iGNB 
0.037 0.070 
nGNB+NB 
MYCN 
MNNA 
0.000 0.000 
MNA 
11q 
ND 
0.000 0.000 
D 
Genetic profile 
NCA 
0.000 0.000 
SCA 
Risk group 
Non-high risk 
0.000 0.000 
High risk 
The Kaplan-Meier survival probability curves are shown in 
figures 30 to 35. 
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2.2.1. Clinical variables 
A. Stage 
Patients with stages L1, L2 and Ms had a better survival 
compared to those with stage M (figure 32). 
 
Figure 32: Kaplan-Meier survival curves showing the A) EFS and B) OS, 
depending on the stage (p<0.001). 
   IV. RESULTS 
-  - 
 
B. Age 
Given the low % of patients with 12-18 months at diagnosis in 
our cohort, the differences were only found between < and ≥ 18 
months (2), with the patients under 18 months of age presenting the 
best prognosis (figure 33). 
 
Figure 33: Kaplan-Meier survival curves showing the A) EFS and B) OS, 
depending on the age (p<0.001). 
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2.2.2. Histopathology 
Histological category as considered in the INRG did not show a 
statistical relationship with OS/EFS. Nevertheless, the p-value for OS 
was very near to 0.05 and the p-value for EFS when combining 
ganglioneuroma and intermixed ganglioneuroblastoma vs. nodular 
ganglioneuroblastoma and neuroblastoma was statistically significant. 
We can therefore assume that histological category shows a strong 
tendency towards risk of relapse or death, with differentiated histology 
indicating a better prognosis (figure 34). 
 
Figure 334 Kaplan-Meier survival curves showing the A) EFS and B) OS, 
depending on histopathology (p>0.05). GN+iGNB: ganglioneuroma and 
intermixed ganglioneuroblastoma,   nGNB+NB:  nodular ganglioneuroblastoma 
and neuroblastoma. 
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2.2.3. Genetic variables 
A. MYCN state 
MYCN non-amplifyed tumors had a lower risk of relapse or 
death than MYCN amplifyed tumors (figure 35). 
 
Figure 35: Kaplan-Meier survival curves showing the A) EFS and B) OS, 
depending on MYCN state (p<0.001). MNNA: MYCN non-amplified, MNA: 
MYCN amplified.  
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B. 11q state 
11q non-deleted tumors have a better prognosis than tumors 
with 11q deletion (figure 36). 
 
Figure 36: Kaplan-Meier survival curves showing the A) EFS and B) OS, 
depending on 11q state (p<0.001). D: deleted, ND: non-deleted. 
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C. Genetic profile 
Overall numerical chromosome aberration genetic profile is 
associated to a decreased risk of progression compared to tumors with 
segmental chromosome aberrations (figure 37). 
 
Figure 37: Kaplan-Meier survival curves showing the A) EFS and B) OS, 
depending on the genetic profile (p<0.001). SCA: Segmental chromosome 
aberrations, NCA: Numerical chromosome aberrations. 
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D. Risk group 
Non-high risk patients have a decreased risk of progression 
compared to high risk patients (figure 38). 
 
Figure 38: Kaplan-Meier survival curves showing the A) EFS and B) OS, 
depending on the risk group (p<0.001). VLR: Very low risk, LR: Low risk, IR: 
Intermediate risk, HR: High risk. 
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2.3. Multivariate survival analysis 
All the variables which showed significant relationship with 
tEFS plus histopathology (given the proximity to significance) 
underwent multivariate analysis using Cox regression (table 22). 
According to it, the most influencing stage on the risk of 
relapse was stage M, followed by MYCN status with a HR of 1.7 (1.1-
2.7), genomic profile with a HR of 2.4 (1.1-5.3) and, finally, 
histopathology, although the latest is associated with a p-value >0.05. 
Regarding OS, Cox regression includes MYCN status as the most 
influencing factor, followed by Stage and, finally, by 11q status. 
Table 22: p-values resulting from relating the INRG variables to EFS and OS.  
Variable Wald HR (95% CI) p-value 
 EFS 
Stage 31.9 
 
0.000 
MYCN 6.2 1.7 (1.1-2.7) 0.013 
Genetic profile 5.2 2.4 (1.1-5.3) 0.022 
Histopathology 7.03 
 
0.071 
 OS 
MYCN 34.3 4.5 (2.7-7.6) 0.000 
Stage 20.1 
 
0.000 
11q 6.1 1.9 (1.1-3.2) 0.013 
HR: Hazard ratio, CI: Confidence interval. 
 The very strong influence of stage on EFS masked the influence 
of other parameters with known prognostic value. Accordingly, a 
second Cox regression (table 23) was made, excluding the stage 
variable, to know the influence of the remaining factors. Cox regression 
results for EFS and OS without considering the stage, started with 
MYCN status and included the age variable but did not take into 
account the histopathology before 11q. The last influencing parameter 
was genomic profile. 
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Table 23: p-values resulting from relating the INRG variables to EFS and OS.  
Variable Wald HR (95% CI) p-value 
 EFS 
MYCN 16.7 2.7 (1.6-4.3) 0.000 
Age 9.8 2.1 (1.3-3-5) 0.002 
11q 9.2 2.0 (1.2-3-2) 0.002 
Genetic profile 3.9 2.2 (1.0-5.0) 0.047 
 OS 
MYCN 30.2 4.3 (2.5-7.4) 0.000 
Age 8.8 2.4 (1.3-4.4) 0.003 
11q 8.04 2.1 (1.2-3.5) 0.005 
Genetic profile 3.9 3.4 (1.0-11.9) 0.048 
HR: Hazard ratio, CI: Confidence interval.  
3. Study of the GAGs. 
3.1. Histological observation 
After the observation of alcian blue stained images, we could 
generalize patterns of GAGs accumulation regarding neuroblastic cells, 
leukocytes and blood vessels. Most frequently, undifferentiated and 
poorly differentiated neuroblastic cells areas did not present GAGs, 
which appeared restricted to stromal fibrous areas in more or less 
contact with neuroblastic cells clusters and, exceptionally, GAGs could 
accumulate within neuroblastic cells (figure 39). We also observed that 
GAGs accumulates were detectable in GN and iGNB ECMs, frequently 
coincident with the perineurum of nervous bundles, too (figure 40). 
Regarding the correlation of GAGs accumulation and leucocyte 
infiltrations, we could observe that leucocyte accumulations also 
lacked alcian blue positivity within the cells or around the clusters 
(figure 41). Finally, GAGs did not ussualy accumulate around blood 
vessels exept in few samples (figure 42). 
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Figure 39: Example of one GAGs accumulation regarding neuroblastic cells. A) 
GAGs are mostly restricted to fibrous trabecules between neuroblastic cells 
clusters. B) Exceptionally, they can accumulate within neuroblastic cells or C) 
in small spaces between tumor cells. 
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Figure 40: Ganglioneuroma showing an accumulation of GAGs in perineurum 
of nervous boundles. A ganglionar cell is signaled with an arrow. 
 
Figure 41: Tertiary lymph node with absent GAGs. 
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Figure 42: Arrangement of GAGs around blood vessels. A) Blood vessels are 
ussualy not surrounded by an accumulation of GAGs. B) Occasionaly, blood 
vessels present a GAGs rich area around. 
3.2. Description of the variables 
Among the 458 patients, 71 were excluded from the GAGs 
study: 48 biopsies corresponded to lost cylinders and 23 were not 
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representative of neuroblastic tissue or presented some type of 
artefact. 
The biopsies analyzed (n=387) had an average stained area of 
4.11±4.37% and a median of 2.82%. In general, neuroblastic tumors 
presented a scant amount of GAGs in their ECM, with the minimum 
value being 0.14% and the maximum amount found being 32.46% 
(figure 43, table 24). 
 
Figure 43: Different degrees of presence of GAGs. The % of stained area is 
shown. A) NB with scarce GAGs in its ECM. B) NB with high amount of GAGs.  
C) Salivary gland as positive control, with a very high % of area occupied by 
GAGs. 
Table 24: Description of the morphometric measurements of the 
GAGs in a subset of 387 primary samples. 
Parameter Mean Median SD Min. Max. 
% stained area 4.11 2.82 4.37 0.14 32.4 
Most of the primary tumors (63%) presented an homogeneous 
distribution of the GAGs in their stroma. Nevertheless, a not negligible 
(36%) subset of biopsies had GAGs distributed heterogeneously in the 
ECM, with the heterogeneity being focal or diffuse in quite the same 
proportion. A different pattern between the different cylinders of the 
same biopsy was found in 16.5% of the samples (table 25).  
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Table 25: Description of the distribution pattern of the GAGs in a subset of 387 
samples. 
Spatial distribution Count % 
Homogeneous 246 63.6 
Heterogeneous: 141 36.4 
 Focal heterogeneous 44 11.4 
 Diffuse heterogeneous 33 8.5 
 Combined both focal/diffuse 14 3.6 
 Combined homogeneous/ heterogeneous 50 12.9 
3.3. Favorable and unfavorable GAGs 
histological patterns 
The results of the univariate non-parametric analysis 
comparing the GAGs abundance and distribution with the INRG 
variables with prognostic value are shown in table 26. The amount of 
ECM GAGs in primary tumors was related to the stage of the disease, 
the histopathology of the tumor and the risk group. A tendency was 
observed towards being related with the state of MYCN oncogene. The 
spatial distribution of such GAGs was not related to the INRG clinical 
and biologic characteristics.  
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Table 26: p-values resulting from relating the quantification of the 
GAGs and the clinical and genetic INRG variables.  
INRG variable/Parameter % stained area 
Spatial 
distribution 
Stage 0.041 - 
Age  - - 
Histopathology 0.000 - 
MYCN 0.060* - 
Genetic profile - - 
11q   - - 
Ploidy - - 
Risk group 0.002 - 
-: not statistically significant, *: tendency. 
How the % of stained area was distributed in the subcategories 
of the clinical and biological INRG variables is shown in figure 44. The 
tumors with differentiated histopathology (GN, iGNB), from patients 
with localized and non-high risk disease had a higher amount of GAGs 
in their ECM, compared to those with undifferentiated histopathology 
and from patients with metastatic and high risk disease. MYCN status 
was almost significantly related to the quantity of GAGs in such a way 
that MNNA samples would present a higher amount of GAGs than MNA 
samples. 
 
Figure 44: Distribution of the amount of GAGs depending on the INRG clinical 
and biological variables. Variables in grey mean no significant statistical 
relationship. Colored variables show significant statistical relationship (table 
12). The median value is shown. 
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An image summarizing how different neuroblastic tumors 
subgroups were associated with different amounts of GAGs is 
presented in figure 45. 
 
Figure 45: Summary of the associations between the INRG parameters and 
GAGs. A) Localized and non-high risk disease and differentiated histopathology 
(and MNNA) is related to high content of GAGs. A ganglionic cell is marked 
with an arrow. B) Metastatic and high risk disease and undifferentiated NB 
(with MNA) are related to poor amount of GAGs. 
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3.4. Survival analysis 
The whole cohort, as well as the high risk patients subgroup 
who could potentially more beneficiate from an enhanced pre-
treatment stratification or new therapeutic targets, were studied. 
3.4.1. Multivariate analysis 
When testing the GAGs variables on their own or in 
combination with the INRG variables, both the amount of GAGs and 
the pattern did not influence survival, whether including or excluding 
the stage. A table showing HR and p-values is therefore not provided.  
3.4.2. Study of the high risk group 
The dichotomized variables using the first quartile, the median 
and the third quartile did not show statistically significant differences 
of survival (OS, EFS) depending on the amount of GAGs. A Kaplan-
Meier graph is therefore not shown. 
3.5. GAGs after treatment and in other samples 
The stained area of GAGs corresponding to the different 
samples of primary NB, non-primary NB, peritumoral tissue, other 
tumors tissue and non-tumoral tissue is shown in table 27. The results 
of the statistical analysis comparing the different groups of samples are 
presented in table 28.  
In general, tumor samples (primary NB, non-primary NB and 
tissue other tumors) had a lower amount of GAGs in their ECM 
compared to the means of non-tumoral tissue (peritumoral and non-
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tumoral tissue). Primary NB had an ECM with a statistically significant 
lower amount of GAGs compared to non-primary NB. Specifficaly, the 
amount of GAGs was the double in primary NB than in the adrenal 
gland, the major host organ for primary NB development.The sample 
containing the highest ECM GAGs amount was the salivary gland (41%), 
followed by simpathetic ganglia and paraganglia and fat (14%).  
Table 27: % of stained area occupied by GAGs in the different control tissues 
studied. 
Samples 
GAGs 
Mean Median 
Primary NB (n=387) 4.1±4.3 2.8 
Non-primary NB (n=75) 5.3±4.9 3.7 
Peritumoral tissue (n=23): 7.5±13.1 3.0 
 Lymph node (n=1) 0.63 0.63 
 Adrenal gland (n=7) 2.2±1.2 1.6 
 Liver (n=2) 4.2±4.8 4.2 
 Striated muscle (n=1) 1.9 1.9 
 Pancreas (n=2) 1.7±1.0 1.7 
 Simpathetic ganglia and 
paraganglia, fat (n=10) 
14.1±18 
7.0 
Other tumors tissue (not NB) (n=4): 3.3±5.0 1.0 
 Lymphoma (n=1) 0.4 0.4 
 Olfactory estesioNB (n=1) 1.3 1.37 
 CC. sarcoma of the kidney (n=1) 0.6 0.6 
 Adrenocortical carcinoma (n=1) 10.9 10.9 
Non-tumoral tissue/organs (n=25): 6.4±9.5 2.8 
 Kidney (n=12) 6.8±8.8 2.5 
 Liver (n=2) 0.8±0.09 0.8 
 Striated / Smooth muscle (n=5) 6.3±4.0 5.1 
 Spleen (n=1) 1.8 1.8 
 Placenta (n=5/4/5) 3.2±1.9 2.9 
 Salivary gland (n=1) 41.1 41.1 
CC.: Clear cell.  
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Table 28: p-values arising from the comparison of ECM non-cellular 
parameters in different tissues.  
Parameter GAGs 
Prim. NB vs Non-prim. NB 0.010 
Prim. NB vs per. tissue - 
Prim. NB vs other tumors  - 
Prim. NB vs non-tumoral - 
Non-prim. NB vs per. tissue - 
Non-prim. NB vs other tumors - 
Non-prim. NB vs non-tumoral - 
Per. Tissue vs other tumors - 
Per. Tissue vs non-tumoral - 
Other tumors vs non-tumoral - 
Prim. NB: primary NB, not-prim NB: non-primary NB, per.tissue: peritumoral 
tissue. 
4. Study of the fibrous component 
4.1. Reticulin fibers 
4.1.1. Histological observation 
The observation of the images alone enabled the identification 
of some specific arrangements in combination with the tumor cells, 
stromal cells and ECM elements. As explained in the previous section, 
some distribution patterns could be distinguished, meaning that some 
order exists in neuroblastic tumors regarding the distribution of the 
reticulin fibers. Reticulin fibers defined smaller or larger areas with 
more or less isolated cells or cell clusters (figure 46). The arrangement 
of the fibers regarding the immune cells (tertiary node-like structures 
or leucocyte infiltrates) was also peculiar in such a way that these cells 
were surrounded by the fibers or contained within a reticular network 
(figure 47). It is known that blood vessels are wrapped by reticulin 
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fibers. However, in some cases, the fibers were not restricted to the 
vessels outline, but formed an extended network in close relationship 
with the vessels (figure 48).  
 
Figure 46:  Special arrangements of the reticulin fibers around neuroblastic 
cells. Reticulin fibers are intermingled within neuroblastic and stromal cells. In 
some cases, the distribution seems to be arbitrary but, in most of the cases, 
the fibers tend to follow an organization. A) The fibers form lines in between 
the cells arranged in rows. In other cases, the cells seem to be trapped inside 
reticular fibrous structures which surround larger or smaller groups of cells. B) 
Ganglionar individual cells (or groups of two cells) of a ganglioneuroblastoma 
are separated from each other by a stiff fibrous ECM. C) A huge amount of 
neuroblastic cells are grouped inside a reticular septum, isolated from the rest 
Doctoral thesis                                                    Irene Tadeo Cervera 
-  - 
 
of the tumor cells and, in this particular case, a necrotic area can be 
appreciated (arrow) in the center. 
 
Figure 47: Special arrangement of the reticulin fibers around leucocytes. A) 
Structures very similar to tertiary lymph nodes in neuroblastic tumors are 
surrounded by a reticulin fiber scaffold with a scarce amount of fibers inside 
the nodule. B) A leucocytary infiltrate is accompanied by reticulin fibers. Note 
the absence of fibers related to the neuroblastic and other stromal cells.  
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Figure 48: Special arrangement of the reticulin fibers around blood vessels. A) 
Vessels with reticulin fibers only around the lumen, concentric with the 
endothelial cells. B, C) Reticulin fibers can extend around the lumen in such a 
way that they support cells in close relationship with the vessels, which could 
be considered as perivascular niches. B) In this case the cells trapped in the 
reticulin fibers network are of leucocytary origin, whereas in C) the cells in the 
reticulin fibers network arising from the vessel are neuroblasts. Specific 
immunostainings are not show. 
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4.1.2. Description of the morphometric 
variables 
Among the 458 patients, 65 were excluded from the reticulin 
fibers study: 48 biopsies corresponded to lost cylinders and 17 were 
not representative of neuroblastic tissue or presented some kind of 
artefact. The biopsies analyzed (n=393) had a mean number of fibers 
per mm2 of 895±518 and an average stained area of 8.4±7.2% (figure 
49). In general, reticulin fibers of neuroblastic tumors formed networks 
with an average size of 115±179µm2 of area, 21±5.4µm length and 
8±2.9µm width. The average shape measurements were: aspect of 
4±0.8 (2.3 to 8.3), roundness of 7.4±1.7 (4 to 13.5), perimeter ratio of 
0.898±0.04 (0.83 to 0.98), fractal dimension of 1.15±0.1 (1.08 to 1.25) 
and branching of 0.15±0.1 (0 to 0.6) (table 29). 
 
Figure 49: Different degrees of presence of reticulin fibers. The % of stained 
area is shown. A) NB with scarce reticulin fibers in its ECM. B) NB with high 
amount of reticulin fibers.  C) Liver as positive control, with a very high % of 
area occupied by reticulin fibers. 
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Table 29: Description of the morphometric measurements of the reticulin 
fibers in a subset of 393 primary biopsies. 
Parameter Mean Median SD Min. Max. 
Quantity 
Density 895.5 854.0 518.4 4.6 2685.9 
% stained area 8.4 6.6 7.2 0.01 46.7 
Size 
Average area 115.1 72.2 179.3 15.1 2224.3 
Length 21.7 21.0 5.4 11.7 46.9 
Width 8.4 8.2 2.9 2.6 21.7 
Shape 
Aspect 4.0 3.8 0.8 2.3 8.3 
Roundness 7.4 7.1 1.7 4.0 13.5 
Perimeter ratio 0.8984 0.9892 0.04 0.83 0.98 
Fractal 
dimension 
1.15 1.16 0.1 1.08 1.25 
Branching 0.15 0.14 0.1 0.0 0.6 
4.1.3. Description of the spatial 
distribution  
A. Subjective assessment 
Among the 96 biopsies studied (with at least two 
representative cylinders per biopsy), 22 were organoid, 17 were 
lobular, 12 were reticular and 25 were trabecular. 7 cases presented 
different distributions between the two cylinders, being one 
organoid/reticular, 3 of them heterogeneous lobular/reticular and 3 of 
them lobular/trabecular. 4 cases were not representative and 9 were 
lost. Given their similarity, organoid and lobular pattern were 
considered as a single class for statistical approaches. The assignment 
of the subjective distribution is shown in table 30. 
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Table 30: Distribution of the samples in different spatial organization patterns 
regarding reticulin fibers. 
Spatial 
distribution 
Count % 
Organoid 22 23 
Lobular 17 17.7 
Reticular 12 12.5 
Trabecular 25 26 
Heterogeneous 7 7.3 
Unknown 13 13.5 
B. Non-supervised clustering 
All the images were grouped in three clusters with the most 
similar samples put together in a group or cluster (figure 50) which, 
according to figure 51, were not as well defined as they should 
(congress 7).  
 
Figure 50: Dendrogram for the obtaining of the three clusters using all the 
available images. The different clusters are identified by different colors. Every 
signal in the horizontal axis represents a different image. 
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Figure 51: Results of the non-supervised classification from all the cylinders. 
The different clusters are identified by different colors. Each point in the graph 
represents a tumor cylinder in a three-dimension space defined by the three 
first principal components obtained from the variables extracted from the 
images. The three clusters, represented by three different colors should be 
separated from each other. 
The comparison between the subjective spatial distribution 
patterns agreed by three investigators and the cluster assigned is 
shown in table 31. Kappa concordance index was of 0.149, which is 
<0.20. This index corresponded to a negligible concordance, which 
means that this method was not accurate to classify our images 
automatically in the different distribution patterns. 
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Table 31: Comparison between the subjective distribution pattern and the 
clusters. 
Count 
     Subjective distribution pattern 
 
Total 
Org/ 
Lob 
Ret Trab Het Unknown 
C
lu
st
er
   
   
   
 
Org/Lob 15 2 19 2 0 38 
Ret 20 6 6 4 0 36 
Trab 1 4 0 0 0 5 
Het 3 0 0 1 0 4 
Unknow 0 0 0 0 13 13 
        Total 39 12 25 7 13 96 
Org: organoid, Lob: lobular, Ret: Reticular, Trab: trabecular, Het: 
heterogeneous. 
C. Classification based on image dictionaries 
A 65% of correspondence with the subjective distribution 
patterns was achieved. Nevertheless, the majority of the cases were 
classified in a single class and, therefore, this method is not useful in its 
current state (congress 8). 
4.1.4. Favorable and unfavorable 
reticulin fibers histological patterns 
The results of the non-parametric analysis comparing the 
reticulin fibers features with the INRG variables with prognostic value 
are shown in table 32. 
Reticulin fibers morphometric variables were related to the 
majority of the clinical and biological INRG variables. Specifically, 
patients age was associated with the % of stained area (p=0.044) and 
the shape of the fibers (0.047 for fractal dimension and 0.046 for 
branching). All morphometric parameters except branching were 
differentially distributed in neuroblastic tumors depending on the 
histopathology category and grade of differentiation (p<0.05 for the 
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number of fibers, the % of stained area and roundness, and p≤0.01 for 
the remaining parameters). The amount of fibers and the branching 
degree were also different depending on the state of MYCN (p<0.05). 
The size and the shape of the fibers, as well as the stained area, were 
different between the two states of 11q (p<0.05). Finally, whether the 
tumors were diploid or hyperdiploid also showed a difference in all 
morphometric measurements (except for the number of fibers) with p-
values <0.05 except for width, fractal dimension and branching, with 
p≤0.01. The distribution of the morphometric variables was not 
different with respect to stage and genetic profile. Regarding risk 
group, we could observe that the amount of reticulin fibers (p=0.031), 
together with the aspect (0.047) and branching (0.004) shape variables 
were significantly related. 
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How these parameters were distributed in the subcategories of 
the clinical and biological INRG variables is shown in figures 52 to 54. 
Only the parameters with at least one statistically significant 
relationship with the INRG variables are shown.  
 Reticulin fibers quantity variables 
GN and iGNB, MNNA tumors and tumors from non-high risk 
disease had a higher amount of reticulin fibers. For this histopathology 
category, as well as for tumors with 11q non-deleted, these fibers 
occupied a smaller area. Tumors from patients younger than 18 
months of age and hyperdiploid tumors had more area occupied by 
reticulin fibers (figure 52).  
Figure 52: Distribution of the amount of reticulin fibers depending on the 
INRG clinical and biological variables. Variables in grey mean no significant 
statistical relationship. Colored variables show significant statistical 
relationship (table 32). The median values are shown. 
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 Reticulin fibers size variables 
For tumors with favorable histopathology and 11q non-deleted, 
reticulin fibers networks showed a smaller length, width and, thus, 
average area, compared to their counterpart. Ploidy shows significant 
relationships in the opposite sense (figure 53). 
Figure 53: Distribution of the size variables depending on the INRG clinical and 
biological variables. Variables in grey mean no significant statistical 
relationship. Colored variables show significant statistical relationship (table 
32). The median values are shown. 
 Reticulin fibers shape variables 
In general, favorable tumors present a higher aspect, a lower 
roundness (except for ploidy), a higher perimeter ratio (except for 
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ploidy), a lower fractal dimension (except for age) and a higher 
branching (except for ploidy) (figure 54). 
Figure 54: Distribution of the shape variables depending on the INRG clinical 
and biological variables. Variables in grey mean no significant statistical 
relationship. Colored variables show significant statistical relationship (table 
32). The median values are shown. 
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A summary of the previous results is provided as an integrative 
image (figure 55). 
 
Figure 55: Simplified summary of the major associations between the INRG 
parameters and the reticulin fibers. A) Tumors with differentiated 
histopathology (iGNB), no segmental aberrations and triploid DNA content are 
related to less area of smaller reticulin fibers with more regular outlines. A’) 
Binary image to better distinguish the fibers properties in A. B) Tumors with 
unfavorable histopathology (uNB) with segmental aberrations including 11qD 
and MNA and diploid DNA content are related to a higher area covered by 
bigger and more irregular reticulin fibers. B’) Binarized image to better 
distinguish the reticulin fiber networks properties in B. The age variable 
appears to be inversely related to the fractality and branching of the reticulin 
fibers. 
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4.1.5. Survival analysis 
A. Multivariate analysis 
When testing the reticulin fibers variables on their own or in 
combination with the INRG variables, none of them influenced survival, 
whether including or excluding stage. A table showing HR and p-values 
is therefore not provided.  
B. Study of the high risk group 
The dichotomized morphometric variables showed statistically 
significant differences regarding survival (OS, EFS). A table with the 
morphometric parameters and the cut points is provided (table 33). 
The Kaplan-Meier graphs are shown (figure 56 to 60). 
Table 33: Morphometric variables and cut points used to dichoromize them. 
Parameter 
EFS OS 
Cut point p-value Cut point p-value 
Density - - - - 
% of stained area Q2: 5.8 0.03 Q2: 5.8 0.000 
Area - - Q2: 77.7 0.013 
Length - - Q2: 20.8 0.013 
Width - - Q2: 8.5 0.013 
Aspect - - - - 
Roundness Q2: 6.9 0.007 Q2: 6.9 0.002 
Perimeter ratio - - - - 
Fractal dimension - - Q1: 1.15 0.046 
Branching Q1: 0.08 0.014 Q2: 0.12 0.003 
Q1: first quartile, Q2: median, Q3: third quartile, -: not statistically significant. 
 Reticulin fibers quantity variables 
The % of area covered by networks of reticulin fibers defined 
two risk groups within the high risk patients. When the % of stained 
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area was over the median (high stained area), the patients had a 
16.6±7.3% 5-year EFS and a 11.3±6.3% 5-year OS (figure 56).  
 
Figure 56: Kaplan-meier graph showing the different accumulated survival 
depending on the % of stained area. A) EFS and B) OS. 
 Reticulin fibers size variables 
An area, length and width over the median value defined a very 
poor survival group with <17% 5-year OS, within the high risk patients 
group (figure 57). 
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Figure 57: Kaplan-meier graph showing the different accumulated OS 
depending on the size variables. A) Area, B) width and C) length. 
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 Reticulin fibers shape variables 
A roundness over the median value defined a very poor 
prognostic group with <16% 5-year EFS and 5-year OS (figure 58). A 
branghing degree over the 1st quartile for EFS and over the median 
value for OS defined a group with 21.8±6.6% 5-year EFS and 10.9±6.1% 
5-year OS (figure 59). Finally, a fractal dimension over the median 
defined a 13.4±7.7% 5-year OS (figure 60). 
 
Figure 58: Kaplan-meier graph showing the different accumulated survival 
depending on the roundness. A) EFS and B) OS. 
 
Roundness 
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Figure 59: Kaplan-meier graph showing the different accumulated survival 
depending on the branching. A) EFS and B) OS. 
 
Figure 60: Kaplan-meier graph showing the different accumulated OS 
depending on the fractal dimension. 
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4.1.6. Reticulin fibers after treatment 
and in other samples 
The stained area of reticulin fibers corresponding to the 
different samples of primary NB, non-primary NB, peritumoral tissue, 
other tumors tissue and non-tumoral tissue is shown in table 34. The 
statistical analysis comparing the different groups of samples is 
presented in table 35.  
Both primary and non-primary NB samples presented an 
amount of reticulin fibers around 8%, equal to the amount found in 
simpathetic ganglia and paraganglia and fat. Primary NB accounted for 
a lower amont of reticulin fibers compared to peritumor areas and 
non-tumoral areas and, specifically, they had a lower amount of fibers 
than the adrenal glandand similar to the liver.  We also observed that 
non-primary NB presented a decreased amount of fibers compared to 
peritumoral tissue, other tumors tissue and non-tumoral tissue. 
Indeed, a disruption of the organization of the reticulin fibers is 
observed when passing from peritumoral tissue to tumoral tissue, 
which is mainly observable at the tumor-host margin (figure 61). 
Pancreas was the sample with the highest reticulin fiber amount, 
followed by lymphoma, peritumoral liver and lymph node (>17%). 
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Figure 61: TMA cylinder containing A) a poorly differentiated neuroblastic 
tumor and A’) the host tissue, being the adrenal gland. B) The reticulin fibers 
have been selected and the binarized images are shown in B’. A disruption of 
the organization of the fibrous scaffolding is observable in general and mainly 
at the tumor-host boundaries. 
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Table 34: % of stained area occupied by reticulin fibers in the different control 
tissues studied. 
Samples 
Reticulin fibers 
Mean Median 
Primary NB (n=393) 8.4±7.2 6.5 
Non-primary NB (n=76) 8.7±6.9 7.0 
Peritumoral tissue (n=24): 12.7±7.6 12.2 
 Lymph node (n=1) 17.2 17.2 
 Adrenal gland (n=8) 11.9±6.3 12.2 
 Liver (n=2) 17.7±5.6 17.7 
 Striated muscle (n=1) 31.5 31.5 
 Pancreas (n=2) 18.9±6.8 18.9 
 Simpathetic ganglia and 
paraganglia, fat (n=10) 
8.6±5.9 
9.0 
Other tumors tissue (not NB) (n=4): 12.9±4.4 10.7 
 Lymphoma (n=1) 18.0 18.0 
 Olfactory estesioNB (n=1) 9.9 9.9 
 CC. sarcoma of the kidney (n=1) -  - 
 Adrenocortical carcinoma (n=1) 10.7 10.7 
Non-tumoral tissue/organs (n=27): 12.4±4.8 11.7 
 Kidney (n=14) 14.7±3.7 15.2 
 Liver (n=2) 8.2±9.7 8.2 
 Striated / Smooth muscle (n=5) 10.8±7.1 11.6 
 Spleen (n=1) 6.02 6.02 
 Placenta (n=4) 10.2±2.3 10.5 
 Salivary gland (n=1) 11.3 11.3 
CC.: Clear cell, -: data not available (artefactual staining).  
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Table 35: p-values arising from the comparison of ECM non-cellular 
parameters in different tissues.  
Parameter Reticulin fibers 
Prim. NB vs non-prim. NB - 
Prim. NB vs per. tissue 0.002 
Prim. NB vs other tumors  - 
Prim. NB vs non-tumoral 0.000 
Non-prim. NB vs per. tissue 0.007 
Non-prim. NB vs other tumors 0.015 
Non-prim. NB vs non-tumoral 0.000 
Per. Tissue vs other tumors - 
Per. Tissue vs non-tumoral - 
Other tumors vs non-tumoral - 
Prim. NB: primary NB, not-prim NB: non-primary NB, per.tissue: peritumoral 
tissue. 
4.2. Collagen fibers 
4.2.1. Histological observation 
In general, collagen type I fibers distribution is restricted to 
stromal fibrous areas or large trabecules (figure 62). Masson’s 
trichrome staining shows that these fibers are also located in the 
perineurium of nerve bundles (figure 63). Collagen type I fibers are also 
found in the adventitia of large blood vessels (figure 64). 
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Figure 62: Neuroblastic tumor tissue showing a cellular area and a large 
trabecule. A) Masson’s trichrome showing large collagen type I fibers in the 
trabecule and thinner fiebrs within neuroblasts. B) Gomori staining revealing 
black argentic staining of the reticulin fibers within the neuroblasts and wavy 
purple fibers in the trabecule, corresponding to collagen type I fibers. 
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Figure 63: Nerve bundle. A) Masson’s trichrome revealing fine collagen fibers 
in the endoneurium and wavy bundles in the perineurium. B) Gomori staining 
revealing black argentic staining of the reticulin fibers in the endoneurium and 
wavy purple fibers in the perineurium, corresponding to collagen type I fibers. 
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Figure 64: Large blood vessel with a huge adventicia composed by collagen 
type I fibers. A) Masson’s trichrome revealing fine collagen fibers in the 
adventitia. B) Gomori staining revealing black argentic staining of the reticulin 
fibers in the tunica intima and wavy purple fibers in the adventitia, 
corresponding to collagen type I fibers. 
 
4.2.2. Description of the variables 
Given the restrictive parameters used to design a specific 
algorithm to detect only thick bundles of collagen type I fibers, only the 
variable % of stained area was calculated. Although all collagen fibers 
were observable as blue-stained fibers, only those fibers forming 
bundles were measured by restricting the thickness of the elements 
recognized, and the data reported corresponds only to them. 393 
biopsies (84%) were eligible for collagen type I bundles analysis. Among 
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them, the average % of stained area was 2.25±4.35% and the median 
value was of 0.24. This difference was explained by the fact that a very 
high proportion of the biopsies showed no collagen type I fibers in their 
ECM. Specifically, 104 biopsies (26%) had 0% of stained area detected 
and 50 samples had <1% of stained area. The positive biopsies 
presented a collagen type I fibers amount ranging from 0.1% to 31.2% 
(figure 65, table 36). The number samples out of study was of 65, being 
47 of them lost cylinders and 18 of them not representative.  
 
Figure 65: Examples of cylinders with different amounts of collagen fibers in 
the ECM. A) Neuroblastic tumor presenting no collagen type I fibers in the 
ECM but presenting reticulin fibers instead. A’) Detail of the ECM of image A 
where it can be observed that blue stain does not correspond to collagen type 
I fibers. B) Neuroblastic tumor with a very high content (27%) of collagen type 
I fibers in its stroma. B’) Detail of image B. Large collagen type I bundles are 
shown. Reticulin fibres are also stained. C) Control cylinder corresponding to a 
kidney with 1.62% of area covered by collagen type I fibers. C’) Detail of image 
C. The majority of fibers correspond to type III collagen (reticulin fibers). 
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Table 36: Description of the morphometric measurements of the collagen type 
I fibers in a subset of 393 samples. 
Parameter Mean Median SD Min. Max. 
% stained area 2.25 0.24 4.35 0.00 31.2 
4.2.3. Favorable and unfavorable 
collagen type I histological patterns 
The results of the univariate non-parametric analyses 
comparing the collagen fibers amount with the INRG variables with 
prognostic value are shown in table 37. The abundance of collagen 
type I fibers in neuroblastic tumors was related to the age of the 
patient, to the tumor histopathology, genetic aberrations in general 
and, specifically, MYCN status, and, therefore, to the risk group.  
Table 37 p-values resulting from the relation of the morphometric 
characterization of the collagen type I fibers and the clinical and genetic INRG 
variables. 
INRG variable % stained area 
Stage - 
Age 0.006 
Histopathology 0.000 
MYCN 0.005 
Genetic profile 0.014 
11q  - 
Ploidy - 
Risk group 0.011 
-: not statistically significant 
How these parameters were distributed in the subcategories of 
the clinical and biological INRG variables is shown in figure 66. Tumors 
of patients younger than 18 months of age with favorable 
histopathology, MNNA, NCA alterations and non-high risk had a higher 
content of collagen type I.  
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Figure 66: Distribution of the % of collagen type I stained area depending on 
the INRG clinical and biological variables. Variables in grey mean no significant 
statistical relationship. Colored variables show significant statistical 
relationship (table X). The median values are shown. 
How the INRG parameters were associated with the abundance 
of collagen type I fibers is summarized in figure 67.  
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Figure 67: Representation of the associations between the INRG parameters 
and the collagen type I fibers. A) Tumors of children less than 18 months of 
age with differentiated histopathology (iGNB), MNNA and numerical 
aberrations are associated with a higher collagen type I fibers content 
(although minimal) (arrow). B) Tumors from patients over 18 months of age 
with unfavorable histopathology (uNB) with segmental aberrations including 
MNA are related to a lower area covered by collagen type I fibers bundles 
(arrow).  
4.2.4. Survival analysis 
A. Multivariate analysis 
A smaller area covered of collagen type I fibers, alone, 
triggered a poor OS with a HR of 0.876 (0.7-0-9) (table 38). 
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Nevertheless, this factor did not influence EFS. Moreover, when 
combining the amount of collagen type I fibers with the INRG variables, 
no influence was found on survival, whether including of excluding 
stage.  
Table 38: Results of the Cox regression showing the influence of collagen type 
I fibers amount on survival. 
  Variable Wald HR (95% CI) p-value 
EFS 
a,b,c                                                 - 
OS 
a % stained area 4.4 0.876 (0.7-0-9)^ 0.035 
b, c        - 
a: morphometric variable on its own, b: morphometric variables + all INRG 
variables, c: morphometric variables + INRG variables except stage, HR: Hazard 
ratio, CI: Confidence interval, -: no statistically significant morphometric 
variable. ^Inverse correlation. 
B. Study of the high risk group 
The dichotomized variable corresponding to the amount of 
collagen type I fibers in the ECM of high risk neuroblastic tumors did 
not influence survival. A table with the morphometric parameters and 
the cut points is thus not provided.  
4.1.5. Collagen type I fibers after 
treatment and in other samples 
The stained area collagen type I fibers corresponding to the 
different samples of primary NB, non-primary NB, peritumoral tissue, 
other tumors tissue and non-tumoral tissue is shown in table 39. The 
statistical analysis comparing the different groups of samples is 
presented in table 40.  
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Primary NB accounted for a lower amount of collagen type I 
fibers compared to non-primary NB and to peritumor areas. Besides of 
the adrenocortical carcinoma sample, the highest abundance of 
collagen type I fibers corresponded to simpathetic ganglia and 
paraganglia and fat samples and to the salivary gland.  
Table 39: % of stained area occupied by collagen type I fibers in the different 
control tissues studied. 
Samples 
Collagen type I 
Mean Median 
Primary NB (n=393) 2.2±4.3 0.24 
Non-primary NB (n=76) 4.5±8.0 1.1 
Peritumoral tissue (n=24): 5.3±10.4 1.5 
 Lymph node (n=1) 5.8 5.8 
 Adrenal gland (n=7/8/8) 2.6±5.4 0.25 
 Liver (n=2) 0.29±0.4 0.29 
 Striated muscle (n=1) 7.8 7.8 
 Pancreas (n=2) 1.5±0.4 1.5 
 Simpathetic ganglia and 
paraganglia, fat (n=10) 
9.0±14.9 
1.99 
Other tumors tissue (not NB) (n=4): 5.6±6.09 4.7 
 Lymphoma (n=1) 0.0 0.0 
 Olfactory estesioNB (n=1) 1.3 1.32 
 CC. sarcoma of the kidney (n=1) 8.1 8.1 
 Adrenocortical carcinoma (n=1) 13.0 13.0 
Non-tumoral tissue/organs (n=25): 2.1±2.29 1.7 
 Kidney (n=12) 2.0±1.7 1.9 
 Liver (n=2) 0.02±0.03 0.02 
 Striated / Smooth muscle (n=5) 4.48±2.1 1.9 
 Spleen (n=1) 0.0 0.0 
 Placenta (n=5) 1.5±1.8 0.9 
 Salivary gland (n=1) 6.1 6.1 
CC.: Clear cell.  
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Table 40: p-values arising from the comparison of ECM non-cellular 
parameters in different tissues.  
Parameter Collagen type I F 
Prim. NB vs Non-prim. NB 0.015 
Prim. NB vs per. tissue 0.015 
Prim. NB vs other tumors  - 
Prim. NB vs non-tumoral - 
Non-prim. NB vs per. tissue - 
Non-prim. NB vs other tumors - 
Non-prim. NB vs non-tumoral - 
Per. Tissue vs other tumors - 
Per. Tissue vs non-tumoral - 
Other tumors vs non-tumoral - 
Prim. NB: primary NB, not-prim NB: non-primary NB, per.tissue: peritumoral 
tissue. 
4.3. Elastic fibers 
Elastic fibers appear restricted to vascular contours and, in few 
cases, to fibrous trabecules. In every case, the amount of elastic fibers 
in tumor parenquimatous areas was negligible (figure 68). 100% of the 
evaluable cylinders are scored negative: no expression is detected or 
<5% of stained area. 
This ECM element is therefore not specially distributed within 
different subsets of neuroblastic tumors not can be used as prognostic 
factor for neuroblastoma patients. 
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Figure 68: Example of a cylinder stained with Orcein to detect elastic fibers. A) 
The whole cylinder is shown. B) Detail where it can be observed that no elastic 
fibers exist within the tumor cells and that these fibers are restricted to blood 
vessels.  
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5. Study of the blood vessels.  
5.1. Generalities of vascularization  
Among the 458 primary tumors studied, 85 samples could not 
be analyzed for technical reasons (not representative area and mostly 
lost cylinder). Among the 373 samples left, 48 did not show any 
positivity for blood vessels. These cases were counted as samples with 
zero vessels/mm2 and 0% of stained area for quantity variables and 
therefore were not taken into account for size and shape variables, 
which were calculated for a subset of 325 samples (figure 69). 
 
Figure 69: Distibution of the positive samples for CD31 
immunohistochemistry, depending on the type of blood vessels studied, 
according to their maximum diameter or length. 
Doctoral thesis                                                    Irene Tadeo Cervera 
-  - 
 
5.2. Histological observation 
Some vessels had an incomplete outline of epithelial cells 
expressing CD31 (figure70). The outline lacking epithelial cells was 
covered by round or polygonal cells which could be neuroblastic cells, 
immune cells or stem cells. Occationally, other more fusiform cells 
occupied these spaces. This could correspond to angiogenic mimicry. 
 
Figure 70: Example of a blood vessel with incomplete outline. Note the 
neuroblastic-like cells occupying the area without epithelial cells (arrow). 
In a few samples most of the tissue area lacked CD31 
expression, but however presented one or two vessels with CD31 
positive endothelial cells. One example is shown in figure 71. In it, we 
can observe how the cylinder is mainly negative but shows, in the 
lower part of the cylinder two stained vessels, therefore indicating that 
the technique is working properly. Different hypotheses to explain this 
finding will be discussed.   
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Figure 71: Cylinder with no expression for CD31 antibody except for two 
stained blood vessels. A) Detail of a negative area filled with erythrocytes. B) 
Image showing the whole cylinder with several areas such as the one 
presented in A. C) Detail of an area with two CD31 positive blood vessels. 
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In some cases, high endothelial venules (HEV) were found 
associated to tertiary lymph nodes or to non-grouped leukocytes 
(figure 72). Different antibodies were used to characterize the 
leukocytic cells. Moreover, some special organizations of the blood 
vessels with regard to neuroblastic and stromal cells are shown in 
figure 73. Blood vessels could be embolized by tumor cells therefore 
fostering the spreading of the disease, but some observed 
characteristics made difficult to distinguish whether this corresponded 
to a blood vessel embolization or the presence of tumor cell bundles 
isolated and surrounded by several blood vessels which were also 
present inside the clusters. In other cases, blood vessels were found 
collapsed (figure 74). 
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Figure 72: Special blood vessels in a subset of NBs, detected with CD31 
antibody. A) HEV within a tertiary lymph node. B) HEV in close relationship 
with individual leukocytes within the tumor stroma.  
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Figure 73: Spatial relationship between blood vessels and neuroblastic cells 
clusters. A) The vessels are embolized by tumor cells. B) Tumor cells are inside 
a blood vessel or many intermingled vessels surround the tumor cells. Some 
small vessels can be noticed inside the tumor cell cluster. C) In this case we 
can appreciate how many blood vessels with visible lumen are surrounding a 
tumor cell cluster with some microvessels inside. 
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Figure 74: Two examples of blood vessels with collapsed lumen.  
5.3. Total blood vascularization 
5.3.1. Description of the variables 
The description of the quantity, size and shape is shown in 
table 41.  Neuroblastic tumors had an average of 161±177 vessels/mm2 
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(figure 75) occupying an area of 1.7±1.2% of the tissue. The mean 
blood vessel was 14µm long and 7µm wide and had a perimeter of 
42µm with an average area of 101µm2. Regarding the average of the 
shape parameters, neuroblastic tumors blood vessels describe round, 
regular and smooth shapes with low degree of deformity and 
branching. 
 
Figure 75: Different degrees of presence of blood vessels. The number of 
vessels per mm
2
 is shown. A) NB with scarce blood vessels in its ECM. B) NB 
with high amount of blood vessels.  C) Placenta as positive control, with a high 
amount of blood vessels (mainly capillaries). A’, B’, C’: The binarized image of 
A, B, C is shown to better distinguish the blood vessels (in white on a black 
background) 
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Table 41: Description of the morphometric measurements of the blood vessels 
in a subset of 373 samples for quantity variables and 325 for size and shape 
variables. 
Parameter Mean Median SD Min. Max. 
Quantity  
Density 161.1 102.4 177.7 0 1105 
% stained area 1.7 1.2 1.9 0 15 
Size 
Average area 100.9 69.6 278.9 22 4801 
Length 13.9 12.5 13.1 8 239 
Width 6.8 6.6 1.7 4 21 
Perimeter 42.4 40 14.4 21 187 
Shape 
Aspect 2.2 2.1 0.2 2 4 
Roundness 2.4 2.3 0.3 2 4 
Perimeter ratio 0.84 0.85 0.01 0.79 0.90 
Deformity 600.6 427.2 652.8 42 6198 
Shape factor 2.2 0.4 21.5 0.1 373 
Branching 2.7 2.7 0.2 2 4 
5.3.2. Favorable and unfavorable blood 
vessel histological patterns 
Most of the morphometric variables related to blood vessels 
were associated to the risk group. Blood vessels quantity was related to 
histopathology, size was related to MYCN status, shape was related to 
stage (aspect and vertices), histopathology (aspect and shape factor), 
MYCN status (all variables except roundness and perimeter ratio) and 
11q status (aspect). Stage was very close from being significantly 
related to the blood vessels width (p= 0.058) and age was very close 
from being related to the blood vessels roundness (p= 0.051) (table 
42). 
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How these variables behaved depending on the INRG features 
is shown in figures 76 to 798 Only variables with significant relationship 
with at least one INRG variable are shown. 
A. Quantity variables 
Tumors with a differentiated histology had a smaller amount of 
blood vessels which covered a smaller area, than tumors with 
undifferentiated histology (figure 76).  
Figure 76: Distribution of the total number of vessels/mm
2
 depending on the 
INRG clinical and biological variables. Variables in grey mean no significant 
statistical relationship. Colored variables show significant statistical 
relationship (table 42). The median values are shown.  
B. Size variables 
The blood vessels of MNNA tumors and of those from non-high 
risk patients were smaller than the vessels of MNA tumors and from 
high risk patients. Although not completely significant, localized stages 
also had vessels with lower width than advances stages (figure 77). 
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Figure 77: Distribution of the average area of total vascularization depending 
on the INRG clinical and biological variables. Variables in grey mean no 
significant statistical relationship. Colored variables show significant statistical 
relationship (table 42). The median values are shown. 
C. Shape variables 
Aspect was higher and, therefore, blood vessels were more 
ovoid for all better-prognosis INRG categories of stage, histopathology, 
MYCN status, 11q status and risk group. On the contrary, tumors from 
patients younger than 18 months of age tended to have a smaller 
roundness which is associated with a more round (less ovoid) shape. 
Neuroblastic tumors blood vessels had a smaller deformity for MNNA 
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tumors and those from non-high risk patients and a more regular shape 
for MNA and differentiated tumors. Fewer branching was found in 
MNNA tumors with localized disease and from non-high risk patients 
(figure 78). 
Figure 78: Distribution of the aspect of total vascularization depending on the 
INRG clinical and biological variables. Variables in grey mean no significant 
statistical relationship. Colored variables show significant statistical 
relationship (table 42). The median values are shown. 
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5.3.3. Survival analysis 
A. Multivariate analysis 
The results of the analysis of the relationship between the total 
blood vessels morphometric measurements and the EFS and OS 
variables on the 325 samples presenting blood vessels are shown in 
table 43.  
Regarding EFS, we can observe that a larger length and a lower 
roundness were related with a higher risk of relapse with HR of 9.7 
(1.01-1.08) and 4.2 (0.1-0.9), respectivelly. Regarding OS, we could 
observe that a higher branching degree, with a HR of 12.3 (2.0-12.8), 
and a lower amount of vessels, with a HR of 4.2 (0.9-1.0), influenced 
poor OS. Nevertheless, in both cases, the influence was lost when 
including the INRG variables, whether considering or not the stage 
variable.  
Table 43: Results of the Cox regression showing the influence of total blood 
vessels morphometric measurements on their own and in combination with 
the INRG variables on 5 and 10-year EFS%.  
  Variable HR (95% CI) p-value 
  EFS 
a BV length 9.7 (1.01-1.08) 0.002 
BV roundness 4.2 (0.1-0.9)^ 0.036 
b, c  - 
  OS 
a BV branching 12.3 (2.0-12.8) 0.000 
BV density 4.2 (0.9-1.0)^ 0.000 
b, c  - 
a: morphometric variables on their own, b: morphometric variables + all INRG 
variables, c: morphometric variables + INRG variables except stage, BV: blood 
vessels, nº: number of blood vessels, HR: Hazard ratio, CI: Confidence interval, 
-: no statistically significant morphometric variable. ^Inverse correlation. 
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B. Study of the high risk group 
The dichotomized morphometric variables showed statistically 
significant differences regarding survival (OS, EFS). A table with the 
morphometric parameters and the cut points is provided (table 44). 
The Kaplan-Meier graphs are shown (figure 79 to 80). 
Table 44: Morphometric variables and cut points used to dichoromize them. 
Parameter 
EFS OS 
Cut point p-value Cut point p-value 
Density - - - - 
% stained area - - Q3: 2.27 0.020 
Average area - - - - 
Length - - - - 
Width - - - - 
Perimeter - - - - 
       Aspect - - - - 
Roundness - - - - 
Perimeter ratio - - - - 
Deformity - - - - 
Shape factor Q1: 0.28 0.047 Q1: 0.28 0.033 
Branching - - - - 
Q1: first quartile, Q2: median, Q3: third quartile, -: not statistically significant. 
 Blood vessels quantity variables 
The % of area covered by blood vessels defined two risk groups 
within the high risk patients. When the % of stained area was over the 
3rd quartile, the patients had a 23.7±7.0% 5-year OS (figure 79).  
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Figure 79: Kaplan-meier graph showing the different accumulated survival 
depending on the % of stained area. 
 Blood vessels shape variables 
A shape factor over the first quartile value defined a high risk 
group with 30% 5-year EFS and 24% 5-year OS, within our high risk 
cohort (figure 80). 
 
Figure 80: Kaplan-meier graph showing the different accumulated survival 
depending on the shape factor. A) EFS and B) OS. 
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5.3.4. Blood vessels after treatment and 
in other samples 
The number of blood vessels of the different subtypes 
corresponding to the different samples of primary NB, non-primary NB, 
peritumoral tissue, tissue from other tumors and nom-tumoral tissue is 
shown in table 45. The statistical analysis comparing the different 
groups of samples is presented in table 46.  
No statistically significant changes were found between the 
amount of blood vessels in primary tumors and non-primary tumors. 
Both primary and non-primary NB blood vascularization differed from 
peritumoral tissue and non-tumoral tissue blood vessels. In general, 
total and all subtypes of blood vessels are increased in number in 
neuroblastic tumors (primary and non-primary) with respect to the 
major host tissue, the adrenal gland. This rise was more important for 
venules and arterioles. 
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Table 46: p-values arising from the comparison of the blood vessels amount in 
different tissues.  
Parameter TOTAL Cap 
PC/ 
MA 
S Vu/Ao V/A 
Prim. NB vs 
Non-prim. NB 
- - - - - - 
Prim. NB vs per. 
tissue 
- - 0.019 0.026 0.008 - 
Prim. NB vs 
other tumors 
- - - - - - 
Prim. NB vs 
non-tumoral 
- - - 0.033 0.002 - 
Non-prim. NB 
vs per. tissue 
- - 0.009 0.016 0.002 - 
Non-prim. NB 
vs other tumors 
- - - - - - 
Non-prim. NB 
vs non-tumoral 
- - - 0.025 0.001 - 
Per. Tissue vs 
other tumors 
- - - - - - 
Per. Tissue vs 
non-tumoral 
- - - - - - 
Other tumors 
vs non-tumoral 
- - - - - - 
Cap: capillaries, PC/MA: post-capillary venules and metarterioles, S: sinusoid-
like blood vessels, collecting-venules and end-arterioles, Vu/Ao: venules and 
arterioles, V/A: veins and arteries, Prim. NB: primary NB, not-prim NB: non-
primary NB, per.tissue: peritumoral tissue, -: not statistically significant. 
 
5.4. Capillaries (5-15µm) 
5.4.1. Description of the variables 
The majority of the vessels (67.6%) found in neuroblastic 
tumors belonged to this class of small vessels with 5 to 15µm of 
maximum diameter. These are the vessels enabling nutrient and 
oxygen exchange. Neuroblastic tumors had an average of 121 of this 
type of blood vessels per mm2 and a tumor area occupied by vessels of 
0.5%. The features related to these vessels are shown in table 47.  
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Table 47: Description of the morphometric measurements of the blood vessels 
within 5 and 15µm of length, in a subset of 373 samples for quantity and 325 
for size and shape variables.  
Parameter Mean Median SD Min. Max. 
Quantity 
Density 121.1 84.1 130.9 0 735 
% stained area 0.5 0.4 0.4 0 3 
Relative density 67.6 76.1 27.4 0 100 
Relative area 32.3 30.8 21.1 0 100 
Size 
Average area 30.8 31.5 5.6 18 50 
Length 8.6 8.6 0.4 7 10 
Width 5 6.2 0.6 4 7 
Perimeter 25.7 26 1.9 20 33 
Shape 
Aspect 2.1 2 0.3 2 4 
Roundness 1.9 1.9 0.2 2 3 
Perimeter ratio 0.87 0.87 0.008 0.84 0.91 
Deformity 93.6 93.5 15.1 42 155 
Shape factor 0.5 0.2 1.5 0.1 26 
Branching 2.4 2.4 0.1 2 3 
5.4.2. Favorable and unfavorable 
capillaries histological patterns 
Histopathology and MYCN status were related with almost all 
variables of quantity, size and shape. Stage was related to the shape of 
the capillaries and very near to be related with width and aspect. Age 
was related to the % of stained area, relative area and deformity, and 
tended to be related to perimeter. Exactly the same variables of size 
and shape that are related to MYCN status (area, width, aspect, 
roundness and shape factor) area also related to the risk group (table 
48).  
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How these variables were related is shown in figure 81 to 83. 
Only variables with significant relationship with at least one INRG 
variable are shown. 
A. Quantity variables 
The number of capillaries and the stained area were lower in 
the differentiated tumors. This last parameter was higher in tumors 
with MNNA and in tumors from patients younger than 18 months of 
age. Moreover, the tumors with MNNA had a higher amount of their 
vessels corresponding to this group and a higher amount of stained 
area corresponding to capillaries was found in tumors from patients 
younger than 18 months of age (figure 81).  
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Figure 81: Distribution of the number of capillaries/mm
2
 depending on the 
INRG clinical and biological variables. Variables in grey mean no significant 
statistical relationship. Colored variables show significant statistical 
relationship (table 48). The median values are shown. 
B. Size variables 
In general, the capillaries from tumors with favorable features 
(non-high risk patients, differentiated histology and/or MNNA) were 
smaller (area, length, width, perimeter) than their counterparts. The 
same happens with localized tumors for the width variable. Patients 
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older than 18 months of age have tumor capillaries with small 
perimeter (figure 82). 
Figure 82: Distribution of the average area occupied by capillaries depending 
on the INRG clinical and biological variables. Variables in grey mean no 
significant statistical relationship. Colored variables show significant statistical 
relationship (table 48). The median values are shown. 
C. Shape variables 
Non-high risk patients with tumors with localized disease, 
favorable histology, MNNA and 11ND had capillaries with a higher 
aspect or more ovoid and therefore less round with less deformity, 
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higher shape factor and lower branching than their counterpatrs. 
Tumors from patients <18 months have a more deform cappilaries than 
those from patients >18 months (figure 83). 
Figure 48: Distribution of the aspect of the capillaries depending on the INRG 
clinical and biological variables. Variables in grey mean no significant statistical 
relationship. Colored variables show significant statistical relationship (table 
32). The median values are shown. 
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5.4.3. Survival analysis 
A. Multivariate analysis 
The results of the analysis of the relationship between the 
morphometric measurements of capillaries and the EFS and OS 
variables on 325 samples (those presenting capillaries) are shown in 
table 49.  
This table indicates that a lower amount of capillaries affected 
EFS although the influence was not strong enough to be found in 
combination with the INRG variables, with and without including the 
stage variable. Regarging OS, we could observe that, again a lower 
amount of capillaries, together with a lower relative amount of vessels 
corresponding to this subgroup affected survival.  
Table 49: Results of the Cox regression showing the influence of capillary 
morphometric measurements on their own and in combination with the INRG 
variables on EFS and OS.  
  Variable Wald HR (95% CI) p-value 
EFS 
a C density 5.5 0.99 (0.9-1.0)^ 0.019 
b, c          - 
OS 
a C density 6.0 0.99 (0.94-0.99)^ 0.014 
C rel. density 5.7 0.96 (0.94-0.99)^ 0.017 
b MYCN 25.0 4.97 (2.6-9.3) 0.000 
Stage 19.46 
 
0.000 
c MYCN 28.8 5.36 (2.9-9.9) 0.000 
Age 6.5 2.40 (1.2-4.7) 0.010 
a: morphometric variables on their own, b: morphometric variables + all INRG 
variables, c: morphometric variables + INRG variables except stage, C: 
capillary, rel. density: relative number of vessels corresponding to this 
subgroup, HR: Hazard ratio, CI: Confidence interval, -: no statistically 
significant morphometric variable. ^Inverse correlation. 
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B. Study of the high risk group 
The dichotomized morphometric variables showed statistically 
significant differences regarding survival (OS, EFS). A table with the 
morphometric parameters and the cut points is provided (table 50). 
The Kaplan-Meier graphs are shown in figure 84. 
Table 50: Morphometric variables and cut points used to dichoromize them. 
Parameter 
EFS OS 
Cut point p-value Cut point p-value 
Density - - - - 
% stained area - - - - 
Relative density - - - - 
Relative area - - - - 
Average area - - - - 
Length - - - - 
Width - - - - 
Perimeter - - - - 
       Aspect - - - - 
Roundness Q1: 1.71 0.026 - - 
Perimeter ratio - - - - 
Deformity - - - - 
Shape factor Q2: 0.24 0.006 - - 
Branching - - - - 
Q1: first quartile, Q2: median, Q3: third quartile, -: not statistically significant. 
 Capillaries shape variables 
A roundness over the first quartile defined an ultra-high risk 
subgroup with 30±5 % of 5-year EFS. Moreover, a shape factor over the 
median value was associated with an ultra-high risk group with 12% 5-
year EFS, within the high risk patients group (figure 84). 
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Figure 84: Kaplan-meier graph showing the different accumulated survival 
depending on the shape parameters. A) roundness and B) shape factor. 
5.5. Post-capillary venules and metarterioles 
(15-20µm) 
5.5.1. Description of the variables 
Almost 8% of the vessels belonged to this class of small vessels 
with 15 to 20µm of length. Neuroblastic tumors showed an average of 
18.5 of this type of blood vessels per mm2 and a tumor area occupied 
by vessels of 0.18%. The features related to these vessels were shown 
in table 51. Among the 325 samples with positivity for CD31, 6 cases 
did not present any vessel between 15 and 20µm of length. 
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Table 51: Description of the morphometric measurements of the blood vessels 
within 15 and 20µm of length, in a subset of 373 samples for quantity and 319 
for size and shape variables. 
Parameter Mean Median SD Min. Max. 
Quantity 
Density 18.5 14.7 19 0 143 
% stained area 0.18 0.12 0.19 0 1 
Relative density 7.8 8.5 4.1 0 23 
Relative area 9.8 10.8 5.7 0 37 
Size 
Average area 88 88.1 14.6 34 145 
Length 17.1 17.2 0.8 16 19 
Width 8.92 8.98 1.2 4 13 
Perimeter 54.5 54.8 4.6 19 71 
Shape 
Aspect 2.3 2.2 0.4 1 6 
Roundness 2.9 2.8 0.4 1 4 
Perimeter ratio 0.79 0.79 0.04 0.41 0.90 
Deformity 467 168.2 93 109 1004 
Shape factor 0.74 0.44 1.2 0.1 13 
Branching 3.26 3.29 0.3 1 4 
5.5.2. Favorable and unfavorable post-
capillaries venules and metarterioles 
histological patterns 
Stage, MYCN status and risk group were the variables most 
related with the morphometric variables. Stage was related to the size 
(area, length, width), the aspect and the shape index of the vessels 
within 15 and 20 µm. MYCN status was related to the relative amount 
of vessels corresponding to this subgroup, to the area and width, and 
to the aspect, roundness, shape factor and branching. The risk group 
was related to the same size and shape parameters than MYCN. The 
age was related to the number of vessels. Finally, histopathology was 
related to the shape parameters aspect and shape factor (table 52).  
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How these variables were related is shown in figures 85 to 87. 
Only variables with significant relationship with at least one INRG 
variable are shown. 
A. Quantity variables 
Tumors from patients under 18 months of age had a higher 
amount of post-capillary venules and metarterioles. On the contrary, 
although not statistically significant, the rest of parameters related to 
better prognosis presented a lower amount of blood vessels of this 
type. Moreover, tumors with MNNA had a lower relative number of 
blood vessels corresponding to this subgroup than tumors with MNA 
(figure 85). 
Figure 85: Distribution of the number of post-capillary venules and 
metarterioles/mm2 depending on the INRG clinical and biological variables. 
Variables in grey mean no significant statistical relationship. Colored variables 
show significant statistical relationship (table 52). The median values are 
shown. 
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B. Size variables 
Post-capillary venules and metarterioles with the lower size 
were related to localized stages (average area, length and width), non-
high risk patients (width) and MNNA tumors (average area and width) 
(figure 86). 
Figure 86: Distribution of the average area of post-capillary venules and 
metarterioles depending on the INRG clinical and biological variables. 
Variables in grey mean no significant statistical relationship. Colored variables 
show significant statistical relationship (table 52). The median values are 
shown. 
C. Shape variables 
Tumors corresponding to localized stage disease, with 
differentiated histopathology, MNNA and from non-high risk patients 
had more ovoid vessels in this subgroup and a lower shape factor. 
Roundness is lower for MNA tumors but higher for tumors from non-
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high risk patients than for their counterparts. A lower branching was 
detected in MNNA tumors and those from non-high risk patients 
compared to MNA tumors and from high risk patients (figure 87).  
Figure 87: Distribution of the aspect of post-capillary venules and 
metarterioles depending on the INRG clinical and biological variables. 
Variables in grey mean no significant statistical relationship. Colored variables 
show significant statistical relationship (table 52). The median values are 
shown. 
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5.5.3. Survival analysis 
A. Multivariate analysis 
The results of the analysis of the relationship between the 
capillaries morphometric measurements and the EFS and OS variables 
on 325 samples (those presenting post-capillary venules and 
metarterioles) are shown in table 53.  
Both for EFS and for OS, the size variables larger area and 
shorter length were influencing survival when including in the analysis 
only the morphometric variables. For EFS, a higher shape factor was 
also related with poor survival after a larger area and a shorter length. 
When including all INRG variables, the shorter length remained 
significantly related to EFS, with a HR of 0.625 (0.4-0.8), after stage, 
histopathology, thicker width, with a HR of 1.4 (1.1-1.7), and genomic 
profile. Regarding OS, the stage variable was so strong that the 
influence of the size morphometric variables disappeared. When 
considering all INRG variables except the stage, some size variables 
appeared as significantly related to survival. Specifically, a larger area 
was related to EFS with a HR of 1.02 (1.0-1.03) and thicker and shorter 
vessels were related to OS with HRs of 1.4 (1.1-1.8) and 0.7 (0.5-0.9), 
respectively. Moreover, a higher shape index and a lower perimeter 
ratio were found related to EFS after MYCN status, with a HR of 0.0 
(0.0-0.03). 
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Table 53: Results of the Cox regression showing the influence of post-capillary 
venules and metarterioles morphometric measurements on survival.  
  Variable Wald HR (95% CI) 
p-
value 
EFS 
a PC/MA shape factor 4.3 1.1 (1.0-1.3) 0.036 
 PC/MA area 19.2 1.0(1.02-1.05) 0.000 
PC/MA length 11.5 0.6 (0.4-0.8)^ 0.001 
b Stage 22.04 
 
0.000 
Histopathology 6.9 
 
0.072 
PC/MA width 7.7 1.4 (1.1-1.7) 0.005 
Genomic profile 4.9 2.5 (1.1-5.7) 0.027 
PC/MA length 4.4 0.7 (0.5-0.9)^ 0.035 
c MYCN 13.3 2.8 (1.6-5.0) 0.000 
PC/MA per. ratio 10.6 0.0 (0.0-0.03)^ 0.001 
11q 9.1 2.2 (1.3-3.8) 0.003 
Age 5.8 2.0 (1.1-3.5) 0.016 
PC/MA area 5.5 1.02 (1.0-1.03) 0.018 
OS 
a PC/MA area 17.7 1.03 (1.02-1.05) 0.000 
PC/MA length 10.0 0.6 (0.4-0.8)^ 0.002 
b                    - 
c MYCN 18.4 4.0 (2.1-7.7) 0.000 
Age 7.3 2.6 (1.3-5.4) 0.007 
PC/MA width 7.2 1.4 (1.1-1.8) 0.007 
11q 6.4 2.2 (1.2-4.0) 0.011 
PC/MA length 4.3 0.7 (0.5-0.9)^ 0.037 
a: morphometric variables on their own, b: morphometric variables + all INRG 
variables, c: morphometric variables + INRG variables except stage, PC/MA: 
post-capillary venules and metarterioles, per. ratio: perimeter ratio, HR: 
Hazard ratio, CI: Confidence interval, -: not statistically significant 
morphometric variable. ^Inverse correlation. 
B. Study of the high risk group 
No differences were found in EFS and OS for high risk patients 
regarding the post-capillaries/metarterioles morphometric variables. 
Kaplan-Meier curves are therefore not shown. 
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5.6. Sinusoid-like blood vessels (20-50µm) 
5.6.1. Description of the variables 
An average of almost 10% of the vessels belonged to this class 
of small vessels with 20 to 50 µm of length. These were the second 
most frequent type of vessels in NB, which had an average of 24,8 of 
this type of blood vessels per mm2 and an area occupied by vessels of 
0,5% of the tumor area. The features related to these vessels are 
shown in table 54. Among the 325 samples with positivity for CD31, 6 
cases did not present any vessel between 20 and 50µm of length. 
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Table 54: Description of the morphometric measurements of the blood vessels 
within 20 and 50µm of length, in a subset of 373 samples for quantity and 319 
for size and shape variables. 
Parameter Mean Median SD Min. Max. 
Quantity 
Density 24.8 19.7 27 0 200 
% stained area 0.52 0.31 0.61 0 4 
Relative density 9.87 10.4 6.3 0 28 
Relative area 24.7 27.6 13.7 0 60 
Size 
Average area 196.3 191.3 57.7 84 768 
Length 28.4 28.4 2.7 20 50 
Width 12.8 12.8 2 7 27 
Perimeter 95 94.6 13.7 64 210 
Shape 
Aspect 2.6 2.5 0.3 1 4 
Roundness 4.1 4 0.76 2 14 
Perimeter ratio 0.75 0.75 0.37 0.58 0.88 
Deformity 1478.3 1456.2 398 356 3699 
Shape factor 1.1 0.7 2 0.7 26 
Branching 3.8 3.8 0.3 3 6 
5.6.2. Favorable and unfavorable 
sinusoid-like blood vessels histological 
patterns 
Stage was related to the amount of vessels and the relative 
number of vessels of to this type, to width, aspect, roundness, shape 
factor and branching. Histopathology was related to all variables except 
relative number, length, roundness and deformity. MYCN was related 
to relative number, all size variables except perimeter and all shape 
variables except deformity. Age was related to the branching degree of 
sinusoid-like blood vessels. Genetic profile, 11q status and ploidy did 
not show any statistically significant relationship with the 
morphometric variables regarding this subgroup of vessels. Again, risk 
group was related to exactly the same variables than MYCN (except for 
length and perimeter ratio) (table 55). 
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How these variables were related is shown in figures 88 to 90. 
Only variables with significant relationship with at least one INRG 
variable are shown. 
A. Quantity variables 
Tumors with the lower amount of sinusoid-like blood vessels 
corresponded to differentiated neuroblastic tumors with localized 
stage disease. Differentiated tumors also had a lower stained area, and 
a lower amount of vessels belonging to this subgroup (relative area). 
Non-high risk patients with localized disease and tumors MNNA had a 
lower relative number of vessels corresponding to sinusoid-like blood 
vessels (figure 88). 
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Figure 88: Distribution of the number of sinusoid-like blood vessels/mm
2
 
depending on the INRG clinical and biological variables. Variables in grey mean 
no significant statistical relationship. Colored variables show significant 
statistical relationship (table 55). The median values are shown. 
B. Size variables 
Tumors from non-high risk patients (for area and width) with 
differentiated histology, MNNA (except for perimeter) and from 
patients with localized disease (for width) had smaller blood vessels in 
this subgroup (figure 89). 
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Figure 89: Distribution of the average area of sinusoid-like blood vessels 
depending on the INRG clinical and biological variables. Variables in grey mean 
no significant statistical relationship. Colored variables show significant 
statistical relationship (table 55). The median values are shown. 
 
C. Shape variables 
High risk patients with localized disease and MNNA tumors had 
sinusoid-like blood vessels with a higher aspect, a higher roundness, a 
higher shape and a lower branching degree than their counterparts. 
MNNA tumors were also associated with a lower perimeter ratio (more 
irregular outline), contrarily from tumors with differentiated 
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histopathology. The later also had sinusoid-like blood vessels with a 
higher aspect, shape factor and branching than undifferentiated 
tumors. Finally, age under 28 months was related to a lower branching 
degree (figure 90). 
Figure 90: Distribution of the aspect of sinusoid-like blood vessels depending 
on the INRG clinical and biological variables. Variables in grey mean no 
significant statistical relationship. Colored variables show significant statistical 
relationship (table 55). The median values are shown. 
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5.6.3. Survival analysis 
A. Multivariate analysis 
The results of the analysis of the relationship between the 
sinusoid-like blood vessels measurements and the EFS and OS variables 
on the 319 samples are shown in table 56.  
A lower roundness and aspect were related to EFS with HRs of 
0.5 (0.3-0.8) and 0.3 (0.1-0.8), respectively, when testing the 
morphometric variables on their own. A lower aspect was also related 
to OS with a HR of 0.1 (0.3-0.2), together with a higher perimeter ratio, 
with a HR of 8.2e5 (175-3.8e9) and a higher relative number of blood 
vessels corresponding to sinusoid-like blood vessels, with a HR of 1.0 
(1.0-1.1). When including all INRG variables, short sinusoid-like blood 
vessels were significantly related to a higher risk of relapse whether 
including or not the stage (0.8 (0.7-0.9)). Regarding OS, we could 
observe that shorter sinusoid-like blood vessels were also related to 
poor prognosis in combination with a higher relative number of vessels 
corresponding to this subgroup, when considering all INRG variables 
with or witout the stage. 
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Table 56: Results of the Cox regression showing the influence of sinusoid-like 
blood vessels morphometric measurements in combination with the INRG 
variables on 5 and 10-year OS%.  
  Variable Wald HR (95% CI) p-value 
EFS 
a S roundness 7.8 0.5 (0.3-0.8)^ 0.05 
S aspect 6.0 0.3 (0.1-0.8)^ 0.014 
b Stage 20.1 
 
0.000 
MYCN 16.4 3.2 (1.8-5.8) 0.000 
S length 8.6 0.8 (0.7-0.9)^ 0.003 
11q 8.1 2.2 (1.2-3.9) 0.004 
c MYCN 24.1 4.3 (2.4-7.7) 0.000 
11q 17.1 3.0 (1.8-5.1) 0.000 
S length 8.0 0.8 (0.7-0.9)^ 0.004 
Age 5.3 1.9 (1.1-3.2) 0.021 
OS 
a S aspect 20.1 0.1 (0.3-0.2)^ 0.000 
S per. ratio 9.9 8.2e5 (175-3.8e9) 0.002 
S rel. density 8.6 1.0 (1.0-1.1) 0.003 
b MYCN 24.1 5.0 (2.6-9.5) 0.000 
Stage 19.9 
 
0.000 
S length 9.8 0.8 (0.7-0.9)^ 0.002 
S rel. density 6.6 1.0 (1.0-1.1) 0.002 
11q 5.6 2.1 (1.1-4.0) 0.017 
c MYCN 27.3 5.9 (3.0-11.5) 0.001 
S length 10.2 0.8 (0.7-0.9)^ 0.001 
11q 10.1 2.6 (1.4-4.9) 0.001 
Age 8.8 2.8 (1.4-5.5) 0.003 
S rel. density 4.5 1.0 (1.0-1.1) 0.033 
a: morphometric variables on their own, b: morphometric variables + all INRG 
variables, c: morphometric variables + INRG variables except stage, S: 
Sinusoid-like blood vessels, per. ratio: perimeter ratio, rel. density: relative 
number of vessels corresponding to this subgroup, HR: Hazard ratio, CI: 
Confidence interval. ^Inverse correlation. 
B. Study of the high risk group 
No differences were found in EFS and OS for high risk patients 
regading the sinusoid-like blood vessels morphometric variables. 
Kaplan-Meier curves are therefore not shown. 
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5.7. Venules and arterioles (50-200µm) 
5.7.1. Description of the variables 
Only 1.7% of the vessels belonged to this class of vessels with 
20 to 50 µm of length. Neuroblastic tumors had an average of 13 blood 
vessels this type of per mm2 and an area occupied by vessels of 0.4% of 
the tumor area. The features related to these vessels are shown in 
table 57. Among the 325 samples with positivity for CD31, 57 cases did 
not present any vessel between 50 and 200µm of length. 
Table 57: Description of the morphometric measurements of the blood vessels 
within 50 and 200µm of length, in a subset of 373 samples for quantity and 
268 for size and shape variables. 
Parameter Mean Median SD Min. Max. 
Quantity 
Density 13.2 2.6 27.4 0.0 271.2 
% stained area 0.4 0.2 0.7 0.0 4.6 
Relative 
density 
1.7 1.1 2.1 0.0 15.2 
Relative area 16.2 13.9 15.7 0.0 81.4 
Size 
Average area 992.0 836.8 748.3 168.7 8168.3 
Length 74.0 72.0 14.9 50.1 150.0 
Width 27.1 26.2 9.8 9.1 100.4 
Perimeter 280.1 271.1 97.6 134.8 1124.6 
Shape 
Aspect 3.37 3.27 0.94 1.44 7.74 
Roundness 7.73 7.63 2.31 1.93 16.28 
Perimeter ratio 0.66 0.66 0.08 0.40 0.93 
Deformity 10649 9358 6924 993 79615 
Shape factor 5.96 2.04 14.47 0.05 127.05 
Branching 5.30 5.33 0.72 3.00 9.00 
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5.7.2. Favorable and unfavorable 
venules and arterioles histological patterns 
Histopathology, MYCN status, ploidy and the risk group showed 
statistically significant relationships with few morphometric variables 
regarding venules and arterioles. Histopathology was related to 
roundness, MYCN status, the relative density and the relative area; and 
ploidy was related to all size variables (area, length, width and 
perimeter) (table 58).  
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How that these variables were related is shown in figures 91 to 
93. Only variables with significant relationship with at least one INRG 
variable are shown. 
A. Quantity variables 
MNNA tumors presented a lower relative number of venules 
and arterioles that occupied a lower relative area with respect to total 
blood vasculature, compared to MNA tumors. Tumors from low risk 
patients also presented a lower relative number of vessels 
corresponding to venules and arterioles than tumors from high risk 
patients (figure 91). Although not statistically significant, all INRG 
variables related with good-prognosis were also associated to a lower 
relative amount and area corresponding to venules and arterioles. 
Figure 91: Distribution of the number of venules and arterioles/mm
2
 
depending on the INRG clinical and biological variables. Variables in grey mean 
no significant statistical relationship. Colored variables show significant 
statistical relationship (table 58). The median values are shown. 
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B. Size variables 
Only ploidy was related to all size variables. Hyperdiploid 
tumors had smaller venules and arteries in area, length and width and 
perimeter than diploid tumors (figure 92). 
Figure 92: Distribution of the average area of venules and arterioles 
depending on the INRG clinical and biological variables. Variables in grey mean 
no significant statistical relationship. Colored variables show significant 
statistical relationship (table 58). The median values are shown. 
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C. Shape variables 
Tumors with the better prognosis-related histopathology 
showed venules and arteries with a rounder shape (lower roundness 
value) than tumors with undifferentiated or poorly differentiated 
histopathology (figure 93).  
Figure 93: Distribution of the roundness of venules and arterioles depending 
on the INRG clinical and biological variables. Variables in grey mean no 
significant statistical relationship. Colored variables show significant statistical 
relationship (table 58). The mean values are shown. 
5.7.3. Survival analysis 
A. Multivariate analysis 
The results of the analysis of the relationship between the 
venules and arterioles measurements and the EFS and OS variables on 
the 268 samples are shown in table 59.  
Regarding EFS, we could observe that a higher shape factor of 
the venules and arterioles affected survival with a HR of 1.01 (1.00-
1.02). When including all INRG variables in the analysis, a lower relative 
area occupied by venules and arterioles appeared to be associated with 
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poor survival after stage, MYCN and 11q status, whether including or 
excluding the stage variable with HRs of 0.97 (0.95-0.99) and 0.96 
(0.94-0.98), repectively, and, when excluding the stage variable, longer 
vessels also influenced EFS with a HR of 1.02 (1.00-1.04) after MYCN 
status, 11q status, relative area and age. 
Regarding OS, a higher shape factor, a higher relative number 
or a lower relative area covered by venules and arterioles appeared as 
related with survival in the three cases. When considering all 
morphometric variables together with the INRG variables, a higher 
percentage of stained area was also significantly related to prognosis, 
whether including or not the stage variable. 
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Table 59: Results of the Cox regression showing the influence of venules and 
arterioles morphometric measurements on their own and in combination with 
the INRG variables on survival.  
  Variable Wald HR (95% CI) p-value 
EFS 
a Vu/Ao shape factor 6.8 1.0 (1.00-1.02) 0.009 
b Stage 20 
 
0.000 
 MYCN 17.4 3.9 (2.0-7.5) 0.000 
 11q 6.36 2.1 (1.1-3.8) 0.012 
  Vu/Ao rel. area 6.35 0.9 (0.95-0.99)^ 0.012 
c MYCN 24.0 4.9 (2.6-9.4) 0.009 
 11q 16.0 3.2 (1.8-5.8) 0.000 
 Vu/Ao rel. area 8.9 0.9 (0.94-0.98)^ 0.037 
 Age 6.8 2.2 (1.2-4.1) 0.009 
  Vu/Ao length 4.3 1.0 (1.00-1.04) 0.037 
OS 
a Vu/Ao shape factor 10.9 1.01 (1.00-1.03) 0.001 
  Vu/Ao rel density 5.3 1.1 (1.0-1.3) 0.021 
b MYCN 28.1 7.9 (3.6-17.1) 0.000 
 Stage 9.9   
 11q 7.1 2.6 (1.3-5.3) 0.007 
 Vu/Ao rel. area 6.7 0.96 (0.94-0.99)^ 0.010 
 Vu/Ao shape factor 3.9 1.0 (1.00-1.02) 0.048 
  Vu/Ao % stained area 3.7 1.4 (0.9-2.1) 0.053* 
c MYCN 32.6 8.5 (4.0-17.8) 0.000 
 11q 9.7 3.0 (1.5-5.9) 0.002 
 Vu/Ao rel. area 7.1 0.96 (0.93-0.99)^ 0.007 
 Vu/Ao shape factor 6.3 1.0 (1.00-1.02) 0.012 
 Age 5.2 2.3 (1.1-4.9) 0.022 
  Vu/Ao % stained area 4.5 1.5 (1.0-2.3) 0.032 
a: morphometric variables on their own, b: morphometric variables + all INRG 
variables, c: morphometric variables + INRG variables except stage, Vu/Ao: 
Venules/arterioles, rel. density: relative number of vessels corresponding to 
this subgroup, rel. area: relative area covered by vessels corresponding to this 
subgroup, HR: Hazard ratio, CI: Confidence interval, *: not statistically 
significant. ^Inverse correlation. 
B. Study of the high risk group 
The dichotomized morphometric variables showed statistically 
significant differences regarding survival (OS, EFS). A table with the 
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morphometric parameters and the cut points is provided (table 60). 
The Kaplan-Meier graphs are shown (figure 94 to 95). 
Table 60: Morphometric variables and cut points used to dichoromize them. 
Parameter 
EFS OS 
Cut point p-value Cut point p-value 
Density - - - - 
% stained area - - - - 
Relative density - - - - 
Relative area - - - - 
Average area - - Q2: 872.3 0.013 
Length - - - - 
Width - - - - 
Perimeter - - - - 
       Aspect - - - - 
Roundness - - Q1: 5.86 0.047 
Perimeter ratio - - - - 
Deformity - - - - 
Shape factor - - - - 
Branching - - - - 
Q1: first quartile, Q2: median, Q3: third quartile, -: not statistically significant. 
 Venules and arterioles size variables 
The area of venules and arterioles defined two risk groups 
within the high risk patients. When the area was over the median, the 
patients had a 10±6% 5-year OS (figure 94).  
Doctoral thesis                                                    Irene Tadeo Cervera 
-  - 
 
 
Figure 94: Kaplan-meier graph showing the different accumulated survival 
depending on the area. 
 Venules and arterioles shape variables 
A roundness over the first quartile defined an ultra-high risk 
subgroup with 26±5 % of 5-year OS (figure 95). 
 
Figure 95: Kaplan-meier graph showing the different accumulated survival 
depending on the roundness parameter. 
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5.8. Veins and arteries (>200µm) 
5.8.1. Description of the variables 
0,1% of the vessels belonged to this class of vessels with 20 to 
50 µm of length. Neuroblastic tumors had an average of 2,8 blood 
vessels of this type per mm2 and a tumor area occupied by vessels of 
0,1%. The features related to these vessels are shown in table 61. 
Among the 325 samples with positivity for CD31, only 55 presented 
vessels > 200µm of length. 
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5.8.2. Favorable and unfavorable veins 
and arteries histological patterns 
Stage and age were related to the area and width of the veins 
and arteries. Roundness and shape factor for stage and shape factor 
and branching for age were also statistically related. Histopathology 
and the risk group were related to the width of this subgroup of blood 
vessels. Finally, ploidy was related to the % of stained area 
corresponding to veins and arteries (table 62).  
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How that these variables were related is shown in figures 96 to 
98. Only variables with significant relationship with at least one INRG 
variable are shown. 
A. Quantity variables 
Hyperdiploid tumors had a higher relative stained area 
corresponding to veins and arteries, compared to diploid tumors 
(figure 96). 
Figure 96: Distribution of the % of stained area corresponding to of veins and 
arteries depending on the ploidy. Variables in grey mean no significant 
statistical relationship. Colored variables show significant statistical 
relationship (table 62). The median values are shown. 
B. Size variables 
Tumors from localized disease (L1, L2) had smaller area and 
width for blood vessels corresponding to veins and arteries than the 
metastatic tumors (M). Veins and arteries were thicker in advanced 
stages, unfavorable histopathologies and high risk patients than their 
counterparts. On the contrary, tumors from patients younger than 18 
(n
G
N
B
/N
B
)d
 
(n
G
N
B
/N
B
)p
d
,u
 
N
o
n
-h
ig
h
 r
is
k 
Doctoral thesis                                                    Irene Tadeo Cervera 
-  - 
 
months of age had larger veins and arteries in total area and width 
(figure 97). 
Figure 97: Distribution of the average area of veins and arteries depending on 
the INRG clinical and biological variables. Variables in grey mean no significant 
statistical relationship. Colored variables show significant statistical 
relationship (table 62). The median values are shown. 
C. Shape variables 
Tumors from patients with stage Ms of the disease had rounder 
blood vessels corresponding to veins and arteries (lower roundness 
value) and with a higher shape factor. Tumors from patients under 18 
months of age also had a higher shape factor and a higher branching 
degree than those from older patients (figure 98).  
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Figure 98: Distribution of the roundness of veins and arteries depending on 
the INRG clinical and biological variables. Variables in grey mean no significant 
statistical relationship. Colored variables show significant statistical 
relationship (table 62). The median values are shown. 
5.8.3. Survival analysis 
A. Multivariate analysis 
The statistically significant relationships between veins and 
arteries morphometric measurements and the survival variables on 55 
samples (those presenting veins and arteries) are shown in table 63.  
Regarding EFS, we could observe that a higher relative area 
corresponding to veins and arteries was affecting survival when 
considering the morphometric variables on their own, with a HR of 1.0 
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(1.00-1.03), and also when considering the INRG variables except stage, 
with a HR of 1.03 (1.01-1.05). In the later case, a higher aspect of veins 
and arteries also affected survival with a HR of 1.3 (1.0-1.7). A higher 
aspect was only related to OS when considering the morphometric 
variables on their own, with a HR of 1.3 (1.0-1.7). Given the low 
number of valid cases for this section, the results should be taken with 
care. 
Table 63: Results of the Cox regression showing the influence of veins and 
arteries morphometric measurements on their own on 5 and 10-year OS%.  
  Variable Wald HR (95% CI) p-value 
 EFS 
a V/A rel. area 4.2 1.0 (1.00-1.03) 0.040 
b              - 
c V/A rel. area 8.3 1.03 (1.01-1.05) 0.004 
 MYCN 6.8 6.4 (1.5-25.7) 0.009 
 V/A aspect 4.0 1.3 (1.0-1.7) 0.044 
OS 
a V/A aspect 4.2 1.3 (1.0-1.7) 0.038 
b, c               - 
a: morphometric variables on their own, b: morphometric variables + all INRG 
variables, c: morphometric variables + INRG variables except stage, V/A: veins 
and arteries, rel. area: relative area covered by vessels corresponding to this 
subgroup, HR: Hazard ratio, CI: Confidence interval, -: no statistically 
significant morphometric parameter. 
B. Study of the high risk group 
No differences were found in EFS and OS for high risk patients 
regarding the veins and arterioles morphometric variables. Kaplan-
Meier curves are therefore not shown. 
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6. Topological integration of reticulin fibers and 
blood vessels regarding neuroblastic cells 
This procedure has shown some hints of discrimination 
regarding the organization and co-location of these elements. On the 
one hand, we found that this method could differentiate between 
samples from high risk and non-high risk patients except for some high 
risk cases which are found within the non-high risk samples (figure 99). 
On the other hand, when focusing on the misclassified samples, we 
found that they correlated with the topology of MNNA samples, well 
differentiated thanks to the network characteristics of these two ECM 
elements with respect to the neuroblastic cells (figure 100). Taken 
together, this means that the topological organization of the ECM 
markers is different depending on the clinical and genetic features of 
the samples and that MNA carries a detectable topological change 
within the high risk patients group. 
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1. Morphometric techniques 
The digitization of the samples is required to perform 
morphometric analysis. As described in the material and methods 
section, the method available in most laboratories is the capture of 
several images per sample with a photomicroscope. This is a process 
that requires too much time when analyzing more than 500 samples. 
The use of a slide scanner is the only method that permits the 
digitization of a high number of cases in a reasonable time when 
developing a routine image biobank (187, 188) or a research project as 
ours. Additionally, the use of slide scanners provides the possibility to 
standardize the image quality using preserved light conditions. Three 
different scanners were tested (Aperio Scanscope from Aperio 
technologies, Panoramic Midi from3D Histech and the Ventana iScann 
Coreo Au from Roche) (187, 189). Aperio Scanscope XT was chosen 
because of its time sparing and quality properties.  
As a consequence of this study, an image database including 
5,725 images was obtained and a total of 107,630 data were 
generated. This number of images of whole tissue cylinders (at 40x 
magnification) would be extremely hard to obtain without the use of a 
slide scaner and the data would be really difficult to obtain or analyze 
subjectively or with methods other than morphometry and statistics. 
Additionally, we decided to store the working images in JPEG format. 
The slight loss in the image quality carried by JPEG compression does 
not compromise the quality of the image analysis and the storage and 
the analysis of this amount of images would have been very slow 
otherwise (180-182). Only the images corresponding to blood vessels 
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were stored in TIFF, because of the need to detect the stained pixels 
very restrictivelly and specifically. 
The proper software for each ECM element has been selected 
from the available systems (Image Pro-plus, providing shape and size 
measurements for fibers) or, when not available, it has been used from 
other laboratories (Positive Pixel Count, Aperio, in Ciudad Real for 
GAGs) or even designed (Angiopath, in collaboration with VISILAB, for 
blood vessels (183, 185)). The innovative algorithms configured in the 
present work for reticulin fibers, collagen type I fibers, GAGs and blood 
vessels made possible the quantification of these elements in 
neuroblastic tumors and, in the case of reticulin fibers and blood 
vessels, not only they have been quantified, but also their shape and 
size have been evaluated. 
Several studies have focused on glycosaminoglycans in tumors. 
Nevertheless, the vast majority of them detect the presence of specific 
glycosaminoglycans or sulfation patterns or quantify them by means of 
molecular techniques (124, 190) or even by analyzing the infrared 
spectra (191). Few studies have described the presence of 
glycosaminoglycans by histochemistry on histological sections or have 
quantified them subjectively by pathologists in tumors (192-195). To 
the best of our knowledge, this is the first time that acid 
glycosaminoglycans have been automatically and objectively quantified 
in tumor tissue sections and in neuroblastic tumors with histological 
methods. As there were no specific requirements to distinguish alcian 
blue staining from the background and the cell staining, the 
commercial Aperio ImageScope software with the positive pixel count 
algorithm was used.  
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The grading of fibrosis in general and namely of reticulin fibers 
is of main interest in bone marrow pathologies (196) and pathologies 
of the liver (197). For this reason, different methods for the 
quantification of reticular fibrosis have been developed, some of them 
consisting in automated morphometry (198-204). However, these 
methods quantify the percentage of stained area and we considered 
that not only the amount of fibers but also the morphometric features 
were relevant for neuroblastoma prognosis, given that in other 
pathologies these are subjectively assessed (133, 170). Algorithms to 
quantify collagen fibers based on Masson’s trichrome staining have 
also been described but (198, 205), as we wanted to differentially 
detect collagen type I fibers with respect to other collagens stained 
blue, by means of the restriction of color hues and size features, we 
had to customize our own algorithm with Image Pro-plus (170).  
A common feature of tumor vessels studies is that the 
researchers focus on microvessel density overlooking other parameters 
that might be significant, such as the size and shape of the microvessels 
(206). Studies have revealed the importance of the size and shape of 
blood vessels in, for instance, laryngeal tumors (207). To our 
knowledge, there are only two applications providing vessel closing 
when the whole perimeter of the vessels is not completely stained, 
which could be a basic feature in translational research. Aperio’s 
application for angiogenesis analysis is an excellent tool for managing 
microvessels analysis (208). This software allows performing many 
measurements on whole slide images but the closing algorithm is not 
automatic. For closing vessels, the user must draw manually the lost 
segment on the image. The second algorithm is free and available at 
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http://www.caiman.org.uk/ (209). This algorithm cannot process image 
files larger than 2MB. Both softwares measure shape parameters but 
the measuremetns are global; the properties of each microvessel are 
not calculated individually. Other softwares have also been developed 
in order to calculate morphometric measurements in microvessels 
(186, 207, 210-213). Most of them are semiautomatic and require 
manual interaction. Some extract morphometric measurements like 
area, perimeter, convex perimeter, or circularity in microvessels but 
when the vessels are not closed a manual correction is performed (212, 
213). The division of the process into two tasks, microvessel selection 
and measurements, has also been proposed through the use of filters 
and image segmentation techniques for selecting microvessels (186). 
Other studies are based on the selection of each microvessel manually 
and work with the grayscale image (210). Then, measurements of these 
vessels are calculated using other image analysis software, i. e., VIDAS 
release 2.5 (Kontron Elektronik, Eching, Germany) and ImageJ software 
(National Institute of Health, USA). These processes do not consider 
open vessels. Our aim was to develop a morphometric tool able to 
perform a segmentation of blood and lymphatic vessels to study 
vascularization following the hypothesis that tumor prognosis may not 
only be influenced by microvascular density but also by the shape and 
size of the vessels. A robust morphometric tool providing microvessel 
closing and shape measurements can only be achieved through an 
integrating effort from informatics/engineers and scientists. Thus, the 
tool we have used is able to deal with closed and open vessels and 
provides morphometric measurements for each detected vessel. 
Besides, the tool provides two kinds of executions, an automatic 
execution without user interaction and another where the user can 
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select the vessels to be analyzed. To this end, a segmentation algorithm 
based on two complementary methodologies has been developed to 
segment closed and open vessels. The design of this software has been 
published (183, 214) and the copyright has been requested. 
We believe that the systematic quantification of such digitized 
cohort of neuroblastic tumors provides useful information in the 
following critical areas:  
 Ensure consistency of results with less intra- and inter-observer 
variability 
 Compare the tumor ECM markers obtained by 
immunohistochemistry and genetic techniques 
 Relate the biomarker expression and the genotypic signatures 
of tumor cells 
Indeed, the tests performed in our study indicate that the 
algorithms are standardized, correlate with subjective assessment, are 
reproducible and robust enough to be applied in samples obtained 
from different image capture methods and different subjective 
parameters considered when customizing the algorithm. Nevertheless, 
we recommend maintaining the same configurations to compare the 
results between different samples for a good morphometric study. 
2. Our clinical and biological data (INRG)  
We could confirm that our data behave as previously described 
in bibliography  in that stage, age, MYCN, 11q and genomic profile are 
related to survival as expected (2, 4, 7, 9, 11-13). Nevertheless, 
histopathology does not completely respond to the published patterns 
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in our cohort. This difference may be due to the fact that, in the INRG 
classification, 96% of the cases (n=3889) were uNB, pdNB+nGNB and 
only 4% of the cases (n=182) were dNB + GN + iGNB. Furthermore, 
according to the INRG classification, histological category and grade of 
tumor differentiation only shows an influence on the risk of relapse in 
the localized tumors (stages L1 and L2). International collaborative 
studies are needed to increase the number of studied cases and 
therefore confirm and extrapolate our results. Regarding the potential 
implication of our results on the clinical practice, the study of our 
cohort has revealed that some of the morphometric measurements of 
the ECM elements studied could be used to improve the INRG pre-
treatment risk stratification. Moreover, some of them may help to 
define a neuroblastic tumor patient’s subgroup with ultra-high risk of 
relapse or death, within the high risk patients group, as will be 
discussed next. 
3. ECM elements patterns, potential use as 
prognostic markers and treatment strategies 
3.1. GAGs 
Given that the histological category of neuroblastic tumors 
(GN, GNB and NB) is related to the amount of Schwannian stroma (12), 
and that GAGs are components of this stroma, it could be expected 
that the amount of GAGs were proportional to the amount of stroma. 
In the same way that tumor GAGs amount is driven by the abundance 
of stroma, the degree of differentiation has reciprocally been shown to 
be regulated by some EMC GAGs. Recent studies have demonstrated 
that ECM GAGs enhance differentiation of some cell types (215) and 
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specifically HS participates in the neuroblastic differentiation to 
suppress neuroblastoma growth. When ECM GAGs increase, 
neuroblastic cells can bind to the matrix and settle in a substrate where 
they differentiate (216). In fact, in our cohort, the poorest amount of 
GAGs (2.3% of stained tissue area) is related with NBpd/u, which are 
stroma-poor neuroblastomas (12).  An intermediate percentage of 
GAGs (2.9%) are related to nGNB tumors (a mix of stroma-
rich/dominant for GNB and stroma-poor for the nodular area) and and 
dNB (stroma-poor tumors). Finally, the category related to the highest 
percentage of GAGs (4.8%) was the GN and iGNB group which is 
composed of stroma-dominant and stroma-rich tumor, respectively 
(12). The quantity of GAGs per tumor is thus found dependent of the 
abundance of tumor schwannian stroma (histological category of 
neuroblastoma) and grade of tumor differentiation (appendix 2).  
An ECM without or with scant amount of GAGs may arise from 
the destruction of local GAGs by different enzymes (heparanases or 
hyaluronidases, for example), from an inhibited synthesis of GAGs or 
from a combination of both. It could also be due to an increased 
presence of fibers or cell components which limit the physical space 
available for GAGs. The expression of heparanase is significantly higher 
in the NB patients with age >12 months and/or NBpd, and/or high MKI 
(217). In other malignancies such as sarcomas and carcinomas, 
heparanase is upregulated and is a potent modulator of tumor 
behavior due to its protumorigenic, proangiogenic and prometastatic 
activities (218, 219). The expression of elevated hyaluronidase levels 
correlates with tumor aggressiveness and poor patient survival in 
bladder and prostate cancer (123, 220-222). Hyaluronidases on the 
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surfaces of cancer cells may produce HA oligosaccharides wich induce 
cleavage of the HA receptor involved in cell-cell and cell-matrix 
interactions, CD44, promoting motility and invasion (223).  
As HS chains of proteoglycans are involved in the organization 
of the ECM though binding with other ECM molecules, such as 
collagens, it has been shown that the presence of HS chains in ECM 
proteoglycans promotes cell adhesion, whereas their absence 
promotes invasion and migration in malignant cells (224). The amount 
of HA has been contradictorily associated with prognosis in 
adenocarcinomas (breast, lung and ovarian cancer) compared to 
squamous cell carcinoma and melanoma. In the two later, the low 
content of HA is directly correlated with the metastatic potential, 
whereas the opposite effect occurs in adenocarcinomas (225-227). The 
presence of HS and CS has also been related with neuronal 
morphogenesis and neuroprotection (228-230). A common 
proteoglycan is lumican, whose overexpression has been shown to 
negatively affect the migration of human colon cancer cells through 
filamentous actin reorganization, or to inhibit melanoma cell migration 
dependent on the binding with integrins (231, 232). The effects of ECM 
GAGs on the capacity of tumor cells to spread and metastatize in some 
malignancies are examples helping to better understand our results. 
Neuroblastomas with the highest amount of GAGs correspond to 
localized stages (L1 and L2), whereas the neuroblastic tumors with the 
lowest amount of GAGs are stage M (appendix 2). Indeed, some 
malignancies, including prostate carcinomas, osteosarcomas and 
neuroblastomas carrying MNA have the capacity to downregulate the 
receptor of HA, CD44 (125, 233-237). The binding with HA regulates 
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several processes such as cell migration and mechanosensing (125, 
236, 238). Our data showed that a lower percentage of GAGs is found 
in tumors presenting MNA compared to MNNA samples. The 
suppression of the expression of functional CD44 receptor by MNA 
could entail the downregulation of HA synthesis or the destruction of 
existing HA and would explain our findings related to GAGs in 
neuroblastoma. 
The scant amount of GAGs in the ECM does not affect survival 
in our cohort but, because of the strong correlation with some of the 
variables determining the risk of relapse, it can be considered as an 
actor contributing to malignancy. Neuroblastic cells may modify ECM 
GAGs to escape cell-matrix binding and ECM GAGs may contribute to 
neuroblastic differentiation. Therefore, GAGs and interacting elements 
can be used to revert the agresiveness of neuroblastoma. Indeed, 
current treatment approaches in patients with neuroblastoma, 
simultaneously result in a small, although statistically significant, rise in 
the amount of ECM GAGs (from 4.1% to 5.3% stained area) which 
correlates with a slight increase of the proportion of GN, GNB and NBd 
found in our cohort.  
GAGs are related to tumor cells and to the fibrous scaffolding, 
and also to tumor vascularization. For example, HS proteoglycans have 
long been implicated in the control of angiogenesis and have evolved 
as important receptors for several molecules with angiogenic activity 
(239, 240). Therefore, a first therapeutic approach would be the 
manipulation of this GAG to affect angiogenic functions. The use of 
GAGs and, more frequently, HS and CS, in cancer treatment has long 
been investigated given their known biological roles and even some 
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clinical trials are being developed (241-243). Most of the studies focus 
on the inhibition of the synthesis (244-246) and the function of GAGs 
by impeding cell-ECM interactions (245, 246). Other studies use GAGs 
as vectors for the release of therapeutic agents, because of their ability 
to deliver chemicals (247, 248). Nevertheless, in neuroblastoma, a 
scant amoung of GAGs is related to poor prognosis and, therefore, 
therapeutic strategies focusing in GAGs and GAGs-receptors synthesis, 
inyection or the inhibition of degrading enzimes may be considered.  
3.2. Fibrous scaffolding 
Tumor tissue stiffness is mostly produced by the fibrous 
scaffold and, specially, by collagen fibers, and it influences the tumor 
progression (249). Increased tissue stiffness has been correlated with 
liver, pancreatic or prostate cancer where it contributes to cancer 
progression (250-252), evidencing that cells are highly responsive to 
the mechanical properties of their surroundings and vicecersa (253). In 
this sense, the North American Division Health Ministries have recently 
introduced the requirement to inform about the mammographic 
density (254), understood as the ratio between the ECM collagen to 
adipose cell volume, given that a high mammographic density predicts 
a two- to sixfold higher risk of developing breast cancer (255, 256). 
Regarding neuroblastoma, neuroblastic cells are highly sensitive to the 
biomechanical properties of their microenvironment and exhibit 
changes in differentiation behavior in response to 3-D culture matrices 
(61, 63). It has been published that an increasing ECM stiffness carried 
by collagen type I scaffoldings enhances neuritogenesis, suppresses cell 
proliferation and also reduces the expression of MYCN (61). In our 
samples, a slightly higher area covered by collagen type I fibers, 
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implying a stiffer and less porous collagen type I ECM, was associated 
with differentiated histology and favorable genetic features and clinical 
presentations.  However, neuroblastic tumors ECM is composed by 
networks of reticulin fibers in a notably higher amount (mean of 8.4% 
and median of 6.6% of stained area) than by thick bundles of collagen 
type I fibers, which are mainly rare as interneuroblastic scaffolding 
(mean of 2.5% and median of 0.24% of stained area) and, moreover, 
elastic fibers were found only restricted to vessels contours and are 
negligible in interneuroblastic cells stroma in our cohort. Consequently, 
the reticulin fibers features are those better determining the behavior 
of ECM in neuroblastic tumors (appendix 2). Neuroblastic tumors seem 
to have different reticulin fibers amounts in relationship with 
malignancy defined by the INRG parameters. A higher area occupied by 
reticulin fibers correlates with undifferentiated histopathology and 11q 
deletion whereas a lower stained area correlates with age over 18 
months and diploid tumors. 11q deletion includes the 11q22.3 region 
where the MMP-1 gene is found (257). A deletion of this region will 
trigger the incapacity of secreting collagenases to the ECM and could 
explain why collagens type I and III are found in a higher amount in 11q 
deleted than in 11q non-deleted tumors. Other factors of poor 
prognosis are related, although not statistically significant, with a low 
area covered by reticulin fibers. However, not only an increase in 
tumor fibers content triggers stiffness, but matrix reorganization and 
alignment, which is mainly observable at the tumor-host margin (figure 
61, page 143), can also result in a stiffer matrix (135, 258).  
Tumor cells utilize contractility events to reorganize the ECM to 
provide contact guidance that facilitates 3D migration and invasion 
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along oriented collagen fibers (135, 259). This fiber alignment, in turn, 
correlates with increased tumor invasion.  It has been described that 
tumor-associated collagens (type I and III) are often linearized and 
crosslinked, reflecting elevated deposition and significant post-
translational modification (133). This fact restructures and 
progressively stiffens the ECM which thereafter elicits diverse effects 
on cellular differentiation, gene expression, proliferation, survival and 
migration, which can in turn significantly modify tumor progression and 
influence treatment response (100, 133). In breast cancer, it has been 
shown that tumorigenesis is accompanied by collagen crosslinking, 
ECM stiffening and increased focal adhesion and that stiff crosslinked 
collagen can modulate tissue fibrosis to force focal adhesions, growth 
factor signaling and predicts poor survival (100, 260). It has also been 
found that physical compaction of human glioblastoma cell lines 
induces expression of some collagen types and collagen crosslinking by 
the ezyme lysyl oxidase which is involved in creating a growth 
permissive fibrotic microenvironment capable of supporting metastatic 
growth (261, 262). In our cohort, we found that tumors with 
undifferentiated histopathology, 11q deletion and/or diploid DNA 
content have mostly reticulin fibers forming large networks (large size, 
low aspect), crosslinking (high roundness), with a tortuous outline (low 
perimeter ratio) and reorganized with high spatial complexity (high 
fractal dimension). Although undifferentiated tumors and tumors with 
11q deletion present a higher branching, the age of the patient over 18 
months, together with MNA, are related to a low presence of 
transverse anastomosis (low branching), associated with the linearized 
fibers described in other tumors (133). In general, the ECM reticulin 
fibers scaffold of tumors with unfavorable characteristics is stiff and 
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with low porosity. Therefore, our data correlate with the reported 
behavior of ECM collagens. 
Some of the pathways by which tumor stiffening promotes 
tumor spread have been described and are related to biotensegrity 
(258, 263). ECM collagen-generated tensile forces regulate a signaling 
circuit that activates microRNA expression to drive tumor progression. 
Increased ECM stiffness transctiptionally activates MYC and miR-18a, 
leading to reduced expression of the tumor suppressor phosphatase 
and tensin homolog (PTEN) and therefore, inducing invasion and 
metastasis in mice (264). Other pathways described include the 
promotion of integrin clustering by ECM stiffness, which enhaces ERK 
activity and increased Rho/ROCK-generated cell contractility that can 
disrupt tissue organization and promote tumorigenesis (265). Finally, a 
rigid extracellular matrix promotes invasiveness of tumor cells via 
increased activity of invadopodia (266), which enable tumor cells to 
migrate along stiff collagen fibers, now turned into highways for 
migration into the adjacent stroma (133, 249, 267). This relationship 
between the fibrous scaffold and cells was observed in our cohort as is 
reflected in figures 46 and 47 (results section, page 141 and 142), 
were we could observe special arrangements around tumor and 
stromal cells. Tumor and stromal cells may be using reticulin fibers as 
pathways along which to migrate. Indeed, evidence has been provided 
supporting the reticular network as a pathway for lymphocyte 
migration (268). However, collagen in tissues can also represent a 
physical barrier against invasion and the proteolysis of types I and IV 
collagen by MMP and cathepsins, among others, is essential for 
migration through the ECM (269-271). In this sense, we also observed 
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this phenomenon in several analyzed tumors. Figure 46 B represents 
this idea by showing differentiated neuroblastic cells apparently 
trapped within a network of reticulin and collagen type I fibers and, as 
we can see in figure 46 C, reticulin fibers surround a huge cell cluster 
while being scant within the cells and may be isolating tumor cells. In 
this case, an initiating necrosis can be observed in the center of the 
tumor cell cluster, which may be a consequence of the fibrous scaffold 
barrier. In fact, it has been described that the distribution of collagens 
in the stroma is not uniform in human breast and prostate cancer. 
Dense collagen type I was detected in normoxic regions while it was 
excluded from hypoxic regions of the tumor, which would in turn 
correlate with the scant amount found in unfavorable tumors ECM 
(272). In this sense, the detected reticulin fibers patterns in the cohort 
analyzed must play a role in necrosis and therefore in prognosis. 
Nevertheless, more approaches must be done to properly assess the 
spatial distribution of the ECM elements automatically and objectively.  
Neuroblastic tumors ECM fibrous scaffolding does not have 
prognostic value in our cohort in combination with the INRG variables. 
Nevertheless, the study of survival within the high risk group shows 
that some morphometric features defining ECM stiffness, carried by 
reticulin fibers, define a new group within the high risk patients with 
very high risk of relapse or death (mostly under 15% of 5-year EFS or 
OS). This subgroup is composed by tumors whose ECMs presents 
reticulin fibers occupying a huge stained area and forming large 
networks with high crosslinking, high branching and disorganized 
within the tumor tissue space (appendix 3). Therefore, these 
parameters could be used to enhance the pre-treatment risk 
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stratification through the definition of an ultra-high risk group of 
patients who could benefit from more accurate and targeted 
treatments against the ECM fibrous scaffolding.  
We have described that the increased deposition or 
crosslinking of fibers in the ECM contributes to a stiffer and thickened 
ECM which is associated to malignancy in neuroblastoma. The 
accumulation of non-fluid elements in the tumor ECM carries the 
establishment of a solid pressure within the tumor tissue, which, 
together with other pressure sources, leads to an elevated tumor 
interstitial pressure (273). Elevated tumor pressure alters gene 
expression, cancer cell proliferation, apoptosis and invasiveness, 
stromal cell function and extracellular matrix synthesis and 
organization (274-276). Additionally, it has a negative impact on cancer 
treatment and is known to reduce the efficacy of cancer therapy 
through a reduced uptake and heterogeneous distribution of drugs 
(277, 278). The understanding of the fact that biomechanical forces 
affect cell-cell and cell-matrix crosstalk and alter tumor cells fate, 
suggests the possibility of developing new therapies that can target the 
behaviors that arise from these complex interactions (258). Regarding 
ECM fibers, therapies that attack some of the major physical changes 
themselves, such as inhibiting matrix crosslinking, could be developed 
to revert pressure within the tumor tissue (279). Most of the 
therapeutic strategies under study are based on altering the 
fibroblastic pathways of collagen synthesis and inhibiting fibroblast 
growth factor (280-283). Fibroblasts are rather scant in neuroblastic 
tumors ECM, being replaced by Schwann cells. Indeed, fibroblasts are 
inversely correlated with the presence of Schwann cells, suggesting 
Doctoral thesis                                                    Irene Tadeo Cervera 
-  - 
 
that these could prevent the activation of fibroblasts (284). Schwann 
cells synthesize distinct types of collagen and express collagen 
receptors belonging or not to the integrin family, which enable them to 
adhere and migrate on collagen substrates (285). Maybe the same 
strategies regulating collagens biosynthesis pathways in fibroblasts can 
be applied to these supportive cells. Otherwise, strategies focusing on 
the destruction of existing fibrosis should be developed. In this sense, 
collagenase has been shown to reduce tumor interstitial pressure by 
cleaving collagen and consequently destroying the collagen crosslinked 
networks in tumors in human osteosarcoma xenografts (286). 
Moreover, this enzyme could indirectly affect tumor ECM by degrading 
the reticulin fibers associated with blood vessels. Another therapeutic 
approach not affecting the amount of fibers but the morphology 
consists in impeding an increased crosslinking. The reduction of lysyl-
oxydase-like-2, catalyzing the production of a crosslinked collagenous 
matrix, by the monoclonal antibody AB0023, was efficacious in 
reducing disease in different models of cancer and fibrosis (279). 
Incorporating biomechanical forces into our current picture of the 
tumor microenvironment fundamentally changes the context in which 
we study the basic cell and molecular biology of cancer. If there is one 
core message from the last two decades of research into the tumor 
ECM, it is that context matters (258). 
Finally, the fibrous scaffold is not only important as a support 
for tumor and stromal cells migration. It has also been found to play a 
key role in tumor angiogenesis development which is, at least in part, 
regulated by the mechanical interactions between neovessel sprouts 
and the ECM (287). Additionally, the crosslinking of collagen scaffolds 
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promotes vascular stability. In fact, figure 48 (results section, page 
141) showed how reticulin fibers were arranged around blood vessels 
to support and stabilize them and, some times, extended inwards and 
outwards the vessels, probably allowing stromal or tumor cell 
migration and perhaps the establishment of perivascular tumor niches. 
3.3. Blood vascularization 
Several studies have revealed the relashionship between 
vascular density and prognosis. High microvascular density was 
associated with poor differentiation and advanced stage and correlated 
with poor survival in invasive pulmonary adenocarcinoma (288). 
Increased vascularization has also been related to unfavourable 
outcome in endometrial carcinomas (289) or with higher stages in 
prostate cancer (290). The opposite was found for other malignancies 
such as pancreatic ductal adenocarcinoma where well differentiated 
samples contained higher microvascular density than poorly 
differentiated carcinomas (291).  A recent study points out the clinical 
importance of low microvascular density at the tumor center as an 
independent prognostic factor of distant metastasis development in 
breast cancer (292). In neuroblastic tumors, different studies have 
related vascularization with prognosis, showing sometimes 
contradictory results, probably because of the different techniques 
used (149-154, 293). Our data show that, in out cohort, total blood 
vessels density is significantly increased in undifferentiated tumors 
although it is decreased for the rest of unfavorable clinical and 
biological features albeit these results are not statistically significant 
(appendix 2). In our cohort, a percentage of stained area over the 3rd 
quartile can be used to define a very poor prognosis group (23% of 5-
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year OS) within the high risk patients (appendix 3). When we focus on 
the different microvasculature and macrovasculature subgroups, we 
can observe that capilaries and post-capillaries/metarterioles densities 
decrease in tumors with poor prognosis wereas the amount of 
sinusoid-like blood vessels, venules/arterioles and veins and arteries 
are increased in density and occupied tissue area. Moreover, in the 
poor-prognosis group, the relative amount of blood vessels 
corresponding to capillaries, regarding total vascularization, is lessened 
and the relative amount of blood vessels corresponding to sinusoid-like 
blood vessels, venules/arterioles and veins/arteries is increased. In 
addition, the total vascular density is increased in both primary and 
non-primary NB, corresponding to a significant rise in post-
capillaries/metarterioles, sinusoid-like blood vessels, venules/arterioles 
and veins/arteries with respect to normal tissue and to peritumoral 
tissue, while the capillaries amount is decreased (appendix 2). 
Translated to biological significance, this would mean that tumors with 
unfavorable characteristics present mostly sinusoid-like blood vessels 
and a minority of capillaries in their ECM, together with increased 
venules and veins which would be a consequence of the high number 
of pathological sinusoid-like blood vessels and, therefore, the need to 
drain such amount of blood. The fact that sinusoid-like blood vessels 
have thin vessel walls could explain the occurrence of intratumoral 
hemorrhages associated to poor prognosis in neuroblastoma. These 
tumors would therefore be more hypoxic than those with favorable 
features, with much more capillary density and thus oxygenation. 
Hypoxia enhances mutational rate, metastatic spread, and resistance 
to radiation and chemotherapy and promotes dedifferentiation of 
neuroblastoma and breast carcinoma cells as well as the development 
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of stem cell-like features (294). In both tumor forms there is a 
correlation between low differentiation stage and poor outcome, and 
we conclude that the dedifferentiating effect of lowered oxygen adds 
to the aggressive phenotype induced by hypoxia (295). 
In general, tumor vessels are highly disorganized, tortuous and 
dilated, with uneven diameter, excessive branching and shunts (145, 
146, 296). For instance, a study of angiogenesis in laryngeal tumor 
material revealed that vessel structure, size and shape were related to 
the tumor growth pattern and behavior, small regular vessels 
predominating in benign conditions and large and irregular vessels in 
malignant neoplasms (207). In the same sense, our results show that, in 
general, blood vessels of neuroblastic tumors associated with 
unfavorable features have a bigger size, are more deformed and have 
an increased branching, compared to those from tumors with favorable 
clinical and biological characteristics (appendix 2). Aditionally, a shape 
factor over the 1st quartile is related to very high risk of relapse or 
death within the high risk cohort (30% and 24% 5-year EFS, 
respectively) (appendix 3). Focussing in the different blood vessels 
subtypes we could observe that, with few exceptions related to the 
length parameter, all blood vessel types are present with larger sizes 
(area, width and length) in tumors with unfavorable biological features 
and/or from patients with unfavorable clinical characteristics 
(appendix 2). Solid stresses affect tumor pathophysiology directly by 
compressing cancer and stromal cells but also indirectly by deforming 
blood and lypmphatic vessels as described in pancreatic cancer, where 
compressed vessels are observable at the histological level (277). The 
compression of tumor vasculature also leads to a reduction in tumor 
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blood flow and subsequently reduces the anticancer agent transport to 
tumor cells (297). We could observe that neuroblastic tumors vessels 
are frequently found compressed, with scant or undistinguished lumen, 
as shown in figure 74 (results section, page 181). However, this 
compression, although frequent, is not a rule within neuroblastic 
tumors and is variable from one tumor to the next and potentially from 
the primary site to the metastatic site, like in breast cancers (277) and 
therefore, the shape parameters are more irregularly distributed within 
the different blood vessels subgroups. 
The capillaries of unfavorable tumors are larger (area, width 
and legth) and rounder compared to the favorable tumors capillaries, 
which are smaller and more ovoid or bevel-cut, presumably correlating 
with terminal (such as brain and kidney) and plexiform (such as dermis) 
network configurations, respectively (appendix 2). The anastomotic 
plexiform or network configuration would avoid hypoxia in case of 
occlusion of vascular neworks by tumor embolisms.  Nevertheless, 
when we focus on the high risk cohort, we can observe that more 
irregular shapes (roundness value and shape index value over the 1st 
quartile and the median, respectively) with a higher branching (found 
related to the unfavorable INRG variables) define a subgroup of 
patients with very poor 5-year EFS (30% and 12%, respectively), 
correlating with a plexiform pattern, such as for favorable tumors 
(appendix 3). Our hypothesis is that a good plexiform capillary network 
would be required to maintain tissue homeostasis, but in combination 
with a sinudoid-enriched ECM, it could contribute to an increase of 
intratumoral pressure and chaos within the tumor tissue.  
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Larger post-capillaries/metarterioles with a more regular shape 
(less protrudings) and more irregular outline are found in unfavorable 
neuroblastomas. Thicker and with larger area but shorter length and 
more irregularly shaped and outlined post-capillaries/metarterioles are 
related with poor prognosis and these parameters could be used to 
improve the INRG risk stratification. A more irregular shape and 
outline, together with shorter lengths could be explained by refolded 
vessels with an atypical internal layer detected as an alternation of 
outlines corresponding to endothelial cells and segments filled by the 
morphometric tool in response to frequent lacks of endothelial cells in 
the blood vessel wall. This would correspond to discontinuous and 
permeable post-capillaries/metarterioles. During the angiogenic 
switch, a process by which cancerous tissue acquire angiogenic 
capacity in response of various signals including metabolic stress, 
mechanical stress, immune/inflammatory response and genetic 
mutations (298, 299) tumor vessels develop by sprouting or 
intussusception from pre-existing vessels (300, 301) and the vessel wall 
is not always formed by a homogeneous layer of endothelial cells. 
Instead, it may be lined with only cancer cells or a mosaic of cancer and 
endothelial cells, where cancer cells would be mimicking endothelial 
cells in what is known as vasculogenic mimicry. An example in 
neuroblastic tumors is shown in figure 70 (results section, page 176). 
Cancer cells invading the vessel lumen, co-opted vessels or the 
apoptosis of endothelial cells which exposes underlying cancer cells 
would be alternative hypothesis for vessel wall mosaicism (146). All 
these angiogenic changes result in structurally and functionally 
abnormal tumor vessels. Therapeutic chemicals are normally 
transported through the interstitial space by convection, a transport 
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process that is dependent on pressure gradients, but increased tumor 
vessel permeability creates a less steep gradient along the vessels. This 
leads to a reduction in convective transport across the vessels in tumor 
bulk (301). Aditionally, an increase in vessels permeability enables the 
extravasation of stem and immune cells, among others, and the 
entrance of malignant cells into the bloodstream to promote 
metastasis (305). 
Sinusoid-like vesels which are larger in area and width, with 
poor protrussion and more regular vessel outline are associated with 
poor prognosis. A shorter length is related to poor prognosis and would 
correlate, together with the shape parameters, with sinusoid-like 
vessels forming swollen areas or cisterns in contrast with complex 
sinusoidal networks, which would form longer vessels. The 
consideration of this feature could enhance the stratification of the 
patients, complementary to the INRG variables (appendix 2). The 
abnormal morphology of tumor blood vessels causes a fluid pressure 
which, together with solid pressure, defines the total interstitial 
pressure, which has been indentified as one of the culprits that 
impedes effective cancer treatment (302). Moreover, abnormal and 
tortuous tumor vasculature causes blood stasis, which leads to the 
reduction of oxygen and blood flow in tumors causing hypoxia and 
subsequently ischemia and necrosis (297). This effect increases 
anabolic metabolism which produce an acid ECM that degrades or 
deactivates some therapeutic drugs and renders them ineffective 
(303). Hypoxia also can cause resistance to radiotherapy and can help 
tumor cells to escape immunosurveillance (304). 
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In general, unfavorable neuroblastomas present larger and 
irregularly-shaped venules and arterioles. The irregular shape and the 
larger size of venules and arteries are also related to poor prognosis in 
combination with the INRG prognostic factors and could be used to 
enhance the stratification of the patients (appendix 2). Aditionally, a 
roundness over the 1st quartile (irregularly-sahped vessels), but an area 
under the median, enable the discrimination of a group of high risk 
patients with very poor 5-year OS (26% and 10%, respectively) 
(appendix 3). This could be explained by the fact that venules and 
arterioles from high risk patients with very poor prognosis present 
more invaginations in their vessel walls and are smaller. Given that 
intravascular pressure increases as the luminal diameter of these 
vessels decreases (305), this subgroup of very high risk patients would 
present more altered biotensegrity. This phenomenon results in a 
hostile tumor microenvironment (hypoxia, low pH and high interstitial 
fluid pressure) that facilitates the selection of malignant tumor clones 
and the escape of tumor cells through leaky vessels, as well as it 
impedes the function of immune cells and the distribution of 
chemotherapeutics and oxygen, thereby entering a self-reinforcing 
loop (305-307). 
Given the intrinsic design of the TMAs, areas with huge veins 
and arteries were avoided and the number of samples presenting veins 
and arteries in their ECM is reduced (only 0.1%). The results cannot 
therefore be discussed. 
  Our data show that the blood vascularization, together with 
the fibrous scaffold and the fundamental substance, plays a central role 
in the determination of the fate of the neuroblastic tumors. Because of 
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its importance to the tumor, it also represents an “Achilles’ heel” that 
can be used for cancer therapy (110).  Given the central relevance of 
angiogenesis in tumor development, multiple antiangiogenic 
therapeutic strategies have been developed in the last decades for 
many different malignancies (146). Several direct angiogenic inhibitors 
(angiostatin, endostatin and thrombospondin) targeting  endothelial 
cells and indirect anti-antiangiogenic agents blocking the production or 
activity of pro-angiogenic molecules, such as VEGF, have been 
developed (293). Recent studies have focused on the value of 
normalizing tumor vasculature to improve responses to conventional 
anticancer therapies rather than destroying tumor vessels to starve 
primary tumors from oxygen and induce tumor shrinkage (306). Vessel 
normalization results in reduced vessel diameter, increased pericyte 
coverage and normalized basement membrane, accompanied by 
normalization of its function. This normalized tumor vasculature 
becomes less permeable and tortuous and leads to reduced fluid and 
protein extravasation into the interstitium, resulting in the decrease 
tumor interstitial pressure (308, 309). For example, various preclinical 
studies have shown that the high levels of VEGF observed in tumors 
induce vessel abnormalities (310, 311). Therefore, targeting VEGF using 
anti-VEGF antibodies and inhibitors such as bevacizumab has been 
shown to reduce tumor interstitial pressure (312, 313). Another protein 
playing an important role in tumor angiogenesis is PDGF. Imatinib, a 
PDGFR-inhibitor has been shown to reduce tumor interstitial pressure 
and enhance therapeutic efficacy (314). Other drugs such as 
hydralazine and cachectin are vasodilators that cause a decrease in 
vascular resistance followed by an increase in tumor blood flow, which 
can potentially improve intratumoral transport of macromolecules and 
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that have been shown to reduce intratumoral pressure (315, 316).  In 
adition to these therapeutic drugs, some physical approaches have 
been tested to decrease tumor ECM pressure, that can be summarized 
as follows: irradiation reduces the vascular wall permeability to fluid 
and leads to a reduction of intratumoral pressure (317); induced 
hyperthermia or hypothermia have shown similar results regarding the 
reduction of intratumoral preassure as for irradiation (318); 
ultrasounds due to mechanical (cavitation) and thermal pressure cause 
damage to tumor cells and ECM, which increase the interstitial 
hydraulic conductivity, reduces matrix tension and enhances tumor 
blood flow (319); hyperbaric oxygen increases oxygen tension and 
delivery to tissues (320); finally, photodynamic therapy impaired 
microcirculation in tumors (321). All these strategies are possible by 
the knowledge of the physiopathology of vascularity in tumors ECM. 
Most of them are in the initial phases and others are already in clinical 
trials with patients. Neuroblastic tumors present differential vascular 
densities depending on the blood vessel type, specifically focused on 
capillaries and sinusoid-like vessels density. Additionally, not only the 
vessels density but also the shape and size morphologic parameters are 
differentialy found in the neuroblastic histologic categories. These 
parameters can potentially be useful to predict survival, as well. These 
findings, together with the vascular normalization approaches, offer a 
new spectrum of therapeutic opportunities whose application in 
neuroblastoma should be considered and studied.   
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3.4. Topological, genetic and clinical 
integration 
Hanahan and Weinberg have proposed that eigth hallmarks of 
cancer together constitute an organizing principle that provides a 
logical framework for understanding the remarkable diversity of 
neoplastic diseases, including sustained proliferative signalling, evading 
growth suppresors, activating invasion and metastasis or genetic 
changes, among others (322, 323). To study the hallmarks, several 
concepts have been proposed and considered at different scales of 
complexity, such as protein interactions, biochemical pathways, cellular 
functions or whole organism studies (324, 325). A novel ninth hallmark 
which includes the aspect of physics and mechanotransduction has 
recently been emphasized (326). The subjective assessment of the 
latter by the observer by analyzing the structural variations in tumor 
tissues, at diagnosis as well as during tumor progression and after 
treatment, using TMAs, is a challenging process (327). However, the 
difficulty can be overcome by forming mathematical descriptors to 
represent the histological texture and classify the structural changes 
via sophisticated computational methods (328-330). The results of our 
research suggests that genetic information and Schwannian stroma are 
not the only important factors in the molecular and histopathologic 
analysis of neuroblastic tumors but that, in fact, tensegrity and 
mechanotransduction changes carried by some characteristics of 
glycosaminoglycans, reticulin fibers, collagen fibers, blood vessels are 
also relevant to tumor progression and outcome, together with 
immune response stromal cells (lymphocytes B and T) (89).  
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During the last decade, cell-matrix contacts based on the 
transmembrane adhesion receptors from the integrin family (focal 
adhesions) have emerged as the major mechanosensitive structural 
elements that connect, collect, process and integrate the information 
of the ECM. Recent proteomic studies have not only found many more 
components, but have also revealed that many of these elements are 
recruited to focal adhesions in a force-dependent manner, supporting 
the view that focal adhesions harbor a network of mechanosensitive 
processes (331). Specifically, the α8β1 integrin or tensegrin can bind to 
several ECM molecules and has been shown to be associated with focal 
adhesion points, where it participates in the regulation of spreading, 
adhesion, growth and survival in different neuronal and mesenchymal-
derived cell types (332, 333). Indeed, we have shown that the topology 
of reticulin fibers, blood vessels and neuroblastic cells is associated 
with the risk of relapse and death. The topological network analysis 
and the graph theory in combination with Vonoroi tessellations, that 
intend to capture relevant information about the organization of 
different tissue markers, have recently been found to be useful in the 
diagnosis of muscular dystrophies and neurogenic atrophies, in the 
classification of neuromuscular disease or to model the progression of 
dementia (159-161, 334). In neuroblastoma, the topological analysis or 
a subset of samples enables the differentiation between high risk and 
non-high risk samples and betwwen MNA and MNNA samples, 
meaning that clinical and biological changes are reflected in ECM 
topology. Moreover, our preliminary results show that MNA triggers a 
detectable topological change within the high risk samples. This 
topological change, in turn, is translated into changes in 
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mechanotransduction (263). Nevertheless, more studies must be done 
in an increased cohort to confirm our preliminary findings. 
Patients with neuroblastic tumors, specifically those still 
subject to therapeutic failure despite current knowledge, could 
beneficiate from novel therapeutic strategies which could arise from 
the study of the ECM biotensegrity. It is known that neuroblastic cells 
are committed to a complex interaction with the surrounding tumor 
microenvironment. Together, our data strongly support the notion that 
ECM rigidity modulates neuroblastoma cell differentiation and that the 
mechanical signals from the cellular microenvironment influence 
neuroblastoma differentiation and behavior. These observations 
support further research on the role of microenvironmental 
mechanical signals in neuroblastoma proliferation and differentiation 
and suggest that pharmacological agents that modulate the underlying 
mechanotransductive signaling pathways may have a role in 
neuroblastoma therapy. 
  
 
V. CONCLUSIONS/ CONCLUSIONES 
VI. CONCLUSIONS 
 
-  - 
 
The purpose of this work was to demonstrate the importance 
of the extracellular matrix of neuroblastic tumors as a set of elements 
with prognostic and therapeutic value, through their morphometric 
study and the correlation with tumoral aggressiveness.  
Specifically, we have analyzed morphometric parameters of 
glycosaminoglycans, the three types of fibers constituting the tumoral 
scaffolding, and the vascular spectrum and configuration. The obtained 
results were related with the clinical and biological factors with known 
prognostic value in neuroblastoma and with the clinical evolution of 
the patients. Putting all this together, we conclude:  
1. The studied cohort, including more tan 500 tumoral samples, 
meets the criteria of International Neuroblastoma Risk Group 
(INRG), regarding the clinical parameters such as the age and the 
stage, and the biological parameters such as the status of the 
MYCN oncogene, the integrity of the 11q region and the category 
defined by the genomic profile.  
2. Tissue micro array (TMA) slide scanning is required for the 
histological analysis the extracellular matrix elements in large 
amounts of tumor samples, due to the huge morphological 
heterogeneity of neuroblastic tumors. 
3. Novel and accurate image analysis tools are needed for the 
quantification, without inter- and intra-observer, of the 
fundamental substance and the characterization of the fibrous 
scaffolding and the vascular system of neuroblastic tumors. 
4. A decreased amount of glycosaminoglycans, detected in tumors 
associated with poor prognostic factors, could enable neuroblastic 
cells to escape cell-matrix binding and may inhibit neuroblastic 
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differentiation. We propose the research on therapeutic 
approaches attempting to increase extracellular matrix 
glycosaminoglycans in vitro. 
5. Collagen type I bundles are scarce as intercellular scaffolding, 
being less abundant in unfavorable neuroblastomas than in 
favorable neuroblastomas. This extracellular matrix element does 
not seem to influence survival. It would be suitable to perform 
studies on whole histological sections of more than one tumoral 
sample per case to confirm these findings. 
6. After the study of an initial sample subset, we can infer that elastic 
fibers are not specific features in neuroblastic tumors stroma. 
7. Reticulin fibers are the main components of the fibrous scaffolding 
in neuroblastic tumors. Not only the amount but also the shape 
and the size have been found different within the risk groups. 
Specifically, we define, by integrating all the analyzed parameters, 
the presence of a stiff and poorly porous extracellular matrix in 
unfavorable neuroblastomas, compared with a loose and 
permeable matrix found in favorable neuroblastomas. 
8. In general, blood vessels are larger, more abundant and more 
irregularly-shaped in unfavorable neuroblastomas than in 
favorable neuroblastomas. 
9. Specifically, capillaries are less abundant and sinusoid-like blood 
vessels are more abundant in unfavorable neuroblastoma. This 
fact suggests that this type of microvascularization, found in 
aggressive neuroblastomas, triggers a hypoxic microenvironment 
and a high intratumoral pressure. Therefore, we consider it 
reasonable to perform basic research on treatments based on 
vascular normalization in neuroblastic tumors. 
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10. An atypical and discontinuous endothelial layer of post-capillaries 
and metarterioles, together with sinusoid-like vessels forming 
cisterns, and arterioles and venules with irregularly-shaped 
lumens, are related with poor prognosis. These features could be 
used, after multicentric validation, to improve the INRG risk 
stratification.  
11. The subgroup of the high risk cohort with very unfavorable 
prognosis can be defined by morphometric variables regarding 
reticulin fibers and blood vessels. Specificallly, those samples with 
a high stained area occupied by reticulin fibers forming large, 
crosslinking, branching and disorganized networks present a very 
short survival. The samples corresponding to this subgroup of 
patients with ultra-high risk, also present a similar density of blood 
vessels, although these occupy a larger area. Additionally, they 
have capillaries with protrussions, and dilated venules 
andarterioles. 
12. The integration of the topological information of reticulin fibers, 
blood vessels and neuroblastic cells by means of the Graph Theory 
and tessellations enables the identification of different 
dispositions regarding genetic and clinical features. Moreover, our 
preliminary results show how MYCN amplification triggers a 
topological change within the high risk patients group. 
13. The overall results obtained from the morphometric analysis of 
extracellular matrix elements enable, for the fist time, the 
comparison with clinical indicators, biomarkers expression and 
genotypic signatures of tumor cells, and reveal a prognostic value 
and a mecanotherapeutic viability in neuroblastoma.   
VI. CONCLUSIONES 
 
 
El propósito de este trabajo es demostrar la importancia de la 
matriz extracelular en los tumores neuroblásticos como un conjunto de 
elementos con valor pronóstico y terapéutico, a través de su estudio 
morfométrico y de la correlación con la agresividad tumoral.  
Concretamente, hemos analizado parámetros morfométricos 
de glicosaminoglicanos, los tres tipos de fibras que constituyen el 
andamiaje tumoral, y del espectro y configuración vascular.  Los 
resultados obtenidos fueron relacionados con los factores clínicos y 
biológicos con valor pronóstico conocido en el neuroblastoma y con la 
evolución de los pacientes. Con todo esto, concluimos:  
1. La cohorte estudiada, que incluye más de 500 muestras 
tumorales, cumple los criterios de predicción de riesgo de la 
Clasificación Internacional (INRG), en relación a los 
parámetros clínicos como la edad y el estadío y los 
parámetros biológicos como el estatus del oncogen MYCN, la 
integridad de la region cromosómica 11q y la categoría 
definida por el perfil genómico.  
2. La digitalización de micromatrices de tejidos (TMAs) es 
necesaria para el análisis histológico de los elementos de la 
matriz extracelular en gran número de muestras tumorales, 
debido a la gran heterogeneidad morfológica de los tumores 
neuroblásticos.  
3. Son necesarias herramientas de análisis de imágen novedosas 
y precisas para realizar la cuantificación sin variabilidad intra- 
e inter-observador, de la sustancia fundamental y la 
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caracterización del andamiaje fibroso y del sistema vascular 
de los tumores neuroblásticos.  
4. Una baja cantidad de glicosaminoglicanos detectada en 
tumores asociados a factores de mal pronóstico, podría 
permitir a las células neuroblásticas escapar de la union 
célula-matriz e inhibir su diferenciación. Proponemos la 
investigación en aproximaciones terapéuticas centradas en el 
aumento de los glicosaminoglicanos en la matriz extracelular 
in vitro.  
5. Los haces de colágeno tipo I son escasos como andamiaje 
intercelular, siendo menos abundantes en neuroblastomas 
desfavorables que en neuroblastomas favorables. Este 
elemento de la matriz extracelular no parece influir en la 
supervivencia. Para confirmar estos resultados sería 
adecuado realizar estudios con secciones histológicas 
completas de más de una muestra tumoral por caso. 
6. Podemos inferir, por los resultados obtenidos en un subgrupo 
muestral inicial, que las fibras elásticas no son elementos 
característicos del estroma de los tumors neuroblásticos. 
7. Las fibras de reticulina son el componente principal del 
andamiaje fibroso de los tumores neuroblásticos. No sólo la 
cantidad sino también la forma y el tamaño son distintos 
entre los diferentes grupos de riesgo. Específicamente, 
definimos, integrando todos los parámetros analizados, la 
presencia de una matriz rígida y pobremente porosa en 
neuroblastomas desfavorables, frente a una matriz laxa y 
permeable presente en los neuroblastomas favorables. 
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8. En general, los vasos sanguíneos son más grandes, más 
abundantes y tienen una forma más irregular en los 
neuroblastomas desfavorables, con respecto a los 
neuroblastomas favorables. 
9. Concretamente, los capilares son menos abundantes y los 
vasos tipo sinusoide son más abundantes en neuroblastomas 
desfavorables. Esta situación sugiere que este tipo de 
microvascularización, existente en neuroblastomas agresivos, 
genera un microambiente hipóxico y una alta presión 
intratumoral. Así, consideramos razonable realizar 
investigación básica sobre tratamientos centrados en la 
normalización vascular en los tumores neuroblásticos.  
10. Una capa endotelial atípica y discontinua en los vasos post-
capilares y metarteriolas, junto con vasos tipo sinusoide que 
forman cisternas, y arteriolas y venulas con luces de 
conformación irregular, se relacionan con un pronóstico 
pobre. Éstas características podrían ser utilzadas, tras la 
validación multicéntrica, para mejorar la estratificación de 
riesgo de la INRG.  
11. El subgrupo de la cohorte de alto riesgo con pronóstico muy 
desfavorable puede ser definido gracias a variables 
morfométricas de fibras de reticulina y de vasos sanguíneos. 
Concretamente, aquellas muestras tumorales con una gran 
área ocupada por grandes redes entrecruzadas, ramificadas y  
con compleja organización de fibras de reticulina, pertenecen 
a pacientes con muy corta supervivencia. Este subgrupo de 
pacientes con riesgo ultra alto, también presenta en sus 
biopsias  un número similar de vasos sanguíneos, aunque 
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ocupando un área mayor. Además,  tienen capilares con 
mayor número de protrusiones, y vénulas y arteriolas 
dilatadas. 
12. La integración de la información topológica de las fibras de 
reticulina, vasos sanguíneos y células neuroblásticas por 
medio de la Teoría de Grafos y teselaciones, permite la 
identificación de distintas configuraciones relacionadas con 
características genéticas y clínicas. Además, nuestros 
resultados preliminaries muestran cómo la amplificación de 
MYCN conlleva un cambio topológico en el grupo de 
pacientes de alto riesgo. 
13. Los resultados globales obtenidos del análisis morfométrico 
de los elementos de la matriz extracelular estudiados 
permiten, por primera vez, la comparación con los 
indicadores clínicos, la expresion de biomarcadores y las 
firmas genotípicas de las células tumorales, y revelan un valor 
pronóstico y una viabilidad mecanoterapéutica en 
neuroblastoma. V
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Appendix 2: Illustration summarizing the results regarding favorable and 
unfavorable neuroblastic tumors. Only the ECM elements showing differences 
are shown. A) Favorable neuroblastoma: neuroblastic cells differentiate in a 
microenvironment well irrigated by capillaries, rich in fundamental substance 
to which they can bind and with a very loose meshwork of reticulin fibers. B) 
Unfavorable neuroblastoma present an ECM with low porosity due to the 
reticulin fibers scaffolding which also could serve as migratory pathways and 
creates a stiff microenvironment subject to tension. This ECM also presents a 
poor amout of capillaries and an increased presence of sinusoid-like vessels, 
which could promote cell extra- and intra-vasation. 
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Appendix 3: Illustration summarizing the results regarding the high risk 
cohort. Only the ECM elements showing differences are shown. The dilated 
sinusoid-like vessels associated to the unfavorable subgroup are also 
represented. A) High risk tumor. B) Ultra-high risk tumor example. The 
reticulin fibers occupy an increased area and could enable neuroblastic cells to 
further migrate, as well as could contribute to worsen the pathological tension 
within the ECM and the neuroblastic cells. In addition to the dilated sinusoids, 
irregularly-shaped capillaries and venules/arterioles could also contribute to 
the promotion of aggressiveness.  
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Background: New predictors for a more specific pre-treatment stratification are 
required to improve the clinical management of ultra-high risk patients. 
Objective:  We aim to focus on the value of glycosaminoglycans (GAGs), reticulin 
fibers (RetF) and collagen type I fibers (Col-1F) extracellular elements (ECM) morphometric 
measurements as potential risk markers or therapeutic targets within the high risk tumors. 
Materials and methods:  19 tissue microarrays were constructed including at 
least two cylinders per sample of 458 primary tumors including tumors from 110 high risk 
patients, to properly represent tissue histology. Serial sections of the TMAs were cut and 
stained with alcian blue pH2.5 for glycosaminoglycans, Gomori for reticulin fibers and 
Masson’s trichrome for collagen type I.  Image analysis algorithms were set up or designed 
with Aperio ImageScope (Aperio technologies) for GAGs and Image Pro-plus (Media 
cybernetics) for RetF and Col-1F to specifically detect the ECM elements studied and extract 
morphometric measurements. For GAGs and Col-1F, the percentage area covered by the 
ECM element was calculated. For RetF, amount (number of fibers and percentage of stained 
area), size (area, length and width), shape (aspect, roundness or crosslinking, fractal 
dimension, perimeter ratio and branching) and orientation (angle) variables were calculated 
for each tumor sample. All morphometric variables were dichotomized using the median 
values or quartiles and survival analysis were performed in the high risk cohort with the log-
rank test and Kaplan-Meier curves.  Moreover, we carried out a preliminary study of the 
topology, relating blood vessels, RetF and neuroblastic cells by means of graph theory and 
performing Voronoi tessellations. 
Results: The median 5-year event-free survival (EFS) was 35.4±5.3 and the median 
5-year overall survival (OS) was 28.1±4.8. The amount of GAGs did not influence survival in 
the high risk cohort. Regarding RetF, we found that a high percentage of stained area, 
together with large, highly crosslinking and branching networks organized in a messy 
manner (high fractal dimension) defined a subgroup with very poor prognosis within the 
high risk cohort with 5-year EFS and/or OS mostly <15% (ranging from 11.3±6.3% to 
21.8±6.6%). A high percentage of Col-1F stained area also defined a subgroup with 
16.6±7.3% of 5-year EFS. Two different topological organizations were distinguished 
between high risk and non-high risk and between MNA and MNNA samples. Some high risk 
samples were mixed with non-high risk samples and correlated with MNNA samples. MNA 
therefore carries topological changes within the high risk group samples, with respect to the 
relative organization of neuroblastic cells, blood vessels and RetF. 
Conclusions: The quantitative and topological analysis of RetF and Col-1F enables 
the discrimination of a very poor prognostic group within the HR patients. We advocate 
their use as new biomarkers and their potential use as therapeutic targets. 
Future work: We will analyze larger high risk cohorts and ultra-high risk patients 
(when defined) to validate our findings and improve the stratification. This would potentially 
provide new targets for the development of more accurate therapies related to ECM 
elements in the ultra-high risk subgroup. 
Grants: This study was supported by grants from FIS (PI10/15) and RTICC 
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Summary. The extracellular matrix (ECM) constitutes a
three-dimensional network that surrounds all cells,
organs and tissues in the body. It forms a biophysical
filter for protection, nutrition and cell innervation, as
well as the medium for facilitating immune response,
angiogenesis, fibrosis and tissue regeneration. It is the
mechanism by which mechanical forces are transmitted
to the basement membrane which, through the integrins,
supports the tensegrity system and activates the
epigenetic mechanisms of the cell. A review and update
on current knowledge on this topic reveals how
disturbance of the ECM leads to a loss of efficient
filtering, nutrition, elimination, and cell denervation
functions, in addition to loss of regeneration capacity
and disorders in mechanotransduction. Furthermore,
such disturbance results in a loss of substrate, and with it
the ability to provide a proper immune response against
tumor, toxic and infectious agents. Reciprocal
communication between ECM stromal and
parenchymatous cells directs gene expression. The
oncogenic capacity of the stroma derives from the
associated cells as well as from the tumor cells, the
angiogenic microenvironment and from an alteration in
tensegrity; all of which are dependent on the ECM. It
has been shown that the malignant phenotype is
reversible by correction of the altered cues of the ECM.
Key words: Extracellular matrix, Pischinger basic
system, Tensegrity, Desmoplasia, Cancer
Introduction
Body tissues communicate within themselves at a
higher speed to that provided by the nervous system. At
histological level, these support and communication
functions reside in the extracellular matrix (ECM),
which is also responsible for the supply of oxygen and
nutrients, as well as the elimination of CO2, toxins and
other waste materials. The toxins accumulated in the
ECM are drained though the lymphatic system. When
such drainage is insufficient, a response is produced,
resulting in inflammation, acidosis and pain. The ECM
is innervated through the vegetative nerve fibers; the
correct function of which determines the predisposition
of the matrix to respond with an inflammatory process to
any nonphysiologic stimulus. Moreover, the ECM acts
as a reservoir for numerous molecules, including growth
factors, cytokines and proteases (Alvaro et al., 2009b,
2010).
The ECM accounts for 20% of our whole body
weight and as such is the largest organ in our system. It
is composed fundamentally of collagen, and constitutes
the main structural support element in multicellular
animals, performing a central role in tissue organization
and orientation, as well as in cell adhesion, migration,
differentiation, proliferation and apoptosis (Huxley-
Jones et al., 2007, 2009). The ECM consists of a
complex mixture of proteins, proteoglycans (PGs) and
glycoproteins (GPs) that confer the structural properties
of cells and tissues. Each cell presents its own receptor
profile, creating a communication interface with the
surrounding microenvironment. The ECM acts through
these receptors to influence cell growth, death, adhesion,
invasion, gene expression and differentiation processes.
All these cellular events are present in the physiologic
processes of embryonic development, tissue
morphogenesis or angiogenesis. When the correct
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information is lost, these events result in pathologic,
autoimmune, inflammatory, degenerative and neoplastic
processes as well.
Since Virchow first propounded the model of
cellular pathology, it has been considered that the
minimum unit of life in the organism is the cell.
Nevertheless, a single cell cannot survive alone in
isolation from its environment. In recent years, Alfred
Pischinger has suggested the names ‘the third system’,
‘the basic system’, or ‘the basal regulation system’ to
denote the entire structure surrounding the cell, defining
it as a homeostatic system, and proposing the capillary-
ECM-cell triad as the minimum unit of life in vertebrates
(Fig. 1) (Pischinger, 2006). Several scientists have laid
the foundations for knowledge of the ECM and have
each contributed with essential features to the concept of
the third system (Noble, 2008; Saks et al., 2009).
Modern investigation does not understand the ECM as
an inert material or a passive support tissue, but as a
dynamic living component, possessing multiple
functions, “a living matrix” (Oschman, 2009).
Study techniques and ECM histology
The techniques used for the morphologic study of
the ECM, such as immunohistochemistry, immuno-
fluorescence or electronic microscopy, require the
fixation, processing and cutting of tissue, thus limiting
the study of these structures and making dynamic
observation in vivo impossible. The fine structure of the
ECM is poorly preserved by histologic fixatives, usually
appearing as a granular material between the cells and
fibers. When using frozen tissue, the ECM is stained
metachromatically with Periodic Acid Schiff’s reaction
(PAS). 
Other techniques, such as in vivo confocal
microscopy or multi-photon microscopy (MPM),
facilitate the dynamic study of the ECM. MPM is able to
utilize the properties of the collagen fibers of the matrix
to generate a harmonic signal known as second harmonic
generation or frequency doubling, allowing these fibers
to be observed without the need to process the tissue
(Friedl et al., 2007; Schenke-Layland et al., 2008). The
elastic fibers of the ECM can also be studied with this
method (Konig et al., 2005).
The ECM is the structural framework within which
the support cells, the free nerve endings, the capillaries
and the cells of the immune response system reside. It is
constituted by fibers and by the ground substance, a
viscous gel made of highly hydrated macromolecules
694
Tissular hyperstructure
Fig. 1. A. Intestinal mucosae: Lieberkühn’s glands and lamina propia. Hematoxylin and eosin stain. x 100. B. Schematic representation of the selected
area in A. The capillary-ECM-cell triad is the minimum unit of life. It provides the structural support of tensegrity, a matrix through which the stimulus of
innervation is transmitted and a capillary network to provide nutrition and to discard waste materials from the parenchymatous cells. It is also the
framework for monitoring and action by immune system, as well as an energy flow network for high-speed local and distant communication.
(Geneser, 2000; Stevens and Lowe, 2006). The fibers
confer tensile resistance and elasticity, and form a
scaffold upon which the cells are arranged. The fine
structure of PGs and GPs lies between a thick structure
of collagen and elastin fibers, covered by interstitial or
tissular fluid (Fig. 2). 
The collagen system consists of different types of
collagen fibers, each having their own structural and
support function; reticular fibers, which are bundles of
collagen fibrils smaller than 50 nm; collagens associated
to fibrils, which bind the reticular fibers both together
and to other ECM components; and anchorage collagens,
which bind the type I collagen fibers to the basement
membranes and laminas, among others.
Within the elastic system, thinner fibers branch out
and bind together, forming a very irregular network.
PG monomers are formed by sulfated glycosamino-
glycans (GAGs), previously known as mucopoly-
saccharides, linked to central proteins by covalent bonds.
In form they resemble a laboratory brush, with a proteic
central structure and the GAGs simulating the bristles.
The GAGs are long, non-branched polymers of several
disaccharides (up to 200 repeated saccharides),
consisting of one uronic acid (almost always glucuronic
acid) and one hexosamine (glucosamine or galacto-
samine).
The main GAGs are composed of hyaluronic acid,
dermatan sulfate, keratan sulfate, chondroitin sulfate and
heparan sulfate. The PG aggregates are structures
formed by a molecule of hyaluronic acid to which the
PG monomers bind transversely. The hydrophilic
property of the ECM arises from the high overall
presence of GAGs, consisting of very negatively charged
polyanions linked by electrovalent bonds to a high
number of cations, principally sodium, which, in turn,
attract and retain a large quantity of water molecules.
Any change in these electric charges would modify the
hydrophilic properties of the ECM. The PG
macromolecules occupy a large proportion of the ECM,
forming domains or pores with a large, open helical
configuration. The spatial organization and the negative
charge of the PGs, together with an intrinsic turgor,
facilitate the selective diffusion of the various molecules,
creating a tridimensional network which acts as a
biophysical filter opposing compression forces and
counteracting deformation. The PG aggregates are found
not only in the ECM, but also in the basement membrane
(perlecan) or on cell surfaces (syndecan, betaglycan).
PGs and GAGs synthesize rapidly, the fibroblasts are
able to generate these structures in only 1 to 2 minutes,
and their half-life is 2 to 120 days.
Glycoproteins contain oligosaccharide chains
(glycans) covalently attached to polypeptide side-chains.
Structural GP, which occur in connective tissue, help
bind the fibers, cells and ground substance together.
They may also help components of the tissue bind to
inorganic substances, such as calcium in bone.
Fibronectin, with binding sites for cells, collagen and
GAGs, binds to the integrin cell receptors and links the
cell to its extracellular environment. Laminin
participates in this linking of cells and influences the
filtration of molecules through the basement laminas.
Nidogen, tenascin and vitronectin are others of the many
existing structural GPs of the connective tissue.
The interstitial fluid is essential to maintaining the
homeostasis between intracellular and extracellular
areas. It is composed of a water vector containing mainly
fatty acids, amino acids, sugars, coenzymes, chemical
messengers such as cytokines, hormones, neuro-
transmitters, mineral salts and discard products. 
The ECM has various structural patterns and a
number of different biochemical compositions; one of
these elements is the basement membrane, a highly
complex and specialized structure. Epithelial cells
adhere to the basement membrane through which they
receive the controlling signals originating from the
ECM. The basement membrane consists of a lamina
lucida and a lamina densa, as well as GPs which vary
depending on the tissue type: laminin, type IV collagen,
nidogen and heparan sulfate-like PGs (Fig. 3). Among
its functions we can highlight cell adhesion, regulation
of proliferation and its role as a selective filter for
molecular diffusion. 
Biological and functional aspects of the third system
The living cell literally vibrates in permanent
interaction with its surrounding environment. The
formation of tissues and organs is based upon
environment recognition, the distribution of cytoplasmic
compounds, changes in shape, mobilization and directed
displacement of cells; and the establishment of contacts
and associations with other cells and / or extracellular
materials which are scant in epithelial tissue and highly
abundant in connective tissue.
The plasma membrane consists of a double lipid
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Fig. 2. Functional aspects of the third system.
layer and integrated proteins that traverse the membrane
totally or partially. These components are able to make
molecular movements such as turning, tilting from the
outer to the inner surface and moving across the
membrane. This explains cellular functions such as
membrane flow, receptor function, cell recognition,
surface enzyme activity, cell-cell and cell-substrate
adhesion, cell motility in a liquid or over substrates,
endocytosis and exocytosis, changes in cell shape,
interactions and recruitment of ligands, and immune and
histocompatibility phenomena.
The cytoskeleton is also a dynamic structure, made
up of polymers comprising microfilaments, microtubules
and intermediate filaments (Fig. 3). The cytoskeleton
can be modified by extracellular changes in electric
potential.
The main support cells are constituted by
fibroblasts/fibrocytes, chondroblasts/chondrocytes,
osteoblasts/osteocytes, myofibroblasts, adipocytes and
gliocytes, which are essential for the synthesis of the
extracellular fiber structures, as well as the PGs and the
GPs. The quality of the biophysical filter formed by the
PGs and the GAGs of the ECM depends on these
support cells. Healthy support cells facilitate the rapid
repair of the ECM after injury. The macrophages,
neutrophils, mastocytes and other phagocytes remove
the majority of unwanted substances, while the cytotoxic
T lymphocytes and NK cells remove the poisoned or
injured aberrant cells (Fig. 2). 
The niches or biochemical and mechanical
microenvironments are defined by coordinated
competitive interactions between soluble factors, cells
and the ECM. These niches are variable in both function
and number, and can be created or altered under specific
conditions, with a complex and dynamic regulation that
influences stem cell transit, survival, self-renewal,
proliferation and differentiation (Scadden, 2006; Discher
et al., 2009).
Lymphoid cells are the main users of the
communication highways of the ECM along which the
lymphocytes flow easily at high speed (Korpos et al.,
2009). When migrating they exhibit amoeboid
movements which allow the cell body to align with the
collagen fibers, using them as a physical scaffold to
guide migration. This lymphocyte migratory movement
is facilitated principally by Integrins which play a central
role in this process (Lammermann et al., 2008; Sabeh et
al., 2009). 
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Fig. 3. The basement
membrane. It provides
structural support for epithelial
cellularity. The cytoplasmic
framework establishes
connecting links between the
nuclear matrix and the ECM
through focal adhesions and
integrins. The tensegrity and
mechanotransduction forces
are transmitted through the
cytoskeleton; these forces give
shape and movement to the
cell, translate the biochemical
stimuli and activate the
epigenetic mechanisms of the
cell.
CAMs (cell adhesion molecules) and Integrins
CAMs are a group of membrane GPs involved in
biological processes entailing cell-cell or cell-matrix
contact, such as proliferation, migration, differentiation
and cell death. They recognize specific receptors,
usually other CAM molecules located in other cells or in
the cell matrix (Hynes, 1999). CAMs are grouped into
families such as cadherins, immunoglobulins, selectins,
integrins and ECM GPs. They can bind to molecules of a
similar (homophilic interaction) or different nature
(heterophilic interaction).
Cadherins are found on the surface of the majority of
animal cells, and recognize other cadherins in adjacent
cells. Immunoglobulin-type molecules establish
homophilic bonds with immunoglobulins in the adjacent
cells, whereas the selectins form heterophilic bonds, i.e.,
they bind to glucids present in the neighboring cell, and
are important in the binding of leukocytes to the walls of
the endothelium when they leave the bloodstream to
enter the tissues.
Signals from the ECM molecules are transmitted to
the surrounding cells through integrins which act as
specialized mechanoreceptors. Integrins are able to
translate and transmit a mechanical signal from the cell
surface through a specific molecular pathway and
convert it into intracellular biochemical changes,
stimulate other receptors or induce gene expression. In
addition, macromolecular complexes constitute adhesion
points between the ECM and the cell, forming true
mechanosensitive organelles or focal adhesions able to
promote cell survival, the physiologic process of anoikis
(apoptosis in response to an inappropriate relationship
cell/ECM) and the proper replacement of tissue (Fig. 3)
(Gilmore, 2005).
Integrins constitute the most important molecules
involved in binding cells to the ECM. These molecules
comprise a large family of transmembrane proteins that
are expressed according to the type and physiologic
needs of the tissues and cells, and possess an
intracellular domain which is in contact with the
cytoskeleton and an extracellular globular domain able
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Fig. 4. Biotensegrity. The flattened or
rounded morphology of the cellular
elements and the three-dimensional
structure of the tissue patterns, forming
glands, alveoli, ducts and papillae, depend
on the stiffness or f lexibil i ty of the
basement membrane, as well as on its
coordinated movement.
to bind to collagen, integrins and laminins (Akiyama,
1996). 
The ECM provides a direct structural link between
the nuclear matrix and the cell matrix (Getzenberg et al.,
1991; Haque et al., 2006). The cytoskeleton (consisting
of actin microfilaments, tubulin microtubules and
intermediate filaments, specific for each cell type) is
anchored to the nucleus through nesprins 1 and 2, which
bind to actin filaments, whereas nesprin-3 can associate
with intermediate filaments through plectin. Finally, the
nuclear lamina forms a stable structure together with the
nuclear structures, thus completing the mechano-
transduction pathway between the ECM and the interior
of the nucleus (Fig. 3) (Jaalouk and Lammerding, 2009).
Mechanotransduction and biotensegrity
Through the mechanotransduction process (Alenghat
and Ingber, 2002), cells are able to convert mechanical
changes into chemical or genetic changes. This process
has been comprehensively studied in different cell types
(Lin et al., 2009; Mammoto et al., 2009). In the body,
bones constitute the basic compression support structure,
forming part of a more complex framework in which all
muscle, cartilage, ligament and tendons combine to form
a tension structure. The fine balance between the forces
that bind this framework together, through critical points
such as joints, both holds the body together and enables
it to move. Living organisms are holographic structures,
systems within systems which repeat their properties at
different levels. In fact the cell maintains its morphology
and function through an integrated tension system,
denominated tensegrity. Within the cell, microtubules
constitute the compression structures, and the actin
filaments, closely related to myosin filaments, the
tension structures (Ingber, 2008). Mechanical tension
generated by movement is transmitted by pressure to the
ECM which in turn transfers the movement into the cell
through the integrins. The cytoskeleton translates these
forces into chemical signals and mechanical stimuli
which are transferred into the nucleus through the
intermediate filaments that connect with nesprins and
Sun proteins. These in turn communicate with the
nuclear lamina, and the nuclear lamina communicates
with the DNA (Jaalouk and Lammerding, 2009). The
nucleus itself also has its own tensegrity system, and
activates proliferation, cell metabolism, differentiation or
apoptosis through mechanical stimuli.
A system has evolved through which it is possible to
activate different genetic cell programs by modifying the
shape of a cell (Ingber, 1998). Tensegrity may offer a
scientific explanation for the effect of massage and
qigong (Manzaneque et al., 2004), or for the genetic
modification of the cell as a response to relaxation
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Fig. 5. A. Breast carcinoma. Hematoxylin and eosin stain. x 10. B. Schematic representation of the selected area in A. In this tumor, the oncogenic
capacity of the stroma derives from the effect of its own cells, the lymphoid cells, and from the mechanical stimulation of tensegrity of the ECM. The
loss of the tissue architecture causes a lesion to become a malignant tumor. ECM stiffness, the new-angiogenesis and desmoplasia cause an
increased consistency that enables clinical detection of the tumor.
(Dusek et al., 2008). When a cell is flattened, the tension
generated indicates that more cells are needed and the
division process is activated. If the shape becomes
rounded, the opposite process occurs and the apoptosis
or anoikis program is activated. To establish equilibrium,
the cell seeks the optimal conditions for differentiation
and function according to the microenvironment in
which it resides. All cells in the body are subject to this
tensegrity mechanism based on the inner structure of the
nuclear matrix and the cytoskeleton. Thus, every cell
senses its environment and reacts to it according to its
own needs (Fig. 4) (Ingber, 2003a,b, 2006; Discher et
al., 2005). 
Variations in the rigidity of the ECM allow it to
produce a differentiated phenotype in the mesenchymal
stem cells. A soft ECM with a pressure or 1kPa
(kilopascal) would produce neurogenic differentiation; a
stiff ECM of 10kPa would induce muscle differentiation
(Engler et al., 2006). Such isometric tension is vital to
life and explains why cells, organs and tissues take on a
given shape, or why a hollow organ collapses when
opened; this tension is found at the tissular, cellular,
organic and molecular level, including the DNA
structure itself (Getzenberg et al., 1991). A mechanical
force applied to a living organ is transmitted down
through a structural hierarchy that spans multiple size
scales until becoming biochemical cellular stimulus
through specific transduction molecules (Ingber, 2006). 
The mechanotransduction process converts
mechanical stimuli into chemical signals and allows the
cell to adapt to its microenvironment (Jaalouk and
Lammerding, 2009). This mechanism includes steps that
pass from the ECM to the cytoplasmic membrane, the
cytoskeleton and the nuclear membrane, and therefore
involves an enormous amount of proteins and molecules.
These elements have therefore been classified into three
groups, comprising those of the extracellular
microenvironment, those affecting the cell structure and
organization, and finally, those related to cell signaling.
All these proteins and molecules will eventually affect
the nuclear chromatin at a genetic and epigenetic level
(Wang et al., 2009).
Energy flow and physiopathology of the ECM
The electric and magnetic fields generated by tissues
and organs possess an important biologic function. This
function is altered in the pathologic processes of
inflammation, degeneration or the appearance of new
tissue within an organ. The electromagnetic activity of
an organ is not only restricted to the boundaries of the
capsule, but extends outwards involving the fields of
neighboring organs, interrelating and communicating
with adjacent and sometimes distant structures, similar
to the electromagnetic wave sent by the heart throughout
the body via the bloodstream. The essential unit of the
ECM, the matrisome, hosts the function of maintaining
the osmotic, ionic, electromagnetic and protonic
homeostasis, both at local and systemic level.
Biological electricity is an ionic phenomenon linked
to the polarity of the cell membrane, it occurs in nerve
transmission, muscle contractility and in all living cells.
These potential differences are easily measurable,
although electrons and protons produce much smaller
flows. Thus we have a system based on interaction of
energy, which, together with the chemical system
constitutes a language essential to the integrity of the
body; an integrated network that links genes and nuclear
matrix to the ECM and to its collagen fibers through
integrins and focal adhesions. Knowledge of this
structure provides histology with a clue to its function,
allowing the visualization within tissues of the circuits of
energy that support life and its relationships, integrated
through the tensegrity and mechanotransduction
mechanisms. Thus, the nuclear matrix, the cytoplasmic
matrix and the ECM form an interconnected network
linking all molecules in the body (Fig. 5) (Wang et al.,
2009).
Energy pathways and information circuits are routed
principally in the ECM, whose composition and
structure not only provides a supportive element, but
also precise circuits for mechanical, ionic, electrical,
protonic and chemical transmission. The electric fields
produced by movement provide the information that
directs cell activity and the pattern of tissue remodeling
(Bassett, 1993). The ECM is able to provide the means
for high speed communication thanks to its
hydrophilicity, which depends on the intense negative
charges of its GAGs components. All diseases are
accompanied by changes in ions and water content, and
in pH levels of the extracellular fluids, thus affecting the
cell membranes and their electric micropotentials (Goller
et al., 1986; Kim et al., 2007).
ECM components are semiconductors able to
transfer the electricity of the electrons and the proticity
of the protons, which is another function of the ECM
studied by quantum chemistry (Alvaro et al., 2009a).
The ECM is a pool of negative charges able to donate or
absorb electrons, used in the neutralization of free
radicals released by oxidative processes, as in the case of
inflammation. 
The ECM determines tissue specificity and takes an
active part in the development and maturation of the
central nervous system, its remodeling, axonal guidance,
regeneration after injury and the capacity for neural
plasticity (Zimmermann and Dours-Zimmermann, 2008)
(Huang et al., 2009). Furthermore, it can act as a
stimulus for cell survival, as well as affecting its
viability. The molecules of the ECM are related to the
processes of cell life and death through the balance
between metalloproteinases (MMP) and its inhibitors
(MMPI), and can play an important role in tumor
progression, inducing or suppressing apoptosis
(Marastoni et al., 2008). The balance between MMP and
MMPI affect different physiologic and pathologic
processes, including embryonic implantation,
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angiogenesis and carcinogenesis (Huang et al., 2009),
thus constituting new potential therapeutic targets in
inflammatory (Korpos et al., 2009) and tumor (Denys et
al., 2009) processes. In prostate cancer the metastatic
process is associated with changes in the ECM (Stewart
et al., 2004); and in melanoma the degradation of the
basement membrane and remodeling of the ECM are
produced by MMP and its inhibitors (Hofmann et al.,
2005).
The evidence available suggests that one of the
mechanisms by which a lesion is converted into a
malignant tumor is through the loss of tissue architecture
(Fig. 6). The parenchymatous cells are anchored three-
dimensionally through interactions with the ECM. This
contact is essential for cell survival, to the point that
anoikis occurs when a cell becomes detached from the
network and is left with no locational reference
(Gilmore, 2005); only metastatic tumor cells escape this
law. The majority of malignant tumors show an increase
in consistency due to the stiffness of their ECM.
Mechanical changes to the matrix activate integrins,
which not only promote cell proliferation through the
Ras and Erk pathways, but also affect cell contractility
through the Rho pathway (Huang and Ingber, 2005)
whereby the greater the rigidity, the greater the
stimulation of the integrins, which in turn increases
stiffness, a fact that is reflected in the malignant
phenotype of the epithelial tumors (Fig. 7).
The ECM, furnishing the tumor microenvironment
The concept of genetic determinism is currently
under review given the evidence that tumors are
heterogeneous cellular entities whose growth depends on
the interaction between the genetically altered cells and
the tumor microenvironment in which they develop
(Ingber, 2008). This microenvironment consists of ECM,
stroma cells and immune response, determining not only
the morphology and the classification of the tumor, but
also the clinical aggressiveness, prognosis and response
to treatment (Alvaro et al., 2009a; Lejeune and Alvaro,
2009). A tumor could therefore be considered as a
functional tissue, connected and dependent on the
microenvironment which sends and receives signals to
and from the tumor tissue itself. Thus, cancer may be a
disease of neoplastic cell development, whose abnormal
growth could be normalized through embryonic tissues
or the ECM itself (Kenny and Bissell, 2003), changes in
the ECM and in normal tissue architecture being as
oncogenic as radiation or viruses (Ingber, 2008). The
oncogenic capacity of the stroma derives from the effect
of its own cells, the lymphoid cells, and from the
mechanical stimulation of tensegrity of the ECM (Li et
al., 2007).
Tumor stromal cells derive from bone marrow
progenitors which are mobilized through the
bloodstream until entering the tumor microenvironment
(Roorda et al., 2009) where they differentiate following
different cell pathways in endothelia, fibroblasts and
histiocyte-macrophages, which control tumor cell
growth, the metastatic potential of the tumor and also
determine the response to treatment (Li et al., 2007). The
collaboration of one of these cell types in particular, the
macrophages, is essential in the processes of migration,
invasion and tumor metastasis (Condeelis and Pollard,
2006); however it is the mesenchymal stem cells of the
tumor stroma that drive the tumor cells to metastasize
(Karnoub et al., 2007). Stem cells in the bone marrow
are the precursors of metastasis to distant organs, and
ensure the activation of an optimal microenvironment or
niche to receive and host the tumor cells which arrive
later (Kaplan et al., 2005; Hu and Polyak, 2008).
Fibroblasts are the chief fabricators of ECM and are able
to change their phenotype and function both in
physiologic and pathologic contexts. In the tumor
context we can find myofibroblasts, peritumoral
fibroblasts, reactive stromal cells and carcinoma-
associated fibroblasts (CAF) (Fig. 5) (Olumi et al., 1999)
acting on tumor cells, as well as on the rest of the tumor
microenvironment (Fig. 8) (Tlsty and Coussens, 2006).
The stromal cells and their products are able to
produce cellular oncogenic transformation (Pupa et al.,
2002), which acts through alteration in the homeostatic
regulation of the tissue. Under normal conditions this
regulation is responsible for maintaining architecture,
adhesion, and programmed cell death or cell
proliferation signals; so if the cells cease to receive this
information from the ECM, firstly their function will be
altered, followed by their structure and, finally, the
oncogenic change will occur (Alvaro et al., 2009a).
Remodeling of the tumor microenvironment will
determine both the response to cytotoxic treatment and
tumor prognosis.
The number of inflammation-derived mediators with
the potential to promote cell proliferation, genomic
instability and metastasis is virtually endless. Some
examples are the release of cytokines and chemokines,
the release of cytotoxic mediators including reactive
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Fig. 6. Physiopathology of the ECM.
oxygen species, the secretion of proteases (especially
MMP), soluble mediators of cell death and cell
proliferation as TNF, interleukins, interferons and so on.
These mediators are so abundant and have so many
functions that the individual study of any one of these
agents has so far produced little information. This
circumstance calls for a reading at a higher level, that of
the so-called hyperstructures, in an attempt to interrelate
the data coming from the different fields of genomics,
proteomics and all cellular physiology (Amar et al.,
2002). The concept of hyperstructures considers the
interaction of thousands of molecules, genes, ions, lipids
etc. in carrying out a single tissue or cellular function.
This interaction is influenced by extracellular regulatory
signals proceeding from the microenvironment and the
non-neoplastic cells of the tumor stroma, constituting the
epigenetic framework for tumor progression (Huang and
Ingber, 2006).
Transformation from a benign proliferative cell into
a malignant cell can be produced by a peculiar
phenotypic change, known as epithelial-mesenchymal
transition (Guarino et al., 2007). This transformation
involves breaking contact with sister cells and increasing
motility, as the result of a change in the epithelial
cytoskeleton, with its corresponding proprieties for a
pseudomesenchymal phenotype, which enables
migration, invasion and dissemination (Lee et al., 2006).
While normal cells adhere to their environment through
integrins, and their body has a proper consistency, tumor
cells lose that consistency and tensegrity, becoming
easily deformable elements (causing pleomorphism),
with high elasticity (enhancing infiltration) and with an
increased degree of mobility (enabling metastasis)
(Suresh, 2007).
In lymphomas, the ECM regulators, especially
MMP-9, influence angiogenic activity both at local and
distant level (Negaard et al., 2009). Abnormal
vasculature in the stroma, as well as fibrosis and
increased interstitial pressure, confer the firmness of the
tumor on palpation. Under homeostatic conditions,
collagen fibrils are subject to a scant turnover. However,
this turnover is accelerated during tissue remodeling and
tumor development, as evidenced by the serum levels of
its degradation products. A desmoplastic reaction is
frequent in many solid tumors, such as breast, prostate,
colon or lung, in which high levels of TGF-b and PDGF
are found. These growth factors are produced by the
mesenchymal cells of the tumor stroma and induce
immunophenotypic changes. These changes are
observable by studying actin-alpha, myosin, vimentin,
desmin and the altered production of several ECM
proteins, such as collagen, laminin, tenascin, MMP and
MMPI, and several growth factors (Pupa et al., 
2002).
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Fig. 7. The reciprocal communication
between the stromal cells and the
tissue parenchyma directs gene
expression. E-cadherin is involved in
the processes of tissue differentiation
and morphogenesis and plays an
important role in modulating the
invasiveness of tumor cells in breast
cancer and other epithelial tumors.
Studies of the ECM have revealed that the
components of the tumor microenvironment are
fundamental, not only for the regulation of tumor
progression (Tlsty, 2001; Tlsty and Coussens, 2006), but
are also essential even before the tumor appears. The
stromal cells are able to produce the transformation of
the adjacent cells through an alteration in the
homeostatic regulation of the tissue, including the
control of architecture, adhesion, cell death and
proliferation (Pupa et al., 2002).
An overexpression of the ECM molecules
themselves can increase tumor proliferation and confer
resistance to chemotherapy, as in small cell lung
carcinoma. 
Molecular mechanics and therapeutic consequences
of the regulation of the third system
Malignant transformation is accompanied by a
progressive loss of local homeostasis and an alteration in
tissue architecture. This culminates in tumor cell
invasion and the production of distant metastasis.
Throughout this entire process, a series of changes
related to cell and tissue tensegrity are produced and
result in a mechanical phenotypic change in both the
tumor cell and its microenvironment (Figs. 7, 8).
Micromechanical alterations of the ECM, together with
remodeling of the stroma by the tumor cell, are linked to
the phenomena of dysplasia, infiltration and metastasis
(Kumar and Weaver, 2009). Knowledge of the molecular
mechanisms by which a cell receives, processes and
responds to mechanical stimuli is opening up new
perspectives on the biology of cancer and its treatment.
Alterations in the mechanical interaction between cells
and their microenvironment contribute to cellular
dysplasia. Conversely, the homeostatic regulation of the
tensional force within the cell is able to reverse the
malignant phenotype (Paszek et al., 2005; Johnson et al.,
2007).
The emission of filopodia-like projections with a
higher actin density, known as invadopodia, are used by
the tumor cells to help digestion and invasion of the
ECM, remodeling the existing matrix and establishing
new pathways in the ECM which will be used for tumor
invasion (Yamaguchi et al., 2005). During this action,
the tumor cell will suffer significant cytoplasmic and
nuclear deformations, with corresponding changes in
organization of the cytoskeleton on traversing a rigid
stroma. In turn, the expanding tumor compresses the
adjacent ECM, with the consequent reduction of flow in
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Fig. 8. Cancer cells, represented as
the largest ovoid cells, often
metastasize to different organs with
very different microenvironmental and
mechanical properties. The mechanics
of remote tissues and the cancer cells
could regulate cell dormancy,
proliferation and differentiation in these
organs.
the vascular and lymph vessels and of the interstitial
space. Tumor growth is associated, first, to an increased
matrix deposition and the adjacent ECM densification,
and second, to a massive secretion of MMP and
peritumoral matrix digestion.
Currently, two humanized monoclonal antibodies
that act on the integrin interactions have been approved.
Efalizumab interacts with the integrin lymphocyte
function-associated antigen 1 (LFA-1) and is used in the
treatment of patients with chronic plaque psoriasis,
whereas natalizumab interacts with VLA-4 and is used
in the treatment of multiple sclerosis. 
With respect to the CAMs, a large number of
investigations consider them to play a relevant role in
pathology, and several projects to investigate new
therapies with CAMs as the therapeutic target, usually
by means of antibodies to modulate their action, are
underway.
The perspective of the epithelial-mesenchymal
transition in epithelial tumors has opened the door to a
new line of treatment which considers the genetic and
epigenetic mechanisms associated with resistance to
chemotherapy (Sabbah et al., 2008). In breast cancer,
treatment with doxorubicin results in an increase in
fibuline-1, an ECM protein, and its binding proteins,
fibronectin and laminin-1, which constitute a source of
chemoresistance (Pupa et al., 2007). Monoclonal
antibodies against fibulin-1 are able to reverse 
such chemoresistance, and the inhibition of MMP 
seems to have a therapeutic effect (Jodele et al., 
2006).
Chemotherapeutic agents often base their cytotoxic
action on the modification of cell membranes and the
cytoskeleton. For example, doxorubicin produces
peroxidation of the cell membranes, Taxol increases
polymerization of tubulin, and vincristine impedes the
addition of monomers to the microtubules, thus
eliminating the possibility of mitosis (Suresh, 2007). In
follicular lymphoma and diffuse large cell lymphoma,
treatment with lenalidomide affects the immune
synapses of intracellular T lymphocytes (Ramsay et al.,
2009). Similarly, chemotherapeutic agents alter cell
mechanics which increases the risk of vascular
complications, as occurs in the treatment of leukemia. In
leukemias, the treatment of tumor lymphocytes increases
their rigidity due to the reorganization of the actin
filaments, which in turn leads to a decrease in cell
deformability with the consequent leukostasis,
microcirculation obstruction and vascular complications
(Lam et al., 2007). 
Conclusion
Continued advances in cancer treatment require new
and innovative approaches. The discovery that the
malignant phenotype can be reversed through the
correction of cues from the tumor microenvironment
(Kenny and Bissell, 2003), paves the way for a new
focus on experimentation and derived knowledge.
Experimental evidence suggests that the cancerigenic
effect of hormones on an epithelium occurs through an
alteration in the stromal-epithelial interaction, and it has
been shown that inducing changes in the ECM, in vivo
or in vitro, is enough to influence the tumor phenotype.
Nevertheless the opposite is also true, and some tumors
may undergo regression by restoring an ECM which
enables the proper interaction between the epithelium
and the stroma (Ingber, 2008). The discovery that
several cell behaviors are controlled by purely physical
interactions has brought about a new era in which it will
be possible to integrate current knowledge on the ECM
and its function, together with the mechanisms of
biotensegrity, mechanotransduction, energy flow,
immune response and epithelium-mesenchymal
transition. These advances will provide a truly
comprehensive view of the neoplastic process, allowing
a more specific and sensitive therapeutic management of
the body and its diseases. 
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Given that angiogenesis and lymphangiogenesis are strongly related to prognosis in neoplastic and other pathologies and that many
methods exist that provide different results, we aim to construct a morphometric tool allowing us to measure different aspects of
the shape and size of vascular vessels in a complete and accurate way.The developed tool presented is based on vessel closing which
is an essential property to properly characterize the size and the shape of vascular and lymphatic vessels. The method is fast and
accurate improving existing tools for angiogenesis analysis. The tool also improves the accuracy of vascular density measurements,
since the set of endothelial cells forming a vessel is considered as a single object.
1. Background
Angiogenesis is present during development as well as during
embryogenesis and during reparative processes for wound
healing. It also has a significant role during organ transplanta-
tion since new vessel formation can be crucial to successfully
prevent allograft rejection. The role of angiogenesis in the
pathogenesis of chronic inflammatory diseases is of consid-
erable interest. A positive feedback has been found in which
inflammatory state promotes angiogenesis and the angio-
genesis in turn facilitates chronic inflammation [1, 2]. There
is increasing evidence that chronic inflammation is tightly
linked to diseases associated with endothelial dysfunction
and plays a role in the induction of aberrant angiogenesis [3].
Lymphatic vasculature is a prerequisite for the maintenance
of tissue fluid balance and immunity in the body [4].
It is nowwidely accepted that tumor growth andmetasta-
sis are angiogenesis and lymphangiogenesis dependent pro-
viding novel therapeutic targets in malignant disease [5–7].
A common feature of tumor vessels studies is that the investi-
gators focus onmicrovessel density overlooking other param-
eters that might be significant, such as the size and shape of
the microvessels [8]. In many aspects, tumor vessels are dif-
ferent from normal vessels [9, 10]. Studies have revealed the
importance of the size and shape of blood vessels in, for exam-
ple, laryngeal tumors [11].
To our knowledge, there are only two applications pro-
viding vessel closing when the whole perimeter of the vessels
is not completely stained, which could be a basic feature in
translational research. Aperio’s application for angiogenesis
analysis [12] is an excellent tool for managing microvessels.
This software allows to perform many operations in whole
slide images but the closing algorithm is not automatic. For
closing vessels the user must draw manually the lost segment
on the image. The second algorithm is free and available at
http://www.caiman.org.uk/ [13]. The algorithm cannot pro-
cess image files larger than 2MB. Both of themmeasure shape
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parameters but are global measurements; the properties of
each microvessel are not calculated individually.
Other works such as van der Laak et al. [14], Tsuji et al.
[15], Laitakari et al. [11], Luukkaa et al. [16], Virgintino et al.
[17], and Dagnon et al. [18] have been also developed in order
to calculate morphometric measurements in microvessels.
Most of them are semiautomatic and require manual interac-
tion. Van der Laak extractsmorphometricmeasurements like
area, perimeter, convex perimeter, or circularity in microves-
sels but when the vessels are not closed a manual correction
is performed. Selecting regions of interest and vessels is
necessary in Tsuji’s work. Virgintino and Dagnon divide the
process into two tasks, microvessel selection and measure
calculation. Virgintino applies filters and image segmentation
techniques for selecting microvessels. Dagnon selects each
microvessel manually and works with the grayscale image.
Then, measurements of these vessels are calculated using
other image analysis software, that is, VIDAS release 2.5
(Kontron Elektronik, Eching, Germany) and ImageJ software
(National Institute of Health, USA). These processes do not
consider open vessels.
Our aim is to develop a morphometric tool able to per-
form a segmentation of blood and lymphatic vessels to study
vascularization following the hypothesis that tumor progno-
sis may not only be influenced by microvascular density but
also by the shape and size of the vessels. Thus, the tool is able
to deal with closed and open vessels and provide morpho-
metric measurements for each detected vessel. Besides, the
tool provides two kinds of executions, an automatic execution
without user interaction and another where the user can
select the vessels to be analyzed. To this end a segmentation
algorithm based on two complementary methodologies has
been developed to segment closed and open vessels. A
description of thematerials used for this work can be found in
Section 2. Section 2.1 presents the algorithm implementation
and how the applicationworks. Section 3 shows the results for
the implemented tool, called AngioPath, with a comparison
of CAIMAN tool. Finally, conclusions are drawn in Section 4.
2. Materials and Methods
A dataset of 700 cores extracted from 10 TMA scanned slides
was considered. TMA images were formed by several vessels,
from 2 to 600 vessels of different sizes and stains. The
images have been stained with IHQ technique against D2-
40 (lymphatic vessels) and from a previously stained TMA
with anti-CD34 antibody (blood vessels). This dataset was
prepared with an automatic tissue arrayer composed of 70
cores/TMA and digitized with Aperio ScanScope T2 at 40x.
The resolution of Aperio ScanScope T2 at 40x objective is
0.23 𝜇m/pixel. Thus, these cores are images at 40x magnifi-
cation and their size varies between 6200 and 7300 pixels.
Experiments were performed on an Intel Core i7 950
3.07Ghz and 12GBRAM.Themethodhas been implemented
using C/C++ and the IPP libraries for image processing. Also,
the Intel TBB library has been used for parallelization of the
algorithms.
Table 1: Morphometric measurements.
Measurements Meaning Units
Localization 𝑥-𝑦 coordinates Pixels
Area Vessel contour area Physical units(𝜇m2)
Size Vessel width and height Physical units(𝜇m)
Perimeter Perimeter Physical units(𝜇m)
Angle
Angle between the
horizontal axis and the
first side (i.e., length)
Radians
Vascular density Number of vessels
core
Physical units
(vessel number/𝜇m2)
Aspect Major axis
minor axis
∗
Roundness Perimeter
2
4 ∗ 𝜋 ∗ area
Perimeter ratio
Convex perimeter
perimeter
Deformity Convex area− area
Physical units
(𝜇m)
Shape max
𝑖=1,2
󵄨󵄨󵄨󵄨󵄨
𝑚
𝐴
𝑖
− 𝑚
𝐵
𝑖
󵄨󵄨󵄨󵄨󵄨
󵄨󵄨󵄨󵄨𝑚
𝐴
𝑖
󵄨󵄨󵄨󵄨
Vertices
Calculates the
approximate contour
polygon vessel with less
distance between vertices
using the Douglas-Peucker
algorithm [19]
𝑚
𝐴
𝑖
= sign (ℎ𝐴
𝑖
) ⋅ log (ℎ𝐴
𝑖
) and𝑚𝐵
𝑖
= sign (ℎ𝐵
𝑖
) ⋅ log (ℎ𝐵
𝑖
)ℎ
𝐴
𝑖
.
ℎ
𝐵
𝑖
are the Hu moments of the normal and convex contour area (𝐴, 𝐵),
respectively, and 𝑖 represents the seven Hu invariant moments.
∗These axes correspond to the best-fitting ellipsoid of the vessel contour.
2.1. Algorithm Implementation. Histologic sections comprise
two types of vessels: vessels with unquestionable endothelial
cells completely stained in their perimeter (closed vessels)
and vessels whose endothelial cells do not show a completely
staining reaction (open vessels). Closed vessels can present
vascular lumen or not. However, open vessels must always
present a vascular lumen. The database used in this study is
composed of both types of vessels. In the case of closed ves-
sels, their morphometric measurements can be easily calcu-
lated.The challenge appears when the stain is weak or the ves-
sels are not closed. In the first case, color analysis is needed; in
the second case a radial algorithm is also used.
The system developed for vessels segmentation, called
AngioPath, consists of two parts: (a) color-based segmenta-
tion and (b) radial distribution of the vessel contour pixels.
The algorithm is illustrated in Figure 1.
Eleven morphometric measurements are calculated for
each vessel detected. The measurements describe the shape
and geometrical properties of the vessels. They are briefly
explained in Table 1. In addition, a summary of the measure-
ments is also provided.The vessels are grouped by their height
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Figure 1: TMA blood vessel segmentation process. Division of the algorithm in two steps: first the segmentation based on HSV color model
(right) and then the radial algorithm for joining open vessels.
and the measurements are calculated for each group. There
are 5 height groups: between [5 and 15𝜇m), [15 and 20𝜇m),
[20 and 59 𝜇m), [50 and 200𝜇m), and more than 200 𝜇m.
Also, the total area, a percentage of area, and the total number
of vessels are calculated for groups. Finally, an average of the
eleven measurements for all vessels is calculated; thus a total
of 24 morphometric measurements are provided for all the
segmented vessels (see Table 2).
The methods applied for the development of AngioPath
are described as follows.
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Table 2: Summary of measurements.
Height (𝜇m) Ratio measurements Total Percentage Vessels
[5–15), [15–20),
[20–50),
[50–200), ≥200
∑ area of group
𝑖
total vessels of group
𝑖
,
∑width of this group
total vessels of this group
,
∑ height of group
𝑖
total vessels of group
𝑖
,
∑ angle of group
𝑖
total vessels of group
1
,
∑ roundness of group
𝑖
total vessels of group
𝑖
, . . .
Total feature
𝑗
in
group
𝑖
∑ area of group
𝑖
total area
∗ 100
Total vessels
group
𝑖
(𝑖 = 1, . . . , 5) (𝑗 = 1, . . . , 12)
Average
∑ areas
total vessels
, ∑width
total vessels
,
∑ height
total vessels
,
∑ feature
𝑗
total vessels
, . . .
Total area Total percentage ofareas Total vessels
(a) (b) (c)
Figure 2: Vessels in TMA samples with different degrees of staining. (a) Weak stain, (b) normal stain, and (c) strong stain.
2.1.1. Segmentation Based on HSV Color Model. The objective
of this part is brown color segmentation through HSV color
model to detect the endothelial cells. Most of the closed ves-
sels can be detected through their brown color. Open vessels
undergo a radial analysis after segmentation of their endothe-
lial cells. This algorithm proceeds as follows.
(1) Conversion of the RGB TMA Image to the HSV Color
Model. This conversion is useful for segmentation of
brown color; in other words, it allows extracting the
vascular vessels membrane for both closed and open
vessels.
(2) Extraction of the S and H Channels from HSV Image.
The S channel contains most of the shades and brown
stains, but it is not enough.Therefore, theH channel is
also used.
(3) Application of a Binary Thresholding to the H Channel
Image and a Binary Inverted Thresholding to the S
Channel Image. The thresholding operation makes a
comparison between the values of the image pixels
and one threshold value. In case of binary threshold-
ing (see (1)) when the value of the pixel, 𝐼(𝑥, 𝑦), is
larger than the established threshold value, 𝑇H, the
new pixel, 𝐼󸀠(𝑥, 𝑦), will take the maximum value 𝑀
(with𝑀 equal to 255). On the contrary, if the value of
𝐼(𝑥, 𝑦) is lower than 𝑇H, then 𝐼
󸀠
(𝑥, 𝑦) will take value
0:
𝐼
󸀠
(𝑥, 𝑦) = {
𝑀 𝐼 (𝑥, 𝑦) > 𝑇H,
0 otherwise.
(1)
In the binary inverted thresholding the new pixel val-
ues, 𝐼󸀠(𝑥, 𝑦), are inverted.When the value of 𝐼(𝑥, 𝑦) in
the S color image is larger than the established thresh-
old value, 𝑇S, 𝐼
󸀠
(𝑥, 𝑦) will be equal to 0. The pixel
values lower than the threshold𝑇S will take value 255.
Threshold values depend on the stain selected. The
threshold𝑇H applied to theH channel is always 20 but
the inverted threshold𝑇S applied to S channel is 10 for
weak stains, 20 for normal stains, and 30 for strong
stains. Figure 2 shows samples of TMAswith different
degrees of stain. Moreover, the user can select manu-
ally other values for the 𝑇H and 𝑇S.
(4) Application of a Logical OR Operator to Both Binary
Images. This operation segments brown color and
erases the rest of the colors.
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Figure 3: Statistical analysis of the TMA structures based on the image histogram. (a) Original TMA sample with the main structures,
(b) histogram of the green channel image.
(5) Application of a Logical NOT Operator in Order to
Invert the Image.This operation is needed to highlight
the contour vessels.
(6) Elimination of Small Artifacts of the Input Image and
Joining Nearby Structures. Erosion and dilation opera-
tions of 2 and 4 iterations, respectively, are performed
in the image. Erosion, 𝐸(𝑥, 𝑦) (see (2)), is done by
means of a convolution where the minimum value
of the neighborhood pixels are selected. The erosion
allows eliminating small artifacts in the image and
therefore reducing false positives. Then, the dual
operation to erosion, that is, a dilation, 𝐷(𝑥, 𝑦) (see
(3)), is performed to join nearby structures:
𝐸 (𝑥, 𝑦) = min
𝑥
󸀠
,𝑦
󸀠
∈kernel
𝐼 (𝑥 + 𝑥
󸀠
, 𝑦 + 𝑦
󸀠
) , (2)
𝐷(𝑥, 𝑦) = max
𝑥
󸀠
,𝑦
󸀠
∈kernel
𝐼 (𝑥 + 𝑥
󸀠
, 𝑦 + 𝑦
󸀠
) . (3)
(7) Application of a Contour Finding Operator. Finally, a
contour finding operator is applied to find the core
contours. This algorithm computes contours from
binary images like images created by a Canny opera-
tor, which have edges pixel in them, or images created
by a binary thresholding, in which the edges are
implicit as boundaries between positive and negative
regions. Then, the algorithm retrieves contours from
the binary image using the algorithm of Suzuki and
Abe [20].The algorithm allows storing the vessel con-
tour pixels through sequences andmanipulating them
individually.
(8) Discarding Small Artifacts. Contours whose length is
lower than 6 pixels (1.38 𝜇m)or their width and height
are higher than 20 pixels (4.6 𝜇m) are discarded. The
remaining contour pixels are the valid vessels.
2.1.2. Radial Distribution of the Vessel Contour Pixels. This
algorithmfinds the vascular lumen,which is always present in
open vessels, and their brown endothelial surrounding cells.
Then the unconnected parts of the vessel are joined together.
Once the open vessels are closed, themorphometricmeasure-
ments are calculated. The algorithm proceeds as follows.
(1) Extraction of the green channel from RGB image,
Green channel, 𝐼G, helps to distinguish the different
vascular lumens at the TMA core. Besides the use of a
single channel can reduce the computational time and
also reduce the RAMmemory used to process images.
(2) A binary thresholding is applied for extracting vascu-
lar lumens at the 𝐼G image. The threshold value was
established at 236.This was done after statistical anal-
ysis of the image histogram, where it was found that
the vascular lumens have a gray level larger or equal
to 236; see Figure 3.
(3) To join large structures and remove the smaller ones
from the previous binary image, a combination of
morphological transformations was applied. These
transforms were erosion with 3 iterations and dilation
with 2 iterations.
(4) Those closed contours that have internal holes smaller
than a minimum size of about 92 𝜇m (400 pixels) are
filled.
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Figure 4: Different size of vessels to calculate the radial distribution.
(5) Again, an erosion of 1 iteration is performed in the
image.This erosion allows creating space between the
vascular lumen and the vessel membrane.
(6) Radial analysis consists of computing the normal
direction for each vascular lumen point on the border
with a possible vessel point.Then, the radial direction
is used to check if there is any part of the membrane
vessel nearby within a radio of 3 𝜇m. To this end the
endothelial cells detected in the previous algorithm
are also used. Notice that a dilatation of 2 iterations
is performed to the endothelial cells to avoid overlap-
ping with the vascular lumen.
A vessel is considered valid depending on the ratio of
checked pixels that actually belong to the membrane
vessel. The ratio is adjusted depending on the length
of the vascular lumen contour, being equal to 60%,
50%, and 40% for small, medium, and big vessels,
respectively. Small vessels are those with a vascular
lumen contour length lower than 12.42 𝜇m, medium
vessels between 12.42 𝜇m and 31.05 𝜇m, and large
vessels greater than 31.05 𝜇m. Figure 4 shows different
vessels classified by size. Once a pixel is considered as
a valid vessel a linear interpolation is done to close the
open vessels.
(7) Contours finding is a transformation is applied to find
the vessel contours obtained in the radial analysis.
This procedure is similar to point (7) of the color-
based segmentation algorithm.
(8) The small artifacts are removed. This procedure is
similar to point (8) of the color-based segmentation
algorithm.
2.1.3. Extraction of Results. At this point, the algorithm pro-
vides two images composed of closed and open vessels. In the
following steps both images are joined together and the mor-
phometric measurements are calculated.
(9) A binary thresholding is applied on the previous two
images. This thresholding is performed in order to
obtain a binary image with only the vessel contours;
therefore the threshold value is 0.
(10) Application of a logical AND operator to both images
combines into the same image those vessels seg-
mented by the HSV color model and those obtained
by the radial distribution analysis.
(11) Application of a logicalNOToperator is done in order
to invert the image and highlight the contour vessels.
(12) A contour finding algorithm is applied to find the ves-
sel contours of the final image.This procedure is sim-
ilar to point (7) of the color-based segmentation algo-
rithm and the redial analysis.
(13) For each valid vessel, its position by means of its
center pixel and twelve morphometric measurements
are given. Morphometric measurements are also pro-
vided for each group of vessels according to their
height.
(14) The algorithm provides 2 outputs: (a) all morphomet-
ricmeasurements that are saved in anExcel format file
and (b) the final image with the vessel segmented and
labeled. The final image is stored in a tiff format file.
2.2. How Does the ApplicationWork? AngioPath has an intu-
itive interface through which the user selects the execution
parameters (see Figure 5). These parameters are the follow-
ing.
(1) Type of Execution: Automatic or Manual. The system
provides automatically an output with all vessels
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Figure 5: AngioPath graphical user interface. Interface parameters
that can be selected or modified by the user.
and their morphometric measurements. However, in
order to reduce false positives whichmay occur in the
radial analysis, the algorithm allows a manual mode.
In manual mode, the user selects the nondesired ves-
sels just after the ANDoperation, see Figure 1. During
the execution, a window with the vessels found is
displayed. At that time, the nondesired vessels are
selected. This selection is made with mouse clicks on
the center point of the vessel and immediately the
selected vessel ismarked.When all nondesired vessels
have been selected the user must press the enter key
or close the window and the selected vessels will be
removed. Figure 6 illustrates the manual mode with
a TMA sample where 5 vessels have been selected as
nondesired.
(2) Directory of Images. It is compulsory to indicate the
directory where the images are stored. To this end, the
Find option allows browsing through the file system.
The path selected is displayed in the corresponding
text box.
(3) Type of Stain. The user can make use of default values
for the H and S thresholds or rather define them.
Default values depend on three different stain options
for weak (WS), medium (MS), and strong (SS) stain.
The threshold values can also be selected by the user
with Other option. The interface shows the variables
S and H to enter their value when Other option is
selected. Then, the new threshold values, 𝑇S and 𝑇H,
can be entered.
(4) Percentage of Stained Vessels. This option is a list of
percentages between 0.1 and 0.9. The user can specify
the minimum and maximum amount of endothelial
cells needed to close the vessels. Thus, the minimum
amount of brown pixels is 0.1 and the maximum
amount is 0.9. This percentage is related to the inten-
sity of the stain (see Figure 2).
The system also provides warning labels. There are three
types of warnings: (a) if the Start option is selected and the
directory of images has not been previously selected, (b) if the
Other option of stain is selected but the threshold values for S
Figure 6: Working session with AngioPath in manual mode.
Selection of nondesired vessels to be eliminated in the TMA image.
(a)
(b)
(c)
Figure 7: Warning labels. (a) Directory of images not found is
displayed when the Start option is selected and the directory of
images has not been previously selected. (b) Values of S or H not
found is displayed when the Other option of stain is selected but the
threshold values for S or H have not been set and (c) the execution
has finished is displayed when all the images have been processed.
or H have not been set, and (c) if the process has finished, that
is all vessels for all TMA images have been detected andmeas-
ured. Figure 7 shows the warning labels.
When all the options have been set, the Start button
initiates the execution. An example of the final result obtained
with AngioPath is illustrated in Figure 8. Figure 8 shows a
TMA sample with 10 vessels and their morphometric meas-
urements.
3. Results
AngioPath has been compared with the free available algo-
rithm CAIMAN in terms of speed, accuracy, morphometric
measurements, and other properties such as the maximum
allowed image size and the modes of execution. A summary
of the results of this comparison is shown in Table 3. The
comparison was done with a subset of 40 TMA subsamples
composed of 23 samples from our database and 17 from the
CAIMAN database.
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Vessel Area Width Height Angle Roundness Aspect Perimeter
ratio
Perimeter Deformity Shape Vertices
Perimeter
ratio Perimeter Deformity Shape area
area/Vertices
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(height
size)
4951 1
1
1
1
1
1
1
1
1
1
10
2
2
3
4
5
6
7
8
9
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304
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295
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752
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618
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414
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36.69
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30
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29.09
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9.19
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4
2
4
4
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2
2
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38.92
111.78
102.34
5134.69
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69.55
12.86
8.03
17.03
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1.55
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3
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1.99
1.82
91.34
100
7
Total % Group 
total area
Total
vessels
−45
−53.62
−45
−63.43
−87.4
0
−65.96
−45
−45
−78.69
−42.44
−87.4
−78.69
−65.96
−52.91
Pixel x Pixel y
5–15
15–20
20–50
50–200
Figure 8: Results provided by AngioPath. (a) Original image. TMA sample with 10 vessels, (b) segmented vessels and labeled and
(c) morphometric measurements for each vessel and for each group of vessels according to their height.
Our method takes between 10 and 180 seconds for images
with 2 and 600 vessels, respectively. The algorithm accepts
images of any size. The average image size of our dataset is
6300 × 6300 pixels, that is, 120MB. CAIMAN takes an aver-
age of 230 seconds for a 1.5MB image, that is, about 1200 ×
960 pixels. CAIMAN could not handle the image size of our
dataset since the maximum size allowed is 2MB.
Among the parameters measured, the shape factors
roundness and aspect are calculated in both algorithms.
Moreover, AngioPath includes perimeter-ratio which repre-
sents the regularity of the contour of the vessels and which
we found to be related to clinical-biological features in,
at least, neuroblastic tumors. AngioPath provides in total
24 morphometric measurements and CAIMAN provides
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Figure 9: CAIMAN application. (1st row) original images: (a) and (b) are images from our database and (c) is an example image provided by
CAIMAN with a less-lighted caption. (2nd row) segmentation performed by CAIMAN (green line) which does not detect small or too large
vessels (d) and sometimes divide large vessels in small ones or segment blue areas as vessels (e). Their image is well segmented (f). (3rd row)
results provided by AngioPath with the color-based segmentation and the radial analysis.
5 morphometric measurements and 2 related to density, that
is, the average stained area (lumen excluded) and the average
vessel area (lumen included).
Our algorithm runs inmanual mode which allows to cor-
relating ameasurement with a given vessel and eliminating it.
This solves the problem of false positives when segmenting
nondesired vessels. Both CAIMAN and the tool developed
herein show a similar percentage of contour pixels correctly
detected in automaticmode, 95.92% and 96.82%, respectively.
However, CAIMANhas a larger number of false positives; the
specificity of CAIMAN is 80% against 98.75% of AngioPath.
CAIMAN does not detect small or too large vessels and
sometimes takes blue areas as vessels. An example of the
results obtainedwith both systems is shown in Figure 9with 3
TMA subsamples, 2 from our database and 1 from CAIMAN
database. CAIMANprovided better results when segmenting
images from their own database. The discrepancies could
probably be related to a specific and differently designed
brown color spectrum given by the stain or the digital
image quality.Nevertheless, themorphometric tool described
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Table 3: Comparison of AngioPath versus CAIMAN.
AngioPath CAIMAN
Speed 0.27 s/MB 124 s/MB
Measurements 24 features 7 features
Mode Automatic & Manual Automatic
Maximum size No limit 2MB
Sensitivity 96.82% 95.92%
Specificity 98.75% 80.00%
Accuracy 97.78% 87.96%
herein has shown better results in speed and accuracy. An
average value of 97.78% accuracy was obtained for AngioPath
against 87.96% for CAIMAN.
Finally, AngioPath has been validated with 700 cores
obtained from whole slide TMA images [21] by means of a
ROC analysis. An average of 97% sensitivity and 99% speci-
ficity was obtained.
4. Conclusions
This paper has described a morphometric tool implemented
to measure different aspects of the shape and size of vascular
vessels in a complete and accurate way. The developed tool
takes into account both closed and open vessels. Vessel clos-
ing is an essential property to properly quantify and charac-
terize the shape and size of vascular and lymphatic vessels. In
the same way, the set of endothelial cells forming a vessel are
considered together as a single object, making vascular den-
sity measurement more accurate. The tool, called AngioPath,
is able to detect vessels in whole slide TMA images with an
average accuracy of 97.89%.Moreover, AngioPath provides 24
morphometric measurements of the detected vessels.
Although AngioPath has shown encouraging results in
the database tested, it may be improved by applying invariant
color analysis techniques to properly segment vessels with
different stain. By applying this tool it is expected that further
studies can be carried out to testwhether shape and sizemeas-
urements are as important for prognosis as literature suggests.
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Background: Risk classification and treatment stratifica-
tion for cancer patients is restricted by our incomplete pic-
ture of the complex and unknown interactions between the 
patient’s organism and tumor tissues (transformed cells sup-
ported by tumor stroma). Moreover, all clinical factors and lab-
oratory studies used to indicate treatment effectiveness and 
outcomes are by their nature a simplification of the biological 
system of cancer, and cannot yet incorporate all possible prog-
nostic indicators.
Methods: A multiparametric analysis on 184 tumor cylin-
ders was performed. To highlight the benefit of integrating 
digitized medical imaging into this field, we present the results 
of computational studies carried out on quantitative measure-
ments, taken from stromal and cancer cells and various extra-
cellular matrix fibers interpenetrated by glycosaminoglycans, 
and eight current approaches to risk stratification systems in 
patients with primary and nonprimary neuroblastoma.
results: New tumor tissue indicators from both fields, the 
cellular and the extracellular elements, emerge as reliable 
prognostic markers for risk stratification and could be used as 
molecular targets of specific therapies.
conclusion: The key to dealing with personalized therapy 
lies in the mathematical modeling. The use of bioinformatics in 
patient-tumor-microenvironment data management allows a 
predictive model in neuroblastoma.
to clearly distinguish the heterogeneous spectrum of clini-cal, histological, and molecular markers of cancer, and 
thereafter determine the markers essential to diagnosing the 
degree of malignancy and predicting response to therapy, 
remains a difficult challenge. These essential markers may be 
elucidated by considering the patient’s organism and trans-
formed tissues as holistically interconnected and dependent 
on microenvironment interactions via biochemical and bio-
physical signals (1). Mathematical models enable us to inte-
grate measures made at different levels and generate from 
relatively simple to highly complex computational descriptors 
of the disease process of human tumors (2). Digitization of 
clinical data is necessary to deal with the complex hallmarks 
of cancer (3). To achieve personalized therapy, wellness and 
image-defined risk factors must be quantified (4). Hanahan 
and Weinberg have proposed that eight hallmarks of cancer 
together constitute an organizing principle that provides a 
logical framework for understanding the remarkable diver-
sity of neoplastic diseases (5,6). A novel ninth hallmark which 
includes the aspect of physics has recently been emphasized 
(7). The identification of these hallmarks by quantifying the 
structural variations in tumor tissues, at diagnosis as well as 
during tumor progression and after treatment, using whole 
histological sections or tissue microarrays with the human 
eye is a challenging process (8). However, the difficulty can be 
overcome by forming morphometric data to represent the his-
tological texture and classify the structural changes via sophis-
ticated computational methods (9–11). Cancer cell behavior is 
altered due to an accumulation of both genetic and epigenetic 
changes that influence a variety of cellular functions. At the 
same time, the transformed cells are committed in a complex 
interaction with the surrounding tumor microenvironment. 
The tumor microenvironment is comprised of a variety of cell 
types, lying among a dense network of various extracellular 
matrix (ECM) fibers merged within the interstitial fluid and 
gradients of several chemical species, which constantly inter-
play with malignant cells (12). The stromal cells provide a rich 
source of growth factors and cytokines, and play a crucial role 
in modifying the existing connective tissue and depositing new 
matrix. Tissue scaffolds regulate cell behavior and influence 
tumor progression (5–7,12,13). Biomathematical analysis of 
promising biomarker candidates, such as genomic, transcrip-
tomic, proteomic, and epigenomic changes, at the tumor tissue 
level will play an important role in developing a more powerful 
mathematical modeling of tumor– microenvironment interac-
tions (14,15). The information obtained can then be linked to 
tumor progression in patients either refractory to current ther-
apy, or who relapse or who might benefit from novel therapies 
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at an earlier stage, in addition to, or instead of, current strat-
egies (16,17). Nevertheless, the mathematical integration of 
information acquired from clinical and tumor microenviron-
ment interactions into a common description is as difficult to 
achieve as it is to understand the underlying complexities of 
the tumor biology itself, and requires translational research-
ers, experimentalists and biomathematicians (18,19). Due to 
the diverse behavior exhibited by neuroblastoma tumors, an 
algorithm of clinical, histopathological and genetic factors to 
stratify risk assessment and delineate therapeutic decisions has 
a
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b
Figure 1. Heatmap clustering indicating the statistical relationship between established prognostic markers and the tumor tissue markers analyzed in 
(a) primary and (b) nonprimary neuroblastomas. Standard hierarchical clustering showing the correlation in two colors: red (negative) and blue (positive). 
Statistically significant levels are indicated by the gradient between these two colors; brighter colors represent higher significance. Differences were 
considered statistically significant for P values <0.05.
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been devised. Prognostic systems are based on a combination 
of patient age at diagnosis (age cut-off 18 mo); disease stage 
defined by the International Neuroblastoma Risk Grouping 
Staging System or the International Neuroblastoma Staging 
System (20); on histopathological information; MYCN copy 
number and segmental chromosomal aberrations (SCA) such 
as 1p deletion (D) 11q aberrations or 17q gain (G) (21); and 
sometimes DNA ploidy. Accordingly, treatment protocols can 
vary widely (22). The use of precise quantification by imag-
ing technology of pathology specimens to analyze the struc-
tural variations emerging from interactions between cells 
and ECM elements is a sensitive, objective, and reproducible 
method that can provide important information for inclusion 
in computational formulations for risk stratification systems. 
To illustrate some of these principles, we present the math-
ematical integration of multimodal data, combining imaging 
and nonimaging clinical and tumor tissue data, acquired in the 
context of neuroblastoma studies, suggesting testable hypothe-
ses for making prognostic predictions. Harnessing the synergy 
of the various forms of data, including clinical variables and 
biomarker profiles, will allow mathematical predictive models 
to form part of the holistic approach to medicine in the 21st 
century.
RESULTS
Combined multiparametric analysis gives us an idea about the 
relationship between the objectively and subjectively quanti-
fied histological features and the clinical and genetics data. In 
Figure 1 the bright colors show some tumor tissue indicators 
from transformed neuroblastic cells and the cellular and the 
extracellular compartment, emerging statistically as reliable 
prognostic markers in primary (PT) and nonprimary tumors 
(N-PT) (Figure 1a,b respectively).
These results represent an assessment of prognostic criteria 
based on classical clinical, histological, and growth patterns 
(age and stage, amount of Schwannian stroma, neuroblastic 
cell differentiation, and mitosis-karyorrhexis index) and estab-
lished genetics (MYCN status).
Primary Tumors
A summary of statistically significant relationships between the 
established prognostic markers (clinical, histopathological, and 
genetic parameters) and tumor tissue markers (ECM elements 
and tumor and immune cells) with good prognostic impact in 
PT is presented in Table 1. With respect to established prog-
nostic markers and ECM, a high percentage of reticulin fibers 
were associated with neuroblastomas with absent or scarce SCA, 
ovoid reticulin nets were related to localized tumors indicating 
their crosswise arrangement, and regular reticulin nets were 
present in localized tumors, tumors without 17q gain (NG) and 
11q nondeleted (ND). In addition, tumors with scant neuro-
blasts, as well as PT from disease-free patients, were surrounded 
by a large amount of collagen fibers. A high quantity of glycos-
aminoglycans was also associated with localized tumors, gan-
glioneuroma (GN) and intermixed ganglioneuroblastoma or 
tumors with very few neuroblasts, absent or scarce SCAs, MYCN 
nonamplified (MNNA) nor 1p36 deletion (D). Biomathematical 
analyses also revealed that Ki-67+ cells from GN and intermixed 
ganglioneuroblastoma had small nuclei, whereas tumors with-
out anaplasia presented low expression of Ki-67 and aneuploid 
tumors showed irregular Ki-67+ cell nuclei. In addition, MNNA 
tumors expressed a high amount of TH and low amount of 
hypoxia-inducible factor-2α (HIF-2α+). Regarding immune 
cells, a higher quantity of CD20+ cells was observed in tumors 
MNNA, without 1p36 deletion, and PT from alive patients when 
compared with MYCN amplification (A), 1p36 D and PT from 
deceased patients. Figure 2a outlines the characteristics of neu-
roblastoma patients having a better outcome, considering new 
and established prognostic markers.
Figure 2. Mathematical modeling of (a) primary and (b) nonprimary neuro-
blastomas. Synopsis of patient characteristics with better outcome, consider-
ing histopathology, tumor genetics, and tumor tissue prognostic factors. ECM, 
extracellular matrix; GAGs, glycosaminoglycans; GN, ganglioneuroma; iGNB, 
intermixed ganglioneuroblastoma; SCA, segmental chromosomal aberrations.
- Localized tumors
Patient
- Event-free survival
Patient
- Absent or scarce SCA
- 11q ND, 17qNG
Tumor genetics
- Tumor cells HIF-2α− and Ki-67−
- ECM with low crossover
  of collagen fibers
- Abundant CD45+/CD3+
  lymphocytes
New tissue prognostic factors
- GN and iGNB
- Scarce neuroblasts
Histopathology
- Aneuploid
- Absent or scarce SCA
- MNNA, 1p ND, 11q
  ND, 17q NG
Tumor genetics
- ECM rich in reticulin and
  collagen fibers and GAGs
- Tumor cells TH+, Ki-67−,
  HIF-2α−
- Abundant B+
  lymphocytes
New tissue prognostic factors
- Disease-free
- GN and iGNB
- Scarce neuroblasts
- No anaplasia
Histopathology
a
b
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Nonprimary Tumors
A summary of the statistically significant relationships 
between the data in N-PT is presented in Table 2. The inte-
gration of digitized multimodal data showed that tumors from 
alive patients presented low crossover of the thick bundles of 
collagen. In addition, tumors without 11q D and with absent 
or scarce SCA showed a low amount of Ki-67 positive cells. The 
Ki-67+ cells had small, round and irregular nuclei in tumors 
with 17q NG, absent or scarce SCA, as well as tumors from 
patients with long event-free survival. Moreover, GN and 
intermixed ganglioneuroblastoma had a low amount of HIF-
2α+ cells, whereas tumors with scant neuroblasts presented a 
high CD45+/CD3+ cell ratio (P = 0.026). Figure 2b represents 
the predictive guide for N-PT in neuroblastoma patients with 
better outcome.
DISCUSSION
We outline the benefit to clinical practice of combining 
established prognostic clinic-biological markers, and medi-
cal imaging technology of tumor tissue elements, in a digi-
tized form, using primary and nonprimary neuroblastoma 
as an example. The hallmarks of cancer constitute an orga-
nizing principle for rationalizing the complexities of neo-
plastic disease. They include sustaining proliferate signaling, 
evading growth suppressors, avoiding immune destruction, 
resisting cell death, enabling replicate immortality, induc-
ing angiogenesis, deregulating cellular energetics, activat-
ing invasion and metastasis, and physical interactions of 
cancer cells with their microenvironments (5–7). To study 
the hallmarks, several concepts have been proposed and 
considered at different scales of complexity, such as pro-
tein interactions, biochemical pathways, cellular functions, 
or whole organism studies (2,18). The mathematical model 
in which the whole organism is the principal modeling unit 
is most intricate and implies the intercorrelation of data 
from patients, tumor and stromal cells, and extracellular 
tumor matrix. Clinical data used to construct classifiers in 
cancer can be transformed into mathematical descriptors, 
based, at least in part, on medical images for inclusion in 
whole organism modeling (1,23,24). In fact, in neuroblas-
toma it has become crucial to evaluate the clinical signifi-
cance of imaging in detecting PT stage and residual dis-
ease in quality-controlled prospective clinical trials. The 
International Neuroblastoma Risk Grouping has developed 
a staging system based on preoperative features, since diag-
nostic images provide more robust and reproducible data 
than those based on operative findings and approaches (20). 
This new staging  system is not intended to be a substitute 
for the International Neuroblastoma Staging System, and 
currently, it is recommended that both systems be used in 
parallel during a transitional period. We utilized the widely 
used International Neuroblastoma Staging System to define 
the tumor stage of our retrospective cohort, based on the 
age of the patient at diagnosis, local and distant extent of 
the disease, and the resectability of the tumor. Recognition 
of the widespread applicability of image-defined risk factors 
(25) as well as other computational clinical data will increas-
ingly affect the development of mathematical models with 
table 2. Summary of statistically significant relationships between the established hallmarks for current risk stratification and a few of the tumor 
tissue markers analyzed in nonprimary tumors 
Clinical Histopathological Genetics
Alive  
patients
Event-free 
survival
Few  
neuroblasts
GN and  
iGNBa
Absent or  
scarce 
SCAa
17q not  
gained
11q not  
deleteda
ECM Fibers Thick bundles Angle collagen Low  
(P = 0.012)
— — — — — —
Cells Tumor Proliferation % Ki-67 3+ — — — — Low  
(P = 0.000)
— Low  
(P = 0.027)
No. mm2 Ki-67 3+ — — — — High  
(P = 0.000)
— —
Nuclear size Ki-67 3+ — Small  
(P = 0.003)
— — Small  
(P = 0.000)
Small  
(P = 0.019)
—
Aspect Ki-67 3+ — Ovoid  
(P = 0.004)
— — — Ovoid  
(P = 0.002)
—
Perimeter-ratio  
Ki-67 3+
— Irregular  
(P = 0.004)
— — Irregular  
(P = 0.000)
Irregular  
(P = 0.000)
—
Roundness Ki-67 3+ — Round  
(P = 0.004)
— — Round  
(P = 0.000)
Round  
(P = 0.007)
—
Hypoxia No. HIF-2α+ — — — Low  
(P = 0.000)
— — —
Immune Subgroup 
lymphocytes
CD45+/CD3+ — — High  
(P = 0.026)
— — — —
GN, ganglioneuroma; hIF-2α, hypoxia-inducible factor-2α; iGNB, intermixed ganglioneuroblastoma; scA, segmental chromosomal aberrations.
aFactors used for current risk stratification.
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the whole organism as the modeling unit, and not limited to 
neuroblastoma alone, but applicable also to other neoplastic 
diseases.
Technologies for digitizing pathology specimens have 
advanced significantly in the last decade (8,11,26). Slide scan-
ners are capable of producing high-magnification high-reso-
lution images from whole slides and tissue microarrays within 
a few minutes. Hence, it is becoming increasingly feasible for 
basic, clinical and translational research studies to produce 
thousands of slide images (27). It is fundamental to have a 
reliable and objective method for precise and quantitative 
comparison (28,29). We used fast and accurate methods for 
digitization and objective quantification. Computer-aided 
evaluation of pathology image analysis to generate risk strati-
fication have been developed for lymphoma (30), glioblastoma 
(14), breast and prostate cancers (4). A computer-based grad-
ing system to support diagnosis for neuroblastoma that uses 
grades of differentiation and stromal development was pub-
lished (29,31). Discrimination of stroma-poor and stroma-rich 
regions has also been reported using a mathematical model 
performed on digitized hematoxylin-eosin stained whole- 
sections with extraction of textural features (32). Genome 
table 3. Summary of cases with relevant clinical, histopathological, and genetic prognostic factors 
Clinical data Histopathological dataa Genetic datab
PT/N-PT PT/N-PT PT/N-PT
Age at diagnosis (months) ≤18c Histologic category (INPC) FISH (INRG)d
 28.0 ± 34.3/41.8 ± 44.4  Neuroblastoma (NB): 70/13  Status MYCN genec:
 ≤18: 37/4; >18: 40/8  Nodular ganglioneuroblastoma (nGNB): 1/0    MNNA: 33/5;
 ≤12: 29/4; 13–18: 8/0; >18: 40/8  Intermixed ganglioneuroblastoma (iGNB): 4/0    G: 8/3;
Stage (INSS) 1; 2; 3; 4: 4sc  Ganglioneuroma (GN): 2/1    hetA: 5/1;
 1: 18/1; 2: 3/0; 3: 15/5; 4: 35/5; 4s: 6/2 Grade of tumor differentiationc    homA: 31/5
 1 + 2: 21/1; 3 + 4: 50/10; 4s: 6/2  Undifferentiated (u): 22/1  11q deletionc:
Relapse  Poorly differentiated (pd): 44/11    ND: 57/8; D: 15/4
 N: 52/6; Y: 26/7  Differentiating (d): 4/1  1p deletion:
Event-free survival time (months)  Not otherwise specified (NOS): 1/1    ND: 32/5; I: 1/1; D: 39/8; I + D: 2/0
 40.3 ± 36.4/54.3 ± 48.8 Diagnostic  17q gain:
Exitus  uNB: 22/1    NG: 30/2; G: 44/11
 N: 48/9; Y: 30/4  pdNB: 44/11 MLPA/aSNP (INRG)d
Follow-up time (months)  dNB: 2/0  MYCN amplification
 46.2 ± 36.1/68.3 ± 44.2  NOS NB: 1/1    N: 31/3; Y: 21/2
 nGNB: 1/0  SCA
 iGNB: 4/0    N: 19/2; Y: 33/3
Prognostic histologic category (INRG)c  Number of SCA
 GN + iGNB: 6/1    1.7 ± 1.7/1.2 ± 1.3
 nGNB + dNB: 6/0  Deletion
 pdNB + uNB: 66/12    1p: 26/2; 3p: 4/1; 11q: 12/2
Tumor cells (%)  Gain
 60.3 ± 21.5/54.6 ± 23.8    1q: 3/0; 2p: 16/2; 17q: 29/3
Anaplasia  Other SCA
 N: 75/14; Y: 2/0    N: 46/5; Y: 4/1
DNA indexe D; T; Te; P; Oc
 1.6 ± 0.4/1.3 ± 0.4
 D: 19/3; T: 16/4; Te: 3/2; P: 2/0; O: 7/3
 D + Te: 22/5; T + P: 18/4; O: 7/3
D, diploid; GN, ganglioneuroma; hetA, heterogeneous amplification; homA, homogeneous amplification; I, imbalance; INRG, International Neuroblastoma Risk Group; INPc, 
International Neuroblastoma Pathology classification; INss, International Neuroblastoma staging system; N, no; N-PT, nonprimary tumors; O, other; P, pentaploid; PT, primary tumors; 
scA, segmental chromosomal aberrations; T, triploid; Te, tetraploid; Y, yes.
aThe histology category was determined according INPc (37) and the INRG (22). bGenetic results were interpreted following INRG Biology committee guidelines (21,34,35); mean ± 
standard deviations results from quantitative variables. cFactors used for current risk-adapted therapy. dFluorescence in situ hybridization (FIsh), multiplex ligation–dependent probe 
amplification (MLPA), and single-nucleotide polymorphisms arrays (asNP) were performed to detect genetic aberrations in tumor cells, as previously described (36,38,39). eDNA index 
was measured using image cytometry.
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instability, inflammation, and physical interactions are recently 
recognized as characteristics crucial to the acquisition of the 
cancer hallmarks. It is also clear that much  biology is executed 
by virtue of cells of different types interacting with one another 
or by interactions with environmental  signals from tissue scaf-
folds or other cells generating phenotypic/genotypic changes 
(5–7,12,13). The linkage of pathology images with genomics 
presents an opportunity to study morphology in the context 
of genetics and patient outcome. For this reason, we con-
sider it important to include not only quantification of grade 
of tumor differentiation, percentage of tumor cells, protein 
expression of cancer stem cells and differentiated cancer cells, 
various immune system cell markers, and amount of vascular 
structures but also quantification of features of the two major 
components of the ECM (fibrillar proteins and glycosamino-
glycan). The predictive model of these characteristics mea-
sured by image analysis techniques with current digitization 
approaches used for risk stratification system has revealed that 
the clinical, histopathological, and genetic descriptors that 
define clinically relevant groups are reflected in the essential 
characteristics of the cellular morphology and ECM architec-
ture. The mechanical properties of ECM play an important 
role in governing the behavior of neuroblastic, Schwann, and 
lymphocyte cells. Our results suggest that Shwannian stroma 
is not the only important factor in the histopathologic analy-
sis of neuroblastic tumors. Multiparametric analysis of other 
tumor stroma components (reticulin, collagen fibers, glycos-
aminoglycan, and immune cells) detected by classic histo-
chemistry (HC) and immunohistochemistry (IHC) techniques 
and incorporated into a quantitative morphological analysis 
would improve the International Neuroblastoma Pathology 
Classification value. The systematic quantification of a larger 
digitized cohort of neuroblastoma tumors will resolve difficul-
ties in the following critical areas: consistency of results with 
less intra- and interobserver variability; assessment of intra-
tumoral histological and genetic heterogeneity; comparative 
analysis of biomarker expression and genotypic signatures of 
tumor cells; evaluation of the tumor cell markers obtained 
by IHC and genetic techniques; and tumor tissue analysis 
throughout tumor progression. We present a new approach for 
whole organism modeling of neuroblastoma patients, combin-
ing the computational processing of clinicobiological markers 
used for prognostic stratification and digitized tissue measure-
ments. Advanced high-resolution and high-content imaging 
technology and computational studies are being developed 
to integrate knowledge into medical decision support systems 
(33). We consider that a contribution to the overall goal in can-
cer would be to construct high-quality bioinformatics strate-
gies to fuse clinical, histologic, and molecular imaging and 
nonimaging markers for prognosis, response to therapy, and 
prediction of recurrence in patients, as well as for identifying 
patient subgroups for inclusion in future clinical trials for new 
therapeutic compounds. Routine use of digital medical image 
and computational technologies will allow extraction of para-
metric information or new hallmarks that could be used as tar-
gets of specific therapies in cancer.
METHODS
Subjects and Prognostic Factors
Ninety-two tumors from 90 patients (78 original and 14 relapse/
posttreatment) and 4 control tissues included by duplication in two 
tissue microarrays were used for the study; producing a total of 184 
tumor cores and 8 control cores. This study was approved by the 
table 4. Tissue markers with possible prognostic impact for novel treatment schemes 
Antibody Function HCd and IHCe: dilution (source) Algorithm
Reticulin fibersa Delicate support net Gomorid IPP
Collagen fibersa Thick support bundles Masson’s trichromed IPP
GAGsb Diffusion, barrier–matrix interactions Alcian blued PPC
Ki-67a Nuclear protein for cellular proliferation 1/50 (Dako)e IPP
THb Enzyme catalyzing the conversion of L-tyrosine to L-DOPA 1/30 (Novus)e PPC
VEGFb,c Signal protein stimulating vasculogenesis and angiogenesis 1/100 (Santa Cruz Biotechnology)e PPC
HIF-2αc Transcription factor responding to changes in available 
oxygen in ECM
1/1000 (Novus)e —
CD133b,c Cancer stem cell marker CD133 (Abcam)e NQ
SOX-2b,c Transcription factor: embryonic and neural stem cells 1/50 (Abcam)e NQ
CD3b Receptor T lymphocytes 1/100 (Dako)e MQ
CD20b Receptor to enable optimal B-cell immune response 1/100 (Dako)e MQ
CD45b Receptor playing a crucial role in the function of all leucocytes 1/100 (Dako)e MQ
CD31c Protein that marks endothelial cell intercellular junctions 1/100 (Dako)e —
—: Not applied.
cD, cluster of differentiation; cD133, cD133 glycoprotein; cD31, platelet endothelial cell adhesion molecule; GAGs, glycosaminoglycans; hc, histochemistry; hIF-2α, hypoxia-inducible 
factor-2α; Ihc, immunohistochemistry; Ki-67, Ki-67 protein; MQ, Membrane Quantification; NQ, Nuclear Quantification; PPc, Positive Pixel count; Th, tyrosine hydroxylase; VeGF, vascular 
endothelial growth factor.
a,bObjective quantification: aImage Pro-Plus (IPP) software. bAperio Imagescope software. csubjective quantification. dhistochemistry. eImmunohistochemistry; Dako headquarters, 
Denmark; Novus Biologicals, Littleton, cO; santa cruz Biotechnology, santa cruz, cA; Abcam, cambridge, UK.
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Experimental Research Ethics Committee of the Spanish Society of 
Pediatric Hematology and Oncology (File number: 59C18ABR2002; 
EC number: 2010-021396-81). Participants or their family members/
informants signed written informed consent forms. Table 3 summa-
rizes the cases with respect to the eight markers currently used for 
risk-adapted therapy (indicated asc) (21,22,34–39). In addition, we 
created new variables related to age, stage, histopathology and genet-
ics. In total, 8 clinical, 6 histopathological, and 17 genetic variables 
were considered. The hypothetical prognostic factors detected by HC 
and IHC, as well as the function of the markers, staining conditions, 
and quantitative algorithms used, are shown in Table 4.
Image Analysis Measurements
All the slides were digitized at 40× magnification using a ScanScope 
XT scanner (Aperio Technologies, Vista, CA). The image analysis 
flowchart is showed in Figure 3. Considering the 3 HC and the 10 
IHC stains in each tumor core, a total of 2,576 tumor core images 
were obtained. Two objective methods (1 and 2), and one subjective 
method (3) were used to quantify the expression of the markers in the 
digitized images (Figure 4). For objective quantification, different 
algorithms from image analysis software were applied (Table 4 and 
Supplementary Table S1 online). Method 1 used self-designed algo-
rithms with the Image Pro-Plus (IPP) software (MediaCybernetics, 
Warrendale, PA) for noncellular components, such as reticulin and 
Figure 3. Flowchart showing the multiresolution neuroblastoma image analysis system. Images belonging to different samples stained with different 
markers have been quantified by image analysis following a common process including segmentation (differential recognition of the staining) with 
specific input parameters for each marker and method (supplementary table s1 online) and extraction of some given parameters (output parameters 
in Figure 4). The data obtained have been correlated with clinicobiological prognostic data to obtain potential new parameters and ranges for predictive 
guide, therapeutic decisions, and/or therapeutic target (supplementary Figure s1 online). IPP, Image Pro-Plus.
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Output
parameters
Color
Size
Shape
Others
(Supplementary Table
S1 online)
Input
parameters
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collagen fibers, and for cellular proliferation, such as Ki-67 protein 
expression. This method measured several parameters to describe 
the quantity (percentage of stained area; number of objects/mm2), 
the size (width, length, and area), the shape (aspect or how oval the 
object is; roundness; perimeter ratio or how regular is the surface 
of the object; fractal dimension or space-filling capacity of a pat-
tern; branching or how many bifurcations has the object), and the 
orientation (angle) of stained objects. Method 2 applied previously 
designed algorithms from the Aperio ImageScope software (Aperio 
Technologies, Vista, CA): a Positive Pixel Count algorithm for total 
staining area, Membrane Quantification algorithm for membrane 
staining, and Nuclear Quantification algorithm for nuclear stain-
ing. Parameters measured with method 2 estimated the quantity 
(percentage of stained areas/cells; number of stained cells), and the 
staining intensity. Finally, the subjective method (method 3) estab-
lished the pattern (distribution of positive cells), the range (per-
centage of stained cells), and the staining intensity, as previously 
described (40), as well as the presence of vascular structures. A sum-
mary of objective and subjective measurements, including mean and 
standard deviation, distinguishing PT and N-PT tumors is shown in 
Tables 5 and 6 respectively. In total, 23 HC parameters (with objec-
tive quantification) plus 28 IHC parameters (15 with objective and 
13 subjective quantification) were determined in each tumor core 
analyzed. Four possible options for staining intensity (indicated in 
Figure 3d) of the IHC markers were considered for each of the 15 
objectively quantified parameters. In total, 97 parametric measures 
from each core were obtained. Given that the 92 analyzed tumors 
had duplicated cores in tissue microarrays, 17,848 tumor parametric 
measures were obtained overall.
Statistical Analysis
For a more complete statistical analysis, in addition to the 23 HC and 
28 IHC parameters already defined, seven new variables were cre-
ated. For IHC immune cell markers, the three ratios CD45+/CD3+, 
CD45+/CD20+, and CD20+/CD3+ were also calculated. With regard to 
subjectively quantified IHC staining parameters, the sum of staining 
intensity, range, and pattern was created for each analyzed marker, 
except CD31. Moreover, in the objectively quantified IHC staining 
Figure 4. Description of the parameters measured on the tissue markers related to objective (methods 1 and 2) and subjective (method 3) quantification.
Techniques and
tissue markers
Variables
Quantity
Size
Shape
Orientation
Quantity
Intensity
Pattern
Quantity
Intensity
Vasculaturee
Method 2
Method 1
Method 3
Objective
quantification (D)a:
PPC software
MQ software
NQ software
Objective
quantification (D)a:
IPP software
Markers:
Reticulin fibers
Collagen fibers
Ki-67 proteinb
Markers:
Glycosaminoglycans
Proteins: TH, CD3,
CD20, CD45, VEGF,
SOX-2, CD133
Subjective
quantification:
Markers:
Proteins: HIF-2 alpha,
VEGF, SOX-2,
CD133, CD31
Parameter (definition; unit)/schema
Percentage of stained area ([sum of all areas × 100] ÷ area core; percentage)
Number of fibers (number of fibers × 1 mm2 ÷ area core; number/square millimeter)
Width (diameter along minor axis of object; micrometers)
Length (diameter along major axis of object; micrometers)
Area (area of object; square micrometer)
Aspect (ratio between major axis and minor axis of ellipse equivalent to object)
Convex perimeterc
Perimeter
1 1
2
3
Roundness ([perimeter2] ÷ [4 × pi × area])
Perimeter ratio (ratio of convex perimeterc to perimeter)
Fractal dimension (fractal dimension of the object’s outline)
Branching (number of one-pixel-thick open branches)
Angle (angle between the major axis of the object and the vertical; degrees)
Percentage of stained area or cells ([sum of positive areas or cells × 100] ÷ area core or total
cells; percentage)
Number of cells (number of cells × 1 mm2 ÷ area core; number/square millimeter)
Intensity of the staining (0; 1+; 2+; 3+)d
Range (percentage of stained cells; 0+: <10%; 1+: 10–25%; 2+: 26–75%; 3+: >75%)
Intensity of the staining (0: negative; 1+: weak; 2+: moderate; 3+: intense)
Type (1: microvasculature; 2: micro- and macrovasculature)
aDigitalization by ScanScope XT scanner at 40x magnification. bIn all different intensities of staining, the parameters were measured. cPerimeter of the
convex outline of the object. dIntensity options of the markers. eMeasured by CD31 marker.
       Distribution pattern of the positive cells (0: negative; 1: focal; 2: heterogeneous; 3:
       homogeneous) 
Nuclear:
3 2 1
321
Membrane:
Cytoplasm:
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parameters, in addition to the four intensity categories distinguished, 
two new categories were created: the sum of all positive cells (1+, 2+, 
and 3+), and the sum of 2+ and 3+ positive cells. Subsequently, these 
58 tissue marker variables (Tables 4–6) plus the 31 variables derived 
from the patient’s clinical history, the histopathology and the tumor 
genetic information (Table 3) were analyzed. Linear regression mod-
els were used to assess the dependence of the clinical variables upon 
genetic and histopathologic markers. All continuous variables were 
log transformed where necessary to achieve a more normal or sym-
metric distribution. A regression model was constructed for each ana-
lyzed pair of variables. The Wald statistic was used to derive P values 
accounting for the significance of the slope in the model, being differ-
ent from zero. Thus, for continuous variables, linear regression mod-
els provide the same information as the Pearson correlation. Linear 
models also have the advantage of being applicable when the inde-
pendent variable, the marker in our case, is binary or discrete. Thus, 
we can explore the relationship of our clinical variables with each of 
our markers, independently of whether the marker is a continuous or 
a discrete variable. This paradigm is appropriate to our study as half 
our variables, the genetic ones, are discrete while those derived from 
imaging are generally continuous. Separate analyses were carried out 
for PT and N-PT. All P values where corrected for multiple testing to 
control the false discovery rate. The standard procedure described in 
Benjamini–Hochberg was used for this study (41). All analyses where 
done using R statistical software (42). A sample classification would 
be possible after processing a whole set of data for a single patient 
(Supplementary Figure S1 online)
SUPPLEMENTARY MATERIAL
Supplementary material is linked to the online version of the paper at http://
www.nature.com/pr
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Supplemental Table S1. List of softwares, algorithms and input parameters used. 
Method Software Algorithms Markers 
Imput parameters 
Image pre- 
treatment 
Range of colour 
Values of morphometric 
parameters  
Other  
parameters 
 
Staining Counterstaining Background 
1 
Image 
Pro  
Plus 
Self- 
designed 
Reticulin  
fibers 
None 
R,G,B 
<120 
 
 
Roundness 
Area 
Length, Width 
>3 
>7.5 
>8, >1.5 
Smoothing: 3 
Others: off 
Collagen  
fibers 
Brightness: 68 
Contrast: 81 
Gamma: 1 
<17,90,all 
>2 
>7.5 
>8, >10 
Smoothing: 3  
Others: off 
Ki67 None 
>220 
Density blue:  
(1+) 0.22-0.24 
(2+) 0.24-0.37 
(3+) >0,.37 
     
Smoothing: 3 
Others: off 
2 
Aperio  
Image 
Scope 
Positive  
Pixel  
Count 
GAGs 
None 
Average 
R+G+B 
(1+,2+,3+) 
>221  
  
  
 
Default 
VEGF 
210,180,140 
Hue width 0.5 
Hue Value 0.3 
Color saturation  
thereshold:  0.06  
Others: default 
TH 220,187,120 Default 
Membrane  
Quantification 
CD3 255,255,195 
255 255 
Nuclear size 
cell size 
radius 
Completeness 
thereshold 
5-125 
5-125 
4 
78 
Default 
CD20 250,1,140 
CD45 255,1,226 
Nuclear  
Quantification 
SOX-2 
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Cells have the capacity to convert mechanical stimuli into chemical changes.This process is
based on the tensegrity principle, a mechanism of tensional integrity.To date, this principle
has been demonstrated to act in physiological processes such as mechanotransduction
and mechanosensing at different scales (from cell sensing through integrins to molecu-
lar mechanical interventions or even localized massage). The process involves intra- and
extracellular components, including the participation of extracellular matrix (ECM) and
microtubules that act as compression structures, and actin filaments which act as ten-
sion structures.The nucleus itself has its own tensegrity system which is implicated in cell
proliferation, differentiation, and apoptosis. Despite present advances, only the tip of the
iceberg has so far been uncovered regarding the role of ECM compounds in influencing
biotensegrity in pathological processes. Groups of cells, together with the surrounding
ground substance, are subject to different and specific forces that certainly influence bio-
logical processes. In this paper, we review the current knowledge on the role of ECM
elements in determining biotensegrity in malignant processes and describe their implica-
tion in therapeutic response, resistance to chemo- and radiotherapy, and subsequent tumor
progression. Original data based on the study of neuroblastic tumors will be provided.
Keywords: biotensegrity, cancer, extracellular matrix, mechanotherapy, neuroblastoma
INTRODUCTION
The study of spatial and temporal responses to mechanical forces
of tissue structures of biological organisms is a growing field in
health sciences. Such responses can be modified by mechanother-
apeutic interventions, ranging from the molecular level to whole
body systems, and involving a broad spectrum of target molecules
belonging to the microenvironment. In order to carry out mechan-
otherapy effectively, we should consider the stabilizing elements of
tension and compression, or biotensegrity systems, existing at all
structural levels in the body. Tensegrity is an architectural princi-
ple put forth by Buckminster Fuller in the 1960s (1, 2). According
to the tensegrity principle, structures or tensegrity systems are
stabilized by continuous tension with discontinuous compression
(3). Coming under the term biotensegrity, the tensegrity princi-
ple applies to essentially all detectable scales in the body, from the
musculoskeletal system to proteins or DNA (4, 5).
In this review, we highlight the current challenges and on-going
issues for dissecting the mechanisms of tumor extracellular matrix
(ECM) biotensegrity and discuss how these concepts may be trans-
lated into treatment and prognosis of cancer. To illustrate the
biotensegrity principle, we present some preliminary results on the
mathematical integration of multimodal data, combining imag-
ing and non-imaging tumor tissue data, acquired in the context
of neuroblastoma (NB) studies, suggesting testable hypotheses for
making prognostic predictions and therapeutic response related
with this principle.
CELL AND TISSUE BIOTENSEGRAL PHYSIOLOGY
Several studies have demonstrated that cells can function as inde-
pendent pre-stressed tensegrity structures through their cytoskele-
ton architecture. Ingber defined the pre-stressed tensegrity model
as a structural support on biological systems. It is constituted by
a number of continuous elements of tension and a number of
discontinuous elements resistant to compression providing a stabi-
lized structure (6–14). As a tensegrity network,a single cell presents
such continuous tension (mediated by cytoskeleton elements such
as microfilaments and intermediate filaments) and local discon-
tinuous compression (mediated by ECM and other cytoskeleton
elements such as microtubules). The individual pre-stressed cells
are poised and ready to receive mechanical signals and convert
them into biochemical changes (15). Therefore, cell membrane,
nucleus, and all the organelles are hard-wired by the cytoskeletal
scaffold. When the mechanical cue is received, sensed mainly by
focal adhesion complexes induced by integrins, the signal modifies
the cytoskeletal scaffold. Thus, the local mechanical signal is ampli-
fied and propagated through a series of force-dependent biochem-
ical reactions, whereby intra-cellular signaling pathways become
sequentially activated through mechanotransduction (16). At the
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molecular level, several elements resist compression, such as all
structures containing alpha-helix, beta-sheet, or even DNA back-
bone structures, while others, such as attraction and repulsion
forces of molecular, atomic, and ionic bonds (such asVan der Waals
forces, covalent bonds, etc.), resist continuous tension. Many mol-
ecules display such structures and are subject to these two forces
at different stages along the mechanical intra-cellular signal path-
ways. Among these abundant and intermingled pathways, many
remain unknown. We believe that knowledge on how we could
potentially interfere with these signaling pathways or cascades may
provide new therapeutic targets. Nevertheless, as many molecules
play multiple roles in different pathways, molecular therapy based
on mechanotransduction, should be carried out on specific targets
to avoid adverse effects.
The tensegrity architecture of the cytoskeleton and signal path-
ways is linked to the tensegrity elements of the outer and inner
nuclear membrane through KASH–SUN bridges, where KASH
proteins are located in the outer nuclear membrane (Nesprin-1
and Nesprin-2 link nuclei with actin filaments, Nesprin-3 interacts
with intermediate filaments,and Nesprin-4 binds to microtubules)
(17–19) and SUN proteins in the inner nuclear membrane (Samp1
and lamin). This connection is critical for intra-cellular force
transmission in physiological homeostasis (20–22) and might
ensure that chromatin organization is not perturbed when tis-
sues experience stress, and may be fundamental for normal
development (23).
The self-balanced mechanical stability of the cytoskeleton
enables the macro-mechanical forces to be converted into molec-
ular changes. Since cells are connected to each other through cell
junctions, mediated mainly by cadherins, these changes not only
affect the cell that receives the signal, but are also transferred to the
neighboring cells. Indeed, recent biophysical studies have revealed
that the size of cell–cell contacts can be regulated in response to
the mechanical forces exerted on those junctions and that cells are
also able to regulate the forces exerted on their junctions (24–26).
It is known that cell–cell junctions are anchored to neighbor-
ing cells and focal adhesions to ECM, and all are connected to
the intra-cellular cytoskeletal network, therefore the forces that
cross these structures fluctuate strongly when tissue is remodeled.
It is becoming apparent that these structures do not just trans-
mit forces while maintaining tissue cohesion, but also respond to
fluctuations in force by actively influencing cell morphology and
behavior (27). The biological significance of this mechanotrans-
duction is to promote coordinated cytoskeletal reorganizations
that can define changes in shape across the whole tissue. The basal
lamina plays a central role in this process. It provides physical
support to epithelial cells, surrounds muscle cells, fat cells, and
Schwann cells, and is the environment where cells and ECM bind
through focal adhesions and integrins. Accordingly, the shape of
tissue cells (round or flattened) and the three-dimensional struc-
ture of the tissue patterns that constitute glands, alveoli, ducts, and
papillae (among others), depend on the stiffness and flexibility and
on the coordinated movement of the basal lamina (28).
ROLE OF ECM IN BIOTENSEGRITY
During the last decade, cell-matrix contacts based on the trans-
membrane adhesion receptors from the integrin family or focal
adhesions have emerged as the major mechanosensitive struc-
tural elements that connect, collect, process, and integrate the
information of the ECM. Recent proteomic studies have not
only found many more components, but also have revealed that
many of these elements are recruited to focal adhesions in a
force-dependent manner, supporting the view that focal adhesions
harbor a network of mechanosensitive processes (29). Integrins
are transmembrane αβ heterodimer receptors that function as
structural and functional bridges between the cytoskeleton and
ECM molecules. Specifically, α8β1 or tensegrin can bind to sev-
eral ECM molecules and has been shown to be associated with
focal adhesion points, where it participates in the regulation of
spreading, adhesion, growth, and survival in different neuronal
and mesenchymal-derived cell types (30, 31).
Various interconnected cells bind to their microenvironment,
forming a mechanical tensegral system, which implies the exis-
tence of a mechanical balance between compression (ECM) and
tension (cell) forces. The ECM is made up of a mixture of ground
substance [glycosaminoglycans (GAGs) – mostly hyaluronan, pro-
teoglycans, and glycoproteins] situated in close relationship with
a fibrous scaffold [reticulin (Ret F) – elastin and collagen fibers
(Col F)], and supplies much of the structural support available to
parenchymal cells in tissues, by adding tensile strength and flexibil-
ity (32). The ECM is a dynamic and multifunctional regulator and
has its own biotensegrity with Ret F and elastin fibers acting as ten-
sional elements, and ground substance and Col F as compression-
resistance elements. This tensegral network is considered to be a
solid-state regulatory system of all cell functions, responsible for
changes in genes and proteins, as well as alterations in cell shape
and movement (33–35). One result of cell–ECM biotensegrity is
substrate rigidity, which can control nuclear function and hence
cell function (36). Cells can use this substrate rigidity to exert
traction forces, thus altering the ECM. Indeed, in a state of rec-
iprocal isometric mechanical tension, a dynamic balance exists
between cell traction forces and points of resistance within the
ECM. This dynamic biotensegral system with its mechanotrans-
duction phases (Figure 1) enables our cells to mechanosense,
modifying their microenvironment, thus promoting ECM remod-
eling in homeostasis and in tissue disorders (37). Manipulation of
this mechanical balance could be used to promote tissue regen-
eration. In fact, various studies have demonstrated that different
elasticities of the ECM drive mesenchymal stem cell differentiation
in a very specific way. Neurogenic, myogenic, or osteogenic differ-
entiations are induced under identical matrix serum conditions,
with variations in ECM softness, strength, and stiffness (38). Fur-
thermore, ECM stiffness guides cell migration. It has been shown
that fibroblasts prefer rigid substrates and when placed on flexible
sheets of polyacrylamide, they migrate from the soft to the stiff
areas (39). Under homeostatic conditions, collagen fibrils have
a minimal turnover. However, this turnover is accelerated dur-
ing tissue remodeling and tumor development, as evidenced by
the serum levels of its degradation products (40). Studies of the
ECM have revealed that the components of the tumor microen-
vironment are fundamental, not only for the regulation of tumor
progression (41, 42), but also are essential even before the tumor
appears. The stromal cells are able to transform the adjacent cells
through an alteration in the homeostatic regulation of the tissue,
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FIGURE 1 | Mechanotransduction phases. (A) When forces are exerted on
a tissue after proliferation of tumor and stroma cells, a cell within the cell
mass (for example, the one marked in green) is subject to mechanical
deformation in a phase called mechanocoupling. Following the principle of
tensegrity at the tissue level, ECM elements apply compression forces to the
tissue cells and tissue cells exert tension forces between themselves and to
the ECM. Biotensegral elements of the boxed area are detailed in (B–D).
(B) This particular tumor cell activates a biochemical coupling phase in which
the mechanical signal is transformed into intra-cellular biochemical signals
through the integrin–cytoskeleton–nuclear matrix structure or
stretch-activated cation channels within the cell membrane, among other
mechanisms. Some essential players in mechanosensing are shown (44–47).
(C) The biochemical signal is transmitted to neighbor cells (marked in purple)
through cell–cell junctions. Following the principle of tensegrity at the cell
level, the compression elements are the microtubules, whereas the tension
elements are the intermediate filaments and the actin filaments.
(D) A fibroblast neighbor cell can produce a stiff ECM which in turn enables
the first cell to flatten and migrate through this stiffened ECM. The effector
cell response phase arises from the biotensegrity principle: a simple
cytoskeleton when the ECM compression is low switches to a complex
cytoskeleton when the ECM exerts high compression on the cells and the
cells exert high tension on the ECM.
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including the control of architecture, adhesion, cell death, and
proliferation (43).
CELL AND TISSUE BIOTENSEGRITY IN CANCER
Cancer can be understood as a disease of the developmental
processes that govern how cells organize into tissues (48). The
tumor microenvironment is comprised of a variety of cell types
lying among a network of various ECM fibers merged within the
interstitial fluid and gradients of several chemical compounds,
which constantly interplay with malignant cells (34). Therefore,
we can infer that the previously described biotensegral systems
also exist within tumor tissue. In fact, the dynamic mechanical
balance achieved through mechanosensors, cytoskeletal tensegrity,
molecular biotensegral intra-cellular pathways, ECM with com-
pressive and resistant elements, supportive cells (such as fibroblasts
and multiple tumor-associated immune cells), and vascular and
lymphatic vessels tensional structures, can be as important as the
genetic instability of tumor cells in the pathogenesis and evolution
of the malignant process (42, 49). In this regard, various studies
have demonstrated the importance of cell–ECM biotensegrity in
cancer (34, 48, 50). Indeed, a desmoplastic reaction is frequent in
many solid tumors, such as breast,prostate, colon,or lung, in which
high levels of TGF-b and PDGF are found. These growth factors
are produced by the mesenchymal cells of the tumor stroma and
induce immunophenotypic changes. These changes are observable
by studying actin-alpha, myosin, vimentin, desmin, and the altered
production of several ECM proteins, such as collagens, laminin,
tenascin, ECM metalloproteinases (MMP), and MMP-inhibitors
(43). Additionally, ECM stiffness modulates cancer progression;
cancer cells promote stiffening of their environment, which in
turn feeds back to increase malignant behaviors such as loss of
tissue architecture and invasion (51). For instance, the speed of
malignant cells in vitro is affected by the geometry of the ECM.
Human glioma cells move faster through narrow channels than
through wide channels or in non-stretched 2D surfaces. This is
thought to be triggered by an increase in the polarity of the trac-
tion forces between cell and ECM (52). Indeed, recent publications
describe that not only neoplastic ECM stiffness, but also the firm-
ness of tumor cells play a significant role in tumor progression.
The firmness of tumor cells, especially the metastatic cells, has
been found to be lower than that of the normal cells of the same
sample, and is caused by the loss of actin filaments and/or micro-
tubules and the subsequent lower density of scaffold (53, 54). In
this regard, it has been shown that the transformation from a
benign proliferative cell into a malignant cell can be produced by
a peculiar phenotypic change, known as epithelial–mesenchymal
transition (55). This transformation involves breaking contact
with sister cells and increasing motility, as a result of a change in
the epithelial cytoskeleton, with its corresponding proprieties for
a pseudomesenchymal phenotype, which enables migration, inva-
sion, and dissemination (56). While normal cells adhere to their
environment through integrins, and their body has a proper con-
sistency, tumor cells lose that consistency and tensegrity, becoming
easily deformable elements (causing pleomorphism), with high
elasticity (enhancing infiltration) and with an increased degree of
mobility (enabling metastasis) (57). In breast cancer, the genomic
profile expressing mainly mesenchymal features is actually found
in the most invasive cell lines (58). Moreover, it has been published
that chronic growth stimulation, ECM remodeling, alteration of
cell mechanics, and disruption of tissue architecture are non-
genetic influences on cancer progression (42, 49). These ideas
not only agree with basic predictions of cellular tensegrity, but
also support the idea that therapy based on the manipulation of
the biotensegrity principle cues should be considered as a way to
revert the malignant phenotype (59, 60).
In cancer research, the hallmark which includes the physical
aspects of tissue has been less investigated, but it is known that
this hallmark is one of the most basic mechanisms in enhancing
tumor proliferation and creating resistance to cancer treatment,
among other processes (61). A previous study by our group
takes in account some structural elements of ECM that have
the capacity to influence physical conditions and suggests that
Schwannian stroma cells are not the only important factor in the
histopathologic analysis of neuroblastic tumors (50). Specifically,
multi-parametric analysis of other tumor stroma components
(Ret F, Col F, GAG, and immune cells) detected by classic his-
tochemistry (HC) and immunohistochemistry (IHC) techniques
and incorporated into a quantitative morphological analysis would
improve the value of the International NB Pathology Classifica-
tion (62). As we will show later, chemotherapy and radiotherapy
are known to act on tumor cells as well as on stromal cells and
ECM elements (63, 64). As a consequence, injury to the ECM can
contribute directly to treatment resistance, creating niches of resis-
tant tumor cells (64, 65). Furthermore, damage to DNA induces
the production of cytokines and growth factors by stromal cells,
this triggers inflammation, cell survival, and tumor progression,
thus the effect of therapy on ECM may be to promote relapse or
chemoresistance (66, 67). We hypothesize that studying the dif-
ferent elements of the ECM, as one of the main contributors to
biotensegrity, through objective morphometric analysis and the
creation of mathematical networks of histologic sections stained
with HC and IHC, can shed light on how biotensegrity influences
tumor microenvironment and could provide clues to its action
mechanism.
EVIDENCES OF ECM BIOTENSEGRITY CHANGES IN
MALIGNANT TISSUE
It is known that tumor cells alter the mechanical properties of
the microenvironment in order to create favorable conditions for
their proliferation and/or dissemination (68). In addition, adhe-
sion molecules such as E-cadherin are involved in the processes of
tissue differentiation and morphogenesis and play an important
role in modulating the invasiveness of tumor cells in breast cancer
and other epithelial tumors (69). For instance, the reciprocal com-
munication between the stromal cells and the tissue parenchyma
directs gene expression, and in prostate carcinoma and breast car-
cinoma, the oncogenic potentiality arises from stroma-associated
fibroblasts, immune response, and the alterations of biotenseg-
rity (49, 70). Deregulation and disorganization of the composi-
tion, structure, and stiffness of the ECM elements progressively
increase interstitial fluid pressure, leading to limited penetration
and dissemination of therapeutic agents within solid tumors, thus
enabling the creation of niches within tissues and organs that
offer sanctuary to tumors and activate therapy resistance programs
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(11–13, 64, 65). Tumor cells are not the only cells that change the
mechanical properties of the microenvironment. Despite all the
efforts of tumor cells to make ECM elements work for their sur-
vival and proliferation, tumor stromal cells, specifically, immune
system cells, try to reverse the pathological condition. Indeed,
two lymphoproliferative syndromes (follicular lymphoma and
Hodgkin lymphoma) are good examples of the fact that a tumor
can be considered as functional tissue, connected and dependent
on the microenvironment, which sends and receives signals to and
from the tumor tissue itself. In such syndromes, tumor microen-
vironment stromal cells, including immune response, determine
the morphology, clinical stratification, aggressiveness, prognosis,
and response to treatment of the tumor (71).
In the next two sub-sections, we describe the methods devel-
oped for the study of biotensegrity in neuroblastic tumors.
MORPHOMETRIC ANALYSIS OF ECM ELEMENTS – AN EXAMPLE IN NB
Accurate quantification of pathology specimens using imaging
technology to analyze the variations in structural tissue that arise
from interactions between tumor and stroma cells and ECM ele-
ments is providing important information. This approach would
allow biotensegral patterns to be included in computational for-
mulations for risk stratification systems and aid in designing better
anti-cancer treatment strategies (29). However, the validity of
the model depends on the quality of the data. This quantifi-
cation depends on the staining, scanning, image analysis, and
statistical evaluation. For that purpose, automatic stained sections
must be digitized using microscopic preparation scanners such as
Aperio Scanscope XT (Aperio technologies) or Panoramic Midi
(3Dhistech) or with a photomicroscope if a scanner is not avail-
able. Different image analysis systems can be used, such as Image
Pro-plus software (Media cybernetics), ImageScope (Aperio tech-
nologies),Panoramic viewer (3D Histech), free software (ImageJ of
the NIH), or self-designed software to obtain customized macros
or algorithms (informatic protocols) to detect and characterize
the quantity (number of objects and area occupied), size (area,
width, length), shape (aspect, roundness, perimeter ratio, frac-
tal dimension), and orientation (angle), among other parameters,
of the ECM elements of interest. All systems provide mark-up
images or masks, which represent the recognized and measured
element in white upon a black background. The use of tissue
microarrays is advised for standardization purpose of background
subtraction and color segmentation, given that these techniques
tend to be dependent of the intensity of the staining and algo-
rithms must be recalibrated with every change of intensity/ground
noise/contrast staining, thus losing objectiveness. Further details
regarding objective quantification of different cell and ECM ele-
ments and a flowchart of the analysis used by our group, are
described elsewhere (50).
Neuroblastic cells are known to be committed in a complex
interaction with the surrounding tumor microenvironment and
we believe that patients with neuroblastic tumors, specifically those
still subject to therapeutic failure despite current knowledge, could
benefit from novel therapeutic strategies which could originate
from the study of ECM biotensegrity. To investigate such new
therapeutic targets, we have objectively quantified Ret F, Col I
F, GAGs (Gomori, Masson’s trichrome, and Alcian blue pH 2.5
HC, respectively), blood vessels (CD31 IHC, Dako), lymph vessels
(D2-40 IHC, Dako), and cell markers, including leukocyte lin-
eage (CD45/LC IHC, Dako) and NB cells, in primary NB. A first
approach to the evaluation of the role of ECM biotensegrity in neu-
roblastic tumors is the observation of the mark-up images of tissue
microarrays cylinders comprising a mixture of tumor and normal
tissue either in the primary and/or metastatic location. In the par-
ticular case presented in Figure 2, included for illustrative purpose,
a clear disruption in the organization of the ECM elements can be
observed when passing from the normal tissue area to the neoplas-
tic tissue. In the tumor area, Ret F becomes disorganized, Col I F
is slightly increased (although minimal), GAGs almost disappear,
CD45 reactive cells accumulate, and blood vessels vary in size and
characteristics.
Statistical analysis of the quantitative data of fibers, GAGs,
tumor cells, and immune system markers compared with the
current parameters used to predict risk of relapse (stage, age,
histopathology, state of MYCN oncogene, state of 11q region,
overall genomic profile, and ploidy) (72–74) and other genetic
markers of prognostic interest in a subset of 78 primary neu-
roblastic tumors has already been published by our group, and
highlights the interest of studying ECM in neuroblastic tumors
(50). The fact that ECM elements differ depending on the char-
acteristics of the tumors and, more interestingly, the fact that the
characteristics of ECM elements are related to prognosis (relapse
or overall survival) advocates on behalf of the regulatory role of
ECM biotensegrity in tumor progression.
DEVELOPMENT OF MATHEMATICAL TOPOLOGY OF ECM
ELEMENTS – AN EXAMPLE IN NB
The combination of multidisciplinary efforts by clinicians, biol-
ogists, pathologist, bioengineers, and biostatisticians could eluci-
date how ECM elements interact with tumor and stromal cells. In
this respect, a new and interesting approach is to analyze biopsies
by converting the tissue into a mathematical network of cell-to-cell
contacts (75–78). Using graph theory concepts, these networks can
provide organizational information that seems relevant in embry-
ologic development and disease. For example, this method has
been applied to the analysis of neuromuscular diseases, serving
as a diagnostic tool able to quantify the severity of the pathology
in a muscle biopsy (77). We propose that this technology can be
adapted to the analysis of tumor biopsies. It is already possible to
compare different mark-up images obtained from the analysis of
several markers which have been assessed on serial thin sections
with preserved histology. These overlapping images enable sev-
eral markers to be considered at the same time and allow the
co-location and study of the interaction between continuous ten-
sional elements and discontinuous compression elements. In this
regard, we have analyzed the relationship between different biopsy
components taking the cell nuclei as a reference. The procedure
is based in the identification of the cell nuclei and the calcula-
tion of their respective centroids. These centroids serve as seeds
to perform a Voronoi diagram of Voronoi cells (79, 80). A new
partitioned image is produced in which each nuclei is associated
with its corresponding Voronoi cell. In this way, it is possible to
construct a network based on the neighboring Voronoi cells. Topo-
logical approaches and the use of Voronoi cells need to be able
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FIGURE 2 |Tissue microarray cylinders representing an adrenal
gland infiltration by a poorly differentiated neuroblastoma.
Hematoxylin and eosin staining of (A) adrenal gland and (A’) tumor
tissue. (B–F) Several histochemical and immunohistochemical
stainings of extracellular matrix elements and (B’–F’) their
corresponding mark-up images after image analysis are shown. The
cylinder tissue was stained with (B) Gomori for Ret F, (C) Masson’s
trichrome for Col I F, and (D) Alcian blue pH 2.5 for GAGs; and
immunostained with (E) anti-CD45 for leukocyte-common antigen and
(F) anti-CD31 for Blood vessels. Tumors tend to disrupt the topology of
the ECM of the organ in which they settle, producing changes in
biotensegrity. AG, antigen.
to capture the presence and relative disposition of tissue hetero-
geneities derived from, for example, the luminal space of glands,
blood and lymph vessels, or larger extracellular spaces. They will
be reflected through different characteristics and will be taken into
account for the study, testing if they can be part of the relevant fea-
tures that define a specific condition. The selection of regions of
interest in each biopsy will allow studying only tumor tissue areas
without artifacts that could bias the study, leading to wrong con-
clusions. The combination of graph-related parameters with the
morphometric information will enable a comprehensive analysis
of the changes arising from different compression forces in rela-
tion to the different types of ECM (stiff/soft, organized/chaotic)
in combination with the tumor stroma cells such as immune cell
infiltrates. We have performed preliminary comparisons based
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FIGURE 3 | Network construction from a NB biopsy image. (A) Gomori
staining to visualize Ret F and nuclei from the NB biopsy. (B) Combination
of nuclei (green) and Ret F mark-up images obtained from (A). The white
circumference represents the region of interest processed in (C). (C) Each
nucleus (green) is taken as a seed to build a Voronoi diagram (red) of
Voronoi cells. This allows the creation of a network of cell-to-cell contacts
(black lines) that can be used to extract topological characteristics of the
tissue.
on the genetic features of NB using Ret F and blood vessels (in
addition to the nuclei) as the reference features for providing the
biological clues. This procedure has shown some hints of dis-
crimination regarding the organization and co-location of these
elements (Figure 3). We found that some network characteristics
were relevant to perform this initial separation. This suggests that
diverse backgrounds can respond differently to the pathological
process depending on the organization of the tumor. Following
the same approach, we will use other mark-up images of the posi-
tive cells stained with the different monoclonal antibodies against
the different cells of the leukocyte lineage. We hope that this com-
bination of mathematical and statistical methods will answer the
question on the relationships between ECM biotensegrity and the
changes mediated by the cell infiltrate.
EFFECT OF TREATMENT ON TUMOR MICROENVIRONMENT
AND CONSEQUENCES
There is much evidence that the lack of total specificity of can-
cer therapeutic agents (chemotherapy and radiotherapy) causes
collateral damage to the mechanical properties of the tumor
ECM and benign stromal cells (which were previously fighting
the tumor), creating resistance to therapy and favoring relapse
and metastasis. This fact becomes evident while analyzing post-
treatment biopsies, which contain a high degree of fibrosis and
calcification. Some studies have shown that cancer therapy can
sometimes damage tumor DNA and stromal cells, which results in
the secretion of a spectrum of proteins, including the Wnt fam-
ily members. For example, in prostate cancer, the expression of
this proteins in the tumor microenvironment, regulated by lymph
B cells, attenuates the effects of cytotoxic chemotherapy in vivo,
promoting tumor cell survival and disease progression (63, 81).
It has also been reported that in follicular lymphoma and dif-
fuse large cell lymphoma, treatment with lenalidomide affects
the immune synapses of intra-tumoral T lymphocytes (82). In
breast cancer, treatment with doxorubicin results in an increase in
fibuline-1, an ECM protein, and its binding proteins, fibronectin
and laminin-1, which constitute a source of chemoresistance (83)
and triggers overexpression of maspin protein, which induces the
accumulation of collagen fibers, thus causing disease progression
(84). A novel Toll receptor-9-dependent mechanism that initiates
tumor regrowth after local radiotherapy has also been reported
(85). Monoclonal antibodies against fibulin-1 are able to reverse
such chemoresistance, and the inhibition of MMP seems to have
a therapeutic effect (86).
An example of the effect of treatment in NB is shown in
Figure 4. When comparing a primary NB with its non-primary
sample, we can appreciate that Ret F, GAGs, and Col I F accu-
mulate in the ECM of the post-treatment sample. The amount
of blood macrovasculature is slightly decreased. All these findings
describe a stiffer ECM after multimodal treatment.
POTENTIALITY OF MECHANOTHERAPY
The changes exerted on ECM by therapeutic agents and the per-
spective of the epithelial–mesenchymal transition in epithelial
tumors have opened the door to a new line of treatment, which
considers the genetic and epigenetic mechanisms associated with
resistance to chemotherapy (59, 87). There is a need to personalize
therapeutics taking into account not only the features known to
have prognosis impact, but also new markers, such as the mechan-
ical stress of the tumor ECM elements. Indeed, because of its
importance to the tumor, the ECM represents an “Achilles heel”
that can be exploited in designing cancer therapy. The bionet-
work between the ECM and tumor cells is dynamic, and for every
action, such as exposure to genotoxic stress, there are reactions
and consequences throughout the micro and macrosystem (65).
Removal of ECM barriers will either have a direct negative effect on
tumor cells or facilitate anti-tumor immune responses and drug
treatment, through better intra-tumoral penetration and acces-
sibility to target cells. In this regard, a number of experimental
approaches are aimed toward the transient degradation or down
regulation of ECM proteins using injection of ECM-degrading
enzymes into the tumor or their intra-tumoral expression after
viral- or stem cell-based gene transfer (65). Other approaches
attempt to indirectly decrease tumor-associated ECM by killing
tumor stromal cells that produce ECM proteins (64) or aim
at enhancing the host immune response (88). The potentiality
of therapeutic agents to modify ECM can be turned around in
such a way that new chemicals can be applied to modify a given
ECM stiffness or composition into one shown to trigger a better
prognosis.
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FIGURE 4 | Changes in the ECM after treatment in one neuroblastic
tumor. Several stainings (HC and IHC) of (A–E) a primary neuroblastoma and
(A’–E’) its post-treatment biopsy are shown. The presented mark-up images
of (B,B’) Ret F, (C,C’) Col I F, and (D,D’) GAGs show that these ECM elements
are increased in NPNB. Regarding blood vessels (E,E’), the amount of does
not seem to change after treatment but the type of vessels has changed in
such a way that they are smaller in NPNB. The remodeling characteristics of
the ECM components, with different mechanical properties, are differentially
related to prognostically significant clinical and biological features in NB. The
percentages of stained area are indicated. PNB, primary neuroblastoma;
NPNB, non-primary neuroblastoma (after treatment); HE, hematoxylin and
eosin.
CONCLUDING REMARKS
Biotensegrity is the structural principle of mechanotherapy. Cells
are linked both to each other and to the ECM forming a mechan-
ical biotensegral system in homeostasis. Cell–cell junctions are
anchored to neighboring cells and focal adhesions to ECM, allow-
ing forces to cross via intra-cellular cytoskeletal and nuclear net-
works. These structures fluctuate, and the multiple responses
appear to strongly affect tissue remodeling and cell transfor-
mation. As described, normal organs tissue, primary NB, and
post-treatment NB have a different amount and topography of
biotensegral ECM elements. Conventional approaches have tra-
ditionally focused on the neoplastic cell. Moreover, an arsenal of
mechanotherapeutic approaches to enhance the efficacy of more
classical cancer therapeutics and overcome treatment resistance
has already been discovered. To achieve more effective person-
alized strategies, further studies should consider to improve the
definition of the interactions between tumor and stromal cells and
the ECM elements and vascular constituents of the tumor, as well
as their influence on treatment. We propose that integrating the
tumor topo-functional networks of the ECM elements with the
clinical, histopathology, and genetic information could provide
new information about the impact of biotensegrity on patient
care. Understanding the mechanical properties of tumor ECM
components, related to variations in quantity, degree of interfer-
ence, and types of organization, is key to defining new potential
mechanotherapeutic targets and agents.
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Abstract We recently identified vibrational spectroscopic
markers characteristic of standard glycosaminoglycan
(GAG) molecules. The aims of the present work were to
further this investigation to more complex biological systems
and to characterize, via their spectral profiles, cell types with
different capacities for GAG synthesis. After recording spec-
tral information from individual GAG standards (hyaluronic
acid, chondroitin sulfate, dermatan sulfate, heparan sulfate)
and GAG-GAG mixtures, GAG-defective mutant Chinese
hamster ovary (CHO)-745 cells, wild-type CHO cells, and
chondrocytes were analyzed as suspensions by high-
throughput infrared spectroscopy and as single isolated cells
by infrared imaging. Spectral data were processed and
interpreted by exploratory unsupervised chemometric
methods based on hierarchical cluster analysis and principal
component analysis. Our results showed that the spectral
information obtained was discriminant enough to clearly de-
lineate between the different cell types both at the cell suspen-
sion and single-cell levels. The abilities of the technique are to
perform spectral profiling and to identify single cells with
different potentials to synthesize GAGs. Infrared
microspectroscopy/imaging could therefore be developed for
cell screening purposes and further for identifying GAG mol-
ecules in normal tissues during physiological conditions (ag-
ing, healing process) and numerous pathological states (arthri-
tis, cancer).
Keywords Glycosaminoglycans . Chondrocytes . Chinese
hamster ovary cells . Infrared spectroscopy . Image analysis .
Data analysis
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Introduction
Proteoglycans (PGs) are ubiquitous major macromolecules of
extracellular matrices, cell surfaces, and some intracellular
granules [1]. They exhibit an architectural role and maintain
the integrity of the tissue. PGs are composed of a glycoprotein
core to which one or several sulfated glycosaminoglycan
(GAG) chains are attached by covalent linkage. GAGs are
expressed in a spatially and temporally regulated manner [2].
The structure and abundance of GAG chains vary according to
the tissue, cell types, developmental states, and regulatory
signals received from soluble factors [3].
Physicochemical analysis of GAGs from tissue sections
was first reported for hyaluronic acid (HA) and chondroitin
sulfate (CS) [4, 5], for CS/dermatan sulfate (DS) [6], and for
keratan sulfate (KS) [7, 8]. These studies involved ion pairing
chromatography and mass spectrometry applied to enzyme
digest solutions. The chemical analysis of such preparations is
therefore a tedious task accomplished by enzymatic depoly-
merization of the chain with specific bacterial enzymes
followed by disaccharide analysis by high-performance liquid
chromatography, capillary electrophoresis, or fluorophore-
assisted carbohydrate electrophoresis [9, 10].
Methods were developed to analyze GAGs from small
tissue quantities. Considering the heterogeneity of normal
tissue and the cell microenvironment, a profiling method for
GAG applicable to the histological scale was recently devel-
oped [11]. To better understand the roles of GAGs in physi-
ology and pathophysiology, it is important to be able to
determine the structures of GAGs from a small quantity of
tissue but even better at the cell scale according to the cell
phenotype.
We previously showed that infrared (IR) and Raman
microspectroscopies are sensitive enough to characterize, dif-
ferentiate, and classify types and subtypes of GAGs despite
their close molecular structures [12, 13]. The first IR spectra of
GAGs were published more than 50 years ago [14]. IR phys-
icochemical characterization of isolated GAGs was described
[15–24]. In terms of structural and compositional analysis, IR
spectroscopy is able to give a complete “molecular finger-
print” of the studied sample. It is highly sensitive to the
structure, composition, and environment of the molecules
constituting the studied specimen. Furthermore, this
biophotonic method is rapid, non-destructive, and non-
contact and does not require external markers. The association
of spectroscopy with powerful data analytical methods gives
more insight into the interpretation of the spectral information
and molecular-level phenomena. When coupled with a
microscope, vibrational microspectroscopies become highly
sensitive methods capable of probing at the micron level, thus
necessitating only small amounts of sample.
With the use of chemometric methods, such as hierarchical
cluster analysis (HCA) and principal component analysis
(PCA), some characteristic spectral regions and bands were
identified, which could be used to well characterize standard
GAGs by vibrational microspectroscopy [12, 13]. These re-
sults could be extremely useful for performing quality tests on
GAG samples. Moreover, vibrational microspectroscopy was
shown to be both qualitative and quantitative. Therefore, the
aim of this study was to apply infrared spectroscopy and
imaging to get in a first step the spectroscopic signatures of
molecular mixtures of different GAGs and in a second step
those of cells expressing different levels of GAG molecules,
both in suspensions and in isolated single cells.
Cartilage chondrocytes are the cells with the highest capac-
ity for GAG synthesis. Cartilage plays an important role as a
shock absorber and space holder in living organisms [25].
These physical properties are closely connected with its mo-
lecular structure and intermolecular interactions between
polymeric components, such as GAGs. The swelling of carti-
lage is based on the binding of water to polar groups of GAGs
(carboxylate, sulfate), on the electrostatic repulsion between
GAG molecules and entropic contributions resulting from the
mixing of water and counterions [14]. HA and CS belong to
the most important GAG molecules present in cartilage. The
CHO-745 cell line, lacking xylosyl transferase, is the only
known mutant deficient in the synthesis of CS and heparan
sulfate (HS) [26] which results in a decreased amount of
GAGs in these cells, compared to the wild-type CHO
(CHO-WT). In the present work, we first report IR spectros-
copy of major types of GAGs, i.e., HA, heparin (HEP), HS,
C4S, C6S, and DS. We next determined the mean IR spectra
of CHO-745, CHO-WT, and chondrocyte cells in suspension
and performed IR imaging of single cells. Spectral data were
analyzed by HCA and PCA chemometric methods in order to
characterize these cell types exhibiting from low to high levels
of GAG synthesis.
Materials and methods
GAG samples
Six standard glycosaminoglycans (Table 1) were analyzed. In
our previous study, the range of the concentrations of these
standard GAG solutions was defined [13]. Each GAG was
solubilized in sterilized water at 1 mg/mL concentration. For
infrared imaging, one drop of 3 μL for each GAG (or their
mixtures) was deposited in three replicates on a calcium
fluoride substrate, transparent to infrared radiation, and dried
at room temperature.
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Cell culture
In this study, three cell cultures were carried out: two cell lines,
CHO-WT (CHO-K1, ATCC® CCL-61TM) and CHO mutated
cells lacking xylosyl transferase (CHO-745, ATCC® CRL-
2242TM), and one primary culture of human chondrocytes.
Chondrocytes and CHO cells were grown in DMEM/F-12
medium (Dulbecco’s Modified Eagle Medium: Nutrient Mix-
ture F-12, Gibco, Invitrogen, France) supplemented with an
antifungal agent (Amphotericin B, Gibco, Invitrogen, France).
Cultures were maintained at 37 °C in a humidified atmosphere
containing 5 % (v/v) CO2. Cells were detached at 80 % of
confluency with 0.5 % trypsin/EDTA (Invitrogen). Cells in
suspension were centrifuged at 420g for 3 min, then pellets
were resuspended. Cell viability was assessed by trypan blue
exclusion assay. For infrared high-throughput analysis, 5 μL
of cell suspension (1×105 cells/5 μL) was deposited in five
replicates on a silicon 384-well optical substrate and air-dried
at room temperature. For infrared imaging, the three different
cell types were plated on a calcium fluoride substrate at 1.5×
104 cells/mL and allowed to adhere. After 24 to 48 h, CaF2
substrates were removed from the culture medium andwashed
three times with Dulbecco’s phosphate buffer saline (DPBS).
Cell fixation was performed using 4 % paraformaldehyde for
30min at room temperature. Cells were rinsed with DPBS and
distilled water to remove PFA, then air-dried.
High-throughput infrared analysis of cells in suspension
Cells in suspension were deposited on the silicon sample
plate, dried, and placed in the high-throughput screening
HTS-XT extension (Bruker Optics GmbH, Ettlingen, Germa-
ny) which was coupled to a Tensor 27 (Bruker Optics GmbH)
spectrometer (see Electronic Supplementary Material (ESM)
Fig. S1a). Fourier transform infrared (FTIR) measurements
were performed in transmission mode and were recorded at a
spectral resolution of 4 cm−1 using 64 scans in the spectral
range 4,000-400 cm−1 (OPUS v6.5 software, Bruker Optics
GmbH, Ettlingen, Germany). Before each sample measure-
ment, a background was taken in the same conditions and
subsequently subtracted automatically.
Infrared imaging of GAG dried drops and single cells
IR images were acquired in transmission mode using the
PerkinElmer Spectrum Spotlight 400 imaging system
(Courtaboeuf, France) at a spatial resolution of 25 μm/pixel
for GAG drops and 6.25 μm/pixel for cells (see ESM,
Fig. S1b). The spectral range 4,000-800 cm−1 was used at a
spectral resolution of 4 cm−1. Sixteen and 128 scans were
averaged for GAG drops and for single cells, respectively. The
raw spectra were subjected to atmospheric correction algo-
rithm to compensate for water vapor and CO2 contributions
(Spectrum-Image, version 1.6, PerkinElmer).
Spectral images of GAG samples were taken across the
diameter of each drop, and all spectra were averaged. For
fixed cells, spectral images were taken of the whole single
cell and all spectra were averaged after removing spectral
contribution from the CaF2 substrate.
Data analysis
Spectra were preprocessed with the OPUS 6.5 software
(Bruker Optics GmbH, Ettlingen, Germany). The following
procedures were used: baseline correction, spectral averaging,
second derivative, and vector normalization. Preprocessed
spectral data sets were analyzed by two unsupervised explor-
atory methods: HCA and PCA. HCA is a method of cluster
analysis that seeks to construct a hierarchy of clusters. It gives
the heterogeneity between spectra by calculating the distance
between them. This constitutes the linkage criterion, and the
most common distance measured is the Euclidean distance or
the squared Euclidean distance. Another criterion is the meth-
od used for cluster combination. The agglomerative method
based on the closest neighbor principle (Ward’s algorithm)
was used for FTIR data. Therefore, HCA groups spectra
according to their similarities and the final representation is
a dendrogram. HCA was performed using the OPUS 6.5
software (Bruker Optics GmbH).
PCA is a statistical procedure which, via an orthogonal
transformation, converts a set of observations of possibly
correlated variables into a set of values of linearly uncorrelated
variables called principal components (PCs). In this case, the
first principal component carries the largest possible variance
Table 1 Description of the stan-
dard GAG molecules used Glycosaminoglycans Abbreviation Species Tissue Supplier
Hyaluronic acid HA Undefined Undefined MP Biomedicals
Chondroitin-4-sulfate C4S Whale Cartilage Sigma
Chondroitin-6-sulfate C6S Shark Cartilage Sigma
Dermatan sulfate DS Undefined Undefined Celsus
Heparan sulfate HS Undefined Undefined Celsus
Heparin HEP Undefined Undefined US Biomedical
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in the data and each succeeding component in turn has the
highest variance possible. PCA reveals the internal structure
of the data in a way that best explains the variance in the data.
It is a common algorithm used to reduce high-dimensional
data such as spectroscopic data and to represent them in the
new space composed of the principal components. The dis-
crimination between spectral data can be observed using the
scores of the PCs and represented via 2D or 3D scatterplots.
PCA was performed using an in-house routine built in the
MATLAB software (MathWorks, Natick, MA, USA).
Results and discussion
Infrared microspectroscopy of GAG mixtures
Each GAG molecule (HA, HS, HEP, DS, C4S, C6S) was
analyzed independently in the form of a dried drop using
infrared microspectroscopy. The representative spectrum of
each GAG was calculated by averaging all spectra across the
drop diameter (see ESM, Fig. S2). The spectral window
1,800–900 cm−1 was used because this range was found to
be most specific for individual GAG molecules in our previ-
ous studies [13]. The bands near 1,610 and 1,410 cm−1 were
assigned, respectively, to the presence of the planar –COO−
group antisymmetric and symmetric vibrations in the C6 po-
sition of the disaccharide unit of uronic acid. The band around
1,250 cm−1 corresponded to the sulfate group (SO3
−) antisym-
metric vibration present in GAG except for hyaluronic acid
which is a non-sulfated GAG. For this vibration, the most
intense band was attributed to HEP and the least one to HS.
The region covering the range 1,100–1,000 cm−1 was associ-
ated to the vibrations of saccharide molecular links corre-
sponding to C–O–C, C–C–C, and C–C–O stretchings of the
pyranose ring structures of the GAG molecules [27].
The arithmetic mean spectrum was computed using the six
representative spectra. Then, the six solubilized GAG mole-
cules were mixed and the resulting solution was analyzed in
the form of dried drops. When the mean spectrum of the
mixture was compared to the arithmetic mean spectrum (see
Fig. 1), there was no discernable difference between the two
mean spectra, indicating an absence of interactions between
the GAG molecules.
Characterization of GAGs in cells in suspension
by high-throughput FTIR spectroscopy
Taking into account the characteristic spectral information
obtained with individual GAG molecules and GAG mixtures,
Fig. 1 FTIR spectroscopy of GAG mixtures. Comparison between the
mean spectrum of a mixture of six glycosaminoglycan standards (pink
curve) and the arithmetic sum of the spectra of the six GAGs (black dotted
curve) in the spectral range 1,800–900 cm−1. The six GAG standards used
were hyaluronic acid, heparan sulfate, heparin, dermatan sulfate, chon-
droitin-6-sulfate, and chondroitin-4-sulfate. Bands are tentatively
assigned to their corresponding chemical group vibration. υ stretching,
as antisymmetric, s symmetric vibrations
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we have undertaken measurements to characterize cells capa-
ble of synthesizing GAGs from very low to high levels, i.e.,
CHO-745, CHO-WT, and chondrocytes. In Fig. 2a, we com-
pared the normalized mean FTIR spectrum of these cell types
obtained from cells in suspension. Visually, the spectral pro-
files of CHO-745, CHO-WT, and chondrocytes were quite
similar in the 1,800–900-cm−1 spectral range, with, however,
some veryminor modifications for chondrocytes in the 1,200–
900-cm−1 spectral range (saccharide absorption region).
The cell suspension spectra of CHO-745, CHO-WT, and
chondrocytes were analyzed by the HCA multivariate
statistical analysis. This method was performed on all second
derivative spectra (n=5) for each cell suspension in the 1,200–
900-cm−1 spectral range. The five spectra of each cell suspen-
sion were grouped in the same cluster and exhibited a low
degree of heterogeneity, indicating a good reproducibility of
the measurements and, therefore, a low intra-group variability.
The inter-group variability was sufficiently high to distinguish
the three cell types (Fig. 2b). The dendrogram also revealed
that the variability between CHO-745 and CHO-WT was
lower than the variability between the two CHO types and
the chondrocytes. The clear-cut classification using the second
Fig. 2 Data processing of infrared spectra from high-throughput analysis
of cells in suspension. a Comparison between the mean spectra of CHO-
745 (red curve), CHO-WT (blue curve), and chondrocytes (green curve)
in suspension in the spectral range 1,800–900 cm−1. Each mean spectrum
is an average of five replicate spectra. b Hierarchical cluster analysis
(HCA) of CHO-745, CHO-WTcell lines, and chondrocyte spectra. HCA
was calculated on second derivative spectra in the spectral range 1,200–
900 cm−1. All replicates of each cell type are well clustered together, and
each cell type is well discriminated. c 3D PCA score plot of different cell
suspension spectra CHO-745 (red circles), CHO-WT (blue crosses), and
chondrocytes (green triangles). PCAwas calculated on derivative spectra
in the spectral range 1,200–900 cm−1. All cell replicates are well grouped
together. Each cell type is well discriminated
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derivative spectra in the 1,200–900-cm−1 spectral range indi-
cated that chondrocytes differed from CHO types by their
spectral differences in the saccharide absorption region.
FTIR spectra were then analyzed by PCA to validate these
results. Figure 2c shows the PCA score plot of the three cell
types using the three first principal components carrying the
highest explained variance. The first principal component
(PC1) carried 83 % of the total variance and allowed clear
separation of CHO-745 and CHO-WT from chondrocytes.
These results also demonstrated that PC2, representing
9.1 % of the total variance, was discriminant enough to
separate between CHO-745 and CHO-WT.
When PCA was applied to the CHO-745 and CHO-WT
datasets only, only the first two PCs were enough to give a
good separation between the two cell types (see ESM,
Fig. S3a). PC1 carried the maximum explained variance
Fig. 3 Data processing of infrared spectra from a single-cell image. a
White light image (left) and corresponding spectral image built on the
total absorbance (right) of the same chondrocyte. A spectrum of the
whole single cell can be averaged from the spectral image (cf. dotted
rectangle). b Comparison between mean single-cell spectra of CHO-745
(red curve), CHO-WT (blue curve), and chondrocytes (green curve) in
the spectral range 1,800–900 cm−1. Each mean spectrum is an average
calculated from five single-cell images. c HCA analysis of single-cell
spectra of CHO-745, CHO-WT, and chondrocytes. HCAwas calculated
on second derivative spectra in the spectral range 1,200–900 cm−1. All
replicate spectra of each single cell are well clustered together, and each
cell type is well discriminated. d 3D PCA score plot of different single-
cell spectra of CHO-745 (red circles), CHO-WT (blue crosses), and
chondrocytes (green triangles). PCAwas calculated on derivative spectra
in the spectral range 1,200–900 cm−1. All replicate spectra are well
grouped together. Each cell type is well discriminated
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(71.8 %) between these two cell types. PCA therefore con-
firmed the results obtained with HCA, i.e., cells with different
capacity for GAG synthesis can be clearly delineated. In the
same way, Fig. S3b shows a good discrimination between
CHO-WT and chondrocytes. PC1, explaining the maximum
of the explained variance (92.3 %), was discriminant enough
to differentiate the two cell types. Thus, PCA can discriminate
cell types with low and high ability to synthesize GAGs.
Characterization of GAGs in single cells by FTIR imaging
After the evidence obtained above with cells in suspension,
we wanted to transpose the experiments to the single-cell level
and verify our working hypothesis that the cell types can be
distinguished. FTIR micro-imaging of single cells was carried
out on the individual cells grown on specific substrates, fixed,
and then dried before analysis. First, a white light image of the
cell was taken to localize it on the substrate and to determine
the acquisition zone for imaging (Fig. 3a, left panel). After
acquisition, a pseudo-color spectral image of the cell (Fig. 3a,
right panel) was obtained based on the total absorbance, with a
color coding going from black (lowest absorption) to white
(highest absorption). In this spectral image, each pixel element
of 6.25 μm contained a spectrum and the dotted line indicated
the area selected to calculate an average spectrum of the
imaged cell.
For each cell type, five individual cells were imaged and
their corresponding average spectra, computed as explained
earlier, were compared (Fig. 3b). It can be noticed that the
mean spectra of CHO-745 and CHO-WT were very similar.
On the other hand, for chondrocytes, the spectral changes
depicted mainly in the 1,200–900-cm−1 range (saccharide
absorbing region) were more marked than those of cells in
suspension. Further analysis by HCAwas performed on aver-
age spectra of each cell type using the 1,200–900-cm−1 spec-
tral range. It can be observed that, as for cells in suspension,
the mean spectra of the same cell type were grouped in the
same cluster, indicating the low level of heterogeneity be-
tween the micro-FTIR spectra of the same cell type. The
inter-group variability allowed separating the different cell
types (Fig. 3c). The classification showed a slightly higher
intra-group variability and a lower inter-group distance be-
tween CHO-745, CHO-WT, and chondrocytes as compared to
data from cells in suspension.
The cell-typing potential of FTIR at the single-cell level
was confirmed by the PCA on the three cell types (Fig. 3d).
The PCA score plot was built using the three PCs with the
highest explained variance. The outcome of the score plot
showed that the average spectra of each cell type were
Fig. 4 Identification of GAG spectral profiles from single cells. Com-
parison between mean second derivative spectra of the mixture of six
GAG standards and CHO-745 (red curve), CHO-WT (blue curve), and
chondrocytes (green curve) in the spectral range 1,800–900 cm−1. The six
GAG standards (black curve) used were hyaluronic acid, heparan sulfate,
heparin, dermatan sulfate, chondroitin-6-sulfate, and chondroitin-4-sul-
fate. Each mean spectrum was the average of five cells
Infrared glycosaminoglycan profiling in cells
grouped together. The first PC carrying 87.8 % of the total
variance allowed separating CHO-745 and CHO-WT from
chondrocytes. CHO-745 and CHO-WT could be well distin-
guished with the variance carried by principal component 2
(5.7 %).
PCA computation of the CHO-745 and CHO-WT data sets
gave a good separation between these two cell types, with PC1
carrying the maximum explained variance (82.6 %) between
the two groups (see ESM, Fig. S3c). Further, CHO-WT and
chondrocytes were well separated (see ESM, Fig. S3d), with a
maximum of explained variance for PC1 (93 %). PCA results
confirmed that FTIR spectroscopy could apparently discrim-
inate, at the single-cell level, different cell types with varying
potentials for GAG synthesis. This clustering between CHO-
745 versus CHO-WT and CHO-WT versus chondrocytes
confirmed the findings obtained with the cells in suspension.
In an attempt to find the spectral signature of GAG mole-
cules at the individual cell level, we compared the mean
spectra of CHO-745, CHO-WT, and chondrocytes with that
of the GAG mixture. For this, all mean spectra underwent a
second derivative to increase the spectral differences. The
comparison between the three cell types with different capac-
ities for GAG synthesis should allow the removal of the
cellular contribution in the FTIR spectrum and to possibly
identify the spectral information originating from GAGs.
Figure 4 shows the spectral comparison, at the single-cell
level, between the different cell types, CHO-745, CHO-WT,
chondrocytes, and the mixture of the six GAGs. Two zones
can be highlighted: zone A and zone B for protein and sac-
charide absorption regions, respectively. In zone A, mean
derivative spectra of three cell types show many distinct
bands. The three profiles looked very similar and are attribut-
ed to the cellular profile. In zone B, spectra of CHO-745 and
CHO-WTexhibited very similar profiles and very small bands
while the chondrocyte spectrum showed some bands that
seem to correspond with those of the GAG mixture in the
same spectral zone.
These results tend to point out that by using the saccharide
absorbing region as a marker region, FTIR imaging could help
to identify, via the spectral profile of single cells, those that
exhibit the potential to synthesize GAG molecules.
Indeed, our previous studies on GAG standards by infrared
and Raman microspectroscopies allowed the identification of
characteristic bands specific to their conformation [12, 13].
However, it is difficult to determine the GAG conformation in
a complex biological system like a cell compared to GAG
standards. Most conformational studies on GAG standards
showed that these molecules exhibit a high flexibility [28,
29]. Further works are required to analyze the secreted GAGs
in the cell medium in order to identify them, but again, the
conformation will be different from that adopted in the cell.
Raman microspectroscopy is foreseen as a promising ap-
proach for characterizing these cells in live conditions and
with higher spatial resolution. In addition, the development of
the nanoparticle-based SERS approach using antibody-
directed techniques could be a specific tool in particular for
probing cell surface GAGs [30].
Conclusions
In this study, we have applied high-throughput FTIR spec-
troscopy and FTIR imaging to investigate cell suspensions
and single cells, respectively, with the aim of verifying wheth-
er it was possible to identify, at both levels, cells with different
capacities of synthesizing GAGs. Based on the spectral pro-
files obtained from cell suspensions and cell images, there was
a clear-cut difference between the different cell types. Thus, it
was possible, via the use of two different chemometric clus-
tering approaches, to distinguish between the CHO-WT cell
line and its mutant counterpart, CHO-745, lacking xylosyl
transferase. The inter-group differences were more marked
when the latter two cell lines were compared to the primary
culture from human chondrocytes. Our findings suggest that
FTIRmethodology can be a useful approach for screening and
identifying cells that exhibit the capacity for GAG synthesis.
Furthermore, the method is rapid, non-destructive, non-
contact, and label-free. Taking into account the importance
of GAGs in the biomedical field, it will be challenging and
further work is needed to transpose the methodology to tissue
analysis in order to identify GAG molecules in normal tissues
and during pathophysiological conditions (aging, healing, and
numerous pathological states).
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